0001333493-13-000082.txt : 20131108 0001333493-13-000082.hdr.sgml : 20131108 20131108144956 ACCESSION NUMBER: 0001333493-13-000082 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20130930 FILED AS OF DATE: 20131108 DATE AS OF CHANGE: 20131108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: eHealth, Inc. CENTRAL INDEX KEY: 0001333493 STANDARD INDUSTRIAL CLASSIFICATION: INSURANCE AGENTS BROKERS & SERVICES [6411] IRS NUMBER: 770470789 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33071 FILM NUMBER: 131204209 BUSINESS ADDRESS: STREET 1: 440 EAST MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-584-2700 MAIL ADDRESS: STREET 1: 440 EAST MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 10-Q 1 ehth-20130930x10q.htm 10-Q 192be20c932b4b4

 

 

 

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

WASHINGTON, D.C. 20549 

 

 

 

FORM 10-Q

 

þ     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

 

For the quarterly period ended September 30, 2013 

 

OR 

 

¨  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

 

For the transition period from                 to 

 

001-33071 

(Commission File Number)  

_____________________________________________ 

EHEALTH, INC. 

(Exact name of registrant as specified in its charter) 

_____________________________________________

 

 

 

 

 

 

 

Delaware 

(State or other jurisdiction of 

incorporation or organization)

 

56-2357876 

(I.R.S Employer  

Identification No)

440 EAST MIDDLEFIELD ROAD 

MOUNTAIN VIEW, CALIFORNIA 94043 

 (Address of principal executive offices) 

 

(650) 584-2700 

(Registrant’s telephone number, including area code) 

 

Not Applicable 

(Former name, former address and former fiscal year, if changed since last report) 

____________________________________________________________ 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES x NO ¨ 

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulations S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  YES x NO ¨ 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

 

 

 

 

Large accelerated filer         ¨

 

Accelerated filer                  x

Non-accelerated filer          ¨

 

Smaller reporting company ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  YES ¨ NO x 

 

The number of shares of the registrant’s common stock, par value $0.001 per share, outstanding as of October  31, 2013 was  18,621,347 shares. 

 

  

 

 

 

 


 

EHEALTH, INC. FORM 10-Q 

TABLE OF CONTENTS

 

 

 

 

 

 

PART I FINANCIAL INFORMATION

PAGE

 

 

 

Item 1.

Financial Statements (unaudited)

1

 

Condensed Consolidated Balance Sheets at December 31, 2012 and September 30, 2013

1

 

Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September  30, 2012 and 2013

2

 

Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2012 and 2013

3

 

Notes to Condensed Consolidated Financial Statements

4

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

13

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

34

Item 4.

Controls and Procedures

35

 

 

 

 

PART II OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings

36

Item 1A.

Risk Factors

37

Item 6.

Exhibits

64

 

Signatures

65

 

  

 

 

 

 


 

PART I 

FINANCIAL INFORMATION 

 

 

 

ITEM 1.

FINANCIAL STATEMENTS

 

 

EHEALTH, INC. 

CONDENSED CONSOLIDATED BALANCE SHEETS 

(In thousands)  

 

 

 

 

 

 

 

 

 

December 31, 2012

 

September 30, 2013

Assets

(1)

 

(unaudited)

Current assets:

 

 

 

 

 

Cash and cash equivalents

$

140,849 

 

$

97,751 

Accounts receivable

 

4,468 

 

 

6,599 

Deferred income taxes

 

4,098 

 

 

7,115 

Prepaid expenses and other current assets

 

6,643 

 

 

6,720 

Total current assets

 

156,058 

 

 

118,185 

Property and equipment, net

 

6,185 

 

 

10,677 

Deferred income taxes

 

2,928 

 

 

4,198 

Other assets

 

8,123 

 

 

6,082 

Intangible assets, net

 

8,911 

 

 

7,850 

Goodwill

 

14,096 

 

 

14,096 

Total assets

$

196,301 

 

$

161,088 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities and stockholders’ equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

$

6,123 

 

$

4,230 

Accrued compensation and benefits

 

8,244 

 

 

10,764 

Accrued marketing expenses

 

3,941 

 

 

3,746 

Deferred revenue

 

926 

 

 

4,353 

Other current liabilities

 

1,575 

 

 

2,969 

Total current liabilities

 

20,809 

 

 

26,062 

Non-current liabilities

 

4,625 

 

 

6,222 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Common stock

 

27 

 

 

28 

Additional paid-in capital

 

232,903 

 

 

246,190 

Treasury stock, at cost

 

(90,991)

 

 

(149,998)

Retained earnings

 

28,743 

 

 

32,424 

Accumulated other comprehensive income

 

185 

 

 

160 

Total stockholders’ equity

 

170,867 

 

 

128,804 

Total liabilities and stockholders’ equity

$

196,301 

 

$

161,088 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

  

1 

 


 

 

 

EHEALTH, INC. 

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME 

(In thousands, except per share amounts, unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

 

 

 

 

 

 

 

 

 

 

Commission

$

31,291 

 

$

36,000 

 

$

93,358 

 

$

109,193 

Other

 

6,295 

 

 

6,008 

 

 

16,810 

 

 

15,822 

Total revenue

 

37,586 

 

 

42,008 

 

 

110,168 

 

 

125,015 

Operating costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

1,099 

 

 

806 

 

 

3,538 

 

 

4,441 

Marketing and advertising

 

13,988 

 

 

14,852 

 

 

39,142 

 

 

43,448 

Customer care and enrollment

 

8,823 

 

 

8,936 

 

 

21,152 

 

 

23,914 

Technology and content

 

5,503 

 

 

9,117 

 

 

16,018 

 

 

23,585 

General and administrative

 

6,744 

 

 

7,540 

 

 

19,938 

 

 

22,191 

Amortization of intangible assets

 

354 

 

 

354 

 

 

1,261 

 

 

1,061 

Total operating costs and expenses

 

36,511 

 

 

41,605 

 

 

101,049 

 

 

118,640 

Income from operations

 

1,075 

 

 

403 

 

 

9,119 

 

 

6,375 

Other income (expense), net

 

 

 

(22)

 

 

41 

 

 

(68)

Income before provision for income taxes

 

1,079 

 

 

381 

 

 

9,160 

 

 

6,307 

Provision for income taxes

 

874 

 

 

207 

 

 

4,525 

 

 

2,626 

Net income

$

205 

 

$

174 

 

$

4,635 

 

$

3,681 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share:

 

 

 

 

 

 

 

 

 

 

 

Basic

$

0.01 

 

$

0.01 

 

$

0.24 

 

$

0.19 

Diluted

$

0.01 

 

$

0.01 

 

$

0.23 

 

$

0.18 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average number of shares used in per share amounts:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

19,970 

 

 

18,436 

 

 

19,711 

 

 

19,310 

Diluted

 

20,750 

 

 

19,096 

 

 

20,563 

 

 

19,912 

 

 

 

 

 

 

 

 

 

 

 

 

Comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

Net income

$

205 

 

$

174 

 

$

4,635 

 

$

3,681 

Foreign currency translation adjustment

 

 

 

(7)

 

 

 

 

(25)

Comprehensive income

$

208 

 

$

167 

 

$

4,636 

 

$

3,656 

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

  

 

2 

 


 

 

 

EHEALTH, INC. 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 

(In thousands, unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended September 30,

 

2012

 

2013

 

 

 

 

Operating activities

 

 

 

 

 

Net income

$

4,635 

 

$

3,681 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Deferred income taxes

 

15 

 

 

(3,951)

Depreciation and amortization

 

1,740 

 

 

2,290 

Amortization of book-of-business consideration

 

1,990 

 

 

2,822 

Amortization of intangible assets

 

1,261 

 

 

1,061 

Stock-based compensation expense

 

4,326 

 

 

5,361 

Deferred rent and other

 

51 

 

 

917 

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

4,799 

 

 

(2,131)

Prepaid expenses and other assets

 

(656)

 

 

(852)

Accounts payable

 

2,180 

 

 

(1,895)

Accrued compensation and benefits

 

913 

 

 

2,504 

Accrued marketing expenses

 

(2,332)

 

 

(196)

Deferred revenue

 

390 

 

 

3,794 

Other current liabilities

 

341 

 

 

1,370 

Net cash provided by operating activities

 

19,653 

 

 

14,775 

 

 

 

 

 

 

Investing activities

 

 

 

 

 

Purchases of property and equipment

 

(3,128)

 

 

(6,735)

Consideration paid in connection with book-of-business transfers

 

(6,243)

 

 

 -

Net cash used in investing activities

 

(9,371)

 

 

(6,735)

 

 

 

 

 

 

Financing activities

 

 

 

 

 

Proceeds from exercise of common stock options

 

4,014 

 

 

4,650 

Cash used to net-share settle equity awards

 

(991)

 

 

(940)

Excess tax benefits from stock-based compensation

 

2,358 

 

 

4,217 

Repurchase of common stock

 

(8,441)

 

 

(59,007)

Principal payments in connection with capital leases

 

(31)

 

 

(41)

Net cash used in financing activities

 

(3,091)

 

 

(51,121)

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

 

 

(17)

 

 

 

 

 

 

Net decrease in cash and cash equivalents

 

7,193 

 

 

(43,098)

Cash and cash equivalents at beginning of period

 

123,607 

 

 

140,849 

Cash and cash equivalents at end of period

$

130,800 

 

$

97,751 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

  

 

 

3 

 


 

Table of Contents 

EHEALTH, INC. 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTSCONTINUED

 

 

Note 1 - Summary of Business and Significant Accounting Policies

 

Description of BusinesseHealth, Inc. (the “Company,” “eHealth,” “we” or “us”) is the leading online source of health insurance for individuals, families and small businesses in the United States. Through our website addresses (www.eHealth.com,  www.eHealthInsurance.com,  www.eHealthMedicare.com and www.PlanPrescriber.com), consumers can get quotes from leading health insurance carriers, compare plans side-by-side, and apply for and purchase individual and family, Medicare-related, small business and ancillary health insurance plans. We actively market the availability of Medicare-related insurance plans and offer Medicare plan comparison tools and educational materials for Medicare-related insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans.  Our ecommerce technology also enables us to deliver consumers’ health insurance applications electronically to health insurance carriers. As a result, we simplify and streamline the complex and traditionally paper-intensive health insurance sales and purchasing process. We are licensed to market and sell health insurance in all 50 states and the District of Columbia. 

 

Basis of Presentation—The accompanying condensed consolidated balance sheet as of September 30, 2013, the condensed consolidated statements of comprehensive income for the three and nine months ended September 30, 2012 and 2013 and the condensed consolidated statements of cash flows for the nine months ended September 30, 2012 and 2013, respectively, are unaudited. The condensed consolidated balance sheet data as of December 31, 2012 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2012, which was filed with the Securities and Exchange Commission on March 13, 2013. The accompanying statements should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K.  

 

The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or U.S. GAAP, for interim financial information. Accordingly, they do not include all of the financial information and footnotes required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2012, and include all adjustments necessary for the fair presentation of eHealth’s statement of financial position as of September 30, 2013, its results of operations for the three and nine months ended September 30, 2012 and 2013 and its cash flows for the nine months ended September 30, 2012 and 2013. All adjustments are of a normal recurring nature. The results for the three and nine months ended September 30, 2013 are not necessarily indicative of the results to be expected for any subsequent period or for the fiscal year ending December 31, 2013.  

 

Seasonality—The number of individual and family health insurance applications submitted through our ecommerce platform has generally increased in our first quarter compared to our fourth quarter and in our third quarter compared to our second quarter. Conversely, we have generally experienced a decline or flattening of individual and family submitted applications in our second quarter compared to our first quarter and in our fourth quarter compared to our third quarter. This seasonality could change in the fourth quarter of 2013 as a result of the initial open enrollment period under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act, which began on October 1, 2013 and is scheduled to run through March 31, 2014.

 

The majority of Medicare plans are sold in our fourth quarter during the Medicare annual enrollment period, when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, we generate a significant amount of Medicare plan-related revenue in the fourth quarter of the year resulting from the sale of new Medicare plans. Additionally, we recognize a majority of our renewal Medicare Advantage and Medicare Part D prescription drug plan commission revenue in the first quarter of each year as the majority of policies sold during the annual enrollment period typically renew on January 1 of each year.

 

Since a significant portion of our marketing and advertising expenses are driven by the number of health insurance applications submitted on our ecommerce platform, those expenses are influenced by these patterns. As a result, marketing and advertising expenses related to individual and family health insurance plans have been highest in our first and third quarters, while marketing and advertising expenses related to Medicare-related plans have been highest in our third and fourth quarters. However, the historical trend of marketing and advertising expenses related to individual and family health insurance plans could be impacted by the initial open enrollment period for individual and family plans that began on October 1, 2013. 

 

4 

 


 

Table of Contents 

EHEALTH, INC. 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTSCONTINUED

 

Additionally, in preparation for the Medicare annual enrollment period, and to a lesser extent the initial open enrollment period for individual and family plans, we begin ramping up our customer care center staff during our second and third quarters to handle the anticipated increased volume of health insurance transactions during the fourth quarter. Accordingly, our customer care center staffing costs are significantly higher in our third and fourth quarters compared to our first and second quarters.

 

Recently Adopted Accounting Standards—Effective January 1, 2013, we adopted an accounting standards update with new guidance on the presentation of reclassifications from accumulated other comprehensive income to net income. This standard requires an entity to present reclassifications from accumulated other comprehensive income to net income either on the face of the condensed consolidated financial statements or in the notes to the condensed consolidated financial statements. In the nine months ended September 30, 2013 we did not have any reclassifications from accumulated other comprehensive income to net income.

 

 

Note 2 – Cash, Cash Equivalents and Accounts Receivable

 

Cash and Cash EquivalentsAs of December 31, 2012 and September 30, 2013, our cash equivalents consisted of money market accounts that invested in U.S. government-sponsored enterprise bonds and discount notes, U.S. government treasury bills and notes and repurchase agreements collateralized by U.S. government obligations. At December 31, 2012 and September 30, 2013, our cash equivalents carried no unrealized gains or losses and we did not realize any significant gains or losses on sales of cash equivalents during the three and nine months ended September 30, 2012 and 2013.  

 

As of December 31, 2012 and September 30, 2013, our cash and cash equivalent balances were invested as follows (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2012

 

September 30, 2013

 

 

 

 

 

 

Cash

$

27,484 

 

$

19,632 

Money market funds

 

113,365 

 

 

78,119 

Total cash and cash equivalents

$

140,849 

 

$

97,751 

 

We used observable prices in active markets in determining the classification of our money market funds as Level 1 as of December 31, 2012 and September 30, 2013. 

 

Accounts ReceivableAs of December 31, 2012 and September 30, 2013, our accounts receivable consisted of the following (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2012

 

September 30, 2013

 

 

 

 

 

 

Accounts receivable - from other revenues

$

3,319 

 

$

3,340 

Commissions receivable

 

1,149 

 

 

3,259 

Total accounts receivable

$

4,468 

 

$

6,599 

5 

 


 

Table of Contents 

EHEALTH, INC. 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTSCONTINUED

 

  

 

 

 

 

Note 3 – Stockholders’ Equity

 

Stock Plans—The following table summarizes activity under our 2006 Equity Incentive Plan, 1998 Stock Plan and 2005 Stock Plan (collectively, the “Stock Plans”) (in thousands):

 

 

 

Shares Available for Grant (1)

Shares available for grant December 31, 2012

3,982 

Additional shares authorized (2)

818 

Restricted stock units granted

(564)

Options granted

(119)

Restricted stock units cancelled

21 

Options cancelled

72 

Shares available for grant September 30, 2013

4,210 

 

(1)

Shares available for grant do not include treasury stock shares that could also become available for grant if we determined to do so. 

 

(2)

On January 1, 2013, the number of shares authorized for issuance under the 2006 Equity Incentive Plan was automatically increased pursuant to the terms of the 2006 Equity Incentive Plan.  

 

The following table summarizes stock option activity under the Stock Plans (in thousands, except per share amounts and weighted average remaining contractual life data): 

 

 

 

 

 

 

 

 

 

 

 

 

Number of Stock Options

 

Weighted Average Exercise Price

 

Weighted-Average Remaining Contractual Life (years)

 

Aggregate Intrinsic Value (1)

Balance outstanding at December 31, 2012

2,956 

 

$

13.41 

 

3.91 

 

$

41,642 

Granted

119 

 

$

21.18 

 

 

 

 

 

Exercised

(834)

 

$

5.57 

 

 

 

 

 

Cancelled

(72)

 

$

18.52 

 

 

 

 

 

Balance outstanding at September 30, 2013

2,169 

 

$

16.68 

 

4.21 

 

$

33,784 

Vested and expected to vest at September 30, 2013

2,108 

 

$

16.65 

 

4.17 

 

$

32,911 

Exercisable at September 30, 2013

1,389 

 

$

16.14 

 

3.48 

 

$

22,389 

 

(1)

The aggregate intrinsic value is calculated as the difference between eHealth’s closing stock price as of December 31, 2012 and September 30, 2013 and the exercise price of in-the-money options as of those dates. 

 

The total grant date fair value of stock options vested during the three and nine months ended September 30, 2012 was $0.5 million and $1.9 million, respectively. The total grant date fair value of stock options vested during the three and nine months ended September 30, 2013 was $0.7 million and $2.6 million, respectively.

6 

 


 

Table of Contents 

EHEALTH, INC. 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTSCONTINUED

 

 

 

The following table summarizes restricted stock unit activity, including performance-based restricted stock unit activity, under the Stock Plans (in thousands, except weighted average remaining contractual life data): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number Outstanding

 

Weighted-Average Remaining Contractual Life (years)

 

Aggregate Intrinsic Value (1)

Balance outstanding as of December 31, 2012

381 

 

2.22 

 

$

10,464 

Granted

564 

 

 

 

 

 

Vested

(172)

 

 

 

 

 

Cancelled

(21)

 

 

 

 

 

Balance outstanding as of September 30, 2013

752 

 

2.55 

 

$

24,248 

 

(1)

The aggregate intrinsic value is calculated as eHealth’s closing stock price as of December 31, 2012 and September 30, 2013 multiplied by the number of restricted stock units outstanding as of December 31, 2012 and September 30, 2013, respectively.   

 

The fair value of the restricted stock units is based on eHealth’s stock price on the date of grant, and compensation expense related to these awards is recognized on a straight-line basis over the vesting period. The fair value of performance-based restricted stock units is based on eHealth’s stock price on the date of grant, and compensation expense related to these awards is recognized on an accelerated basis over the vesting period. The total grant date fair value of restricted stock units vested during the nine months ended September 30, 2012 was $3.7 million. The total grant date fair value of restricted stock units vested during the three months ended September 30, 2012 was not material. The total grant date fair value of restricted stock units vested during the three and nine months ended September 30, 2013 was $0.2 million and $3.5 million, respectively.

Stock Repurchase Programs—On September 10, 2012, we announced that our board of directors approved a stock repurchase program authorizing us to purchase up to $30 million of our common stock and on March 6, 2013, we announced that our board of directors increased the approved repurchase amount under this program to $60 million. Purchases under this program were made in the open market and complied with Rule 10b-18 under the Securities Exchange Act of 1934, as amended. The cost of the repurchased shares was funded from available working capital. 

For accounting purposes, common stock repurchased under our stock repurchase programs is recorded based upon the settlement date of the applicable trade. Such repurchased shares are held in treasury and are presented using the cost method. 

Stock repurchase activity under our stock repurchase programs during the nine months ended September 30, 2013 is summarized as follows (dollars in thousands, except share and per share amounts): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Number of Shares Purchased

 

Average Price Paid per Share (2)

 

Amount of Repurchase

Cumulative balance at December 31, 2012 (1)

6,397,803 

 

$

14.22 

 

$

90,991 

Repurchases of common stock

2,911,466 

 

$

20.27 

 

 

59,007 

Cumulative balance at September 30, 2013 (1)

9,309,269 

 

$

16.11 

 

$

149,998 

 

7 

 


 

Table of Contents 

EHEALTH, INC. 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTSCONTINUED

 

(1)

Cumulative balances at December 31, 2012 and September 30, 2013 consist of shares repurchased in connection with our stock repurchase program announced on September 10, 2012, as well as previous stock repurchase plans announced in 2011, 2010 and 2008.  

(2)Average price paid per share includes commissions. 

 

In addition to the shares repurchased under our repurchase programs as of September 30, 2013, we have in treasury 209,925 shares that were previously surrendered by employees to satisfy tax withholdings due in connection with the vesting of certain restricted stock units. As of December 31, 2012 and September 30, 2013, we had a total of 6,556,303 shares and 9,519,194 shares, respectively, held in treasury. 

Stock-Based Compensation—The fair value of stock options granted to employees for the three and nine months ended September 30, 2012 and 2013 was estimated using the following weighted average assumptions: 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

Expected term

 

4.6 years

 

 

4.3 years

 

 

4.7 years

 

 

4.3 years

Expected volatility

 

43.3% 

 

 

39.8% 

 

 

44.3% 

 

 

39.7% 

Expected dividend yield

 

0% 

 

 

0% 

 

 

0% 

 

 

0% 

Risk-free interest rate

 

0.61% 

 

 

1.13% 

 

 

0.90% 

 

 

0.79% 

Weighted-average fair value

$

6.46 

 

$

8.39 

 

$

6.41 

 

$

7.02 

 

The following table summarizes stock-based compensation expense recorded during the three and nine months ended September 30, 2012 and 2013 (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

Common stock options

$

717 

 

$

654 

 

$

2,076 

 

$

2,103 

Restricted stock units

 

622 

 

 

1,291 

 

 

2,250 

 

 

3,258 

Total stock-based compensation expense

$

1,339 

 

$

1,945 

 

$

4,326 

 

$

5,361 

 

The following table summarizes stock-based compensation expense by operating function for the three and nine months ended September 30, 2012 and 2013 (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

Marketing and advertising

$

330 

 

$

517 

 

$

932 

 

$

1,446 

Customer care and enrollment

 

90 

 

 

92 

 

 

243 

 

 

261 

Technology and content

 

233 

 

 

425 

 

 

783 

 

 

1,129 

General and administrative

 

686 

 

 

911 

 

 

2,368 

 

 

2,525 

Total stock-based compensation expense

$

1,339 

 

$

1,945 

 

$

4,326 

 

$

5,361 

 

 

  

 

 

8 

 


 

Table of Contents 

EHEALTH, INC. 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTSCONTINUED

 

 

 

 

 

 

 

 

Note 4 – Income Taxes

 

The following table summarizes our provision for income taxes and our effective tax rates for the three and nine months ended September 30, 2012 and 2013 (in thousands, except effective tax rate):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

Income before provision for income taxes

$

1,079 

 

$

381 

 

$

9,160 

 

$

6,307 

Provision for income taxes

$

874 

 

$

207 

 

$

4,525 

 

$

2,626 

Effective tax rate

 

81.0% 

 

 

54.3% 

 

 

49.4% 

 

 

41.6% 

 

Our effective tax rate in the three and nine months ended September 30, 2012 was higher than statutory federal and state tax rates due primarily to non-deductible lobbying expenses and tax shortfalls related to share-based payments. Our effective tax rate in the three and nine months ended September 30, 2013 was higher than statutory federal and state tax rates due primarily to non-deductible lobbying expenses, partially offset by a tax benefit resulting from the recent extension of the federal research tax credit through December 31, 2013.

 

During the three and nine months ended September 30, 2012, we utilized excess federal and state tax benefits related to share-based payments, which resulted in increases of $1.2 million and $2.4 million, respectively, in Additional Paid-In Capital in the condensed consolidated balance sheets. During the three and nine months ended September 30, 2013, we utilized excess federal and state tax benefits related to share-based payments, which resulted in increases of $0.3 million and $4.2 million, respectively, in Additional Paid-In Capital in the condensed consolidated balance sheets. These amounts are also classified in the condensed consolidated statements of cash flows as both a reduction to operating cash flows and as a financing cash inflow. 

   

  

9 

 


 

Table of Contents 

EHEALTH, INC. 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTSCONTINUED

 

 

 

  

 

Note 5 – Net Income Per Share

 

Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding for the period (excluding shares subject to repurchase). Diluted net income per share is computed by dividing the net income for the period by the weighted average number of common and common equivalent shares outstanding during the period. Diluted net income per share is computed giving effect to all potential dilutive common stock equivalent shares, including options, restricted stock and restricted stock units. The dilutive effect of outstanding awards is reflected in diluted net income per share by application of the treasury stock method.  

 

The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share amounts):  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

2012

 

2013

 

2012

 

2013

Basic:

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

Net income allocated to common stock

$

205 

 

$

174 

 

$

4,635 

 

$

3,681 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

Net weighted average number of common stock shares outstanding

 

19,970 

 

 

18,436 

 

 

19,711 

 

 

19,310 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share—basic:

$

0.01 

 

$

0.01 

 

$

0.24 

 

$

0.19 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted:

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

Net income allocated to common stock

$

205 

 

$

174 

 

$

4,635 

 

$

3,681 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

Net weighted average number of common stock shares outstanding

 

19,970 

 

 

18,436 

 

 

19,711 

 

 

19,310 

Weighted average number of options

 

703 

 

 

528 

 

 

750 

 

 

478 

Weighted average number of restricted stock units

 

77 

 

 

132 

 

 

102 

 

 

124 

Total common stock shares used in per share calculation

 

20,750 

 

 

19,096 

 

 

20,563 

 

 

19,912 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share—diluted:

$

0.01 

 

$

0.01 

 

$

0.23 

 

$

0.18 

10 

 


 

Table of Contents 

EHEALTH, INC. 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTSCONTINUED

 

 

For each of the three- and nine- month periods ended September 30, 2012 and 2013, we had securities outstanding that could potentially dilute net income per share, but the shares from the assumed exercise of these securities were excluded in the computation of diluted net income per share as their effect would have been anti-dilutive. The number of outstanding weighted average anti-dilutive shares that were excluded from the computation of diluted net income per share consisted of the following (in thousands): 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

Common stock options

1,484 

 

127 

 

1,327 

 

439 

Total

1,484 

 

127 

 

1,327 

 

439 

 

 

  

 

 

 

Note 6 – Geographic Information and Significant Customers

 

Geographic Information—As of December 31, 2012 and September 30, 2013, our long-lived assets consisted primarily of property and equipment, goodwill and other indefinite-lived intangible assets and finite-lived intangible assets. Our long-lived assets are attributed to the geographic location in which they are located. Long-lived assets by geographical area were as follows (in thousands):  

 

 

 

 

 

 

 

 

As of

 

As of

 

December 31, 2012

 

September 30, 2013

 

 

 

 

 

 

United States

$

37,037 

 

$

38,363 

China

 

278 

 

 

342 

Total

$

37,315 

 

$

38,705 

 

Significant Customers—Substantially all revenue for the three and nine months ended September 30, 2012 and 2013 was generated from customers located in the United States. Carriers representing 10% or more of our total revenue in the three and nine months ended September 30, 2012 and 2013 are presented in the table below: 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

Humana

19% 

 

18% 

 

16% 

 

20% 

WellPoint (1)

13% 

 

12% 

 

13% 

 

12% 

UnitedHealthcare (2)

12% 

 

11% 

 

13% 

 

11% 

Aetna (3)

7% 

 

10% 

 

7% 

 

9% 

 

(1)

Wellpoint also includes other carriers owned by Wellpoint. 

(2)

UnitedHealthcare also includes other carriers owned by UnitedHealthcare. 

(3)

Aetna also includes other carriers owned by Aetna. 

 

Commission revenue attributable to major medical individual and family health insurance plans was approximately 79% and 78% of our commission revenue in the three and nine months ended September 30, 2012, respectively. Commission revenue attributable to major medical individual and family health insurance plans was approximately 74% and 72% of our commission revenue in the three and nine months ended September 30, 2013, respectively. We define our individual and family plan offerings as major medical individual and family health insurance plans, which do not include

11 

 


 

Table of Contents 

EHEALTH, INC. 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTSCONTINUED

 

small business, Medicare-related health insurance plan offerings and other ancillary products such as short-term, stand-alone dental, life, vision, accident and student insurance plan offerings. 

 

As of December 31, 2012, four customers represented 25%, 22%, 14% and 11%, respectively, for a combined total of 72% of our $4.5 million outstanding accounts receivable balance. As of September 30, 2013, two customers represented 43%  and 33%, respectively of our $6.6 million outstanding accounts receivable balance. No other customers represented 10% or more of our total accounts receivable at December 31, 2012 and September 30, 2013. We believe the potential for collection issues with any of our customers is minimal as of September 30, 2013. Accordingly, our estimate for uncollectible amounts at September 30, 2013 was not material.   

 

 

 

 

 

 

 

12 

 


 

 

 

ITEM 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

 

In addition to historical information, this Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements include, among other things, statements regarding an expected increase in individual and family submitted applications; increasing customer care center staff in the second and third quarters; our beliefs relating to collection issues with our customers; our expectations relating to average commission dollars per policy for individual and family policies that we sell in 2014; the anticipated impact of medical loss ratio requirements on our Medicare Advantage commission rates; the impact of health care reform on our business; a large number of consumers entering the market for individual health insurance; our expectations relating to submitted applications each quarter; seasonality of our marketing and advertising expenses and their relation to the Medicare and individual and family health insurance open enrollment periods; expectations relating to revenue (including commission revenue, lead referral revenue, advertising revenue and other revenue), sources of revenue, cost of revenue, the collectability of our accounts receivable and our estimate of accounts receivable as of September 30, 2013, profitability, operating expenses, marketing and advertising expenses, customer care and enrollment employees and expenses, technology and content expenses, general and administrative expenses; our future commission rate structure; our overall individual and family health insurance commission rate structure; the timing of our recognition of a majority of our first year Medicare Advantage and Medicare Part D prescription drug plan commission revenue; an increase in our commission revenue in absolute dollars in 2013 relative to 2012; the amount of fees we pay to marketing partners for consumer referrals that result in submitted health insurance applications; seasonal and absolute increases in our customer care and enrollment costs; increases in technology and content expenses; increases in general and administrative expenses; our estimate of the number of continuing members on all policies; our significant accounting policies; the sufficiency of our cash generated from operations and our current cash and cash equivalents; the advantages of a long-standing provision of each state’s law relating to health insurance premiums; our intention to perform services for substantially all Medicare leads as a health insurance agent; the seasonality of our business and financial results; the timing and amount of our future lease obligations; the impact of health care reform laws on the health insurance industry and on our business; the timing of health care reform open enrollment periods including restrictions on changes outside of such periods and our readiness  therefore;  our plans and expectations relating to our Medicare business and factors impacting its success; impact of medical loss ratio regulations and commission rate changes; our expectations and projections relating to membership and commission rates; the timing and source of our Medicare-related revenue; estimates relating to critical accounting policies and related impact on our financial statements; the sufficiency of our cash and cash equivalents; future capital requirements; our projections relating to future revenue growth and earnings per share; our future competitors; expansion into new business areas and additional geographic regions; our need for additional regulatory licenses and approvals; as well as other statements regarding our future operations, financial condition, prospects and business strategies. These forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from those reflected in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in this report, and in particular, the risks discussed under the heading “Risk Factors” in Part II, Item 1A of this report and those discussed in our other Securities and Exchange Commission filings. The following discussion should be read in conjunction with our Annual Report on Form 10-K as filed with the Securities and Exchange Commission in March 2013, and the audited consolidated financial statements and related notes contained therein. We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. 

  

Overview 

We are the leading online source of health insurance for individuals, families and small businesses. Through our website addresses (www.eHealth.com,  www.eHealthInsurance.com,  www.eHealthMedicare.com and www.PlanPrescriber.com), consumers can get quotes from leading health insurance carriers, compare plans side-by-side, and apply for and purchase individual and family, Medicare-related, small business and ancillary health insurance plans. Our ecommerce technology also enables us to deliver consumers’ health insurance applications electronically to health insurance carriers.  As a result, we simplify and streamline the complex and traditionally paper-intensive health insurance sales and purchasing process.  

We have invested heavily in technology and content related to our ecommerce platform. We have also invested significant time and resources in obtaining licenses to sell health insurance in all 50 states and the District of Columbia, developing diverse member acquisition programs, obtaining necessary regulatory approvals of our websites and establishing relationships and appointments with leading insurance carriers, enabling us to offer thousands of health insurance plans

13 

 


 

online. Our ecommerce platforms can be accessed directly through our website as well as through our network of marketing partners. 

We generate revenue primarily from commissions we receive from health insurance carriers whose health insurance policies are purchased through our ecommerce platform. Commission revenue represented 83% and 85% of total revenue in the three and nine months ended September 30, 2012, respectively and represented 86% and 87% of total revenue in the three and nine months ended September 30, 2013, respectively.  Historically, the commission payments we receive for individual and family, small business and ancillary health insurance policies have been typically a percentage of the premium on the health insurance policy that we sold and typically made to us on a monthly basis for as long as the policy remains active with us; however during 2013 we received communication from many insurance carriers indicating that in 2014 our commissions will change from being calculated on a percentage of premium basis to flat amount per-member-per-month.  

We actively market the availability of Medicare-related health insurance plans through our online Medicare plan platforms www.eHealthMedicare.com and www.PlanPrescriber.com. Our Medicare plan platforms enable consumers to research and compare Medicare-related health insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans. Commission payments we receive for Medicare Advantage and Medicare Part D prescription drug plans sold by us are typically fixed and are earned over a period of five years, or longer depending on the carrier arrangement, and are paid to us either monthly or annually. Medicare commissions we receive are included in commission revenue. 

As a result of our commission structure, much of our revenue for a given financial reporting period relates to health insurance plans that we sold prior to the beginning of the period and is recurring in nature. Additionally, health insurance pricing, which is set by the health insurance carrier and approved by regulators, is not subject to negotiation or discounting by health insurance carriers or our competitors. 

 

In March 2010, the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act were signed into law. These health care reform laws contain provisions that have and will continue to change the health insurance industry in substantial ways. Among several other provisions, they and the regulations implementing them include a mandate requiring individuals to maintain health insurance or face tax penalties; a mandate that certain employers offer and contribute to their employees group health insurance coverage or face tax penalties if they do not do so in 2015 and thereafter; prohibitions against insurance companies using pre-existing health conditions as a reason to deny an application for health insurance; requirements for minimum individual and small business health insurance benefit levels, including prohibitions on lifetime coverage limits and limitations on annual coverage limits; medical loss ratio requirements that require each health insurance carrier to spend a certain percentage of their premium revenue on reimbursement for clinical services and activities that improve health care quality; establishment of state and/or federal government-run health insurance exchanges to facilitate access to, and the purchase of, health insurance; open enrollment periods for the purchase of individual health insurance during specified times of the year; Medicaid expansion so that a greater number of individuals will be insured under Medicaid programs; and subsidies and cost-sharing credits to make health insurance more affordable for those below certain income levels if they are eligible and purchase individual or small group health insurance through the state or federal health insurance exchange.

 

The initial open enrollment period under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act began on October 1, 2013 and is scheduled to run through March 31, 2014.  In order to be eligible for a subsidy, qualified individuals must purchase subsidy-qualifying health plans through a government-run health insurance exchange during this open enrollment period.  During the third quarter of 2013 we entered into two agreements with the Centers for Medicare and Medicaid Services (“CMS”) to allow us to enroll subsidy-eligible individuals in qualified health insurance plans in the 36 states where the federal government is operating an exchange during the initial open enrollment period.  We are currently in the process of integration and testing with the federal exchange. The federal exchange is currently experiencing technological problems with its website and ability to enroll individuals into qualified health plans.  Our integration with the federal exchange is dependent upon the resolution of these technological problems. Although we are working to provide our customers with access to subsidy-eligible plans in time for January 1, 2014 effective date coverage, the date on which we will be able to enroll customers in subsidy-eligible plans is uncertain. Additionally, we have not entered into a relationship to be able to enroll individuals into qualified health plans with any of the 14 states that are operating state-run exchanges.

Many aspects of health care reform become effective in 2014. Health insurance carriers have been required as a part of health care reform to maintain medical loss ratios of eighty percent in their individual and family health insurance business since the beginning of 2011. The implementation of an eighty-five percent medical loss ratio requirement for Medicare

14 

 


 

Advantage plans is scheduled to be implemented in 2014; however, based on communications received from the majority of our Medicare Advantage health insurance carriers, we do not anticipate the implementation will have a material impact on our Medicare Advantage commission rates.

While aspects of health care reform may positively impact our business, the aggregate future impact of the implementation of health care reform on our business and financial results is uncertain. For instance, it is unclear how our existing members will react to health care reform and whether they will seek or be forced to purchase new health insurance products once health insurance carriers implement new health insurance plans or change existing plans in response to health care reform requirements. Our ability to continue to act as a health insurance agent for our members who switch to a new health insurance product will be dependent upon a number of factors, including health insurance company practices, individual financial circumstances, our members’ existing health insurance plans, the price of health insurance and our ability to expand our offering to include subsidy-eligible health insurance plans. While a large number of consumers may enter the market for individual health insurance in response to health care reform given the requirement that individuals maintain health insurance or face a tax penalty, it is unclear whether the tax penalty will have this intended effect, particularly if health insurance carriers significantly increase the cost of health insurance in response to health care reform. Moreover, we will face new competition in the form of government-run health insurance exchanges and our ability to act as a health insurance agent to health care reform subsidy-eligible individuals is dependent upon our ability to successfully integrate with the government-run exchanges.  Additionally, in order to enroll individuals in subsidy-eligible plans, we need to meet a number of requirements relating to the display of information on our websites as well as new and comprehensive privacy and security requirements. Our ability to meet and maintain compliance with these and other significant requirements could present significant challenges for us. The implementation of open enrollment periods for the purchase of individual health insurance also presents challenges to our ability to enroll a significant number of individuals into health insurance over a limited period of time. Additionally, the restriction on individuals being able to make plan changes outside of open enrollment periods could result in a reduction in the number of health insurance policies purchased through us during such periods. The impact of health care reform on our health insurance carrier partners and their reaction is also unclear. For instance, health insurance carriers have the ability to unilaterally change their relationship with us, including the commission rates we receive for acting as a health insurance agent and may reduce the amount they pay us, alter the manner and geographic areas in which they permit us to sell their products and change our relationship with them in any number of ways. Given the disruption that the implementation of health care reform may have on the health insurance market, health care reform could in the aggregate have a material adverse effect on our business and results of operations.

We derive revenue from our online sponsorship and advertising program that allows carriers to purchase advertising space in specific markets in a sponsorship area on our website. In return, we are typically paid a monthly fee and a performance-based fee based on metrics such as submitted health insurance applications. We also offer Medicare advertising services, which allow Medicare plan carriers to purchase advertising on a separate website developed, hosted and maintained by us. In these instances, we are typically paid a fixed, up-front fee, which we recognize as revenue over the service period. 

We derive revenue from licensing the use of our health insurance ecommerce technology and typically receive a fixed, up-front fee or performance-based fees, or a combination of both. Our technology platform enables health insurance carriers and agents to market and distribute health insurance plans online. We also have licensed our ecommerce technology for use by government agencies.  

In the past we also derived a significant amount of revenue from referral fees paid to us based on leads generated by our online platforms that are delivered and sold to third parties. In early 2012 we began directly servicing most of the Medicare leads we generated as a health insurance agent, while significantly reducing the number of Medicare leads we sold to third parties. As a result, our lead referral revenue declined significantly in 2013 compared to 2012. To the extent that we assist in the sale of Medicare-related insurance plans as a health insurance agent, we generate revenue from commissions we receive from health insurance carriers, rather than one-time referral fees we receive for the sale of Medicare leads. 

 

Sources of Revenue  

 

Commission Revenue  

 

We generate revenue primarily from commissions we receive from health insurance carriers whose health insurance policies are purchased through us. Commissions for individual and family, small business and ancillary health insurance policies, such as stand-alone dental, life, student, vision, accident and short-term insurance plan offerings, have generally represented a percentage of the insurance premium and, to a much lesser extent, commission override payments that

15 

 


 

insurance carriers pay us for achieving sales volume thresholds or other objectives. Commission rates vary by carrier and by the type of plan purchased by a member. Commission rates can vary based upon the amount of time that the policy has been active, with commission rates for individual and family plans typically being higher in the first twelve months of the policy. After the first twelve months, commission rates generally decline significantly. As a result, if we do not add a sufficient number of members on new policies, our revenue growth will be negatively impacted. Individuals, families and small businesses purchasing health insurance through us typically pay their premiums on a monthly basis. Insurance carriers typically pay commissions to us on these policies monthly, after they receive the premium payment from the member. We generally continue to receive the commission payment from the relevant insurance carrier until the health insurance policy is cancelled or we otherwise do not remain the agent on the policy. As a result, the majority of our commission revenue is recurring in nature.

 

During 2013 we received communication from certain health insurance carriers indicating that in 2014 commission fees will change from a percentage of premium basis to flat amount per-member-per-month. The amount to be paid per-member-per-month will generally decline after the initial policy year. To date, we have received commission rate schedules applicable to 2014 coverage from approximately sixty percent of our individual and family carrier partners. These rate schedules are generally effective for policies with 2014 effective dates although existing policies for some carriers will also be affected. Based upon this data, we expect that the average commission dollars per policy for individual and family policies we sell in 2014 will be equal to, or slightly higher than, our average commission dollars per policy for policies we sold during the period from July 2011 to June 2012, which represents the latest annual period for which we have received a full year of commission payments.   

 

We generally recognize individual and family, small business and ancillary health insurance plan revenue when commissions are reported to us by a health insurance carrier, net of an estimate for future forfeiture amounts payable to carriers due to policy cancellations. Commissions are reported to us by a cash payment and commission statement.  We generally receive these communications simultaneously. In instances when we receive the cash payment and commission statement separately and in different accounting periods, we recognize revenue in the period that we receive the earliest communication, provided we receive the second corroborating communication shortly after the end of the accounting period. If the second corroborating communication is not received shortly after the end of the accounting period, we recognize revenue in the period the second communication is received. We use the data in the commission statements to help identify the members for which we are receiving a commission payment and the amount received for each member, and to estimate forfeitures payable to carriers. As a result, we recognize the net amount of compensation earned as the agent in the transaction. Commission override revenue, which we recognize on the same basis as premium commissions, is generally reported to us in a more irregular pattern than premium commissions. As a result, our revenue for a particular quarter could be higher or lower than expectations due to the timing of the reporting of commission override revenue to us.  

 

The number of individual and family health insurance applications submitted through our ecommerce platform has generally increased in our first quarter compared to our fourth quarter and in our third quarter compared to our second quarter. Conversely, we have generally experienced a decline or flattening of individual and family submitted applications in our second quarter compared to our first quarter and in our fourth quarter compared to our third quarter.  This seasonality is expected to change in the fourth quarter of 2013 as a result of an anticipated increase in the number of individual and family applications submitted during the initial open enrollment period under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act, which began on October 1, 2013 and is scheduled to run through March 31, 2014. We expect the number of submitted individual and family plan applications to increase, relative to historical levels, during the fourth quarter of 2013 and the first quarter of 2014 as a result of the initial open enrollment period. We expect to experience a decline in individual and family applications submitted during the second and third quarters of 2014 relative to the first quarter of 2014 because the initial open enrollment period ends on March 31, 2014.  In years subsequent to 2014, since qualified individual and families will be able to change their qualified health plan only during annual enrollment periods scheduled to occur from October 15 through December 7 of each year, subject to states extending the period and exceptions for special enrollment periods for certain qualifying events, we expect to experience a decline in individual and family applications submitted during the first, second, and third quarters and an increase in the fourth quarter of each year.

 

During the third quarter of 2013 we entered into two agreements with the Centers for Medicare and Medicaid Services (“CMS”) to allow us to enroll subsidy-eligible individuals in qualified health insurance plans in the 36 states where the federal government is operating an exchange during the initial open enrollment period.  We are currently in the process of integration and testing with the federal exchange.  Although we are working to provide our customers with access to

16 

 


 

subsidy-eligible plans in time for January 1, 2014 effective date coverage, the date on which we will be able to enroll customers in subsidy-eligible plans is uncertain. 

We actively market the availability of Medicare-related insurance plans through our online Medicare plan platforms, including  (www.eHealthMedicare.com and www.PlanPrescriber.com). These platforms enable consumers to research and compare Medicare-related insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans. We offer online application and telephonic enrollment capabilities for certain Medicare plans. To the extent that we assist in the sale of Medicare-related insurance plans as a health insurance agent, through either online applications or telephonically, we generate revenue from commissions we receive from health insurance carriers. The commission payments we receive for Medicare Supplement plans are typically a percentage of the premium on the policy that we sold and are paid to us on a monthly basis for as long as a policy remains active with us. For both Medicare Advantage and Medicare Part D prescription drug plans, we receive a fixed, annual commission from insurance carriers after the policy is approved by the carrier and either a fixed, monthly commission beginning with and subsequent to the second policy year for a Medicare Advantage policy or a fixed, annual commission beginning with and subsequent to the second policy year for a Medicare Part D prescription drug policy. Additionally, these commission rates may be higher in the first twelve months of a policy if the policy is the first Medicare-related policy issued to the member. We may earn commission revenue for both Medicare Advantage and Medicare Part D prescription drug plans typically for a period of five years, or longer depending on the carrier arrangement, provided that the policy remains active with us. 

We recognize commission revenue for both Medicare Advantage and Medicare Part D prescription drug plans for the entire policy year once the annual or first monthly commission amount for the policy year is reported to us by the carrier, net of an estimate for future forfeiture amounts due to policy cancellations. For commissions paid to us on a monthly basis, we record a receivable for the commission amounts to be received over the remainder of the policy year, net of an estimate for commission amounts not expected to be collected due to policy cancellations, which is included in Accounts Receivable in the accompanying condensed consolidated balance sheets.  We continue to receive the commission payments from the relevant insurance carrier until the earlier of the cancellation of the policy, our no longer remaining the agent on the policy, or our commission term with the carrier expires, typically for a period of five years from the effective date of the policy, or longer depending on the carrier arrangement. We determine that there is persuasive evidence of an arrangement when we have a commission agreement with a health insurance carrier. Our services are complete when a carrier has approved an application in the initial year and when a member has renewed in a renewal year. The seller’s price is fixed or determinable and collectability is reasonably assured when a carrier has approved an application and the carrier reports to us the annual or first monthly renewal commission amount for each policy year. 

The majority of Medicare plans are sold in our fourth quarter during the Medicare annual enrollment period, when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, we generate a significant amount of Medicare plan-related revenue in the fourth quarter of the year resulting from the sale of new Medicare plans. Additionally, we recognize a majority of our renewal Medicare Advantage and Medicare Part D prescription drug plan commission revenue in the first quarter of each year as the majority of policies sold during the annual enrollment period typically renew on January 1 of each year.   

 

Commission revenue attributable to major medical individual and family health insurance plans was 79% and 78% of commission revenue in the three and nine months ended September 30, 2012, respectively, and was 74% and 72% of commission revenue in the three and nine months ended September 30, 2013, respectively. The decline in the percentage of commission revenue attributable to major medical individual and family health insurance plans in the three and nine months ended September 30, 2013, compared to the three and nine months ended September 30, 2012, was due primarily to an increase in commission revenue attributable to both ancillary health insurance plans, consisting primarily of dental, accident and vision insurance plan offerings, and Medicare-related insurance plans.  

 

We expect commission revenue to increase in absolute dollars in 2013 compared to 2012, primarily as a result of an increase in Medicare-related commission revenue, and to a lesser extent, increases in both individual and family plan and ancillary plan commission revenues. 

 

Other Revenue  

 

In addition to the commission revenue we derive from the sale of health insurance plans, we derive other revenue from our online sponsorship and advertising program, from licensing the use of our ecommerce technology and from generating and delivering leads, primarily for Medicare plans. 

17 

 


 

Online Sponsorship and Advertising.  We offer advertising services for our Medicare plan carriers to purchase advertising on separate websites developed, hosted and maintained by us for a pre-determined amount of time. In these instances, we are typically paid a fixed, up-front fee, which we recognize as revenue over the service period. We also derive revenue from online sponsorship and advertising programs that allows carriers to purchase advertising space in specific markets in a sponsorship area on our website. In return, we are typically paid a monthly fee and a performance-based fee based on metrics such as submitted health insurance applications.

Technology Licensing.  We derive revenue from licensing the use of our health insurance ecommerce technology. Our technology platform enables health insurance carriers and agents to market and distribute health insurance plans online.  In our technology licensing business, we are paid implementation fees and performance-based fees that are based on metrics such as submitted health insurance applications. Typically, we are paid a one-time implementation fee commencing once the technology is available for use by the third party, which we recognize on a straight-line basis over the term of the agreement. In addition, we generate revenue based on performance criteria that are either measured based on data tracked by us, or based on data tracked by the third party. In instances where the performance criteria data are tracked by us, we recognize revenue in the period of performance. In instances where the performance criteria data are tracked by the third party, we recognize revenue when the amounts earned are fixed or determinable and collection is reasonably assured. Typically, this occurs through our receipt of a cash payment from the third party along with a detailed statement containing the data that is tracked by the third party. 

Medicare Lead Referral.  Our online Medicare plan platforms (www.eHealthMedicare.com and www.PlanPrescriber.com) enable consumers to research and compare Medicare-related insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans. The Medicare-related revenue we have generated includes referral fees paid to us based on Medicare leads generated by our online platforms that are delivered and sold to third parties. Prior to 2012, the majority of our lead referral revenue was generated during the Medicare annual enrollment period, which occurs during the fourth quarter of the calendar year. In the second quarter of 2012, we began to perform services for substantially all Medicare leads ourselves as a health insurance agent, for which we are entitled to receive commissions. As a result, our Medicare lead referral revenue declined substantially. In the future, we intend to continue to perform services for substantially all Medicare leads ourselves as a health insurance agent. 

 

We expect other revenue to decline in absolute dollars in 2013 compared to 2012 due primarily to a decrease in Medicare lead referral revenue as a result of our strategic decision to directly service most of the Medicare leads we generate as a health insurance agent, while significantly reducing the number of Medicare leads we sell to third parties. As a result of this decision, we expect Medicare-related commission revenue to continue to increase in 2013. We also expect the decline in Medicare lead referral revenue to be partially offset by an increase in online sponsorship and advertising revenue. 

 

Member Acquisition  

 

An important factor in our revenue growth is the growth of our member base. Our marketing initiatives are an important component of our strategy to grow our member base and are focused on three primary member acquisition channels: direct, marketing partners and online advertising. Our marketing initiatives are primarily designed to encourage consumers to complete an application for health insurance. Our marketing channels are as follows: 

 

Direct.  Our direct member acquisition channel consists of consumers who access our website addresses, including www.eHealth.com, www.eHealthInsurance.com, www.eHealthMedicare.com and www.PlanPrescriber.com, either directly or through algorithmic natural search listings on Internet search engines and directories. For the three and nine months ended September 30, 2012, applications submitted through us for individual and family health insurance from our direct channel constituted 48% and 46%, respectively, of all individual and family health insurance applications submitted on our website. For the three and nine months ended September 30, 2013, applications submitted through us for individual and family health insurance from our direct channel constituted 51% and 49%, respectively, of all individual and family health insurance applications submitted on our website. 

 

Marketing Partners.  Our marketing partner member acquisition channel consists of consumers who access our websites through a network of affiliate partners and financial services and other companies. Growth in our marketing partner channel depends upon our expanding marketing programs with existing partners and adding new partners to our network.  For the three and nine months ended September 30, 2012, applications submitted through us for individual and family health insurance plans from our marketing partner member acquisition channel constituted approximately 31% and 32%, respectively, of all individual and family health insurance applications submitted on our website. For the three and nine months ended September 30, 2013, applications submitted through us for individual and family health insurance plans from

18 

 


 

our marketing partner member acquisition channel constituted approximately 33% and 32% respectively, of all individual and family health insurance applications submitted on our website.

 

Online Advertising.  Our online advertising member acquisition channel consists of consumers who access our websites through paid keyword search advertising from search engines such as Google, Bing and Yahoo!, as well as various Internet marketing programs such as banner advertising and email marketing. For the three and nine months ended September 30, 2012, applications submitted through us for individual and family health insurance plans from our online advertising channel constituted approximately 20% and 22%, respectively, of all individual and family health insurance applications submitted on our website. For the three and nine months ended September 30, 2013, applications submitted through us for individual and family health insurance plans from our online advertising channel constituted approximately 16% and 18%, respectively, of all individual and family health insurance applications submitted on our website.

 

In addition to our marketing channels, we have acquired health insurance members through transactions with broker partners. We have entered into several agreements, whereby the partners have transferred certain of their existing health insurance members to us as the broker of record on the underlying policies. These transfers included primarily Medicare plan members. The first of these transferred books-of-business occurred in February 2009 and the most recent in June 2012.

 

Operating Costs and Expenses  

 

Cost of Revenue  

 

Included in cost of revenue are payments related to health insurance policies sold to members who were referred to our website by marketing partners with whom we have revenue-sharing arrangements. In order to enter into a revenue-sharing arrangement, marketing partners must be licensed to sell health insurance in the state where the policy is sold. Costs related to revenue-sharing arrangements are expensed as the related revenue is recognized.  

 

Additionally, cost of revenue includes the amortization of consideration we paid to certain broker partners in connection with the transfer of their health insurance members to us as the new broker of record on the underlying policies. These transfers include primarily Medicare plan members. Total consideration paid in connection with these transfers amounted to $13.9 million. Consideration for all book-of-business transfers is being amortized to cost of revenue as we recognize commission revenue related to the transferred members over a period of up to five years for each arrangement.

  

We expect cost of revenue to increase in absolute dollars in 2013 compared to 2012 due to an increase in the amortization of consideration we paid to certain broker partners in connection with the transfer of their health insurance members to us as the new broker of record on the underlying policies.

 

Marketing and Advertising  

 

Marketing and advertising expenses consist primarily of member acquisition expenses associated with our direct, marketing partner and online advertising member acquisition channels, in addition to compensation and other expenses related to marketing, business development, partner management, public relations and carrier relations personnel who support our offerings. Our direct channel expenses primarily consist of costs for e-mail marketing and may also include costs for television advertising, radio advertising, print advertising, direct mail and email marketing. 

 

Our marketing partner channel expenses consist primarily of fees paid to marketing partners with which we have a relationship. We compensate a significant number of our marketing partners by paying a fee each time a consumer referral from a partner results in a submitted health insurance application, regardless of whether the consumer’s application is approved by the health insurance carrier. Many of our marketing partners have tiered arrangements in which the amount of the fee increases as the volume of submitted applications we receive from the marketing partner increases over a particular period. We recognize these expenditures in the period when a marketing partner’s referral results in the submission of a health insurance application. Since a significant portion of our marketing and advertising expenses are driven by the number of health insurance applications submitted on our ecommerce platform, those expenses are influenced by these patterns. As a result, marketing and advertising expenses related to individual and family health insurance plans have been highest in our first and third quarters, while marketing and advertising expenses related to Medicare-related plans have been highest in our third and fourth quarters.  However, with the implementation of the initial open enrollment period for individual and family plans on October 1, 2013, we expect to experience an increase in marketing and advertising expenses related to individual

19 

 


 

and family plans during the fourth quarter of 2013 and the first quarter of 2014, and then in the fourth quarter of 2014 and future fiscal years.

 

The majority of Medicare plans are sold in our fourth quarter during the Medicare annual enrollment period, when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. Since a significant portion of our marketing and advertising expenses are driven by the number of health insurance applications submitted on our website, those expenses are influenced by these patterns. In addition, because the total volume of submitted applications that we receive from our marketing partners is largely outside of our control, particularly during any short-term period, and because of our tiered marketing partner arrangements, we could incur expenses in excess of, or below, the amounts we had planned in periods of rapid change in the volume of submitted applications from marketing partner referrals. An unanticipated increase in submitted applications resulting from marketing partner referrals could cause our net income to be lower than our expectation, since the revenue to be derived from submitted applications that are approved by health insurance carriers will not be recognized until future periods. 

  

Paid keyword search advertising on search engines represents the majority of expenses in our online advertising channel. We incur expenses associated with search engine advertising in the period in which the consumer clicks on the advertisement.  Similar to our marketing partner channel, expenses in our online advertising channel will increase or decrease in relation to any increase or decrease in consumers referred to our website as a result of search engine advertising.  For example, due to the substantial increase in the number of consumers referred to our website from paid keyword search advertising during the Medicare annual enrollment period in the fourth quarter of 2012, we experienced a significant increase in online advertising expenses during the fourth quarter of 2012 compared to the other quarters of 2012. We also increased our discretionary spending for Medicare plan-related online advertising in the third quarters of 2012 and 2013, compared to the first and second quarters, in conjunction with the Medicare annual enrollment period in the fourth quarter of each year. Because the majority of our Medicare plan-related revenue is not generated until the fourth quarter, our discretionary online advertising expenses had a negative impact on our profitability during the third quarters of 2012 and 2013.  During the third quarter of 2013 our direct channel generated 51% of all individual and family health insurance applications submitted, compared to 48% during the third quarter of 2012 resulting from a decrease in spending on paid keyword search advertising for individual and family health insurance products relative to total advertising expense. 

We expect our marketing and advertising expenses to increase in absolute dollars in 2013 compared to 2012 due primarily to an increase in our Medicare-related online marketing and advertising expenditures during 2013, including paid keyword search advertising. We also expect our marketing and advertising expenses to decline as a percentage of total revenue in 2013 compared to 2012 as the growth rate in total revenue is expected to be higher than the growth rate in marketing and advertising expenses.

  

Customer Care and Enrollment  

Customer care and enrollment expenses primarily consist of compensation and benefits costs for personnel engaged in pre-sales assistance to applicants who call our customer care center and for enrollment personnel who assist applicants during the underwriting process. In preparation for the Medicare annual enrollment period, and to a lesser extent the initial open enrollment period for individual and family plans, we begin ramping up our customer care center staff during our second and third quarters to handle the anticipated increased volume of health insurance transactions during the fourth quarter. Accordingly, our customer care center staffing costs are significantly higher in our third and fourth quarters compared to our first and second quarters.  Because the majority of our Medicare plan-related revenue related to new sales is not generated until the fourth quarter, our temporary customer care center staffing costs incurred in the third quarter has had a significant negative impact on our profitability during that quarter. These seasonal trends have continued in 2013.

We expect customer care and enrollment expenses to increase in absolute dollars in 2013 compared to 2012 as a result of additional personnel we have hired and expect to hire to service the expected increase in the volume of Medicare demand and to a lesser extent the expected increase in the volume of individual and family demand in 2013 and due to an increase in expenditures to further develop our sales capabilities. 

 

Technology and Content  

 

Technology and content expenses consist primarily of compensation and benefits costs for personnel associated with developing and enhancing our website technology as well as maintaining our website. A majority of our technology and content group is located at our wholly-owned subsidiary in China, where technology development costs are generally lower than in the United States.  

20 

 


 

 

In order for us to offer and sell subsidy-eligible health insurance plans on our websites, we are required to meet certain conditions, such as compliance with standards for display of health plan and related information; providing consumers the ability to view all subsidy-eligible plans offered on the state’s exchange; displaying all subsidy-eligible health plan data on the state’s exchange; and providing a mechanism for consumers to withdraw from the application process to the state exchange. We have increased our technology and content spending throughout 2013 in order to increase functionality to meet the conditions required to offer and sell subsidy-eligible health insurance plans and to enhance the user experience. We expect that technology and content spending will be impacted in future years by additional infrastructure necessary to maintain compliance with these conditions. 

 

We expect technology and content expenses to increase in absolute dollars and as a percentage of total revenue in 2013 compared to 2012 as a result of an increase in labor and personnel costs in our product management and engineering departments as we increase our investment in our technology platform to further enhance the user experience, increase functionality and meet the requirements to offer and sell subsidy-eligible health insurance plans

 

General and Administrative  

 

General and administrative expenses include compensation and benefits costs for staff working in our executive, finance, corporate development, investor relations, government affairs, legal, human resources, internal audit, facilities and internal information technology departments. These expenses also include fees paid for outside professional services, including audit, tax, legal, government affairs and information technology fees.  

 

We expect our general and administrative expenses to increase in absolute dollars in 2013 compared to 2012 as we add infrastructure to support company growth.

 

Summary of Selected Metrics 

 

The following table shows certain selected quarterly metrics for the three months ended September 30, 2012 and 2013 and as of September 30, 2012 and 2013: 

 

 

 

 

 

 

 

Key Metrics:

Three Months Ended September 30, 2012

 

Three Months Ended September 30, 2013

 

 

 

 

 

Operating cash flows (1)

$

6,928,000 

 

$

8,678,000 

 

 

 

 

 

 

IFP submitted applications (2)

 

120,100 

 

 

123,300 

 

 

 

 

 

 

IFP approved members (3)

 

99,500 

 

 

112,300 

Total approved members (4)

 

174,500 

 

 

210,700 

 

 

 

 

 

 

Commission revenue (5)

$

31,291,000 

 

$

36,000,000 

Commission revenue per estimated member for the period (6)

$

34.70 

 

$

32.39 

 

 

 

 

 

 

 

As of

 

As of

 

 September 30, 2012

 

 September 30, 2013

 

 

 

 

 

 

IFP estimated membership (7)

 

698,600 

 

 

765,500 

Medicare estimated membership (8)

 

48,400 

 

 

85,300 

Other estimated membership (9)

 

179,600 

 

 

296,300 

Total estimated membership (10)

 

926,600 

 

 

1,147,100 

 

21 

 


 

 

 

 

 

 

 

 

Other Metrics:

Three Months Ended September 30, 2012

 

Three Months Ended September 30, 2013

 

 

 

 

 

 

Source of IFP submitted applications (as a percentage of total IFP applications for the period):

 

 

 

 

 

Direct (11)

 

48% 

 

 

51% 

Marketing partners (12)

 

32% 

 

 

33% 

Online advertising (13)

 

20% 

 

 

16% 

Total

 

100% 

 

 

100% 

 

22 

 


 

Notes: 

 

 

(1)

Net cash provided by operating activities for the period from the condensed consolidated statements of cash flows. 

(2)

IFP applications submitted on eHealth’s website during the period. Applications are counted as submitted when the applicant completes the application, provides a method for payment and clicks the submit button on our website and submits the application to us. The applicant generally has additional actions to take before the application will be reviewed by the insurance carrier, such as providing additional information and providing an electronic signature. In addition, an applicant may submit more than one application. We include applications for IFP plans for which we receive commissions as well as other forms of payment. We define our “IFP” offerings as major medical individual and family health insurance plans, which does not include small business, short-term, stand-alone dental, life, student or Medicare-related health insurance plans.

(3)

New IFP members reported to eHealth as approved during the period. Some members that are approved by a carrier do not accept the approval and therefore do not become paying members.

(4)

New members for all products reported to eHealth as approved during the period. Some members that are approved by a carrier do not accept the approval and therefore do not become paying members.

(5)

Commission revenue (from all sources) recognized during the period from the condensed consolidated statements of comprehensive income.

(6)

Calculated as commission revenue recognized during the period (see note (5) above) divided by average estimated membership for the period (calculated as beginning and ending estimated membership for all plans for the period, divided by two).

(7)

Estimated number of members active on IFP insurance policies as of the date indicated.

(8)

Estimated number of members active on Medicare-related insurance policies as of the date indicated.

(9)

Estimated number of members active on insurance policies other than IFP and Medicare-related policies as of the date indicated.

(10)

Estimated number of members active on all insurance policies, including Medicare-related policies, as of the date indicated.

(11)

Percentage of IFP submitted applications from applicants who came directly to the eHealth website through algorithmic search engine results or otherwise. See note (2) above for further information as to what constitutes a submitted application.

(12)

Percentage of IFP submitted applications from applicants sourced through eHealth’s network of marketing partners. See note (2) above for further information as to what constitutes a submitted application.

(13)

Percentage of IFP submitted applications from applicants sourced through paid search and other online advertising activities. See note (2) above for further information as to what constitutes a submitted application.

 

Our insurance carrier partners bill and collect insurance premiums paid by our members. Carrier partners do not report to us the number of members that we have as of a given date. The majority of our non-Medicare members who terminate their policies do so by discontinuing their premium payments to the carrier and do not inform us of the cancellation. Also, some of our non-Medicare members pay their premiums less frequently than monthly. Given the number of months required to observe non-payment of commissions in order to confirm cancellations, we estimate the number of members who are active on insurance policies as of a specified date. We estimate the number of continuing members on all policies as of a specific date as follows:

 

·

For individual and family health insurance policies, we take the sum of (i) the number of members for whom we have received or applied a commission payment for the month that is six months prior to the date of estimation (after reducing that number using historical experience for assumed member cancellations over the six-month period); and (ii) the number of approved members over the six-month period prior to the date of estimation (after reducing that number using historical experience for an assumed number of members who do not accept their approved policy and for estimated member cancellations through the date of the estimate).

 

·

For ancillary insurance policies (such as short-term, dental, vision, accident and student), we take the sum of (i) the number of members for whom we have received or applied a commission payment for the month that is one to three months prior to the date of estimation (after reducing that number using historical experience for assumed member cancellations over the one to three-month period); and (ii) the number of approved members over the one to three-month period prior to the date of estimation (after reducing that number using historical experience for an assumed number of members who do not accept their approved policy and for estimated member cancellations through the date of the estimate).  The one to three-month period varies by insurance product and is largely dependent upon the timeliness of commission payment and related reporting from the related carriers.

 

·

For Medicare-related insurance policies, we take the number of members for whom we have received or applied a commission payment prior to the date of estimation (after reducing that number using historical experience for assumed member cancellations, including rapid disenrollment).

 

·

For small business health insurance policies, we estimate the number of members using the number of initial members at the time the group is approved, and we update this number for changes in membership if such

23 

 


 

changes are reported to us by the group or carrier in the period it is reported. However, groups generally notify the carrier directly of policy cancellations and increases or decreases in group size without informing us. Additionally, our carrier partners often do not communicate this information to us. We often are made aware of policy cancellations at the time of annual renewal and update our membership statistics accordingly in the period they are reported. 

As a result, a member who purchases and is active on multiple standalone insurance policies will be counted as a member more than once.  For example, a member who is active on both an individual and family health insurance policy and a standalone dental policy will be counted as two continuing members.

After we have estimated membership for a period, we may receive information from health insurance carriers that would have impacted the estimate if we had received the information prior to the date of estimation. We may receive commission payments or other information that indicates that a member who was not included in our estimates for a prior period was in fact an active member at that time, or that a member who was included in our estimates was in fact not an active member of ours. For instance, we reconcile information carriers provide to us and may determine that we were not historically paid commissions owed to us, which would cause us to have underestimated our membership. Conversely, carriers may require us to return commission payments paid in a prior period due to policy cancellations for members we previously estimated as being active. We reflect updated information regarding our membership in the membership estimate for the current period that we are estimating, if applicable. As a result of the delay in our receipt of information from insurance carriers, actual trends in our membership are most discernible over periods longer than from one quarter to the next. In addition, and as a result of the delay we experience in receiving information about our membership, it is difficult for us to determine with any certainty the impact of current economic and other conditions on our membership retention.

 

Critical Accounting Policies and Estimates  

 

The preparation of financial statements and related disclosures in conformity with U.S. generally accepted accounting principles, or U.S. GAAP, requires us to make judgments, assumptions, and estimates that affect the amounts reported in the consolidated financial statements and the accompanying notes. These estimates and assumptions are based on current facts, historical experience, and various other factors that we believe are reasonable under the circumstances to determine reported amounts of assets, liabilities, revenue and expenses that are not readily apparent from other sources. To the extent there are material differences between our estimates and the actual results, our future consolidated results of operations may be affected. 

 

An accounting policy is considered to be critical if the nature of the estimates or assumptions is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change, and the effect of the estimates and assumptions on financial condition or operating performance. The accounting policies we believe to reflect our more significant estimates, judgments and assumptions and are most critical to understanding and evaluating our reported financial results are as follows:   

 

"

Revenue Recognition; 

"

Stock-Based Compensation;   

"

Realizability of Long-Lived Assets; and 

"

Accounting for Income Taxes. 

During the three and nine months ended September 30, 2013, there were no significant changes to our critical accounting policies and estimates. Please refer to Management's Discussion and Analysis of Financial Condition and Results of Operations contained in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2012, for a complete discussion of our critical accounting policies and estimates. 

24 

 


 

Results of Operations  

 

The following table sets forth our operating results and the related percentage of total revenues for the three and nine months ended September 30, 2012 and 2013 (dollars in thousands):  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2012

 

2013

 

2012

 

2013

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commission

$

31,291 

 

83 

%

$

36,000 

 

86 

%

$

93,358 

 

85 

%

$

109,193 

 

87 

%

Other

 

6,295 

 

17 

 

 

6,008 

 

14 

 

 

16,810 

 

15 

 

 

15,822 

 

13 

 

Total revenue

 

37,586 

 

100 

 

 

42,008 

 

100 

 

 

110,168 

 

100 

 

 

125,015 

 

100 

 

Operating costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

1,099 

 

 

 

806 

 

 

 

3,538 

 

 

 

4,441 

 

 

Marketing and advertising

 

13,988 

 

37 

 

 

14,852 

 

35 

 

 

39,142 

 

36 

 

 

43,448 

 

35 

 

Customer care and enrollment

 

8,823 

 

23 

 

 

8,936 

 

21 

 

 

21,152 

 

19 

 

 

23,914 

 

19 

 

Technology and content

 

5,503 

 

15 

 

 

9,117 

 

22 

 

 

16,018 

 

15 

 

 

23,585 

 

19 

 

General and administrative

 

6,744 

 

18 

 

 

7,540 

 

18 

 

 

19,938 

 

18 

 

 

22,191 

 

18 

 

Amortization of intangible assets

 

354 

 

 

 

354 

 

 

 

1,261 

 

 

 

1,061 

 

 

Total operating costs and expenses

 

36,511 

 

97 

 

 

41,605 

 

99 

 

 

101,049 

 

92 

 

 

118,640 

 

95 

 

Income from operations

 

1,075 

 

 

 

403 

 

 

 

9,119 

 

 

 

6,375 

 

 

Interest and other income (expense), net

 

 

 -

 

 

(22)

 

 -

 

 

41 

 

 -

 

 

(68)

 

 -

 

Income before provision for income taxes

 

1,079 

 

 

 

381 

 

 

 

9,160 

 

 

 

6,307 

 

 

Provision for income taxes

 

874 

 

 

 

207 

 

 -

 

 

4,525 

 

 

 

2,626 

 

 

Net income

$

205 

 

%

$

174 

 

 -

%

$

4,635 

 

%

$

3,681 

 

%

Operating costs and expenses include the following amounts of stock-based compensation expense  (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

Marketing and advertising

$

330 

 

$

517 

 

$

932 

 

$

1,446 

Customer care and enrollment

 

90 

 

 

92 

 

 

243 

 

 

261 

Technology and content

 

233 

 

 

425 

 

 

783 

 

 

1,129 

General and administrative

 

686 

 

 

911 

 

 

2,368 

 

 

2,525 

Total stock-based compensation expense

$

1,339 

 

$

1,945 

 

$

4,326 

 

$

5,361 

25 

 


 

 

Three and Nine Months Ended September 30, 2012 and 2013 

 

Revenue  

The following table presents our commission, other revenue and total revenue for the three and nine months ended September  30, 2012 and 2013 and the dollar and percentage changes from the prior year periods (dollars in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Change

 

Nine Months Ended

September 30,

 

Change

 

2012

 

2013

 

$

 

%

 

2012

 

2013

 

$

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commission

$

31,291 

 

$

36,000 

 

$

4,709 

 

15% 

 

$

93,358 

 

$

109,193 

 

$

15,835 

 

17% 

Percentage of total revenue

 

83% 

 

 

86% 

 

 

 

 

 

 

 

85% 

 

 

87% 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other

$

6,295 

 

$

6,008 

 

$

(287)

 

(5%)

 

$

16,810 

 

$

15,822 

 

$

(988)

 

(6%)

Percentage of total revenue

 

17% 

 

 

14% 

 

 

 

 

 

 

 

15% 

 

 

13% 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total revenue

$

37,586 

 

$

42,008 

 

$

4,422 

 

12% 

 

$

110,168 

 

$

125,015 

 

$

14,847 

 

13% 

 

Three Months Ended September 30, 2012 and 2013Commission revenue increased in the three months ended September 30, 2013, compared to the three months ended September 30, 2012, due primarily to a $2.2 million increase in commission revenue related to individual and family plans, including commission overrides. Additionally, commission revenue related to ancillary health insurance products, consisting primarily of short-term, dental, vision and accident insurance plan offerings, increased $1.5 million and Medicare-related commission revenue increased $1.0 million.

  

Other revenue decreased in the three months ended September 30, 2013, compared to the three months ended September 30, 2012, due primarily to a $0.6 million decrease in Medicare-related advertising revenue and a $0.2 million decrease in revenue related to technology licensing arrangements, partially offset by a $0.5 million increase in advertising revenue related to individual and family plans. 

 

Nine Months Ended September 30, 2012 and 2013Commission revenue increased in the nine months ended September 30, 2013, compared to the nine months ended September 30, 2012, due primarily to a $6.3 million increase in Medicare-related commission revenue. Commission revenue related to individual and family plans, including commission overrides, increased $5.4 million and commission revenue related to ancillary health insurance products increased $4.1 million. 

  

Other revenue decreased in the nine months ended September 30, 2013, compared to the nine months ended September 30, 2012, due primarily to a $1.1 million decrease in Medicare-related health insurance product lead referral revenue and a $0.5 million decrease in revenue related to technology licensing arrangements, partially offset by a $0.6 million increase in online sponsorship and advertising revenue. 

 

Operating Costs and  Expenses 

 

Cost of Revenue 

The following table presents our cost of revenue for the three and nine months ended September 30, 2012 and 2013 and the dollar and percentage changes from the prior year periods (dollars in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Change

 

Nine Months Ended September 30,

 

Change

 

2012

 

2013

 

$

 

%

 

2012

 

2013

 

$

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

$

1,099 

 

$

806 

 

$

(293)

 

(27%)

 

$

3,538 

 

$

4,441 

 

$

903 

 

26% 

Percentage of total revenue

 

3% 

 

 

2% 

 

 

 

 

 

 

 

3% 

 

 

4% 

 

 

 

 

 

 

26 

 


 

Three Months Ended September 30, 2012 and 2013Cost of revenue decreased in the three months ended September 30, 2013, compared to the three months ended September 30, 2012, due primarily to a decrease of $0.3 million  in amortization expense associated with consideration we paid in connection with several book-of-business transactions in which we acquired broker of record status on a number of Medicare health insurance plans. The amount of book-of-business consideration we amortize to cost of revenue each quarter is proportional to the amount of commission revenue we recognize on the underlying policies each quarter.

 

Nine Months Ended September 30, 2012 and 2013Cost of revenue increased in the nine months ended September 30, 2013, compared to the nine months ended September 30, 2012, due primarily to a $0.8 million increase in amortization expense associated with consideration we paid in connection with several book-of-business transactions in which we acquired broker of record status on a number of Medicare health insurance plans. The amount of book-of-business consideration we amortize to cost of revenue each period is proportional to the amount of commission revenue we recognize on the underlying policies each period.   

  

Marketing and Advertising  

The following table presents our marketing and advertising expenses for the three and nine months ended September 30, 2012 and 2013 and the dollar and percentage changes from the prior year periods (dollars in thousands):  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Change

 

Nine Months Ended September 30,

 

Change

 

2012

 

2013

 

$

 

%

 

2012

 

2013

 

$

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketing and advertising

$

13,988 

 

$

14,852 

 

$

864 

 

6% 

 

$

39,142 

 

$

43,448 

 

$

4,306 

 

11% 

Percentage of total revenue

 

37% 

 

 

35% 

 

 

 

 

 

 

 

36% 

 

 

35% 

 

 

 

 

 

Three Months Ended September 30, 2012 and 2013Marketing and advertising expenses increased in the three months ended September 30, 2013 compared to the three months ended September 30, 2012, due to an increase of $0.6 million in advertising expenses, including fees we pay to marketing partners for referrals that result in the submission of a health insurance application on our website, direct online advertising costs and paid keyword search advertising costs on Internet search engines, primarily related to Medicare health insurance plans, as well as $0.2 million in compensation, benefits, stock-based compensation and other personnel costs resulting from an increase in marketing and advertising personnel. 

Nine Months Ended September 30, 2012 and 2013Marketing and advertising expenses increased in the nine months ended September 30, 2013 compared to the nine months ended September 30, 2012, due to an increase of $3.2 million in advertising expenses related to both individual and family and Medicare health insurance plans,  as well as $1.0 million in compensation, benefits, stock-based compensation and other personnel costs resulting from an increase in marketing and advertising personnel. 

 

Customer Care and Enrollment  

The following table presents our customer care and enrollment expenses for the three and nine months ended September 30, 2012 and 2013 and the dollar and percentage changes from the prior year periods (dollars in thousands):  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Change

 

Nine Months Ended September 30,

 

Change

 

2012

 

2013

 

$

 

%

 

2012

 

2013

 

$

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Customer care and enrollment

$

8,823 

 

$

8,936 

 

$

113 

 

1% 

 

$

21,152 

 

$

23,914 

 

$

2,762 

 

13% 

Percentage of total revenue

 

23% 

 

 

21% 

 

 

 

 

 

 

 

19% 

 

 

19% 

 

 

 

 

 

 

Three Months Ended September 30, 2012 and 2013Customer care and enrollment expenses increased $0.1 million in the three months ended September 30, 2013 compared to the three months ended September 30, 2012, due primarily to compensation, benefits, stock-based compensation and other personnel costs associated with additional customer care center personnel hired to service the increased traffic for individual and family and ancillary health insurance products.

 

27 

 


 

Nine Months Ended September 30, 2012 and 2013Customer care and enrollment expenses increased $2.8 million in the nine months ended September 30, 2013 compared to the nine months ended September 30, 2012, due primarily to compensation, benefits, stock-based compensation and other personnel costs associated with additional customer care center personnel hired to service the increased volume of Medicare leads serviced directly by us as well as the increased traffic for individual and family and ancillary health insurance products. 

 

Technology and Content  

The following table presents our technology and content expenses for the three and nine months ended September 30, 2012 and 2013 and the dollar and percentage changes from the prior year periods (dollars in thousands):  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Change

 

Nine Months Ended September 30,

 

Change

 

2012

 

2013

 

$

 

%

 

2012

 

2013

 

$

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Technology and content

$

5,503 

 

$

9,117 

 

$

3,614 

 

66% 

 

$

16,018 

 

$

23,585 

 

$

7,567 

 

47% 

Percentage of total revenue

 

15% 

 

 

22% 

 

 

 

 

 

 

 

15% 

 

 

19% 

 

 

 

 

 

 

Three Months Ended September 30, 2012 and 2013Technology and content expenses increased in the three months ended September 30, 2013 compared to the three months ended September 30, 2012, primarily due to an increase of $2.8 million in compensation, benefits, stock-based compensation and other personnel costs as a result of an increase in technology and content personnel. Additionally, equipment maintenance costs and depreciation expense increased $0.2 million and $0.2 million respectively. The increase in expense is reflective of investments made in preparation for the initial open enrollment period under the healthcare reform legislation and investments made to enhance the user experience.  

 

Nine Months Ended September 30, 2012 and 2013Technology and content expenses increased in the nine months ended September 30, 2013 compared to the nine months ended September 30, 2012, primarily due to an increase of $6.4 million in compensation, benefits, stock-based compensation and other personnel costs as a result of an increase in technology and content personnel. Additionally, equipment maintenance costs and depreciation expense increased $0.5 million and $0.4 million, respectively. The increase in expense is reflective of investments made in preparation for the initial open enrollment period under the healthcare reform legislation and investments made to enhance the user experience.

 

General and Administrative  

The following table presents our general and administrative expenses for the three and nine months ended September 30, 2012 and 2013 and the dollar and percentage changes from the prior year periods (dollars in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Change

 

Nine Months Ended September 30,

 

Change

 

2012

 

2013

 

$

 

%

 

2012

 

2013

 

$

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

$

6,744 

 

$

7,540 

 

$

796 

 

12% 

 

$

19,938 

 

$

22,191 

 

$

2,253 

 

11% 

Percentage of total revenue

 

18% 

 

 

18% 

 

 

 

 

 

 

 

18% 

 

 

18% 

 

 

 

 

 

 

Three Months Ended September 30, 2012 and 2013General and administrative expenses increased in the three months ended September 30, 2013 compared to the three months ended September 30, 2012,  due primarily to an increase of $0.8 million in compensation, benefits, stock-based compensation and other personnel costs as a result of an increase in general and administrative personnel as we add infrastructure to support company growth.

 

Nine Months Ended September 30, 2012 and 2013General and administrative expenses increased in the nine months ended September 30, 2013 compared to the nine months ended September 30, 2012, due primarily to an increase of $2.1 million in compensation, benefits, stock-based compensation and other personnel costs as a result of an increase in general and administrative personnel as we add infrastructure to support company growth.   

28 

 


 

Amortization of Intangible Assets 

 

The following table presents our amortization of intangible assets for the three and nine months ended September 30, 2012 and 2013 and the dollar and percentage changes from the prior year periods (dollars in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Change

 

Nine Months Ended September 30,

 

Change

 

2012

 

2013

 

$

 

%

 

2012

 

2013

 

$

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of intangible assets

$

354 

 

$

354 

 

$

 -

 

0% 

 

$

1,261 

 

$

1,061 

 

$

(200)

 

(16%)

Percentage of total revenue

 

1% 

 

 

1% 

 

 

 

 

 

 

 

1% 

 

 

1% 

 

 

 

 

 

 

Three Months Ended September 30, 2012 and 2013Amortization expense related to intangible assets purchased through our acquisition of PlanPrescriber remained flat in the three months ended September 30, 2013 compared to the three months ended September 30, 2012.

 

Nine Months Ended September 30, 2012 and 2013Amortization expense related to intangible assets purchased through our acquisition of PlanPrescriber decreased in the nine months ended September 30, 2013 compared to the nine months ended September 30, 2012, respectively, as certain intangible assets were fully amortized during 2013.  

 

Other Income  (Expense), Net  

The following table presents our other income  (expense), net, for the three and nine months ended September 30, 2012 and 2013 and the dollar and percentage changes from the prior year periods (dollars in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Change

 

Nine Months Ended September 30,

 

Change

 

2012

 

2013

 

$

 

%

 

2012

 

2013

 

$

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense), net

$

 

$

(22)

 

$

(26)

 

(650%)

 

$

41 

 

$

(68)

 

$

(109)

 

(266%)

Percentage of total revenue

 

0% 

 

 

(0%)

 

 

 

 

 

 

 

0% 

 

 

(0%)

 

 

 

 

 

 

Three and Nine Months Ended September 30, 2012 and 2013Interest earned on our invested cash more than offset administrative bank fees, investment management fees and interest expense on our capital leases in the three and nine months ended September 30, 2012. Administrative bank fees, management fees and interest expense on our capital lease obligations more than offset interest earned on our invested cash in the three and nine months ended September 30, 2013.

 

Provision for Income Taxes  

The following table presents our provision for income taxes for the three and nine months ended September 30, 2012 and 2013 and the dollar changes from the prior year periods (dollars in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

September 30,

 

 

 

 

Nine Months Ended

September 30,

 

 

 

 

2012

 

2013

 

Change $

 

2012

 

2013

 

Change $

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

$

874 

 

$

207 

 

$

(667)

 

$

4,525 

 

$

2,626 

 

$

(1,899)

Percentage of total revenue

 

2% 

 

 

0% 

 

 

 

 

 

4% 

 

 

2% 

 

 

 

 

 

Three Months Ended September 30, 2012 and 2013In the three months ended September 30, 2012 and 2013, we recorded a provision for income taxes representing effective tax rates of 81.0% and 54.3%, respectively. Our effective tax rate for the three months ended September 30, 2012  was higher than statutory federal and state tax rates due primarily to non-deductible lobbying expenses and tax shortfalls related to share-based payments. Our effective tax rate for the three months ended September 30, 2013 was higher than statutory federal and state tax rates due primarily to non-deductible lobbying expenses. 

 

Nine Months Ended September 30, 2012 and 2013In the nine months ended September 30, 2012 and 2013, we recorded a provision for income taxes representing effective tax rates of 49.4% and 41.6%, respectively. Our effective tax

29 

 


 

rate for the nine months ended September 30, 2012 was higher than statutory federal and state tax rates due primarily to non-deductible lobbying expenses and tax shortfalls related to share-based payments. Our effective tax rate for the nine months ended September 30, 2013 was higher than statutory federal and state tax rates due primarily to non-deductible lobbying expenses.

  

Liquidity and Capital Resources  

 

At September 30, 2013, our cash and cash equivalents totaled $97.8 million. Cash equivalents, which are comprised of financial instruments with an original maturity of 90 days or less from the date of purchase, consist of money market funds. At December 31, 2012, our cash and cash equivalents totaled $140.8 million.  The decrease in cash and cash equivalents reflects $59.0 million used to repurchase 2.9 million shares of common stock, partially offset by cash flows generated from operations.

On September 10, 2012, we announced that our board of directors approved a stock repurchase program authorizing us to purchase up to $30 million of our common stock and on March 6, 2013, we announced that our board of directors increased the approved repurchase amount under this program to $60 million. Purchases under this program were made in the open market and complied with Rule 10b-18 under the Securities Exchange Act of 1934, as amended. The cost of the repurchased shares was funded from available working capital. 

For accounting purposes, common stock repurchased under our stock repurchase programs is recorded based upon the settlement date of the applicable trade. Such repurchased shares are held in treasury and are presented using the cost method. 

Stock repurchase activity under our stock repurchase programs during the nine months ended September 30, 2013 is summarized as follows (in thousands, except share and per share amounts): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Number of Shares Purchased

 

Average Price Paid per Share (2)

 

Amount of Repurchase

Cumulative balance at December 31, 2012 (1)

6,397,803 

 

$

14.22 

 

$

90,991 

Repurchases of common stock

2,911,466 

 

$

20.27 

 

 

59,007 

Cumulative balance at September 30, 2013 (1)

9,309,269 

 

$

16.11 

 

$

149,998 

 

(1)

Cumulative balances at December 31, 2012 and September 30, 2013 consist of shares repurchased in connection with our stock repurchase programs announced on September 10, 2012, as well as previous stock repurchase plans announced in 2011, 2010 and 2008.  

(2)Average price paid per share includes commissions. 

In addition to the shares repurchased under our repurchase programs as of September 30, 2013, we have in treasury 209,925 shares that were previously surrendered by employees to satisfy tax withholdings due in connection with the vesting of certain restricted stock units. As of December 31, 2012 and September 30, 2013, we had a total of 6,556,303 shares and 9,519,194 shares, respectively, held in treasury. 

 

The following table presents a summary of our cash flows for the nine months ended September 30, 2012 and 2013 (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended September 30,

 

2012

 

2013

 

 

 

 

 

 

Net cash provided by operating activities

$

19,653 

 

$

14,775 

Net cash used in investing activities

$

(9,371)

 

$

(6,735)

Net cash used in financing activities

$

(3,091)

 

$

(51,121)

 

During the nine months ended September 30, 2012 and 2013, we utilized excess federal and state tax benefits related to share-based payments, which resulted in increases of $2.4 million and $4.2  million, respectively, in Additional Paid-In  

30 

 


 

Capital in the condensed consolidated balance sheets. These amounts are also classified in the condensed consolidated statements of cash flows as both a reduction to operating cash flows and as a financing cash inflow. 

 

Operating Activities 

 

Cash provided by operating activities primarily consists of net income, adjusted for certain non-cash items including deferred income taxes, depreciation and amortization, including amortization of intangible assets, stock-based compensation expense and the effect of changes in working capital and other activities.  

 

The timing of the recognition of our commission revenue depends upon the timing of our receipt of commission reports and associated commission payments from health insurance carriers. If we were to experience a delay in receiving a commission payment from a health insurance carrier at the end of a quarter, our operating cash flows for that quarter could be adversely impacted. Additionally, commission override payments are reported to us in a more irregular pattern than premium commissions. For example, a carrier may make a commission override payment to us on an annual basis, which would positively impact our cash flows in the quarter the payment is received. The annual commission override payments we receive are typically higher during the first quarter of the year.  

 

Historically, we have experienced a reduction in operating cash flows during the first quarter of the year compared to the other quarters due to the payment of annual performance bonuses to employees in the first quarter of the year. In the first quarter of 2012, we collected a substantial amount of lead referral payments related to Medicare leads sold during the annual enrollment period in the fourth quarter of 2011. The seasonal impact of Medicare lead referral collections was minimal in 2013 as we have transitioned away from lead referral transactions. Additionally, a significant portion of our marketing and advertising expenses are driven by the number of health insurance applications submitted on our ecommerce platform. Since our marketing and advertising costs are expensed as incurred and the revenue from approved applications is recognized as commissions are subsequently reported to us, our operating cash flows could be adversely impacted by a substantial increase in the volume of applications submitted during a quarter or positively impacted by a substantial decline in the volume of applications submitted during a quarter. The impact of open enrollment periods beginning during the fourth quarter of 2013 for the purchase of major medical health insurance plans will have on our future cash flows is unclear. The first open enrollment period began in October 2013 and runs through March 2014. Thereafter, it is scheduled to occur within the fourth quarter each calendar year starting in 2014. We expect total marketing expenses will increase to some extent during the open enrollment period as consumers switch health insurance policies.

 

Nine Months Ended September 30, 2013Our operating activities generated cash of $14.8 million during the nine months ended September 30, 2013 and consisted of net income of $3.7 million, increased by non-cash items of $8.5 million and cash provided by working capital and other activities of $2.6 million. Adjustments for non-cash items primarily consisted of $6.2 million of depreciation and amortization, including amortization of book-of-business consideration and amortization of intangible assets,  and $5.4 million of stock-based compensation expense, partially offset by $4.0 million of deferred income taxes,  consisting primarily of excess tax benefits from stock-based compensation. Cash provided by working capital and other activities primarily consisted of an increase of $3.8 million in deferred revenue, an increase of $2.5 million in accrued compensation and other benefits, and an increase of $1.4 million in other current liabilities, partially offset by an increase of $2.1 million in accounts receivable, a decrease of $1.9 million in accounts payable, and an increase of $0.9 million in prepaid expenses and other assets. 

 

Nine Months Ended September 30, 2012—Our operating activities generated cash of $19.7 million during the nine months ended September 30, 2012 and consisted of net income of $4.6 million, increased by non-cash items of $9.4 million and cash provided by working capital and other activities of $5.6 million. Adjustments for non-cash items primarily consisted of $4.3 million of stock-based compensation expense and $5.0 million of depreciation and amortization, including amortization of book-of-business consideration and amortization of intangible assets. Cash provided by working capital and other activities primarily consisted of a decrease of $4.8 million in accounts receivable, an increase of $2.2 million in accounts payable, an increase of $0.9 million in accrued compensation and other benefits and increases totaling $0.7 million in deferred revenue and other current liabilities, partially offset by a decrease of $2.3 million in accrued marketing expenses and an increase of $0.7 million in prepaid expenses and other assets.

 

31 

 


 

Investing Activities  

 

Our investing activities primarily consist of purchases of computer hardware and software to enhance our website and to support our growth and include consideration paid to a partner in connection with the transfer to us of certain Medicare plan members.  

 

Nine Months Ended September 30, 2013—Net cash used in investing activities of $6.7 million during the nine months ended September 30, 2013 was attributable entirely to capital expenditures.  

 

Nine Months Ended September 30, 2012—Net cash used in investing activities of $9.4 million during the nine months ended September 30, 2012 was attributable to cash consideration of $6.2 million paid to a partner related to the transfer of two books-of-business in the nine months ended September 30, 2012, whereby we became the broker of record on the underlying policies for certain Medicare insurance members that were transferred to us, and capital expenditures of $3.1 million.

 

Financing Activities  

 

Our financing activities primarily consist of net proceeds from the exercise of common stock options, cash used to net-share settle equity awards and excess tax benefits from stock-based compensation. Additionally, in periods in which we have an active stock repurchase program in effect, our financing activities include repurchases of common stock. 

 

Nine Months Ended September 30, 2013Net cash used in financing activities of $51.1 million during the nine months ended September 30, 2013 was due to $59.0 million used to repurchase 2.9 million shares of our common stock and $0.9 million used to net-share settle the tax obligation related to vesting equity awards, partially offset by $4.7 million of proceeds from the exercise of common stock options and $4.2 million of excess tax benefits from stock-based compensation.  

 

Nine Months Ended September 30, 2012Net cash used in financing activities of $3.1 million during the nine months ended September 30, 2012 was due to $8.4 million used to repurchase 0.6 million shares of our common stock and $1.0 million used to net-share settle the tax obligation related to vesting equity awards, partially offset by $4.0 million of proceeds from the exercise of common stock options and $2.4 million of excess tax benefits from stock-based compensation.

 

Future Needs 

 

We believe that cash generated from operations and our current cash and cash equivalents will be sufficient to fund our operations for at least the next twelve months. Our future capital requirements will depend on many factors, including our level of investment in technology and advertising initiatives. We currently do not have any bank debt, line of credit facilities or other borrowing arrangements. To the extent that available funds are insufficient to fund our future activities, we may need to raise additional capital through public or private equity or debt financing to the extent such funding sources are available. 

 

32 

 


 

Contractual Obligations and Commitments 

 

Operating Lease Obligations 

 

We lease our operating facilities and certain of our equipment and furniture and fixtures under various operating leases, the latest of which expires in July 2023. Certain of these leases have free or escalating rent payment provisions. We recognize rent expense on our operating leases on a straight-line basis over the terms of the leases, although actual cash payment obligations under certain of these agreements fluctuate over the terms of the agreements. 

In March 2012, we entered into an agreement to lease a building in Mountain View, California, adjacent to our headquarters office. The term of the operating lease is ten years from the date the building was delivered to us in August 2013 and the base rent is approximately $0.6 million for the first year of the lease. The base rent increases annually by 3%. Future minimum payments related to this operating lease total $7.0 million over the ten-year term of the lease plus our proportionate share of certain operating expenses, insurance costs and taxes for each calendar year during the lease. Lease payments began in the third quarter of 2013. 

 

Upon signing the Mountain View, California lease agreement, we  entered into a financial guarantee consisting of a standby letter of credit for $0.6 million, which may be reduced in increments of 25% of the original amount thereof on the first, second and third anniversaries of the commencement date, subject to our compliance with the applicable conditions to such reductions set forth in the lease.   

 

In April 2013, we entered into an agreement to lease approximately 20,000 square feet of office space in Westford, Massachusetts. The lease commenced in July 2013 and is for a term of 5 years and 3 months. Future minimum payments will total approximately $2.1 million over the term of the lease. 

    

Service and Licensing Obligations  

 

We have entered into service and licensing agreements with third party vendors to provide various services, including network access, equipment maintenance and software licensing. The terms of these services and licensing agreements are generally up to three years. We record the related service and licensing expenses on a straight-line basis, although actual cash payment obligations under certain of these agreements fluctuate over the terms of the agreements.  

 

The following table presents a summary of our future minimum payments under non-cancellable operating lease agreements and certain contractual service and licensing obligations as of September 30, 2013 (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Years Ending December 31,

Operating Lease Obligations

 

Service and Licensing Obligations

 

Total Obligations

 

 

 

 

 

 

 

 

2013 (three months)

$

985 

 

$

189 

 

$

1,174 

2014

 

3,790 

 

 

948 

 

 

4,738 

2015

 

2,515 

 

 

138 

 

 

2,653 

2016

 

2,560 

 

 

 -

 

 

2,560 

2017

 

2,617 

 

 

 -

 

 

2,617 

Thereafter

 

6,024 

 

 

 -

 

 

6,024 

Total

$

18,491 

 

$

1,275 

 

$

19,766 

 

Off-Balance Sheet Arrangements  

 

We do not have any off-balance sheet arrangements, investments in special purpose entities or undisclosed borrowings or debt. Additionally, we are not a party to any derivative contracts or synthetic leases.

33 

 


 

 

 

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

 

 Our financial instruments that are exposed to concentrations of credit risk principally consist of cash and cash equivalents and accounts receivable. As of December 31, 2012 and September 30, 2013, our cash and cash equivalents were invested as follows (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2012

 

September 30, 2013

 

 

 

 

 

 

Cash (1)

$

27,484 

 

$

19,632 

Money market funds (2)

 

113,365 

 

 

78,119 

Total cash and cash equivalents

$

140,849 

 

$

97,751 

 

(1)

We deposit our cash and cash equivalents in accounts with major banks and financial institutions and such deposits are in excess of federally insured limits. We also have deposits with major banks in China that are denominated in both U.S. dollars and Chinese Renminbi and are not insured by the U.S. federal government.   

 

(2)

At December 31, 2012 and September 30, 2013 money market funds consisted of U.S. government-sponsored enterprise bonds and discount notes, U.S. government treasury bills and notes and repurchase agreements collateralized by U.S. government obligations. 

 

We do not require collateral or other security for our accounts receivable. As of December 31, 2012,  four customers represented 25%, 22%, 14% and 11%, respectively, for a combined total of 72% of our  $4.5 million outstanding accounts receivable balance. As of September 30, 2013,  two customers represented 43% and 33% respectively, for a combined total 76% of our $6.6 million outstanding accounts receivable balance. No other customers represented 10% or more of our total accounts receivable at December 31, 2012 and September 30, 2013. We believe the potential for collection issues with any of our customers is minimal as of September 30, 2013. Accordingly, our estimate for uncollectible amounts at September 30, 2013 was not material. 

 

Significant Customers 

 

Substantially all revenue for the three and nine months ended September 30, 2012 and 2013 was generated from customers located in the United States. Carriers representing 10% or more of our total revenue in the three and nine months ended September 30, 2012 and 2013 are presented in the table below: 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

Humana

19% 

 

18% 

 

16% 

 

20% 

WellPoint (1)

13% 

 

12% 

 

13% 

 

12% 

UnitedHealthcare (2)

12% 

 

11% 

 

13% 

 

11% 

Aetna (3)

7% 

 

10% 

 

7% 

 

9% 

 

(1)

Wellpoint includes other carriers owned by Wellpoint. 

(2)

UnitedHealthcare includes other carriers owned by UnitedHealthcare. 

(3)

Aetna also includes other carriers owned by Aetna.

 

Foreign Currency Exchange Risk  

 

To date, substantially all of our revenue has been derived from transactions denominated in United States Dollars. We have exposure to adverse changes in exchange rates associated with operating expenses of our foreign operations, which are denominated in Chinese Yuan Renminbi. Foreign currency fluctuations have not had a material impact historically on our results of operations; however, there can be no assurance that future fluctuations will not have material adverse effects on our results of operations. We have not engaged in any foreign currency hedging or other derivative transactions to date.

34 

 


 

 

 

ITEM 4.

CONTROLS AND PROCEDURES

 

 

 

Evaluation of Our Disclosure Controls and Procedures 

 

Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rules 13a-15(b) and 15d-15(b) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this Quarterly Report on Form 10-Q.  

 

Based on management’s evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.  

 

Changes in Internal Control Over Financial Reporting 

 

There were no changes in our internal control over financial reporting that occurred during the three months ended September 30, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.  

 

Inherent Limitations on Effectiveness of Controls 

 

Our management, including our chief executive officer and chief financial officer, do not expect that our disclosure controls or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. 

 

35 

 


 

PART II 

OTHER INFORMATION 

 

ITEM 1.

LEGAL PROCEEDINGS 

 

 

In the ordinary course of our business, we have received and may continue to receive inquiries from state regulators relating to various matters. We also have become, and may in the future become, involved in litigation in the ordinary course of our business.  

 

 

36 

 


 

 

 

ITEM 1A.

RISK FACTORS

 

 

 

In addition to other information in this Quarterly Report on Form 10-Q and in other filings we make with the Securities and Exchange Commission, the following risk factors should be carefully considered in evaluating our business as they may have a significant impact on our business, operating results and financial condition. If any of the following risks actually occurs, our business, financial condition, results of operations and future prospects could be materially and adversely affected. Because of the following factors, as well as other variables affecting our operating results, past financial performance should not be considered as a reliable indicator of future performance and investors should not use historical trends to anticipate results or trends in future periods. 

 

Risks Related to Our Business 

  

Changes and developments in the health insurance system in the United States as a result of health care reform or otherwise could harm our business. 

 

Our business depends upon the private sector of the United States health insurance system, its relative role in financing health care delivery and health insurance carriers’ use of, and payment of commissions to, agents and brokers to market health insurance plans. In March 2010, the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act were signed into law. These health care reform laws contain provisions that have and will continue to change the industry in which we operate in substantial ways. Among several other provisions, they include a mandate requiring individuals to maintain health insurance or face tax penalties; a mandate that certain employers offer their employees group health insurance coverage or face tax penalties; requirements relating to employer contribution to employee health coverage; prohibitions against insurance companies using pre-existing health conditions as a reason to deny an application for health insurance; prohibitions on rescission of health insurance; prohibitions on lifetime coverage limits; requirements for guaranteed renewability of health insurance plans; health insurance premium setting guidelines; limitations on deductibles and cost-sharing; medical loss ratio requirements that require each health insurance carrier to spend a certain percentage of their premium revenue on reimbursement for clinical services and activities that improve health care quality and, if they do not, to provide rebates to policyholders; minimum benefit levels for health insurance plans, including limitations on annual coverage limits; taxes and assessments on health insurance carriers; establishment of state and/or federal health insurance exchanges to facilitate access to, and the purchase of, health insurance; open enrollment periods for individual and family health insurance; assistance for member run health insurance issuers; creation of multi-state health insurance plans to be offered on the exchanges and with oversight from the Office of Personnel Management; requirements for uniform disclosure relating to the costs and benefits of health insurance; government subsidized high risk pools; an expansion of Medicaid so that more individuals will be insured under state Medicaid programs; and subsidies and cost-sharing credits to make health insurance more affordable for those below certain income levels. Many aspects of health care reform do not go into effect until 2014, although certain provisions currently are effective, such as medical loss ratio requirements for individual and family and small business health insurance, a prohibition against insurance companies using pre-existing health conditions as a reason to deny the application of children for health insurance and a requirement that persons 26 years of age and younger be able to stay on a parent’s health insurance plan.  Health care reform legislation requires various departments of the executive branch to adopt regulations implementing its provisions. In addition, state governments have adopted, and will continue to adopt, changes to their existing laws and regulations in light of federal health care reform legislation and regulations.   

 

The implementation of health care reform could increase our competition; reduce or eliminate the need for health insurance agents or demand for the health insurance for individuals, families or small businesses that we sell; decrease the number of health insurance plans that we sell as well as the number of health insurance carriers offering them;  change the benefits and/or premiums for the plans we sell; cause a substantial reduction in our membership; or cause health insurance carriers to reduce our commissions and other amounts they pay  for our services or change our relationship with them in other ways, any of which could materially harm our business, operating results and financial condition.  For instance, beginning in 2014 health insurance carriers offering coverage in the individual or small group health insurance market must ensure that such coverage meets certain actuarial value standards, includes certain minimum health benefits and is not subject to lifetime or, for most health insurance benefits, annual dollar amount coverage limits.  Individuals are required to hold plans providing minimum essential coverage to meet the mandate for health insurance and avoid a tax penalty.  It is unclear whether this tax penalty is sufficient enough to drive a substantial number of new entrants into the health insurance market, and if it does not, our business, operating results and financial condition could be harmed. Moreover, many of the individual and small group health insurance plans we have sold do not cover all of the minimum essential benefits or meet

37 

 


 

other standards under health care reform. We could suffer a substantial reduction in our membership as a result of our members moving to plans that contain minimum essential benefits under health care reform if we do not remain the agent of record on their plan, which would materially harm our business, operating results and financial condition. In addition, certain existing plans of our members are being modified with an increase in the cost of the plan and a number of other plans are being terminated, which also could result in a reduction in our membership and materially harm our business, operating results and financial condition. Various aspects of health care reform have and could continue to cause health insurance carriers to determine to limit the type of health insurance plans we sell and the geographies in which we sell them, to exit the business of selling insurance plans in a particular jurisdiction, to eliminate certain categories of products or attempt to move members into new plans for which we receive lower or no commissions, any of which could materially harm our business, operating results and financial condition.    

 

As a part of healthcare reform, each state was required to implement a health insurance exchange by October 2013 where individuals and small businesses can purchase health insurance. For states that did not implement a health insurance exchange, the federal government has implemented and is operating the exchange for that state. The Federally-Facilitated Exchange (“FFE”) is operating some part of the health insurance exchange in 36 states during the initial open enrollment period that began in October 2013. Among other things, the exchanges have websites where individuals and small businesses can shop for and purchase health insurance, and they also have offline customer support and enrollment capabilities. Individuals who are eligible for government subsidies must purchase qualified health plans through a government exchange to receive their subsidy. The exchanges are a new source of competition for us. In the event our existing members purchase health insurance directly through health insurance exchanges without using our services, as a result of their being eligible for a subsidy or otherwise, we will no longer receive commission revenue as a result of our sale of health insurance to them. Moreover,  the exchanges will compete with us for new members. Competitive pressure from health insurance exchanges may result in our experiencing increased marketing costs, decreased traffic to our website and loss of market share, and may otherwise harm our business, operating results and financial condition.

 

In addition to the expansion of Medicaid eligibility as a part of health care reform, individuals and families whose incomes are between 133% and 400% of the federal poverty level will generally be entitled beginning in 2014 to subsidies in connection with their purchase of health insurance. In order to be eligible for a subsidy, qualified individuals must purchase subsidy qualifying health plans through a government-run health insurance exchange. These qualified health plans are required to be purchased during an initial open enrollment period that began in October 2013 and is currently scheduled to run through March 2014, and qualified individuals can thereafter change their qualified health plan only during annual enrollment periods scheduled to occur from October 15 through December 7 of each year thereafter, subject to states extending the period and exceptions for special enrollment periods for certain qualifying events. States and health insurance carriers also have generally adopted, these open enrollment periods for the purchase of health insurance outside of government-run health insurance exchanges. It may be difficult for us to handle as a business any increased volume of health insurance transactions that would occur in a short period of time during the enrollment periods.  Moreover, with respect to qualified health plans, state and/or the federal governments may not have implemented the ability for agents and brokers to submit health insurance applications for qualified health plans through them and may not permit us to do so.  In the aggregate, a shift to open enrollment periods of limited duration in the individual and family and small business health insurance markets may result in a reduction in our membership and revenue; increase in our expenses, particularly during certain periods of the year; and otherwise may harm our business, operating results and financial condition, particularly given that the open enrollment period for qualified health plans and other health plans will overlap with the annual enrollment period for Medicare plans.

 

A federal regulation promulgated under the Patient Protection and Affordable Care Act has been issued that clarifies that states may, but are not required to, allow agents and brokers such as us to market the qualified health plans offered on government-run health insurance exchanges and that are the plans that subsidy-eligible individuals must purchase in order to receive their subsidies. In order to offer qualified health plans, agents and brokers must meet certain conditions, such as entering into an agreement with the health insurance exchange, ensuring that the enrollment and subsidy application is completed through the state’s health insurance exchange (or the FFE in states without individual health insurance enrollment capability) and complying with privacy, security and other standards, some of which have been recently issued and contain requirements that are new to us. In the event Internet-based agents and brokers such as us use the Internet for completion of qualified health plan selection purposes, their websites are required to meet certain additional conditions, such as compliance with standards for display of health plan and related information; providing consumers the ability to view all health plans offered on the government-run exchange; displaying certain  health plan and other data available on the exchange; and providing a mechanism for consumers to withdraw from the application process on the agent or broker’s website. We may experience difficulty in satisfying the conditions and requirements to offer qualified health plans to our

38 

 


 

existing members and new potential members. Moreover, while we have entered into agreements with the federal government that relate to our enrolling individuals into qualified health plans through the FFE, we have not entered into a relationship with any of the 14 states that are not a part of the FFE to be able to enroll individuals into qualified health plans. A substantial number of our existing members in these states are likely eligible for subsidies in connection with their purchase of health insurance and we may lose these members and potential new members as a result, which would harm our business, operating results and financial condition.

 

During the third quarter of 2013, we entered into agreements with the Centers for Medicare and Medicaid Services, or CMS, relating to our ability to enroll individuals in qualified health plans through the FEE.  The first agreement we entered into with CMS (the “CMS Agreement”) relates to our gaining access to information from the federal government data hub that contains information necessary for determining the eligibility of individuals to purchase qualified health plans and to receive subsidies in connection with their purchase of health insurance. The CMS Agreement contains comprehensive privacy and security and other requirements that we must meet and implement.  In order to be able to enroll individuals into qualified health plans, we also must satisfy several other regulatory requirements and comply with additional laws and regulations. Another agreement we entered into with CMS (the “CMS Agent Agreement”) is required for all agents and brokers who wish to enroll eligible individuals in qualified health plans through the FFE, including those that do not use their Internet website to assist individuals in applying for qualified health plans through the FFE. There are risks and uncertainties relating to our ability to enroll individuals into qualified health plans through the FFE.  Among other things, we must satisfy the requirements contained in the relevant agreements as well as applicable laws and regulations; complete development of a compliant web platform incorporating those requirements; obtain qualified health plan information from health insurance carriers and CMS and incorporate it into our web platform; implement a privacy and security program to conform to the privacy and security requirements of our agreement with CMS as well as applicable laws and regulations; and successfully integrate with the federally operated exchange so that information may be passed to and from us relating to qualified health plan and subsidy eligibility. We may experience difficulty in satisfying the conditions and requirements to offer qualified health plans to our existing members and new potential members through the FFE.  A substantial number of our members in states where the government-run exchange is operated by the FFE are likely eligible for subsidies in connection with their purchase of health insurance.  As a result, if we do not satisfy these conditions and requirements, we will not be able to offer qualified health plans through the FFE and our business, operating results and financial condition would be harmed.   

 

We depend upon the federal government for a number of things relating to our ability to enroll individuals into qualified health plans through the FFE, including certain qualified health plan information that is required under the applicable regulations to be displayed on our website and integration so that we are able to pass information to and from the FFE relating to enrollment and qualified health plan and subsidy eligibility. The FFE is currently experiencing severe technological problems with its website and ability to enroll individuals into qualified health plans. Our integration with the FFE to sell qualified health plans depends on the FFE fixing these problems. If the FFE does not do so, or if it delays in doing so, our ability to offer qualified health plans through the FFE will be prevented or delayed, which would harm our business, operating results and financial condition. We may not be able to enroll individuals into qualified health plans during the current initial enrollment period or within any other specific timeframe.  If we are not able to enroll individuals into qualified health plans during the current initial enrollment period in time for January 1 effective date coverage, our business, operating results and financial condition would be harmed.

 

In addition to the satisfaction of conditions and requirements to sell qualified health plans and government health insurance exchange technical difficulties, we also depend upon health insurance companies to allow us to sell qualified health plans and to pay us commissions in connection with their sale. In the event we are not successful in gaining the ability to sell individual and family qualified health insurance plans, or if health insurance carriers pay us no commissions or reduced commissions in connection with the sale of these plans, we could lose a substantial number of existing and potential members and commission revenue we receive as a result of the sale of individual and family and small business health insurance products, which would materially harm our business, operating results and financial condition. In part to attempt to satisfy conditions necessary for us to use our Internet technology platform to enroll individuals into qualified health plans as a health insurance agent, and assist individuals in applying for subsidies, through government-run health insurance exchanges, we have incurred increased operating expenses and expect to continue to do so. These past and expected increased operating expenses may not result in increased revenue for a number of reasons both within and outside of our control. If our revenues do not increase to offset these expected increases in costs and operating expenses, our financial condition and results of operations could be negatively affected. 

 

39 

 


 

A large number of lawsuits have been filed challenging various aspects of the Patient Protection and Affordable Care Act and related regulations.  For example, certain lawsuits have been filed that challenge the ability of individuals to receive subsidies if they purchase their qualified health plan through the FFE as opposed to an exchange established by a state.  In the event lawsuits attacking the Patient Protection and Affordable Care Act and related regulations are successful and result in the unenforceability of aspects of the law or regulations that are beneficial to our business, our business, operating results and financial condition could be harmed.  In addition, the FFE and state health insurance exchanges have experienced a large number of technical and other issues that have been reported to have adversely impacted enrollment in health insurance through the exchanges.  There have been reports that the federal government may delay the mandate that individuals purchase health insurance or pay a tax penalty contained in the Patient Protection and Affordable Care Act as a result.  Should that occur, the impact on our business is unclear, but our business, operating results and financial condition could be harmed.

 

The medical loss ratio requirements that are a part of health care reform have harmed and will continue to harm our business. 

 

The federal Patient Protection and Affordable Care Act enacted in March 2010 and related amendments in the Health Care and Education Reconciliation Act of 2010 contain provisions requiring health insurance carriers to maintain specified medical loss ratios. The medical loss ratio requirements for both individual and family and small business health insurance are effective for calendar year 2011 and later years and, among other things, require health insurance companies to spend 80% of their premium revenue in each of their individual and small group health insurance businesses on reimbursement for clinical services and activities that improve health care quality. The medical loss ratio requirement for Medicare Advantage plans is 85% and goes into effect in 2014. If a health insurance carrier fails to meet medical loss ratio requirements, the health insurance carrier is required to rebate a portion of its premium revenue to its members to make up for the difference. 

 

Carrier reaction to the individual and family medical loss ratio requirements was to significantly reduce the commissions we receive in connection with the sale of individual and family health insurance plans. Health insurance carriers may determine to reduce or further reduce our individual and family, small group or Medicare Advantage plan commissions as a result of the medical loss ratio requirements or other aspects of health care reform, which would harm our business, operating results and financial condition. In addition, if health insurance companies fail to meet medical loss ratio requirements, we may be required to pay back commissions that are related to any premium amounts the carriers are required to rebate policy holders as a result, which would harm our business, operating results and financial condition. The medical loss ratio requirements also may cause certain health insurance carriers to limit the geographies in which they sell health insurance or exit certain markets altogether, place less reliance on agents to distribute their plans, or limit their health insurance offerings in any number of other ways, each of which would harm our business, operating results and financial condition.  The implementation of medical loss ratio requirements has caused and could further cause health insurance carriers to reduce the amount they are willing to spend in connection with our sponsorship and advertising and technology licensing businesses, which also could harm our business, operating results and financial condition.  

 

Our business may be harmed if we lose our relationship with health insurance carriers or our relationship with health insurance carriers is modified. 

 

We typically enter into contractual agency relationships with health insurance carriers that are non-exclusive and terminable on short notice by either party for any reason.  In many cases, health insurance carriers also may amend the terms of our agreements unilaterally on short notice. Carriers may be unwilling to allow us to sell their existing or new health insurance plans, or desire to amend our agreements with them, for a variety of reasons, including for competitive or regulatory reasons, or because they do not want to be associated with our brand. In addition, many aspects of health care reform are scheduled to be implemented in 2014, which may cause carriers to modify their relationship with us given the substantial changes in the industry in which we operate.  For instance, in addition to the medical loss ratio requirements, health care reform contains taxes and assessments on health insurance carriers that may make their businesses less profitable.  In the future, and as a result of health care reform or for other reasons, an increasing number of health insurance carriers may decide to reduce our commissions, rely on their own internal distribution channels, including traditional in-house agents and carrier websites, to sell their own plans and, in turn, could limit or prohibit us from selling their plans on our ecommerce platform. For instance, carriers may choose to exclude us from their most profitable or popular plans or may determine not to distribute insurance plans in the individual and family and small business markets in certain geographies or altogether. The termination or amendment of our relationship with a carrier could reduce the variety of health insurance plans we offer, which could harm our business, operating results and financial condition. It also could adversely impact, or cause the termination of, commissions for future sales and for past sales, which would materially harm our business,

40 

 


 

operating results and financial condition. Our business could also be harmed if in the future we fail to develop new carrier relationships and are unable to offer consumers a variety of health insurance plans in each jurisdiction.  

 

The health insurance industry in the United States has experienced a substantial amount of consolidation over the past several years, resulting in a decrease in the number of health insurance carriers. In the future, we may be forced to offer insurance policies from a reduced number of insurance carriers or to derive a greater portion of our revenue from a more concentrated number of carriers as our business and the health insurance industry evolve. We derived 16% and 20%  of our total revenue in the nine months ended September 30, 2012 and 2013, respectively, from Humana. We derived 13% and 12% of our total revenue in the nine months ended September 30, 2012 and 2013,  respectively, from carriers owned by Wellpoint. We derived 13% and 11% of our total revenue in the nine months ended September 30, 2012 and 2013,  respectively, from carriers owned by UnitedHealthcare. We have several agreements that govern our sale of health insurance plans with these health insurance carriers. They may be unilaterally amended or terminated by the carrier on short notice and the amendment or termination could adversely impact or cause the termination of the commission payments that we receive from these health insurance carriers, which would harm our business, operating results and financial condition. Notwithstanding our separate agreements with various carriers directly or indirectly owned by the same entity, certain carriers have attempted and may continue to attempt to consolidate our relationship with them, which could increase the impact of carrier concentration on us, decrease the commission rates we receive and adversely affect our financial results, particularly in states where we offer health insurance from a relatively smaller number of carriers or where a small number of carriers dominates the market. The termination, amendment or consolidation of our relationship with these and other health insurance carriers could materially harm our business, operating results and financial condition. 

 

Our revenues and earnings may decline.  

 

In 2011, we experienced a significant reduction in the commission rates that health insurance carriers pay us on the individual and family health insurance plans that we sell, primarily as a result of health care reform. We also have in the past and may in the future continue to make significant expenditures related to the development of our business, including expenditures relating to marketing, website technology development and the development of our business selling Medicare-related health insurance plans. Our ability to grow revenue and earnings will depend on a number of factors, including the success of our Medicare plan marketing and sales business, our ability to attract individuals, families and small businesses to purchase health insurance through our ecommerce platform, our maintaining our relationships with health insurance carriers and the commission rates we receive for our sale of health insurance plans and our ability to maintain our relationship with existing members within historical levels. If we are not successful in these areas, our business, operating results and financial condition will be harmed. 

 

Our revenue will be adversely impacted if our membership does not grow. The individual and family commission rates that we receive are typically higher in the first twelve months of a policy. After the first twelve months, they generally decline significantly. The Medicare-related commission rates that we receive may be higher in the first twelve months of a policy if the policy is the first Medicare-related policy issued to the member. Accordingly, to the extent that our net addition of new members slows, our revenue would be adversely impacted due to a decline in commissions we receive for members whose policies have been active for less than twelve months in addition to the reduction in revenue growth that would occur solely as a result of a decline in our membership. The commission rates we receive are impacted by a variety of other factors, including the particular health insurance plans chosen by our members, the carriers offering those plans, our members’ states of residence, the laws and regulations in those jurisdictions and health care reform. Our commission rate per member has, and could in the future, decrease as a result of either reductions in contractual commission rates or unfavorable changes in health insurance carrier override commission programs, each of which are beyond our control and may occur on short notice. To the extent these and other factors cause our commission rate per member to decline, our rate of revenue growth may decline and our business, operating results and financial condition would be harmed. 

 

We may not be successful in our efforts to market and sell Medicare-related health insurance plans as a health insurance agent.  

 

In 2010 we began to actively market the availability of Medicare-related health insurance plans using our ecommerce platforms, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans. We refer to these plans as Medicare plans. We market Medicare plans to Medicare-eligible individuals, who are predominately senior citizens over the age of 65. The sale of Medicare Advantage and Medicare Part D prescription drug plans are subject to an annual enrollment period during the fourth quarter of each year, when a substantial percentage of the annual sales of these plans occur. We sell Medicare plans as a health insurance agent using our websites and customer care centers.   

41 

 


 

  

Our Medicare plan related revenue is concentrated in a small number of health insurance carriers. The success of our entry into the market for Medicare plans as a health insurance agent will depend upon our ability to enter into new and maintain existing relationships with health insurance carriers on favorable economic terms. The limited number of our Medicare plan carrier relationships makes us vulnerable to changes in carrier commission rates and the competitiveness of our carrier partners Medicare products.  If our Medicare carrier partners reduce our commission rates, reduce the amount they pay us for advertising services, or the competitiveness of their products declines compared to original Medicare or the products of Medicare carriers with which we do not have a relationship, our business, operating results and financial condition would be harmed.  In addition, we may temporarily or permanently lose the ability to market and sell Medicare plans for our Medicare plan carrier partners.  For instance, a carrier may terminate our relationship. Moreover, the Centers for Medicare and Medicaid Services, or CMS, has and will continue to penalize health insurance carriers for certain regulatory violations by not allowing them to market and sell Medicare plans for significant periods of time.  Given the small number of our Medicare carrier relationships, if we lose a relationship with a health insurance carrier to market their Medicare plans temporarily or permanently for this or any other reason, our sales as a health insurance agent and Medicare plan related revenue could suffer significantly, and our business, operating results and financial condition would be harmed. The agreements that we have with health insurance carriers to sell Medicare plans may be unilaterally amended or terminated by the carrier on short notice and the amendment or termination could adversely impact, or cause the termination of, the commission payments that we receive for selling their Medicare plans, which would harm our business operating results and financial condition. 

 

CMS must approve our websites and call center scripts for us to be able to generate Medicare plan demand and sell Medicare plans to Medicare-eligible individuals as a health insurance agent.  Moreover, we use Medicare plan cost and benefit data collected and made publicly available by CMS.  In the event that CMS disapproves, or delays approval, of our websites or call center scripts, or does not timely release Medicare plan cost and benefit data for the following year’s Medicare plans prior to the annual enrollment period, we could lose a significant source of Medicare plan demand and our ability to sell Medicare plans would be adversely impacted, each of which would harm our business, operating results and financial condition. 

 

Our success in expanding into the Medicare plan market as a health insurance agent will also depend upon a number of additional factors, including:   

 

·

our ability to continue to adapt our ecommerce platform to market Medicare plans, including our development or acquisition of marketing tools and features important in the sale of Medicare plans online and the modification of our existing user experience for new plans targeted at a different demographic; 

 

·

our success in marketing our ecommerce platform to Medicare-eligible individuals and in entering into business development relationships to drive Medicare-eligible individuals to our ecommerce platform; 

 

·

our effectiveness in entering into and maintaining relationships with marketing partners, including existing pharmacy chain partners that refer Medicare-eligible individuals to us; 

 

·

our ability to hire and retain additional employees with experience in Medicare, including our ability to timely implement Medicare sales expertise into our customer care centers; 

 

·

our ability to implement and maintain an effective information technology infrastructure for the sale of Medicare plans, including the infrastructure and systems that support our websites, call centers and call recording; 

 

·

our ability to comply with the numerous, complex and changing laws and regulations and CMS guidelines relating to the marketing and sale of Medicare plans, including continuing to conform our online and offline sales processes to those laws and regulations; and 

 

·

the effectiveness with which our competitors market the availability of Medicare plans from sources other than our ecommerce platform. 

 

42 

 


 

As a result of these factors, we may prove unsuccessful in marketing Medicare plans and acting as a health insurance agent in connection with their sale, which would harm our business, operating results and financial condition. In addition, if our efforts to market Medicare plans during any annual enrollment period were impeded due to lack of health insurance carrier or CMS approval, or for other reasons, the impact on our business, operating results and financial condition would be significantly greater given the seasonality of our Medicare-related revenues, membership acquisition and expenses and the fact that much of the sales of Medicare plans occur during this period. 

 

Our ability to sell Medicare-related health insurance plans as a health insurance agent depends on our ability to timely hire, train and retain licensed health insurance agents for our customer care center operations and our ability to maintain information technology systems to facilitate their sale of Medicare plans.  

 

In addition to our websites, we rely upon our customer care centers to sell Medicare plans. The success of our customer care center operations is largely dependent on licensed health insurance agents and other employees.  In order to sell Medicare-related health insurance plans, our health insurance agent employees must first be licensed by the states in which they are selling plans and certified and appointed with the health insurance carrier that offers the plans in each state that the Medicare-related health insurance product is being sold by the agent. Because the majority of Medicare plans are sold in the fourth quarter each year during the Medicare annual enrollment period, we are required to hire and train a significant number of additional employees on a temporary or seasonal basis in a limited period of time.  We must also ensure that our health insurance agent employees are timely licensed in a significant number of states and certified and appointed with the health insurance carriers whose products we sell. We depend upon state departments of insurance and health insurance carriers for their licensing, certification and appointment of our health insurance agent employees. We may not be successful in timely hiring a sufficient number of additional licensed agents or other employees for the Medicare annual enrollment period, and even if we are successful, these employees may experience delays in obtaining health insurance licenses and certifications and health insurance carrier appointments with our health insurance carrier partners.  If we and our health insurance agent employees are not successful in these regards, our ability to sell Medicare-related health insurance plans will be impaired during the annual enrollment period, which would harm our business, operating results and financial condition. 

 

The success of our Medicare plan customer care center operations also is dependent on information technology systems.  The vast majority of our Medicare plan members utilize our customer care center in connection with their purchase of a Medicare plan.  CMS rules require that our health insurance agent employees utilize CMS-approved scripts in connection with the sale of Medicare plans and that we record and maintain the recording of telephonic interactions relating to the sale of Medicare plans.  We rely on telephone, call recording and customer relationship management systems in our Medicare customer care center operations related to these and other functions, and we are dependent on third parties for some of them, including our telephone and call recording systems.  The effectiveness and stability of our Medicare customer care center systems are critical to our ability to sell Medicare plans, particularly during the Medicare annual enrollment period, and the failure or interruption of any of these systems or any inability to handle increased volume during the annual enrollment period would harm our business, operating results and financial condition. 

 

Factors beyond our control may negatively impact our ability to market and sell Medicare plans. 

 

We determined to enter into the Medicare plan market because we believe the number of individuals becoming eligible for Medicare is increasing and these individuals are increasingly using the Internet to shop for health insurance plans. We also believe that, on average, member retention rates and the commissions that health insurance carriers pay in connection with the sale of Medicare plans compare favorably to the member retention rates and commissions we receive in connection with our sale of individual and family health insurance. Should we prove to be wrong, or should these circumstances reverse, our success in marketing Medicare plans would be materially and adversely impacted, which could harm our business, operating results and financial condition. For instance, portions of health care reform impose significant changes to original Medicare and the Medicare Advantage program by, among other things, increasing the benefits original Medicare provides, reducing payments to Medicare Advantage plans and imposing medical loss ratio requirements for Medicare Advantage plans. In addition, CMS may also determine to reduce  the payments it makes to health insurance carriers in connection with the sale of Medicare Advantage plans. In the event health care reform, the actions of the federal government or other circumstances decrease the demand for Medicare Advantage plans or other alternatives to original Medicare, or result in a reduction in the amount paid to us in connection with the sale of these plans, our business operating results and financial condition could be harmed. 

 

43 

 


 

      The marketing and sale of Medicare plans are subject to numerous, complex and frequently changing laws and regulations, and any noncompliance with them could harm our business, operating results and financial condition.  

 

The marketing and sale of Medicare plans are subject to numerous laws, regulations and guidelines at the federal and state level. The marketing and sale of Medicare Advantage and Medicare Part D prescription drug plans are principally regulated by CMS. The marketing and sale of Medicare Supplement plans are principally regulated on a state-by-state basis by state departments of insurance. The laws and regulations applicable to the marketing and sale of Medicare plans are numerous, ambiguous and complex, and, particularly with respect to regulations and guidance issued by CMS for Medicare Advantage and Medicare Part D prescription drug plans, change frequently.  As a result of these laws, regulations and guidelines, we have altered, and likely will have to continue to alter, our websites and sales process to comply with several requirements that are not applicable to our sale of non-Medicare-related health insurance plans. For instance, many aspects of our online platforms and our marketing material and processes, as well as changes to these platforms, materials and processes, including call center scripts, must be approved on a regular basis by CMS and by health insurance carriers in light of CMS requirements.  In addition, certain aspects of our Medicare plan marketing partner relationships with pharmacy chains have been in the past, and will be in the future, subjected to CMS and health insurance carrier review.  Changes to the laws, regulations and guidelines relating to Medicare plans, their interpretation or the manner in which they are enforced could be incompatible with these relationships, our platforms or our sale of Medicare plans.  Due to changes in CMS guidance or enforcement or interpretation of existing guidance, or as a result of new laws, regulations and guidelines, CMS, state departments of insurance or health insurance carriers may determine to object to or not to approve aspects of our online platforms or marketing material and processes and may determine that certain existing aspects of our Medicare-related business are not in compliance.  As a result, the progress of our Medicare operations could be slowed or we could be prevented from operating aspects of our Medicare revenue generating activities altogether, which would harm our business, operating results and financial condition, particularly if it occurred during the Medicare annual enrollment period. It could also result in the write-down of the value of goodwill and intangible assets acquired in our PlanPrescriber acquisition. 

 

The impact that health care reform legislation will have on the market for Medicare plans is unclear, but it could change demand for Medicare plans, the way these plans are delivered, the commissions that carriers pay to health insurance agents in connection with their sale or could adversely impact us in other ways. In the event that laws and regulations adversely impact our ability to market the availability of any type of Medicare plan on our ecommerce platform, or the amounts that health insurance agents are paid for selling these plans, our business, operating results and financial condition would be harmed. 

 

Our future operating results are likely to fluctuate and could fall short of expectations.  

 

Our operating results are likely to fluctuate as a result of a variety of factors, including the factors described elsewhere in this Risk Factors section, many of which are outside of our control. As a result, comparing our operating results on a period-to-period basis may not be meaningful and you should not rely on our past results as an indication of our future performance, particularly in light of the fact that our business and industry are undergoing substantial change as a result of health care reform. If our revenue or operating results fall below the expectations of investors or securities analysts, the price of our common stock could decline substantially. 

 

Our business model is characterized primarily by revenue based on commissions we receive from insurance carriers whose policies are purchased by our members. We receive commissions and record related revenue for an individual and family, small business, ancillary or Medicare Supplement health insurance policy, typically on a monthly basis, until the health insurance policy is cancelled or we otherwise do not remain the agent on the policy. For both Medicare Advantage and Medicare Part D prescription drug plans, we record commission revenue on an annual basis but may receive commission payments from insurance carriers on either a monthly or annual basis typically for a period of five years, or longer depending on the carrier arrangement, provided that the policy remains active with us and we remain the agent on the policy. 

 

A significant component of our marketing and advertising expenses consists of expenses incurred in search engine advertising at the time a consumer clicks on an advertisement and payments owed to our marketing partners in connection with applications submitted on our ecommerce platform by potential members referred to us by our marketing partners. As a result of this timing difference between expense and associated revenue recognition, our operating results and cash flows may be adversely affected in periods where we experience a significant increase in new applicants, which could occur in connection with the implementation of health care reform. The implementation of healthcare reform could cause a substantial number of our existing members to apply for new health insurance products and for us to receive a substantial

44 

 


 

number of health insurance applications from new members, which could cause us to incur a substantial amount of marketing and advertising expense over a limited period of time and harm our business, operating results and financial condition.  In addition, if we incur other unanticipated or one-time expenses in a particular quarter, lose a significant amount of our member base for any reason or our commission rates are reduced, the impact of our incurring increased marketing and advertising expenses would be especially pronounced and we would likely be unable to offset these expenses by increasing sales within that quarter or to replace lost revenue in the quarter with revenue from new members, and our business, operating results and financial condition would be harmed.   

 

Current economic conditions and other factors beyond our control may negatively impact our business, operating results and financial condition.  

 

Our revenue depends upon demand for health insurance in the individual and family and small business markets, which can be influenced by a variety of factors beyond our control. For instance, an increased number of individuals have become self-employed or unemployed. In addition, as a result of substantial health insurance premium inflation in recent years, we believe that many employers have sought to reduce the costs associated with providing health insurance to their employees, including offering fewer benefits to employees, reducing or eliminating dependent coverage, increasing employee health insurance premium contributions and eliminating health insurance benefits altogether. We have no control over the economic and other factors that influence these trends, and they may reverse, including as a result of health care reform legislation. If economic or other factors beyond our control negatively impact our business, our business, operating results and financial condition could be harmed.  

 

We believe that demand for the health insurance and services we offer are impacted by prevailing economic conditions. We cannot be certain of the future impact that economic conditions will have on our business. A softening of demand for health insurance and services offered by us, whether caused by changes in customer preferences or a weak U.S. economy, including as a result of disruptions in the global financial markets or a decrease in general consumer confidence, could adversely impact our operating results. Consumers may attempt to reduce expenses by cancelling existing health insurance purchased through us, determine not to purchase new health insurance through us, or purchase health insurance plans with lower premiums for which we receive lower commissions. To the extent the economy or other factors adversely impact our membership retention or the number or type of health insurance applications submitted through us and that are approved by health insurance carriers, our rate of growth will decline and our business and operating results will be harmed. A continuing negative economic environment could also adversely impact the health insurance carriers whose plans are offered on our ecommerce platform, and they may determine to reduce their commission rates, change their underwriting practices (prior to the implementation of the guaranteed issue aspect of health care reform) so that fewer health insurance applications are approved or take other actions that would negatively impact our sale of health insurance as well as our sponsorship and technology licensing businesses. 

  

If we are not successful in cost-effectively converting visitors to our website and customer call centers into members, our business and operating results would be harmed.  

 

Our growth depends in large part upon growth in our membership. The rate at which consumers visiting our ecommerce platform and customer call centers seeking to purchase health insurance are converted into members is a significant factor in the growth of our membership. A number of factors have influenced, and could in the future influence, the conversion rate for any given period, some of which are outside of our control. These factors include:  

 

changes in consumer shopping behavior due to circumstances outside of our control, such as economic conditions, consumers’ ability or willingness to pay for health insurance, availability of unemployment benefits or proposed or enacted legislative or regulatory changes impacting our business, including health care reform

 

the quality of and changes to the consumer experience on our ecommerce platform or with our customer care center; 

 

regulatory requirements, including those that make the experience on our online platforms cumbersome or difficult to navigate; 

 

the variety, competitiveness and affordability of the health insurance plans that we offer; 

 

45 

 


 

system failures or interruptions in the operation of our ecommerce platform or call center operations; 

 

changes in the mix of consumers who are referred to us through our direct, marketing partner and online advertising member acquisition channels; 

 

health insurance carriers offering the health insurance plans for which consumers have expressed interest, and the degree to which our technology is integrated with those carriers; 

 

health insurance carrier underwriting practices (prior to the implementation of the guaranteed issue aspect of health care reform) and guidelines applicable to applications submitted by consumers and the amount of time a carrier takes to make a decision on that application; and 

 

competitive offerings. 

 

Our conversion rates can be impacted by changes in the mix of consumers referred to us through our member acquisition channels. For example, our conversion rates have historically been lower with respect to consumers referred to us by Internet lead aggregators and relatively higher with respect to consumers coming to us through our direct member acquisition channel. In addition, we may make changes to our ecommerce platform or undertake other initiatives in an attempt to improve consumer experience or for other reasons. These changes in the past, and may in the future, have the unintended consequence of adversely impacting our conversion rates. A decline in the percentage of consumers who submit health insurance applications on our ecommerce platform or telephonically via our customer call centers and are converted into members could cause an increase in our cost of acquiring members on a per member basis. To the extent the rate at which we convert consumers visiting our ecommerce platform or telephonically via our customer call centers into members suffers, our membership growth rate may decline, which would harm our business, operating results and financial condition.

 

We are in the process of attempting to integrate with the FFE to be able to sell qualified health plans to individuals and families in the states in which the FFE operates, particularly those individuals and families eligible for subsidies in connection with their purchase of health insurance as a result of health care reform.  Pursuant to health care reform laws and regulations, the purchase of qualified health plans must occur through a health insurance exchange, which means that a part of the purchasing process will occur on the FFE website and through FFE systems.  We are also dependent on these systems to convey to health insurance carriers that we are the agent in connection with the purchase of health insurance and should receive commissions for a sale.  To date the FFE website and systems have not worked properly and many individuals cannot get through the process of purchasing health insurance using them.  Moreover, the process of applying for a subsidy and to purchase a qualified health plan on the FFE is cumbersome and difficult to complete.  Assuming we complete integration with the FFE and are permitted by the FFE to enroll individuals into qualified health plans through the FFE, we are dependent upon FFE systems and its website experience for individuals to be able to complete the process of purchasing a qualified health plan and to convert into members for which we receive commission revenue.  If the FFE website experience remains unstable, the experience of applying for qualified health plans and subsidies remains cumbersome, or we are not properly identified by FFE systems as the agent of record on health insurance plan sales, we will suffer a reduction in our membership and our commission revenue and our business, operating results and financial condition will be harmed.    

 

If we are unable to retain our members, our business and operating results would be harmed.  

 

We receive revenue from commissions health insurance carriers pay to us for health insurance policies sold through our ecommerce platform. When one of these policies is cancelled, or if we otherwise do not remain the agent on the policy, we no longer receive the related commission revenue. Individuals, families and small businesses may choose to discontinue their health insurance policies for a variety of reasons. For example, individuals and families may replace a health insurance policy purchased through us with a health insurance policy provided by a new or existing employer or may determine that they can no longer afford health insurance. In addition, our members may choose to purchase new policies using a different agent if, for example, they are not satisfied with our customer service or the health insurance plans that we offer. Consumers may also purchase health insurance policies from government-run health insurance exchanges after their implementation as a result of health care reform, including as a result of the requirement that subsidy-eligible individuals must purchase qualified health plans through government-run health insurance exchanges to be able to receive a subsidy under health care reform. Health insurance carriers may also terminate health insurance plans purchased and held by our members. If we are not successful in transferring members covered under a terminated plan to another policy that we offer, we will lose these members and associated commission revenue. Our cost of acquiring a new member is substantially greater than the cost

46 

 


 

involved in maintaining our relationship with an existing member. If we are not able to successfully retain existing members and limit member turnover, our revenue and operating margins will be adversely impacted and our business, operating results and financial condition would be harmed.  

 

Changes in the quality and affordability of the health insurance plans that carriers offer on our ecommerce platform could harm our business and operating results.  

 

The demand for health insurance marketed through our ecommerce platform is impacted by, among other things, the variety, quality and price of the health insurance plans we offer. Some health insurance carriers have announced their intention to exit certain state insurance markets where we have historically represented their insurance plans. If health insurance carriers do not continue to allow us to sell a variety of high-quality, affordable health insurance plans in the individual and family, small business, ancillary and Medicare markets, or if their offerings are limited or terminated as a result of consolidation in the health insurance industry, health care reform legislation or otherwise, our sales may decrease and our business, operating results and financial condition could be harmed. For example, the cost of health insurance is increasing for many individuals as a result of health care reform implementation and some health insurance carriers are exiting the individual and family health insurance business in certain states.  If individuals determine not to purchase health insurance as a result of either of these circumstances, our business, operating results and financial condition could be harmed.   

 

Health insurance carriers could determine to reduce the commissions paid to us or change their underwriting practices in ways that reduce the number of insurance policies sold through our ecommerce platform, which could harm our business and operating results.  

 

Our commission rates, and the commission override payments we receive from health insurance carriers for achieving sales volume thresholds or other objectives, are either set by each carrier or negotiated between us and each carrier. Carriers have altered, and may in the future alter, the contractual relationships we have with them on short notice, either by renegotiation or unilateral action. If these contractual changes result in reduced commissions, our business may suffer and our operating results and financial condition would be harmed. In addition, carriers periodically change the criteria they use for determining whether they are willing to insure individuals as well as other underwriting practices. At various times, carriers have applied more stringent underwriting criteria and practices to applications for health insurance. These practices result in a decrease in the rate at which insurance applications submitted through our ecommerce platform are approved. Changes in carrier underwriting criteria or practices (prior to the implementation of the guaranteed issue aspect of health care reform) could negatively impact sales of insurance policies on our ecommerce platform and could harm our business, operating results and financial condition. 

 

If we are not able to maintain and enhance our brand, our business and operating results will be harmed.  

 

We believe that maintaining and enhancing our brand identity is critical to our relationships with existing members, marketing partners and health insurance carriers and to our ability to attract new members, marketing partners and health insurance carriers. The promotion of our brand in these and other ways may require us to make substantial investments and we anticipate that, as our market becomes increasingly competitive, these branding initiatives may become increasingly difficult and expensive. Our brand promotion activities may not be successful or yield increased revenue, and to the extent that these activities yield increased revenue, the increased revenue may not offset the expenses we incur and our operating results could be harmed.  If we do not successfully maintain and enhance our brand, our business may not grow and we could lose our relationships with health insurance carriers, marketing partners and/or members, which would harm our business, operating results and financial condition.  

 

In addition, we have historically received media attention in connection with our public relations efforts. While we cannot be certain of the impact of media coverage on our business, if it were to be reduced or if we were to receive negative publicity, the number of consumers visiting our platform or customer call centers could decrease, and our cost of acquiring members could increase as a result of a reduction in the number of members coming from our direct member acquisition channel, both of which could harm our business, operating results and financial condition. 

 

System failures or capacity constraints could harm our business and operating results.  

 

The performance, reliability and availability of our ecommerce platforms and underlying network infrastructures are critical to our financial results, our brand and our relationship with members, marketing partners and health insurance

47 

 


 

carriers. Although we regularly attempt to enhance our ecommerce platform and system infrastructure, system failures and interruptions may occur if we are unsuccessful in these efforts, if we are unable to accurately project the rate or timing of increases in our website traffic or for other reasons, some of which are completely outside our control. Although we have experienced only minor system failures and interruptions to date, we could experience significant failures and interruptions in the future, which would harm our business, operating results and financial condition.  

 

We rely in part upon third-party vendors, including data center and bandwidth providers, to operate our ecommerce platforms. We cannot predict whether additional network capacity will be available from these vendors as we need it, and our network or our suppliers’ networks might be unable to achieve or maintain a sufficiently high capacity of data transmission to allow us to process health insurance applications in a timely manner or effectively download data, especially if our website traffic increases. Any system failure that causes an interruption in or decreases the responsiveness of our services would impair our revenue-generating capabilities and harm our business and operating results and damage our reputation. In addition, any loss of data could result in loss of customers and subject us to potential liability. Our database and systems are vulnerable to damage or interruption from human error, earthquakes, fire, floods, power loss, telecommunications failures, physical or electronic break-ins, computer viruses, acts of terrorism, other attempts to harm our systems and similar events. In addition, our operations are vulnerable to earthquakes in the San Francisco Bay Area and elsewhere in Northern California.  

 

Consumers may access our customer care centers for assistance in connection with submitting health insurance applications. We depend upon third parties, including telephone service providers and third party software providers, to operate our customer care centers. Any failure of the systems that we rely upon in the operation of our customer care center could negatively impact sales as well as our relationship with consumers and members, which could harm our business, operating results and financial condition. 

 

If consumers or carriers opt for more traditional or alternative channels for the purchase and sale of health insurance, our business will be harmed.  

 

Our success depends in part upon widespread consumer and health insurance carrier acceptance of the Internet as a marketplace for the purchase and sale of health insurance. Consumers and health insurance carriers may choose to depend more on traditional sources, such as individual agents, or alternative sources may develop, including as a result of health care reform legislation. Our future growth, if any, will depend in part upon: 

  

·

the growth of the Internet as a commerce medium generally, and as a market for consumer financial plans and services specifically; 

 

·

consumers’ willingness to conduct their own health insurance research; 

 

·

our ability to make the process of purchasing health insurance online an attractive alternative to traditional and new means of purchasing health insurance; 

 

·

our ability to successfully and cost-effectively market our services as superior to traditional or alternative sources for health insurance to a sufficiently large number of consumers; and 

 

·

health insurance carriers’ willingness to use us and the Internet as a distribution channel for health insurance plans. 

 

If consumers and health insurance carriers determine that other sources for health insurance and health insurance applications are superior, our business will not grow and our operating results and financial condition would be harmed.  

 

We depend upon Internet search engines to attract a significant portion of the consumers who visit our website, and if we are unable to effectively advertise on search engines on a cost-effective basis, our business and operating results would be harmed.  

 

We derive a significant portion of our website traffic from consumers who search for health insurance through Internet search engines, such as Google, Bing and Yahoo!. A critical factor in attracting consumers to our website is whether we are prominently displayed in response to an Internet search relating to health insurance. Search engines typically provide two

48 

 


 

types of search results, algorithmic listings and paid advertisements. We rely on both algorithmic listings and paid advertisements to attract consumers to our websites.  

 

Algorithmic search result listings are determined and displayed in accordance with a set of formulas or algorithms developed by the particular Internet search engine. The algorithms determine the order of the listing of results in response to the consumer’s Internet search. From time to time, search engines revise these algorithms. In some instances, these modifications have caused our website to be listed less prominently in algorithmic search results, which has resulted in decreased traffic to our website. We may also be listed less prominently as a result of new websites or changes to existing websites that result in these websites receiving higher algorithmic rankings with the search engine. Our website may become listed less prominently in algorithmic search results for other reasons, such as search engine technical difficulties, search engine technical changes and changes we make to our website. In addition, search engines have deemed the practices of some companies to be inconsistent with search engine guidelines and decided not to list their website in search result listings at all. If we are listed less prominently in, or removed altogether from, search result listings for any reason, the traffic to our websites would decline and we may not be able to replace this traffic, which in turn would harm our business, operating results and financial condition. If we decide to attempt to replace this traffic, we may be required to increase our marketing expenditures, which would also increase our cost of member acquisition and harm our business, operating results and financial condition.  

 

We purchase paid advertisements on search engines in order to attract consumers to our website. We typically pay a search engine for prominent placement of our name and website when particular health insurance-related terms are searched for on the search engine, regardless of the algorithmic search result listings. In some circumstances, the prominence of the placement of our advertisement is determined by a combination of factors, including the amount we are willing to pay and algorithms designed to determine the relevance of our paid advertisement to a particular search term. As with algorithmic search result listings, search engines may revise the algorithms relevant to paid advertisements and websites other than our ecommerce platform may become more optimized for the algorithms. These changes may result in our having to pay increased amounts to maintain our paid advertisement placement in response to a particular search term. We could also have to pay increased amounts should the market share of major search engines continue to become more concentrated with a single search engine. Additionally, we bid against our competitors and others for the display of these paid search engine advertisements. Many of our competitors, including many health insurance carriers, have greater resources with which to bid and better brand recognition than we do. We have experienced increased competition from health insurance carriers and some of our marketing partners for both algorithmic search result listings and for paid advertisements, which has increased our marketing and advertising expenses. If this competition increases further, or if the fees associated with paid search advertisements increase as a result of algorithm changes or other factors, our advertising expenses could rise significantly or we could reduce or discontinue our paid search advertisements, either of which could harm our business, operating results and financial condition.  

 

We rely significantly on marketing partners and our business and operating results would be harmed if we are unable to maintain effective relationships with our existing marketing partners or if we do not establish successful relationships with new marketing partners.  

 

In addition to marketing through Internet search engines, we frequently enter into contractual marketing relationships with other online and offline businesses that promote us to their customers. These marketing partners include financial and online service companies, affiliate programs and online advertisers and content providers. We also have relationships with marketing partners, including pharmacy chains, that promote our Medicare platforms to their customers.  We compensate many of our marketing partners for their referrals on a submitted health insurance application basis and, if they are licensed to sell health insurance, may share a percentage of the commission we earn from the health insurance carrier for each member referred by the marketing partner.  

 

Many factors influence the success of our relationship with our marketing partners, including: 

 

·

the continued positive market presence, reputation and growth of the marketing partner; 

 

·

the effectiveness of the marketing partner in marketing our website and services, including whether the marketing partner is successful in maintaining the prominence of its website in algorithmic search result listings and paid Internet advertisements; 

 

49 

 


 

·

the compliance of our marketing partners, and of the manner marketing partners refer consumers to our platforms, with applicable laws, regulations and guidelines; 

 

·

the interest of the marketing partner’s customers in the health insurance plans that we offer on our ecommerce platform; 

 

·

the contractual terms we negotiate with the marketing partner, including the marketing fees we agree to pay a marketing partner; 

 

·

the percentage of the marketing partner’s customers that submit applications or purchase health insurance policies through our ecommerce platform; 

 

·

the ability of a marketing partner to maintain efficient and uninterrupted operation of its website; and 

 

·

our ability to work with the marketing partner to implement website changes, launch marketing campaigns and pursue other initiatives necessary to maintain positive consumer experiences and acceptable traffic volumes. 

 

For instance, we partner with Internet lead aggregators who refer a significant number of consumers to our online platforms. Major search engines have in the past and may in the future determine not to list lead aggregator websites prominently in search result listings for various reasons, which would cause a significant reduction in the number of consumers referred to us through our marketing partner channel. If we are unable to maintain successful relationships with our existing marketing partners or fail to establish successful relationships with new marketing partners, our business, operating results and financial condition will be harmed.  

 

The impact that health care reform will have on our relationships with marketing partners is unclear. To the extent that health care reform makes it less profitable or desirable for marketing partners to promote us to their customers, we may lose relationships with existing marketing partners and may have difficulty entering into relationships with new marketing partners. We may also need to reduce the compensation that we pay to marketing partners to the extent that health care reform has the effect of reducing commissions for individual and family health insurance. There is no guarantee that we will be able to amend our agreements to reduce the compensation that we pay to acceptable levels in light of the commission rates that we receive. If we are not able to do so, our business, operating results and financial condition could be harmed.  In addition, the promulgation of laws, regulations or guidelines, or the interpretation of existing laws, regulations and guidelines, by state departments of insurance or by CMS, could cause our relationships with our marketing partners to be in noncompliance with those laws, regulations and guidelines.  For instance, as a result of our acquisition of PlanPrescriber, we have marketing partner relationships with pharmacy chains that utilize aspects of our platform and tools.  Our relationships with these pharmacy chains result in the referral of a significant number of individuals to us who are interested in purchasing Medicare plans.  If CMS or state departments of insurance were to change existing laws, regulations or guidelines, or interpret existing laws, regulations or guidelines, to prohibit these arrangements, or if pharmacy partners otherwise decided to no longer utilize aspects of our platform and tools, we would experience a significant decline in the number of Medicare-eligible individuals who are referred to our platforms and customer care centers, which would harm our business, operating results and financial condition and could result in a write-down of the value of intangible assets acquired in our PlanPrescriber acquisition.   

  

We rely on health insurance carriers to accurately and regularly prepare commission reports, and if these reports are inaccurate or not sent to us in a timely manner, our business and operating results could be harmed. We also may not recognize trends in our membership as a result of a lack of information from health insurance carriers. 

 

For individual and family, small business, ancillary and Medicare Supplement health insurance plans, health insurance carriers typically pay us a specified percentage of the premium amount on a health insurance policy that we have sold during the period that a member maintains coverage under the policy. For both Medicare Advantage and Medicare Part D prescription drug policies, health insurance carriers typically pay us a fixed commission amount during the period the policy remains active, typically for up to six years, or longer depending on carrier the arrangement, provided that the policy remains active with us. We rely on health insurance carriers to timely and accurately report the amount of commissions earned by us, and we calculate our commission revenue, prepare our financial reports, projections and budgets and direct our marketing and other operating efforts based on the reports we receive from health insurance carriers. There have been instances where we have determined that policy cancellation data reported to us by a health insurance carrier has not been completely accurate. Although we recognize commissions reported to us net of estimated cancellations, the extent to which

50 

 


 

health insurance carriers are inaccurate in their reporting of policy cancellations could cause us to change our cancellation estimates, which could adversely impact our revenues. We apply judgment and make estimates based on historical data and current trends to independently determine whether or not carriers are accurately reporting commissions due to us. To the extent that health insurance carriers understate or fail to accurately report the amount of commissions due to us in a timely manner or at all, we will not recognize revenue to which we are entitled, which would harm our business, operating results and financial condition.  

 

We also depend on health insurance carriers and others for data related to our membership. For instance, with respect to health insurance plans other than small business health insurance, health insurance carriers do not directly report member cancellations to us, resulting in the need for us to determine cancellations using payment data that carriers provide. We infer cancellations from this payment data by analyzing whether payments from members have ceased for a period of time, and we may not learn of a cancellation for several months, given that some of our members pay on a schedule less frequently than monthly (e.g., quarterly). With respect to our small business membership, many groups notify the carrier directly with respect to increases or decreases in group size and policy cancellations. Our insurance carrier partners often do not communicate this information to us, and it often takes a significant amount of time for us to learn about small business group cancellations and changes in our membership within the group itself. We often are not made aware of policy cancellations until the time of the group’s annual renewal. 

 

A substantial number of our existing members may become eligible for health care reform subsidies in connection with their purchase of health insurance. We may experience difficulty in satisfying the conditions required to offer plans to individuals and families who are entitled to subsidies under health care reform, and even if we are able to satisfy them, we depend upon government run health insurance exchanges to permit us to offer these plans and to have systems and a website that allows us to effectively do so. We also depend upon health insurance carriers to allow us to sell these plans and to pay us commissions in connection with their sale. In the event we are not successful in gaining the ability to effectively sell individual and family health insurance products to health care reform subsidy-eligible individuals, or if health insurance carriers pay us no commissions or reduced commissions in connection with the sale of these plans, we could lose a substantial number of existing and potential members and the related commission revenue we receive as a result of the sale of individual and family and small business health insurance products to them, which would materially harm our business, operating results and financial condition. We could also lose a substantial number of existing and potential members as a result of individuals who are not eligible for subsidies shopping for new health care reform health insurance plans and using other health insurance agents or a government-run health insurance exchange to do so. In addition, a substantial amount of individual and family health insurance purchasing activity is expected to occur over a limited period of time as a result of the new open enrollment periods for the purchase of individual and family health insurance, which overlaps with the Medicare annual open enrollment period. The increased amount of health insurance purchasing activity as a result of health care reform over a limited period of time as well as any member turnover that we experience may make it difficult for health insurance carriers to accurately report commission information to us in a timely manner, which would also make it difficult or impossible for us to accurately report and estimate our membership at any given point in time. Delays in accurate reporting of commissions may result in delays in recognition of commission revenue compared to historical patterns and our business, operating results and financial condition could be harmed.  In addition, if we experience a disruption in our ability to accurately estimate our membership it could result in a decrease in our stock price as a result of uncertainty relating to our membership base.

  

After we have estimated membership for a period, we may receive information from health insurance carriers that would have impacted the estimate if we had received the information prior to the date of estimation. We may receive commission payments or other information that indicates that a member who was not included in our estimates for a prior period was in fact an active member at that time, or that a member who was included in our estimates was in fact not an active member of ours. We also reconcile information health insurance carriers provide to us and may determine that we were not historically paid commissions owed to us, which would cause us to have underestimated our membership. As a result of open enrollment periods, we may not receive information from our carriers on as timely a basis as in the past due to significant spikes in volume, which could impair the accuracy of our estimates of the number of members we have for a period of time. Additionally, health insurance carriers may require us to return commission payments paid in a prior period due to policy cancellations for members we previously estimated as being active. For these and other reasons, including if current trends in membership cancellation are inconsistent with past cancellation trends that we use to estimate our membership or if carriers subsequently report changes to the commission payments that they previously reported to us, our actual membership could be different from our estimates, perhaps materially. Total revenue per estimated member for the period would also change if our estimated membership changed. Our estimate regarding the average amount of time our

51 

 


 

members maintain their health insurance plans also could be inaccurate as it depends on the accuracy of our membership estimates.  

  

Our operating results fluctuate depending upon health insurance carrier payment practices and the timing of our receipt of commission reports from health insurance carriers.  

 

The timing of our revenue depends upon the timing of our receipt of commission reports and associated payments from health insurance carriers. There have been instances where the report of commissions and payment have been delayed, such as during holiday periods. Any delay could materially impact our financial results for a given quarter as we would not be able to recognize the related commission revenue in that quarter. In addition, much of our commission override revenue is not reported and paid to us in accordance with a scheduled pattern, and some is only reported and paid to us once per year. The timing of our revenue recognition could result in a large amount of commission revenue from a carrier being recorded in a given quarter that is not indicative of the amount of revenue we may receive from that carrier in subsequent quarters, causing fluctuations in our operating results. We also could report revenue below the expectations of our investors or securities analysts in any particular period if a material report or payment from a health insurance carrier were delayed or not received within the time frame required for revenue recognition.

 

The implementation of open enrollment periods under health care reform for the purchase of individual health insurance may present challenges to our ability to enroll a significant number of individuals into health insurance over a limited period of time. Significant increases in enrollment activity over a limited amount of time may also make it difficult for health insurance carriers to timely and accurately report commission information to us. To the extent health insurance carriers have difficulty in reporting timely and accurate commission information to us, we may be unable to recognize revenue in accordance with our revenue recognition policies, which could cause us to defer a substantial amount of revenue until such time our health insurance carriers are able to resume reporting timely and accurate commission information to us.

 

We may be unsuccessful in competing effectively against current and future competitors.  

The market for selling health insurance plans is highly competitive. We compete with entities and individuals that offer and sell health insurance plans utilizing traditional distribution channels as well as the Internet. Our competitors include local insurance agents across the United States who sell health insurance plans in their communities. There are a number of agents that operate websites and provide an online shopping experience for consumers interested in purchasing health insurance. To remain competitive against our current and future competitors, we will need to continue to invest and improve the online shopping experience and functionalities of our website and other platforms that our current and future customers may access to purchase health insurance products from us.  If we cannot predict, develop and deliver the right shopping experience and functionality in a timely and cost-effective manner, we may not be able to compete successfully against our current or future competitors and our business, operating results and financial condition may be adversely affected.

Some local agents use “lead aggregator” services that use the Internet to find consumers interested in purchasing health insurance and are compensated for referring those consumers to the traditional agent.   In addition to health insurance brokers and agents, many health insurance carriers directly market and sell their plans to consumers through call centers and their own websites. Although we offer health insurance plans for many of these carriers, they also compete with us by offering their plans directly to consumers. We will also compete with state and federal health insurance exchanges implemented as a result of health care reform. Health care reform also will result in health insurance plan cost and benefit data being more readily accessible, which could facilitate additional competition. In connection with our marketing of Medicare plans, we also compete with the original Medicare program.  In addition, CMS offers plan information, comparison tools, call centers and online enrollment for Medicare Advantage and Medicare Part D prescription drug plans. 

 

In licensing our health insurance purchasing platform, we compete with companies providing technology that automates premium quoting, research and analysis of health insurance plans, member enrollment and other tools that support online sales efforts by health insurance carriers and their agents and brokers. 

 

We may not be able to compete successfully against our current or future competitors. Some of our current and potential competitors have longer operating histories, larger customer bases, greater brand recognition and significantly greater financial, technical, marketing and other resources than we do. As compared to us, our current and future competitors may be able to:  

  

undertake more extensive marketing campaigns for their brands and services; 

 

52 

 


 

devote more resources to website and systems development; 

 

negotiate more favorable commission rates and commission override payments; and 

 

make more attractive offers to potential employees, marketing partners and third-party service providers. 

 

In addition, CMS has the ability to regulate our marketing and sale of Medicare Advantage and Medicare Part D prescription drug plans, and government run health insurance exchanges, including CMS with respect to the federal health insurance exchange, have the ability to regulate our marketing and sale of qualified health plans under health care reform.  CMS and the exchanges could impact the commissions we receive in connection with the sale of these plans and impose other restrictions and limitations that make it difficult for us to sell them.     

 

Competitive pressures may result in our experiencing increased marketing costs, decreased traffic to our website and loss of market share, or may otherwise harm our business, operating results and financial condition.  

 

There are many risks associated with our operations in China.  

 

A portion of our operations is conducted in China. Among other things, we use employees in China to maintain and update our ecommerce platform. This and other information is delivered to us through secured communications over the Internet. Our business would be harmed if this connection temporarily failed and we were prevented from promptly updating our software or implementing other changes to our database and systems. Our operations in China also expose us to different and unfamiliar laws, rules and regulations, including different intellectual property laws, which are not as protective of our intellectual property as the laws in the United States, and different labor and tax laws. United States and Chinese trade laws may impose restrictions on the importation of programming or technology to or from the United States. Additionally, we have recently experienced greater competition for qualified personnel in China, which has raised market salaries and increased our compensation costs related to employees in that location. If competition for personnel increases further, our compensation expenses could rise considerably or, if we determine to not increase compensation levels, our ability to attract and retain qualified personnel in China may be impaired, which could harm our business, operating results and financial condition. These risks could cause us to incur increased expenses and could harm our ability to effectively and successfully manage our operations in China, which in turn could cause our business, operating results and financial condition to suffer.  

 

Our subsidiary in China has a subsidiary business insurance agency license in the Fujian province in China pursuant to which we may sell health, accident and life insurance in the Fujian province. Our license is up for renewal at the end of 2014. We have relationships with insurance companies to host on our technology platform certain of those companies’ products that are offered throughout China. Additionally, we have entered, and may in the future continue to enter, into relationships with marketing partners to refer additional consumers to our website. We have limited experience marketing or selling insurance in China or in adapting our business and ecommerce platform to Chinese markets and cultures, legal and regulatory regimes or business customs. For instance, the laws and regulations applicable to our marketing and selling insurance online and assisting others in those efforts in China are unclear, and our operations may be in violation of them. In addition, insurance laws and regulations in China are in a state of development, and the laws and regulations may change to prohibit or restrict our marketing insurance online. The consequences of violating insurance and other applicable laws and regulations in China are unclear, but they could result in the termination of our license and our ability to host insurance products on our technology platform, payment of fines and damages and could harm our business as a whole. For various reasons, we may not expand in China, and even if we do, there can be no assurance that our ecommerce platform in China would ever generate a significant amount of revenue or otherwise be successful. Our success in establishing an insurance-related business in China also depends on many of the factors that influence the success of our business in the United States, including, but not limited to, our receiving regulatory approvals (including the renewal of our license), acceptance of the Internet and our ecommerce platform as a marketplace for the purchase of insurance, our success in marketing our ecommerce platform and in retaining members who purchase insurance through that platform, our ability to enter into and maintain relationships with insurance carriers, commission rates, the affordability of the insurance products offered, insurance carrier business practices, the effectiveness with which we establish a brand identity, performance, reliability and availability of our ecommerce platform, competition, the regulatory environment and the manner in which health care delivery is financed and changes to such environment or manner, our ability to attract and retain qualified personnel and network security. 

 

53 

 


 

Our participation and success in the insurance market in China may be impacted by additional factors given that outside of Xiamen city, the insurance products offered on our website are offered directly by insurance carriers.  As a result, our success in selling insurance outside of Xiamen city depends on many factors, including our dependence on insurance carriers for the products on our website, the insurance carriers’ relationship with consumers, our relationship with the insurance carriers, the insurance carriers’ ability to maintain licenses and regulatory approvals, and the number, quality and attractiveness of the insurance products offered by the insurance carriers through our platform. While there is no certainty that we would be able to expand our presence in the insurance industry in China, we may attempt to do so. If we decide to do so, we will need to receive additional government licenses and approvals or enter into additional relationships and we may face disadvantages in doing so as a result of our subsidiary in China being wholly foreign-owned.  

  

Our sponsorship and advertising business may not be successful.  

 

We sell advertising space to health insurance carriers on our website through our sponsorship and advertising program. Our sponsorship and advertising program allows carriers to purchase advertising space in specific markets in a sponsorship area on our website.  Health insurance carriers have and may continue to determine to eliminate or reduce spending on our sponsorship and advertising program as a result of various aspects of health care reform, including the medical loss ratio requirements that became effective in 2011.  As a result, our business, operating results and financial condition could be harmed.  To the extent that economic conditions, health care reform or other factors impact the amount health insurance carriers are willing to pay for advertising on our ecommerce platform, our sponsorship and advertising program will be adversely impacted. The success of our sponsorship and advertising program depends on a number of other factors, including the effectiveness of the sponsorship and advertising program as a cost-effective method for carriers to obtain additional members, consumer and health insurance carrier adoption of the Internet and our ecommerce platform as a medium for the purchase and sale of health insurance, our ability to attract consumers visiting our ecommerce platform and convert those consumers into members, the existence of a relationship between us and a diverse group of carriers that offer a number of health insurance plans in the markets in which we attempt to sell advertising, the cost, benefit and brand recognition of the health insurance plan that is the subject of the advertising, the impact the advertising has on the sale of the health insurance plan that is the subject of the advertising and the effectiveness of the carrier’s other means of advertising. In addition, while our practice of selling advertising is described on our ecommerce platform, it could cause consumers to perceive us as not objective, which could harm our brand and result in a decline in our health insurance sales. It also could adversely impact our relationship with health insurance carriers that do not purchase our advertising. As a result, our business, operating results and financial condition could be harmed.  

 

We also develop, host and maintain carrier dedicated Medicare plan websites through our advertising program.  Our success in doing so is dependent upon the same factors that could impact our sponsorship program. In addition, since we maintain relationships with a limited number of health insurance carriers to sell their Medicare plans, our Medicare plan-related advertising revenue is concentrated in a small number of health insurance carriers and our ability to generate Medicare plan-related advertising revenue would be harmed by the termination or non-renewal of any of these relationships as well as by a reduction in the amount a health insurance carrier is willing to pay for these services.  Moreover, in light of the regulations applicable to the marketing and sale of Medicare plans, and given that these regulations are often unclear, change frequently and are subject to changing interpretations, we may in the future not be permitted to sell Medicare plan-related advertising.  If we are not successful in generating Medicare plan-related advertising revenue, our business operating results and financial condition could be harmed.  

 

We may not be successful in licensing the use of our ecommerce technology to health insurance carriers and other third parties.  

 

We license the use of our ecommerce technology to health insurance carriers and agents. Carriers use our platform to offer their own health insurance policies on their websites, and agents use it to power their quoting and online content. If we do not grow our revenue from the license of our technology, or if the rate of growth declines, our business, operating results and financial condition may be harmed. The impact that health care reform may have on our technology licensing business is unclear. Health care reform could reduce health insurance carrier and agent demand for our technology licensing platform as a result of the medical loss ratio requirements that became effective in 2011 or for other reasons, and health insurance carriers who currently use the platform could determine to cease using it, reduce the number and type of plans offered on the platform or renegotiate the fees that they pay, any of which would reduce the revenue we receive from our technology licensing business.  

 

54 

 


 

The business of licensing the use of our technology to others could facilitate carrier, health insurance agent and other third party competition with us in the sale of health insurance over the Internet and is subject to a number of additional risks and uncertainties, including consumer and health insurance carrier adoption of our ecommerce platform as a medium for the purchase and sale of health insurance, our ability to establish relationships with new health insurance carriers, the reliability and performance of our ecommerce platform and the relative cost of developing competing technology. If we are not able to offer health insurance carriers and other third parties a reliable platform to cost-efficiently offer their plans over the Internet, our technology licensing business will be unsuccessful.  

 

We may not be able to adequately protect our intellectual property, which could harm our business and operating results.  

 

We believe that our intellectual property is an essential asset of our business and that our technology infrastructure currently gives us a competitive advantage in the distribution of individual and family and small business health insurance. We rely on a combination of copyright, trademark and trade secret laws as well as confidentiality procedures and contractual provisions to establish and protect our intellectual property rights in the United States. We have not filed for protection of our intellectual property in any foreign jurisdiction other than China. We have Chinese-registered computer software copyrights for an internally-developed software system and a project management tool and have certain trademarks in China. We have not filed any patent applications in China. The efforts we have taken to protect our intellectual property may not be sufficient or effective, and our trademarks, copyrights and patents if issued, may be held invalid or unenforceable. Moreover, the law relating to intellectual property is not as developed in China, and our intellectual property rights may not be as respected in China as they are in the United States. Any United States or other patents issued to us may not be sufficiently broad to protect our proprietary technologies, and given the costs of obtaining patent protection, we may choose not to seek patent protection for certain of our proprietary technologies. We may not be effective in policing unauthorized use of our intellectual property, trade secrets and other confidential information, and even if we do detect violations, litigation may be necessary to enforce our intellectual property rights. Any enforcement efforts we undertake, including litigation, could be time-consuming and expensive, could divert our management’s attention and may result in a court determining that our intellectual property or other rights are unenforceable. If we are not successful in cost-effectively protecting our intellectual property rights, trade secrets and confidential information, our business, operating results and financial condition could be harmed.  

  

We may in the future be subject to intellectual property rights claims, which are extremely costly to defend, could require us to pay significant damages and could limit our ability to use certain technologies in the future.  

 

There are a large number of patents, copyrights, trademarks and trade secrets applicable to the internet and technology industries and entities frequently enter into litigation based on allegations of infringement or other violations of intellectual property rights. We have received, and may in the future receive, notices that claim we have misappropriated, infringed or misused other parties’ intellectual property rights, and, to the extent we gain greater visibility, we face a higher risk of being the subject of intellectual property infringement claims. There may be third-party intellectual property rights, including issued or pending patents that cover significant aspects of our technologies or business methods or that cover third-party technology that we use as a part of our websites. Any intellectual property claim against us, with or without merit, could be time consuming, expensive to settle or litigate and could divert our management’s attention and other resources. These claims also could subject us to significant liability for damages and could result in our having to stop using technology found to be in violation of a third party’s rights. We might be required to seek a license for third-party intellectual property, which may not be available on reasonable terms or at all. Even if a license is available, we could be required to pay significant royalties, which would increase our operating expenses. We may also be required to develop alternative non-infringing technology, which could require significant effort and expense. If we cannot license or develop technology for any infringing aspect of our business, we would be forced to limit our services and may be unable to compete effectively. Any of these results would harm our business, operating results and financial condition. 

 

Any legal liability, regulatory penalties, or negative publicity for the information on our website or that we otherwise distribute or provide could harm our business and operating results.  

 

We provide information on our website, through our customer care centers and in other ways regarding health insurance in general and the health insurance plans we market and sell, including information relating to insurance premiums, coverage, benefits, provider networks, exclusions, limitations, availability, plan comparisons and insurance company ratings. A significant amount of both automated and manual effort is required to maintain the considerable amount of insurance plan information on our website. Separately, from time to time, we use the information provided on our website

55 

 


 

and otherwise collected by us to publish reports designed to educate consumers, facilitate public debate, and facilitate reform at the state and federal level relating to the accessibility and affordability of health insurance. If the information we provide on our website, through our customer care centers or otherwise is not accurate or is construed as misleading, or if we do not properly assist individuals and businesses in purchasing health insurance, members, health insurance carriers and others could attempt to hold us liable for damages, our relationships with health insurance carriers could be terminated and regulators could attempt to subject us to penalties, revoke our licenses to transact health insurance business in a particular jurisdiction, and/or compromise the status of our licenses to transact health insurance business in other jurisdictions, which could result in our loss of our commission revenue. In the ordinary course of operating our business, we have received complaints that the information we provided was not accurate or was misleading. Although in the past we have resolved these complaints without significant financial cost, we cannot guarantee that we will be able to do so in the future. In addition, these types of claims could be time-consuming and expensive to defend, could divert our management’s attention and other resources, and could cause a loss of confidence in our services. As a result, whether or not we are able to successfully resolve these claims, they could harm our business, operating results and financial condition.  

 

In the ordinary course of our business, we have received and may continue to receive inquiries from state regulators relating to various matters. We have become, and may in the future become, involved in litigation in the ordinary course of our business. If we are found to have violated laws or regulations, we could lose our relationship with health insurance carriers and be subject to various fines and penalties, including revocation of our licenses to sell insurance which would in turn potentially cause us to lose our commission revenue, and our business, operating results and financial condition would be materially harmed. 

 

Changes in our management and key employees could affect our financial results.   

 

Our success is dependent upon the performance of our senior management and key personnel. Our management and employees can terminate their employment at any time. The loss of the services of any of our executive officers or key employees could harm our business. For example, we appoint a single writing agent with each insurance carrier. If we lose the service of our appointed writing agent, the duties of writing agent will need to be transitioned to other company personnel. Due to our national reach and the large number of carrier partners whose policies are purchased by our members, this transition may be difficult and requires a significant period of time to complete. If the transition is not successful or takes too long to complete, our agency relationship with particular insurance carriers may be terminated, our commission payments could be discontinued or delayed and, as a result, our business, operating results and financial condition would be harmed.  Our success is also dependent upon our ability to attract additional personnel for all areas of our organization. We may not be successful in attracting and retaining personnel on a timely basis, on competitive terms or at all. If we are unable to attract and retain the necessary personnel, our business would be harmed. 

 

If we fail to manage the expansion of our business, our business and operating results would be harmed.  

 

We have expanded our operations significantly and have recently entered into the business of selling Medicare plans.  Our entering into this new area of business places increasing and significant demands on our management, our operational and financial systems and infrastructure and our other resources. If we do not effectively manage this expansion, the quality of our services could suffer, which could harm our business, operating results and financial condition. In order to successfully expand our business, we need to hire, integrate and retain highly skilled and motivated employees. We also need to continue to improve our existing systems for operational and financial management, including our reporting systems, procedures and controls. These improvements could require significant capital expenditures and place increasing demands on our management. We may not be successful in managing or expanding our operations or in maintaining adequate financial and operating systems and controls. If we do not successfully implement improvements in these areas, our business, operating results and financial condition will be harmed.  

 

Seasonality may cause fluctuations in our financial results.  

 

The number of individual and family health insurance applications submitted through our ecommerce platform has generally increased in our first quarter compared to our fourth quarter and in our third quarter compared to our second quarter. Conversely, we have generally experienced a decline or flattening of individual and family submitted applications in our second quarter compared to our first quarter and in our fourth quarter compared to our third quarter.  The majority of Medicare plans are sold in our fourth quarter during the Medicare annual enrollment period, when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, we generate a significant amount of Medicare plan-related revenue in the fourth quarter of the

56 

 


 

year. Additionally, we recognize a majority of our renewal Medicare Advantage and Medicare Part D prescription drug plan commission revenue in the first quarter of each year as the majority of Medicare policies sold during the annual enrollment period typically renew on January 1 of each year.

 

Since a significant portion of our marketing and advertising expenses are driven by the number of health insurance applications submitted on our ecommerce platform, those expenses are influenced by these seasonal patterns. As a result, marketing and advertising expenses related to individual and family health insurance plans are highest in our first and third quarters, while marketing and advertising expenses related to Medicare plans are highest in our third and fourth quarters.  Additionally, in preparation for the Medicare annual enrollment period, we begin ramping up our temporary customer care center staff during our second and third quarters and employ our temporary customer care center staff until the end of the Medicare annual enrollment period in December. Accordingly, our customer care center staffing costs are significantly higher in our third and fourth quarters compared to our first and second quarters.

 

Based on these seasonal trends, our revenue is highest in the fourth quarter of the year and our profitability is relatively higher in the first and fourth quarters and substantially lower in the third quarter of the year.

 

It is unclear what the impact of open enrollment periods for the purchase of major medical health insurance plans will have on our marketing and advertising expenses, although we expect the seasonal patterns for individual and family plan submitted applications, and marketing and advertising expenses, will be impacted. The first open enrollment period began in October 2013 and is currently scheduled to run through March 2014. Thereafter,  it is scheduled to occur within the fourth quarter each calendar year starting in October 2014. We expect our total marketing expenses will increase during the open enrollment period as an increased number of consumers switch health insurance policies.  

 

The seasonality in our business could have an adverse effect on our business, operating results and financial condition and could have a particularly adverse impact in a single quarter.

 

Acquisitions could disrupt our business and harm our financial condition and operating results. 

 

We may decide to acquire businesses, products and technologies. Our ability as an organization to successfully make and integrate acquisitions is unproven.  Acquisitions could require significant capital infusions and could involve many risks, including the following:  

 

·

an acquisition may negatively impact our results of operations because it will require us to incur transaction expenses, and after the transaction, may require us to incur charges and substantial debt or liabilities, may require the amortization, write down or impairment of amounts related to deferred compensation, goodwill and other intangible assets, or may cause adverse tax consequences, substantial depreciation or deferred compensation charges; 

 

·

an acquisition undertaken for strategic business purposes may negatively impact our results of operations; 

 

·

we may encounter difficulties in assimilating and integrating the business, technologies, products, personnel or operations of companies that we acquire, particularly if key personnel of the acquired company decide not to work for us; 

 

·

an acquisition may disrupt our ongoing business, divert resources, increase our expenses and distract our management; 

 

·

we may be required to implement or improve internal controls, procedures and policies appropriate for a public company at a business that prior to the acquisition lacked these controls, procedures and policies; 

 

·

the acquired businesses, products or technologies may not generate sufficient revenue to offset acquisition costs or to maintain our financial results; 

 

·

we may have to issue equity securities to complete an acquisition, which would dilute our stockholders’ ownership and could adversely affect the market price of our common stock; and 

 

57 

 


 

·

acquisitions may involve the entry into geographic or business markets in which we have little or no prior experience. 

 

We cannot assure you that we will be able to identify or consummate any future acquisition on favorable terms, or at all. If we do pursue an acquisition, it is possible that we may not realize the anticipated benefits from the acquisition or that the financial markets or investors will negatively view the acquisition. Even if we successfully complete an acquisition, it could harm our business, operating results and financial condition.  

 

If we fail to maintain proper and effective internal controls, our ability to produce accurate financial statements could be impaired, which could adversely affect our operating results, our ability to operate our business and our stock price. 

 

We have a complex business organization, and we recently expanded our business operations into the sale of Medicare plans. Ensuring that we have adequate internal financial and accounting controls and procedures in place to help ensure that we can produce accurate financial statements on a timely basis is a costly and time-consuming effort that needs to be re-evaluated frequently and is complicated by the expansion of our business operations.  Our management, including our chief executive officer and chief financial officer, does not expect that our internal control over financial reporting will prevent all errors or all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. Over time, controls may become inadequate because changes in conditions or deterioration in the degree of compliance with policies or procedures may occur. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.  

 

  

As a result, we cannot assure that significant deficiencies or material weaknesses in our internal control over financial reporting will not be identified in the future. Any failure to maintain or implement required new or improved controls, or any difficulties we encounter in their implementation, could result in significant deficiencies or material weaknesses, cause us to fail to timely meet our periodic reporting obligations, or result in material misstatements in our financial statements. Any such failure could also adversely affect the results of periodic management evaluations and annual auditor attestation reports regarding disclosure controls and the effectiveness of our internal control over financial reporting required under Section 404 of the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder. The existence of a material weakness could result in errors in our financial statements that could result in a restatement of financial statements, cause us to fail to timely meet our reporting obligations and cause investors to lose confidence in our reported financial information, leading to a decline in our stock price and potential lawsuits against us. 

 

Changes in our provision for income taxes or adverse outcomes resulting from examination of our income or other tax returns could adversely affect our results. 

 

Our provision for income taxes is subject to volatility and could be adversely affected by earnings differing materially from our projections, changes in the valuation of our deferred tax assets and liabilities, expiration of or lapses in the research and development tax credit laws, tax effects of share-based compensation or by changes in tax laws, regulations, accounting principles, including accounting for uncertain tax positions, or interpretations thereof. For instance, in October 2010, the state of California approved budget legislation which substantially limited the utilization of net operating losses. The new law did not affect the amount of net operating losses and tax credits that we expect to ultimately use to offset future California taxes, but limited the amount we could utilize in 2010 and 2011, resulting in our paying higher cash taxes. To the extent that our provision for income taxes is subject to volatility or adverse outcomes as a result of tax examinations, our operating results could be harmed.  

 

Significant judgment is required to determine the recognition and measurement attribute prescribed in U.S. generally accepted accounting principles (“U.S. GAAP”) relating to accounting for income taxes. In addition, U.S. GAAP applies to all income tax positions, including the potential recovery of previously paid taxes, which if settled unfavorably could adversely impact our provision for income taxes or additional paid-in capital. In addition, we are subject to examinations of our income tax returns by the Internal Revenue Service and other tax authorities. We assess the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. There may be exposure that the outcomes from these examinations will have an adverse effect on our operating results and financial condition.  

58 

 


 

 

Risks Related to State Insurance Regulation 

 

Regulation of the sale of health insurance is subject to change, and future regulations could harm our business and operating results.  

 

The laws and regulations governing the offer, sale and purchase of health insurance are subject to change, and future changes may be adverse to our business. For example, a long standing provision in each state’s law that we believe is  advantageous to our business is that once health insurance premiums are set by the carrier and approved by state regulators, they are fixed and not generally subject to negotiation or discounting by insurance companies or agents. Additionally, state regulations generally prohibit carriers, agents and brokers from providing financial incentives, such as rebates, to their members in connection with the sale of health insurance. As a result, we do not currently compete with carriers or other agents and brokers on the price of the health insurance plans offered on our website. If these regulations change, we could be forced to reduce prices or provide rebates or other incentives for the health insurance plans sold through our ecommerce platform, which would harm our business, operating results and financial condition.  

 

States have, and will continue, to adopt new laws and regulations in response to health care reform legislation.  It is difficult to predict how these new laws and regulations will impact our business, but in some cases such laws and regulations could amplify the adverse impacts of health care reform, or states may adopt new requirements that adversely impact our business, operating results and financial condition. 

  

We are also subject to additional insurance regulatory risks, because we use the Internet as our distribution platform. In many cases, it is not clear how existing insurance laws and regulations apply to Internet-related health insurance advertisements and transactions. To the extent that new laws or regulations are adopted that conflict with the way we conduct our business, or to the extent that existing laws and regulations are interpreted adversely to us, our business, operating results and financial condition would be harmed.  

 

If we fail to comply with the numerous state laws and regulations that are applicable to the sale of health insurance, our business and operating results could be harmed.  

 

The sale of health insurance is heavily regulated by each state in the United States. For instance, in addition to the impact and changes in regulations resulting from health care reform, state regulators require us to maintain a valid license in each state in which we transact health insurance business and further require that we adhere to sales, documentation and administration practices specific to that state. In addition, each employee who transacts health insurance business on our behalf must maintain a valid license in one or more states. Because we do business in all 50 states and the District of Columbia, compliance with health insurance-related laws, rules and regulations is difficult and imposes significant costs on our business. Each jurisdiction’s insurance department typically has the power, among other things, to:  

  

·

grant and revoke licenses to transact insurance business; 

 

·

conduct inquiries into the insurance-related activities and conduct of agents and agencies; 

 

·

require and regulate disclosure in connection with the sale and solicitation of health insurance; 

 

·

authorize how, by which personnel and under what circumstances insurance premiums can be quoted and published and an insurance policy sold; 

 

·

approve which entities can be paid commissions from carriers and the circumstances under which they may be paid; 

 

·

regulate the content of insurance-related advertisements, including web pages, and other marketing practices; 

 

·

approve policy forms, require specific benefits and benefit levels and regulate premium rates; 

 

·

impose fines and other penalties; and 

 

·

impose continuing education requirements. 

59 

 


 

 

Due to the complexity, periodic modification and differing interpretations of insurance laws and regulations, we may not have always been, and we may not always be, in compliance with them. New insurance laws, regulations and guidelines also may not be compatible with the sale of health insurance over the Internet or with various aspects of our platform or manner of marketing or selling health insurance plans. Failure to comply with insurance laws, regulations and guidelines or other laws and regulations applicable to our business could result in significant liability, additional department of insurance licensing requirements, the revocation of licenses in a particular jurisdiction and/or our inability to sell health insurance plans, which could significantly increase our operating expenses, result in the loss of our commission revenue and otherwise harm our business, operating results and financial condition.  Moreover, an adverse regulatory action in one jurisdiction could result in penalties and adversely affect our license status or reputation in other jurisdictions due to the requirement that adverse regulatory actions in one jurisdiction be reported to other jurisdictions. Even if the allegations in any regulatory or other action against us are proven false, any surrounding negative publicity could harm consumer, marketing partner or health insurance carrier confidence in us, which could significantly damage our brand. Because some consumers, marketing partners and health insurance carriers may not be comfortable with the concept of purchasing health insurance using the Internet, any negative publicity may affect us more than it would others in the health insurance industry and would harm our business, operating results and financial condition. Changes in insurance laws, regulations and guidelines may also be incompatible with various aspects of our business and require that we make significant modifications to our existing technology or practices, which may be costly and time-consuming to implement and could also harm our business, operating results and financial condition. 

 

In addition, we have received, and may in the future receive, inquiries from regulators regarding our marketing and business practices. We typically respond by explaining how we believe we are in compliance with relevant regulations or may modify our practices in connection with the inquiry. Any modification of our marketing or business practices in response to future regulatory inquiries could harm our business, operating results or financial condition.  

  

Risks Related to the Internet and Electronic Commerce  

 

Our business is subject to security risks and, if we are unable to safeguard the security and privacy of confidential data, including personal health information, our business will be harmed.  

 

Our services involve the collection and storage of confidential information of consumers and the transmission of this information to their chosen health insurance carriers. For example, we collect names, addresses, Social Security and credit card numbers, and information regarding the medical history of consumers in connection with their applications for health insurance. As a result, we are subject to various federal, state and international laws and regulations regarding the collection, maintenance, protection, use, transmission, disclosure and disposal of sensitive personal information.  We cannot guarantee that our facilities and systems, and those of our third party service providers, will be free of security breaches, acts of vandalism, computer viruses, misplaced or lost data, programming and/or human errors or other similar events. Compliance with privacy and security laws, requirements and regulations may result in cost increases due to new constraints on our business, the development of new processes, the effects of potential non-compliance by third party service providers, and enforcement actions.  We may be required to expend significant capital and other resources to protect against security breaches or to alleviate problems caused by security breaches. Despite our implementation of security measures, techniques used to obtain unauthorized access or to sabotage systems change frequently. As a result, we may be unable to anticipate these techniques or to implement adequate preventative measures. Additionally, our third party service providers may cause security breaches for which we are responsible

 

Any compromise or perceived compromise of our security could damage our reputation, cause the termination of our relationship with our members, marketing partners and health insurance carriers, reduce demand for our services and subject us to significant liability and expense as well as regulatory action and private privacy-related lawsuits, which would harm our business, operating results and financial condition. In addition, in the event that data security laws are implemented, or our health insurance carrier or other partners determine to impose new requirements on us relating to data security, we may not be able to timely comply with such requirements or such requirements may not be compatible with our current processes. Changing our processes could be time consuming and expensive, and failure to timely implement required changes could result in our inability to sell health insurance plans in a particular jurisdiction or for a particular health insurance carrier or subject us to liability for non-compliance, any of which would damage our business, operating results and financial condition. 

 

Government regulation of the Internet could adversely affect our business.  

60 

 


 

 

The laws governing general commerce on the Internet remain unsettled and it may take years to fully determine whether and how existing laws such as those governing intellectual property, privacy and taxation apply to the Internet. In addition, the growth and development of the market for electronic commerce may prompt calls for more stringent consumer protection laws that may impose additional burdens on companies conducting business over the Internet. Any new laws or regulations or new interpretations of existing laws or regulations relating to the Internet could harm our business and we could be forced to incur substantial costs in order to comply with them, which would harm our business, operating results and financial condition.  

 

Our business could be harmed if we are unable to correspond with our consumers or market the availability of our ecommerce platform by email.  

 

We use email to market our services to potential members and as the primary means of communicating with our existing members. The laws and regulations governing the use of email for marketing purposes continue to evolve and the growth and development of the market for commerce over the Internet may lead to the adoption of additional legislation. If new laws or regulations are adopted, or existing laws and regulations are interpreted, to impose additional restrictions on our ability to send email to our members or potential members, we may not be able to communicate with them in a cost-effective manner. In addition to legal restrictions on the use of email, Internet service providers, e-mail service providers and others attempt to block the transmission of unsolicited email, commonly known as “spam.” Many Internet and e-mail service providers have relationships with organizations whose purpose it is to detect and notify the Internet and e-mail service providers of entities that the organization believes is sending unsolicited e-mail.  If an Internet or e-mail service provider identifies email from us as “spam” as a result of reports from these organizations or otherwise, we can be placed on a restricted list that will block our email to members or potential members. If we are unable to communicate by email with our members and potential members as a result of legislation, blockage or otherwise, our business, operating results and financial condition would be harmed.  

 

Consumers depend upon third-party service providers to access our website, and our business and operating results could be harmed as a result of technical difficulties experienced by these service providers.  

 

Consumers using our website depend upon Internet, online and other service providers for access to our website. Many of these service providers have experienced significant outages, delays and other difficulties in the past and could experience them in the future. Any significant interruption in access to our website or increase in our website’s response time as a result of these difficulties could damage our relationship with insurance carriers, marketing partners and existing and potential members and could harm our business, operating results and financial condition.  

 

Risks Related to the Ownership of Our Common Stock  

 

The trading price of our common stock may be subject to significant fluctuations and volatility, and our stockholders may be unable to resell their shares at a profit.   

 

The stock markets, in general, and the markets for high technology stocks in particular, have historically experienced high levels of volatility. The market for technology stocks has been extremely volatile and frequently reaches levels that bear no relationship to the past or present operating performance of those companies. These broad market fluctuations may adversely affect the trading price of our common stock. In addition, the trading price of our common stock has been subject to significant fluctuations and may continue to fluctuate or decline, particularly as a result of developments relating to health care reform legislation. Factors that could cause fluctuations in the trading price of our common stock include, but are not limited to, the following: 

 

·

price and volume fluctuations in the overall stock market from time to time; 

 

·

significant volatility in the market price and trading volume of technology companies in general, and companies in our industry; 

 

·

actual or anticipated changes in our results of operations or fluctuations in our operating results; 

 

61 

 


 

·

actual or anticipated changes in the expectations of investors or securities analysts, including changes in financial estimates or investment recommendations by securities analysts who follow our business and changes in perceptions relating to the economy; 

 

·

speculation in the press or investment community; 

 

·

technological advances or introduction of new products by us or our competitors; 

 

·

actual or anticipated developments in our competitors’ businesses or the competitive landscape generally; 

 

·

litigation involving us, our industry or both; 

 

·

actual or anticipated regulatory developments in the United States or foreign countries, including health care reform legislation in the United States; 

 

·

major catastrophic events; 

 

·

announcements or developments relating to the economy; 

 

·

our sale of common stock or other securities in the future; 

 

·

the trading volume of our common stock, as well as sales of large blocks of our stock; or 

 

·

departures of key personnel. 

 

These factors, as well as general economic and political conditions and the announcement of proposed and completed acquisitions or other significant transactions, or any difficulties associated with such transactions, by us or our strategic partners, customers or our current competitors, may materially adversely affect the market price of our common stock in the future. In the past, following periods of volatility in the market price of a company’s securities, securities class action litigation has often been instituted against that company. Such litigation could result in substantial cost and a diversion of management’s attention and resources. In addition, volatility, lack of positive performance in our stock price or changes to our overall compensation program, including our equity incentive program, may adversely affect our ability to retain key employees.  

A limited number of stockholders have the ability to influence the outcome of director elections and other matters requiring stockholder approval.  

 

A small number of greater than 5% stockholders and their affiliated entities beneficially owned more than 50% percent of our outstanding common stock as of September 30, 2013. These stockholders, if they act together, could exert substantial influence over matters requiring approval by our stockholders, including the election of directors, the amendment of our certificate of incorporation and bylaws and the approval of mergers or other business combination transactions. This concentration of ownership may discourage, delay or prevent a change in control of our company, which could deprive our stockholders of an opportunity to receive a premium for their stock as part of a sale of our company and might reduce our stock price. These actions may be taken even if they are opposed by other stockholders. 

 

Certain provisions in our charter documents and Delaware law could discourage takeover attempts and lead to management entrenchment.  

 

Our certificate of incorporation and bylaws contain provisions that could have the effect of delaying or preventing changes in control or changes in our management without the consent of our board of directors. These provisions include:  

  

·

a classified board of directors with three-year staggered terms, which may delay the ability of stockholders to change the membership of a majority of our board of directors; 

 

·

cumulative voting in the election of directors is prohibited, which limits the ability of minority stockholders to elect director candidates; 

 

62 

 


 

·

the exclusive right of our board of directors to elect a director to fill a vacancy created by the expansion of the board of directors or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our board of directors; 

 

·

the ability of our board of directors to determine to issue shares of preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquiror; 

 

·

a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting of our stockholders; 

 

·

the requirement that a special meeting of stockholders may be called only by the chairman of the board of directors, the chief executive officer or the board of directors, which may delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors; and 

 

·

advance notice procedures that stockholders must comply with in order to nominate candidates to our board of directors or to propose matters to be acted upon at a stockholders’ meeting, which may discourage or deter a potential acquiror from conducting a solicitation of proxies to elect the acquiror’s own slate of directors or otherwise attempting to obtain control of us. 

 

We are also subject to certain anti-takeover provisions under Delaware law. Under Delaware law, a corporation may, in general, not engage in a business combination with any holder of 15% or more of its capital stock unless the holder has held the stock for three years or, among other things, the board of directors has approved the transaction.  

 

63 

 


 

 

 

ITEM 6.

EXHIBITS

 

 

(a)  Exhibits 

Except as so indicated in Exhibits 32.1 and 32.2, the following exhibits are filed as part of, or incorporated by reference into, this quarterly report.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Incorporation by Reference Herein

Exhibit 

Number

 

 

Description of Exhibit

 

Form

 

Date

31.1

Certification of Gary L. Lauer, Chief Executive Officer of eHealth, Inc., pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

31.2

Certification of Stuart M. Huizinga, Chief Financial Officer of eHealth, Inc., pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

32.1

Certification of Gary L. Lauer, Chief Executive Officer of eHealth, Inc., pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

32.2

Certification of Stuart M. Huizinga, Chief Financial Officer of eHealth, Inc., pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

101.INS

 

XBRL Instance Document

 

 

 

 

101.SCH

 

XBRL Taxonomy Extension Schema Document

 

 

 

 

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

 

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

 

101.LAB

 

XBRL Taxonomy Extension Label Linkbase Document

 

 

 

 

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

 

 

 

 

Filed herewith.

Furnished herewith.

*

Indicates a management contract or compensatory plan or arrangement.

 

 

64 

 


 

SIGNATURES 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on the 8th day of November 2013. 

 

/ s /  Gary L. Lauer 

Gary L. Lauer 

Chief Executive Officer 

(Duly Authorized Officer on Behalf of the Registrant) 

 

 

/ s /  Stuart M.  Huizinga 

Stuart M. Huizinga 

Chief Financial Officer 

(Principal Financial Officer) 

 

 


 

EXHIBIT INDEX

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Incorporation by Reference Herein

Exhibit 

Number

 

 

Description of Exhibit

 

Form

 

Date

31.1

Certification of Gary L. Lauer, Chief Executive Officer of eHealth, Inc., pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

31.2

Certification of Stuart M. Huizinga, Chief Financial Officer of eHealth, Inc., pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

32.1

Certification of Gary L. Lauer, Chief Executive Officer of eHealth, Inc., pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

32.2

Certification of Stuart M. Huizinga, Chief Financial Officer of eHealth, Inc., pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

101.INS

 

XBRL Instance Document

 

 

 

 

101.SCH

 

XBRL Taxonomy Extension Schema Document

 

 

 

 

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

 

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

 

101.LAB

 

XBRL Taxonomy Extension Label Linkbase Document

 

 

 

 

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

 

 

 

 

 

 

 

Filed herewith.

Furnished herewith.

*

Indicates a management contract or compensatory plan or arrangement.

 

 

 


EX-101.CAL 2 ehth-20130930_cal.xml EX-101.CAL EX-101.DEF 3 ehth-20130930_def.xml EX-101.DEF EX-101.INS 4 ehth-20130930.xml EX-101.INS 0001333493 2012-09-09 2012-09-10 0001333493 2012-01-01 2012-12-31 0001333493 ehth:WellpointMember 2013-07-01 2013-09-30 0001333493 ehth:UnitedhealthcareMember 2013-07-01 2013-09-30 0001333493 ehth:HumanaMember 2013-07-01 2013-09-30 0001333493 ehth:AetnaMember 2013-07-01 2013-09-30 0001333493 ehth:WellpointMember 2013-01-01 2013-09-30 0001333493 ehth:UnitedhealthcareMember 2013-01-01 2013-09-30 0001333493 ehth:HumanaMember 2013-01-01 2013-09-30 0001333493 ehth:AetnaMember 2013-01-01 2013-09-30 0001333493 ehth:WellpointMember 2012-07-01 2012-09-30 0001333493 ehth:UnitedhealthcareMember 2012-07-01 2012-09-30 0001333493 ehth:HumanaMember 2012-07-01 2012-09-30 0001333493 ehth:AetnaMember 2012-07-01 2012-09-30 0001333493 ehth:WellpointMember 2012-01-01 2012-09-30 0001333493 ehth:UnitedhealthcareMember 2012-01-01 2012-09-30 0001333493 ehth:HumanaMember 2012-01-01 2012-09-30 0001333493 ehth:AetnaMember 2012-01-01 2012-09-30 0001333493 ehth:CommissionRevenueMember ehth:MajorMedicalIndividualAndFamilyInsurancePlansMember 2013-07-01 2013-09-30 0001333493 us-gaap:AccountsReceivableMember ehth:ConcentrationRiskCustomerTwoMember 2013-01-01 2013-09-30 0001333493 us-gaap:AccountsReceivableMember ehth:ConcentrationRiskCustomerOneMember 2013-01-01 2013-09-30 0001333493 ehth:CommissionRevenueMember ehth:MajorMedicalIndividualAndFamilyInsurancePlansMember 2013-01-01 2013-09-30 0001333493 ehth:CommissionRevenueMember ehth:MajorMedicalIndividualAndFamilyInsurancePlansMember 2012-07-01 2012-09-30 0001333493 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2012-01-01 2012-12-31 0001333493 us-gaap:AccountsReceivableMember ehth:CustomerThreeMember 2012-01-01 2012-12-31 0001333493 us-gaap:AccountsReceivableMember ehth:CustomerFourMember 2012-01-01 2012-12-31 0001333493 us-gaap:AccountsReceivableMember ehth:ConcentrationRiskCustomerTwoMember 2012-01-01 2012-12-31 0001333493 us-gaap:AccountsReceivableMember ehth:ConcentrationRiskCustomerOneMember 2012-01-01 2012-12-31 0001333493 ehth:CommissionRevenueMember ehth:MajorMedicalIndividualAndFamilyInsurancePlansMember 2012-01-01 2012-09-30 0001333493 2012-09-30 0001333493 2011-12-31 0001333493 us-gaap:StockOptionsMember 2013-07-01 2013-09-30 0001333493 us-gaap:StockOptionsMember 2013-01-01 2013-09-30 0001333493 us-gaap:StockOptionsMember 2012-07-01 2012-09-30 0001333493 us-gaap:StockOptionsMember 2012-01-01 2012-09-30 0001333493 us-gaap:MarketingAndAdvertisingExpenseMember 2013-07-01 2013-09-30 0001333493 us-gaap:GeneralAndAdministrativeExpenseMember 2013-07-01 2013-09-30 0001333493 ehth:TechnologyAndContentExpenseMember 2013-07-01 2013-09-30 0001333493 ehth:CustomerCareAndEnrollmentExpenseMember 2013-07-01 2013-09-30 0001333493 us-gaap:MarketingAndAdvertisingExpenseMember 2013-01-01 2013-09-30 0001333493 us-gaap:GeneralAndAdministrativeExpenseMember 2013-01-01 2013-09-30 0001333493 ehth:TechnologyAndContentExpenseMember 2013-01-01 2013-09-30 0001333493 ehth:CustomerCareAndEnrollmentExpenseMember 2013-01-01 2013-09-30 0001333493 us-gaap:MarketingAndAdvertisingExpenseMember 2012-07-01 2012-09-30 0001333493 us-gaap:GeneralAndAdministrativeExpenseMember 2012-07-01 2012-09-30 0001333493 ehth:TechnologyAndContentExpenseMember 2012-07-01 2012-09-30 0001333493 ehth:CustomerCareAndEnrollmentExpenseMember 2012-07-01 2012-09-30 0001333493 us-gaap:MarketingAndAdvertisingExpenseMember 2012-01-01 2012-09-30 0001333493 us-gaap:GeneralAndAdministrativeExpenseMember 2012-01-01 2012-09-30 0001333493 ehth:TechnologyAndContentExpenseMember 2012-01-01 2012-09-30 0001333493 ehth:CustomerCareAndEnrollmentExpenseMember 2012-01-01 2012-09-30 0001333493 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2013-09-30 0001333493 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2012-12-31 0001333493 2013-07-01 2013-09-30 0001333493 2012-07-01 2012-09-30 0001333493 2012-01-01 2012-09-30 0001333493 2013-09-30 0001333493 2012-12-31 0001333493 2013-10-31 0001333493 2013-01-01 2013-09-30 ehth:state xbrli:pure iso4217:USD xbrli:shares ehth:customer iso4217:USD xbrli:shares false --12-31 Q3 2013 2013-09-30 10-Q 0001333493 18621347 Yes Accelerated Filer eHealth, Inc. EHTH 3941000 3746000 1990000 2822000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:446.40pt;margin-left:0pt;"> <tr> <td valign="top" style="width:446.40pt;padding:0pt 6.5pt"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Note 2 &#x2013; Cash, Cash Equivalents and Accounts Receivable </font></p> </td> </tr> <tr> <td valign="top" style="width:446.40pt;padding:0pt 6.5pt"> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> </tr> </table></div> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Cash and Cash Equivalents</font><font style="display: inline;font-weight:bold;font-style:italic;">&#x2014;</font><font style="display: inline;">As of December 31, 2012 and </font><font style="display: inline;">September 30</font><font style="display: inline;">, 2013, our cash equivalents consisted of money market accounts that invested in U.S. government-sponsored enterprise bonds and discount notes, U.S. government treasury bills and notes and repurchase agreements collateralized by U.S. government obligations. At December 31, 2012 and </font><font style="display: inline;">September 30</font><font style="display: inline;">, 2013, our cash equivalents carried no unrealized gains or losses and we did not realize any significant gains or losses on sales of cash equivalents during the three </font><font style="display: inline;">and nine </font><font style="display: inline;">months ended </font><font style="display: inline;">September 30</font><font style="display: inline;">, 2012 and 2013. &nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">As of December 31, 2012 and </font><font style="display: inline;">September 30</font><font style="display: inline;">, 2013, our cash and cash equivalent balances were invested as follows (in thousands):&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.30pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.30pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.30pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.30pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.30pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.30pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:22.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">December 31, 2012</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:23.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">September 30, 2013</font></p> </td> </tr> <tr> <td valign="top" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:9.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:9.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:9.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:9.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:03.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:9.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:19.84%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:9.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Cash</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,484&nbsp; </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,632&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Money market funds</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>113,365&nbsp; </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>78,119&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Total cash and cash equivalents</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>140,849&nbsp; </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>97,751&nbsp; </td> </tr> </table></div> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">We used observable prices in active markets in determining the classification of our money market funds as Level 1 as of December 31, 2012 and </font><font style="display: inline;">September 30</font><font style="display: inline;">, 2013.</font><font style="display: inline;font-weight:bold;font-style:italic;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Accounts Receivable</font><font style="display: inline;font-weight:bold;font-style:italic;">&#x2014;</font><font style="display: inline;">As of December 31, 2012 and </font><font style="display: inline;">September 30</font><font style="display: inline;">, 2013, our accounts receivable consisted of the following (in thousands):&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:22.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">December 31, 2012</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:23.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">September 30, 2013</font></p> </td> </tr> <tr> <td valign="top" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:10.50pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:10.50pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:10.50pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:10.50pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:03.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:10.50pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:19.84%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:10.50pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Accounts receivable - from other revenues</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,319&nbsp; </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,340&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Commissions receivable</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,149&nbsp; </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,259&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Total accounts receivable</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,468&nbsp; </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,599&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> </p> <p><font size="1"> </font></p><p style="page-break-after:always">&nbsp;</p> <p style="margin:0pt;font-family:Times New Roman;;font-size: 10pt"><font style="display: inline;font-weight:bold;font-style:italic;"></font> </p> <p><font size="1"> </font></p> </div> </div> 1149000 3259000 21152000 8823000 23914000 8936000 -2332000 -196000 51000 917000 750000 703000 478000 528000 102000 77000 124000 132000 4 2 16810000 6295000 15822000 6008000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:22.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">December 31, 2012</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:23.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">September 30, 2013</font></p> </td> </tr> <tr> <td valign="top" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:10.50pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:10.50pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:10.50pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:10.50pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:03.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:10.50pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:19.84%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:10.50pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Accounts receivable - from other revenues</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,319&nbsp; </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,340&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Commissions receivable</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,149&nbsp; </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,259&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Total accounts receivable</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,468&nbsp; </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,599&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:41.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="top" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:23.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:23.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">As of</font></p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">As of</font></p> </td> </tr> <tr> <td valign="top" style="width:41.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">December 31, 2012</font></p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">September 30, 2013</font></p> </td> </tr> <tr> <td valign="top" style="width:41.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="top" style="width:03.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:23.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:03.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:23.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">United States</font></p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:23.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>37,037&nbsp; </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:23.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>38,363&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:41.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">China</font></p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:23.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>278&nbsp; </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:23.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>342&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:41.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Total</font></p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:23.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>37,315&nbsp; </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:23.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>38,705&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:42.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:39.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:42.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:39.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Shares Available for Grant</font><font style="display: inline;"> (1)</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Shares available for grant December 31, 2012</font></p> </td> <td valign="bottom" style="width:42.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,982&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Additional shares authorized (2)</font></p> </td> <td valign="bottom" style="width:42.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>818&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Restricted stock units granted</font></p> </td> <td valign="bottom" style="width:42.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(564) </td> </tr> <tr> <td valign="bottom" style="width:57.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Options granted</font></p> </td> <td valign="bottom" style="width:42.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(119) </td> </tr> <tr> <td valign="bottom" style="width:57.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Restricted stock units cancelled</font></p> </td> <td valign="bottom" style="width:42.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Options cancelled</font></p> </td> <td valign="bottom" style="width:42.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>72&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Shares available for grant September 30, 2013</font></p> </td> <td valign="bottom" style="width:42.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,210&nbsp; </td> </tr> </table></div> <p style="margin:0pt;text-indent:36pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table style="width: 100%" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" style="width: 36.00pt; display: inline;"> <p style="font-family:Times New Roman;font-size: 10pt;margin:0pt;"> <font style="margin:0pt 0pt 0pt 18pt;font-family:Times New Roman;font-size:10pt;;padding:0pt 34.5pt 0pt 0pt;"> (1)</font> </p> </td><td align="left" valign="top"> <p style="font-family:Times New Roman;font-size: 10pt;margin:0pt;"> <font style="display: inline;">Shares available for grant do not include treasury stock shares that could also become available for grant if we determined to do so.</font><font style="display: inline;">&nbsp;</font></p></td></tr></table></div> <p style="margin:0pt 0pt 0pt 58.5pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table style="width: 100%" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" style="width: 36.00pt; display: inline;"> <p style="font-family:Times New Roman;font-size: 10pt;margin:0pt;"> <font style="margin:0pt 0pt 0pt 18pt;font-family:Times New Roman;font-size:10pt;;padding:0pt 34.5pt 0pt 0pt;"> (2)</font> </p> </td><td align="left" valign="top"> <p style="font-family:Times New Roman;font-size: 10pt;margin:0pt;"> <font style="display: inline;">On January&nbsp;1, 2013, the number of shares authorized for issuance under the 2006 Equity Incentive Plan was automatically increased pursuant to the terms of the 2006 Equity Incentive Plan.</font><font style="display: inline;"> &nbsp;&nbsp;</font></p></td></tr></table></div> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Seasonality&#x2014;</font><font style="display: inline;">The number of individual and family health insurance applications submitted through our ecommerce platform has generally increased in our first quarter compared to our fourth quarter and in our third quarter compared to our second quarter. Conversely, we have generally experienced a decline or flattening of individual and family submitted applications in our second quarter compared to our first quarter and in our fourth quarter compared to our third quarter. This seasonality </font><font style="display: inline;">could</font><font style="display: inline;"> change in the fourth quarter of 2013 as a result of the initial open enrollment period under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act, which began on October 1, 2013 and is scheduled to run through March 31, 2014.</font> </p> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The majority of Medicare plans are sold in our fourth quarter during the Medicare annual enrollment period, when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, we generate a significant amount of Medicare plan-related revenue in the fourth quarter of the year resulting from the sale of new Medicare plans. Additionally, we recognize a majority of our renewal Medicare Advantage and Medicare Part D prescription drug plan commission revenue in the first quarter of each year as the majority of policies sold during the annual enrollment period typically renew on January 1 of each year. </font> </p> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Since a significant portion of our marketing and advertising expenses are driven by the number of health insurance applications submitted on our ecommerce platform, those expenses are influenced by these patterns. As a result, marketing and advertising expenses related to individual and family health insurance plans have been highest in our first and third quarters, while marketing and advertising expenses related to Medicare-related plans have been highest in our third and fourth quarters. However, </font><font style="display: inline;">the historical trend of marketing and advertising expenses related to individual and family health insurance plans could be impacted by</font><font style="display: inline;"> the initial open enrollment period for individual and family plans </font><font style="display: inline;">that began </font><font style="display: inline;">on October 1, 2013.&nbsp; </font> </p> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Additionally, in preparation for the Medicare annual enrollment period, and to a lesser extent the initial open enrollment period for individual and family plans, we begin ramping up our customer care center staff during our second and third quarters to handle the anticipated increased volume of health insurance transactions during the fourth quarter. Accordingly, our customer care center staffing costs are significantly higher in our third and fourth quarters compared to our first and second quarters.</font> </p> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 1900000 500000 2600000 700000 10464000 24248000 3700000 3500000 200000 209925 <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:35.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:04.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:35.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:04.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:35.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="9" valign="bottom" style="width:32.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended September 30,</font></p> </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="6" valign="bottom" style="width:30.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Nine Months Ended September 30,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:35.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="3" valign="bottom" style="width:14.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td colspan="2" valign="bottom" style="width:02.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="4" valign="bottom" style="width:15.18%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="3" valign="bottom" style="width:14.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:13.26%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> </tr> <tr> <td valign="bottom" style="width:35.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:02.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.22%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:35.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Income before provision for income taxes</font></p> </td> <td valign="bottom" style="width:03.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td colspan="2" valign="bottom" style="width:10.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,079&nbsp; </td> <td colspan="2" valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td colspan="2" valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>381&nbsp; </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td colspan="2" valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,160&nbsp; </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,307&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:35.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Provision for income taxes</font></p> </td> <td valign="bottom" style="width:03.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td colspan="2" valign="bottom" style="width:10.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>874&nbsp; </td> <td colspan="2" valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td colspan="2" valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>207&nbsp; </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td colspan="2" valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,525&nbsp; </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,626&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:35.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Effective tax rate</font></p> </td> <td valign="bottom" style="width:03.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>81.0%&nbsp; </td> <td colspan="2" valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>54.3%&nbsp; </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>49.4%&nbsp; </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>41.6%&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 16018000 5503000 23585000 9117000 14.22 16.11 3319000 3340000 6123000 4230000 4468000 6599000 185000 160000 232903000 246190000 2400000 1200000 4200000 300000 4326000 243000 783000 2368000 932000 1339000 90000 233000 686000 330000 5361000 261000 1129000 2525000 1446000 1945000 92000 425000 911000 517000 1261000 354000 1061000 354000 1327000 1327000 1484000 1484000 439000 439000 127000 127000 196301000 161088000 156058000 118185000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Basis of Presentation&#x2014;</font><font style="display: inline;">The accompanying condensed consolidated balance sheet as of September 30, 2013, the condensed consolidated statements of comprehensive income for the three and nine months ended September 30, 2012 and 2013 and the condensed consolidated statements of cash flows for the nine months ended September 30, 2012 and 2013, respectively, are unaudited. The condensed consolidated balance sheet data as of December&nbsp;31, 2012 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December&nbsp;31, 2012, which was filed with the Securities and Exchange Commission on March&nbsp;13, 2013. The accompanying statements should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K. &nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or U.S. GAAP, for interim financial information. Accordingly, they do not include all of the financial information and footnotes required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December&nbsp;31, 2012, and include all adjustments necessary for the fair presentation of eHealth&#x2019;s statement of financial position as of September 30, 2013, its results of operations for the three and nine months ended September 30, 2012 and 2013 and its cash flows for the nine months ended September 30, 2012 and 2013. All adjustments are of a normal recurring nature. The results for the three and nine months ended September 30, 2013 are not necessarily indicative of the results to be expected for any subsequent period or for the fiscal year ending December&nbsp;31, 2013. </font><font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 27484000 19632000 123607000 130800000 140849000 97751000 7193000 -43098000 113365000 78119000 27000 28000 4636000 208000 3656000 167000 0.78 0.25 0.22 0.11 0.14 0.72 0.79 0.72 0.43 0.33 0.74 3538000 1099000 4441000 806000 101049000 36511000 118640000 41605000 15000 -3951000 926000 4353000 4098000 7115000 2928000 4198000 1740000 2290000 0.24 0.01 0.19 0.01 0.23 0.01 0.18 0.01 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:446.40pt;margin-left:0pt;"> <tr> <td valign="top" style="width:446.40pt;padding:0pt 6.5pt"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Note 5 &#x2013; Net Income Per Share</font></p> </td> </tr> <tr> <td valign="top" style="width:446.40pt;padding:0pt 6.5pt"> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> </tr> </table></div> <p style="margin:4.5pt 0pt 0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding for the period (excluding shares subject to repurchase). Diluted net income per share is computed by dividing the net income for the period by the weighted average number of common and common equivalent shares outstanding during the period. Diluted net income per share is computed giving effect to all potential dilutive common stock equivalent shares, including options, restricted stock and restricted stock units. The dilutive effect of outstanding awards is reflected in diluted net income per share by application of the treasury stock method. &nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share amounts): &nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:30.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:30.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended </font><br /><font style="display: inline;font-weight:bold;">September 30,</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:30.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:30.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Nine Months Ended </font><br /><font style="display: inline;font-weight:bold;">September 30,</font></p> </td> </tr> <tr> <td valign="top" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="top" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="top" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Basic:</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Numerator:</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Net income allocated to common stock</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>205&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>174&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,635&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,681&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Denominator:</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Net weighted average number of common stock shares outstanding</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,970&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,436&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,711&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,310&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Net income per share&#x2014;basic:</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.01&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.01&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.24&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.19&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Diluted:</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Numerator:</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Net income allocated to common stock</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>205&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>174&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,635&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,681&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Denominator:</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Net weighted average number of common stock shares outstanding</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,970&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,436&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,711&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,310&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Weighted average number of options</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>703&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>528&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>750&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>478&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Weighted average number of restricted stock units</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>77&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>132&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>102&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>124&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 30pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Total common stock shares used in per share calculation</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>20,750&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,096&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>20,563&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,912&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Net income per share&#x2014;diluted:</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.01&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.01&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.23&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.18&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> </p> <p><font size="1"> </font></p><p style="page-break-after:always">&nbsp;</p> <p style="margin:0pt;font-family:Times New Roman;;font-size: 10pt"><font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">For each of the three</font><font style="display: inline;">-</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">and nine- </font><font style="display: inline;">month</font><font style="display: inline;"> periods</font><font style="display: inline;"> ended </font><font style="display: inline;">September 30</font><font style="display: inline;">, 2012 and 2013, we had securities outstanding that could potentially dilute net income per share, but the shares from the assumed exercise of these securities were excluded in the computation of diluted net income per share as their effect would have been anti-dilutive. The number of outstanding weighted average anti-dilutive shares that were excluded from the computation of diluted net income per share consisted of the following (in thousands):&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:38.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:38.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:30.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="3" valign="bottom" style="width:29.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:30.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended September 30,</font></p> </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:30.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="3" valign="bottom" style="width:29.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:30.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Nine Months Ended September 30,</font></p> </td> </tr> <tr> <td valign="top" style="width:38.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="top" style="width:02.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="top" style="width:02.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> </tr> <tr> <td valign="top" style="width:38.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Common stock options</font></p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,484&nbsp; </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>127&nbsp; </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,327&nbsp; </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>439&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:38.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Total</font></p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,484&nbsp; </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>127&nbsp; </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,327&nbsp; </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>439&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 0.494 0.810 0.416 0.543 2000 -17000 8244000 10764000 -991000 -940000 37037000 38363000 278000 342000 0.07 0.16 0.13 0.13 0.07 0.19 0.12 0.13 0.09 0.20 0.11 0.12 0.10 0.18 0.11 0.12 2358000 4217000 19938000 6744000 22191000 7540000 14096000 14096000 9160000 1079000 6307000 381000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:446.40pt;margin-left:0pt;"> <tr> <td valign="top" style="width:446.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:446.40pt;padding:0pt 6.5pt"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Note 4 &#x2013; Income Taxes</font></p> </td> </tr> <tr> <td valign="top" style="width:446.40pt;padding:0pt 6.5pt"> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> </tr> </table></div> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The following table summarizes our provision for income taxes and our effective tax rates for the three and </font><font style="display: inline;">nine</font><font style="display: inline;"> months ended </font><font style="display: inline;">September</font><font style="display: inline;"> 30, 2012 and 2013 (in thousands, except effective tax rate):</font> </p> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:35.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:04.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:35.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:04.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:5.60pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:5.60pt;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:35.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="9" valign="bottom" style="width:32.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended September 30,</font></p> </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="6" valign="bottom" style="width:30.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Nine Months Ended September 30,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:35.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="3" valign="bottom" style="width:14.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td colspan="2" valign="bottom" style="width:02.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="4" valign="bottom" style="width:15.18%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="3" valign="bottom" style="width:14.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:13.26%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> </tr> <tr> <td valign="bottom" style="width:35.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:02.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.22%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:35.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Income before provision for income taxes</font></p> </td> <td valign="bottom" style="width:03.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td colspan="2" valign="bottom" style="width:10.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,079&nbsp; </td> <td colspan="2" valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td colspan="2" valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>381&nbsp; </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td colspan="2" valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,160&nbsp; </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,307&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:35.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Provision for income taxes</font></p> </td> <td valign="bottom" style="width:03.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td colspan="2" valign="bottom" style="width:10.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>874&nbsp; </td> <td colspan="2" valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td colspan="2" valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>207&nbsp; </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td colspan="2" valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,525&nbsp; </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,626&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:35.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Effective tax rate</font></p> </td> <td valign="bottom" style="width:03.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>81.0%&nbsp; </td> <td colspan="2" valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>54.3%&nbsp; </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>49.4%&nbsp; </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>41.6%&nbsp; </td> </tr> </table></div> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Our effective tax rate in the three and </font><font style="display: inline;">nine</font><font style="display: inline;"> months ended </font><font style="display: inline;">September</font><font style="display: inline;"> 30, 2012 was higher than statutory federal and state tax rates due primarily to non-deductible lobbying expenses and tax shortfalls related to share-based payments.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Our effective tax rate in the three and </font><font style="display: inline;">nine</font><font style="display: inline;"> months ended </font><font style="display: inline;">September</font><font style="display: inline;"> 30, 2013 was higher than statutory federal and state tax rates due primarily to non-deductible lobbying expenses, partially offset by a tax benefit resulting from the recent extension of the federal research tax credit through December 31, 2013.</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">During the three and </font><font style="display: inline;">nine</font><font style="display: inline;"> months ended </font><font style="display: inline;">September</font><font style="display: inline;"> 30, 2012</font><font style="display: inline;">, we utilized excess federal and state tax benefits related to share-based payments, which resulted in increases of $</font><font style="display: inline;">1.2</font><font style="display: inline;"> million and $</font><font style="display: inline;">2.4</font><font style="display: inline;"> million, respectively, in Additional Paid-In Capital in the condensed consolidated balance sheets. During the three and </font><font style="display: inline;">nine</font><font style="display: inline;"> months ended </font><font style="display: inline;">September</font><font style="display: inline;"> 30, 2013</font><font style="display: inline;">, we utilized excess federal and state tax benefits related to share-based payments, which resulted in increases of $</font><font style="display: inline;">0.3</font><font style="display: inline;"> million and $</font><font style="display: inline;">4.2</font><font style="display: inline;"> million, respectively, in Additional Paid-In Capital in the condensed consolidated balance sheets. These amounts are also classified in the condensed consolidated statements of cash flows as both a reduction to operating cash flows and as a financing cash inflow.&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp; &nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font><font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <p><font size="1"> </font></p><p style="page-break-after:always">&nbsp;</p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;;font-size: 10pt"><font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 4525000 874000 2626000 207000 2180000 -1895000 -4799000 2131000 390000 3794000 913000 2504000 341000 1370000 656000 852000 93358000 31291000 109193000 36000000 8911000 7850000 196301000 161088000 20809000 26062000 4625000 6222000 39142000 13988000 43448000 14852000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Description of Business</font><font style="display: inline;font-weight:bold;font-style:italic;">&#x2014;</font><font style="display: inline;">eHealth, Inc. (the &#x201C;Company,&#x201D; &#x201C;eHealth,&#x201D; &#x201C;we&#x201D; or &#x201C;us&#x201D;) is the leading </font><font style="display: inline;">online source of health insurance for individuals, families and small businesses in the United States. Through our website addresses (</font><font style="display: inline;font-style:italic;">www.eHealth.com</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;font-style:italic;">www.eHealthInsurance.com</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;font-style:italic;">www.eHealthMedicare.com</font><font style="display: inline;"> and </font><font style="display: inline;font-style:italic;">www.PlanPrescriber.com)</font><font style="display: inline;">, consumers can get quotes from leading health insurance carriers, compare plans side-by-side, and apply for and purchase individual and family, Medicare-related, small business and ancillary health insurance plans. We actively market the availability of Medicare-related insurance plans and</font><font style="display: inline;"> offer Medicare plan comparison tools and educational materials for Medicare-related insurance plans, including </font><font style="display: inline;">Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;">Our ecommerce technology also enables us to deliver consumers&#x2019; health insurance applications electronically to health insurance carriers. As a result, we simplify and streamline the complex and traditionally paper-intensive health insurance sales and purchasing process. </font><font style="display: inline;">We are licensed to market and sell health insurance in all </font><font style="display: inline;">50</font><font style="display: inline;"> states and the District of Columbia.&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> -3091000 -51121000 -9371000 -6735000 19653000 14775000 4635000 205000 3681000 174000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;text-indent:18pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Recently Adopted Accounting Standards&#x2014;</font><font style="display: inline;">Effective January 1, 2013, we adopted an accounting standards update with new guidance on the presentation of reclassifications from accumulated other comprehensive income to net income. This standard requires an entity to present reclassifications from accumulated other comprehensive income to net income either on the face of the condensed consolidated financial statements or in the notes to the condensed consolidated financial statements. In the nine months ended September 30, 2013 we did not have any reclassifications from accumulated other comprehensive income to net income</font><font style="display: inline;font-size:9pt;">.</font> </p> <p><font size="1"> </font></p> </div> </div> 37315000 38705000 50 9119000 1075000 6375000 403000 8123000 6082000 1000 3000 -25000 -7000 1575000 2969000 41000 4000 -68000 -22000 8441000 59007000 6243000 3128000 6735000 6643000 6720000 4014000 4650000 6185000 10677000 31000 41000 2250000 622000 3258000 1291000 28743000 32424000 110168000 37586000 125015000 42008000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:38.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:38.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:30.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="3" valign="bottom" style="width:29.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:30.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended September 30,</font></p> </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:30.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="3" valign="bottom" style="width:29.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:30.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Nine Months Ended September 30,</font></p> </td> </tr> <tr> <td valign="top" style="width:38.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="top" style="width:02.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="top" style="width:02.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> </tr> <tr> <td valign="top" style="width:38.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Common stock options</font></p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,484&nbsp; </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>127&nbsp; </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,327&nbsp; </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>439&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:38.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Total</font></p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,484&nbsp; </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>127&nbsp; </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,327&nbsp; </td> <td valign="bottom" style="width:02.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>439&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:30.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:30.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended </font><br /><font style="display: inline;font-weight:bold;">September 30,</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:30.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:30.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Nine Months Ended </font><br /><font style="display: inline;font-weight:bold;">September 30,</font></p> </td> </tr> <tr> <td valign="top" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="top" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="top" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Basic:</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Numerator:</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Net income allocated to common stock</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>205&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>174&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,635&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,681&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Denominator:</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Net weighted average number of common stock shares outstanding</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,970&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,436&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,711&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,310&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Net income per share&#x2014;basic:</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.01&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.01&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.24&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.19&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Diluted:</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Numerator:</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Net income allocated to common stock</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>205&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>174&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,635&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,681&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Denominator:</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Net weighted average number of common stock shares outstanding</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,970&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,436&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,711&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:24.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,310&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Weighted average number of options</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>703&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>528&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>750&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>478&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Weighted average number of restricted stock units</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>77&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>132&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>102&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>124&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 30pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Total common stock shares used in per share calculation</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>20,750&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,096&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>20,563&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,912&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:08.82%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Net income per share&#x2014;diluted:</font></p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.01&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.01&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.23&nbsp; </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:08.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.18&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.30pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.30pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.30pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.30pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.30pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:8.30pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:22.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">December 31, 2012</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:23.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">September 30, 2013</font></p> </td> </tr> <tr> <td valign="top" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:9.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:9.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:9.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:9.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:03.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:9.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:19.84%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:9.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Cash</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27,484&nbsp; </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,632&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Money market funds</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>113,365&nbsp; </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>78,119&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:51.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Total cash and cash equivalents</font></p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>140,849&nbsp; </td> <td valign="bottom" style="width:03.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.84%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>97,751&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The following table summarizes stock-based compensation expense recorded during the three and nine months ended September 30, 2012 and 2013 (in thousands):&nbsp;</font> </p> <p style="margin:0pt;text-indent:22.5pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:40.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:40.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:22.70pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:22.70pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended September 30,</font></p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:22.70pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:22.70pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Nine Months Ended September 30,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:40.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> </tr> <tr> <td valign="bottom" style="width:40.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:40.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Common stock options</font></p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>717&nbsp; </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>654&nbsp; </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,076&nbsp; </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,103&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:40.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Restricted stock units</font></p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>622&nbsp; </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,291&nbsp; </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,250&nbsp; </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,258&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:40.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Total stock-based compensation expense</font></p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,339&nbsp; </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,945&nbsp; </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,326&nbsp; </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,361&nbsp; </td> </tr> </table></div> <p style="margin:4.5pt 0pt 0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:4.5pt 0pt 0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The following table summarizes stock-based compensation expense by operating function for the three and nine months ended September 30, 2012 and 2013 (in thousands):&nbsp;</font> </p> <p style="margin:0pt;text-indent:22.5pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:42.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="top" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.05pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.05pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended September 30,</font></p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.05pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.05pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Nine Months Ended September 30,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:42.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> </tr> <tr> <td valign="top" style="width:42.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="top" style="width:02.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:10.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:10.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:10.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:10.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Marketing and advertising</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>330&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>517&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>932&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,446&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:42.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Customer care and enrollment</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>90&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>92&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>243&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>261&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:42.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Technology and content</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>233&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>425&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>783&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,129&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:42.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">General and administrative</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>686&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>911&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,368&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,525&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:42.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Total stock-based compensation expense</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,339&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,945&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,326&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,361&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:29.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:29.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:3.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:3.00pt;font-size: 11pt"> <font style="display: inline;font-family:Calibri;font-size:11pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:3.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:3.00pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:3.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:3.00pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:3.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:3.00pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:3.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:3.00pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:3.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:3.00pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:3.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:3.00pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:3.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:3.00pt;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:29.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="3" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">Three Months Ended September 30,</font></p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="3" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">Nine Months Ended September 30,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:29.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">2012</font></p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">2013</font></p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">2012</font></p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">2013</font></p> </td> </tr> <tr> <td valign="top" style="width:29.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:29.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Humana</font></p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>20%&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:29.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">WellPoint (1)</font></p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>13%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>13%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12%&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:29.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">UnitedHealthcare </font><font style="display: inline;font-size:8pt;">(2)</font></p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>13%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11%&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:29.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Aetna (3)</font></p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9%&nbsp; </td> </tr> </table></div> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table style="width: 100%" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" style="width: 36.00pt; display: inline;"> <p style="border-bottom:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt;margin:0pt;"> <font style="margin:0pt 0pt 10pt 18pt;border-bottom:1pt none #D9D9D9;line-height:115%;font-family:Calibri;font-size:10pt;"> (1)</font> </p> </td><td align="left" valign="top"> <p style="border-bottom:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt;margin:0pt;"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">Wellpoint also includes other carriers owned by Wellpoint.</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">&nbsp;</font></p></td></tr></table></div> <div style="width:100%"><table style="width: 100%" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" style="width: 36.00pt; display: inline;"> <p style="border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt;margin:0pt;"> <font style="margin:0pt 0pt 10pt 18pt;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;line-height:115%;font-family:Calibri;font-size:10pt;"> (2)</font> </p> </td><td align="left" valign="top"> <p style="border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt;margin:0pt;"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">UnitedHealthcare also includes other carriers owned by UnitedHealthcare.</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">&nbsp;</font></p></td></tr></table></div> <div style="width:100%"><table style="width: 100%" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" style="width: 36.00pt; display: inline;"> <p style="border-top:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt;margin:0pt;"> <font style="margin:0pt 0pt 10pt 18pt;border-top:1pt none #D9D9D9;line-height:115%;font-family:Calibri;font-size:10pt;"> (3)</font> </p> </td><td align="left" valign="top"> <p style="border-top:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt;margin:0pt;"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">Aetna also includes other carriers owned by Aetna.</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">&nbsp;</font></p></td></tr></table></div> <p style="margin:0pt 0pt 10pt 36pt;line-height:115%;font-family:Calibri;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:48.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Number Outstanding</font></p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Weighted-Average Remaining Contractual Life (years)</font></p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Aggregate Intrinsic Value </font><font style="display: inline;">(1)</font></p> </td> </tr> <tr> <td valign="bottom" style="width:48.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Balance outstanding as of December 31, 2012</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>381&nbsp; </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.22&nbsp; </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.26%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10,464&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:48.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Granted</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>564&nbsp; </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Vested</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(172) </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Cancelled</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(21) </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Balance outstanding as of September 30, 2013</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>752&nbsp; </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.55&nbsp; </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>24,248&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table style="width: 100%" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" style="width: 36.00pt; display: inline;"> <p style="line-height:115%;font-family:Calibri;font-size: 11pt;margin:6pt 0pt 0pt;"> <font style="margin:6pt 0pt 0pt 18pt;line-height:115%;font-family:Calibri;font-size:11pt;"> (1)</font> </p> </td><td align="left" valign="top"> <p style="line-height:115%;font-family:Calibri;font-size: 11pt;margin:6pt 0pt 0pt;"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">The aggregate intrinsic value is calculated as eHealth&#x2019;s closing stock price as of December 31, 2012 and September 30, 2013 multiplied by the number of restricted stock units outstanding as of December 31, 2012 and September 30, 2013, respectively.</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> &nbsp;&nbsp;</font><font style="display: inline;">&nbsp;</font></p></td></tr></table></div> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt 0pt 0pt 36pt;line-height:115%;font-family:Calibri;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:42.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Number of Stock Options</font></p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Weighted Average Exercise Price</font></p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Weighted-Average Remaining Contractual Life (years)</font></p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Aggregate Intrinsic Value</font><font style="display: inline;"> (1)</font></p> </td> </tr> <tr> <td valign="bottom" style="width:42.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Balance outstanding at December 31, 2012</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,956&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>13.41&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.91&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>41,642&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:42.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Granted</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>119&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21.18&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Exercised</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(834) </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.57&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Cancelled</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(72) </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18.52&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Balance outstanding at September 30, 2013</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,169&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16.68&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4.21&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>33,784&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:42.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Vested and expected to vest at September 30, 2013</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,108&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16.65&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4.17&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>32,911&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:42.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Exercisable at September 30, 2013</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,389&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16.14&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.48&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,389&nbsp; </td> </tr> </table></div> <p style="margin:9pt 0pt 0pt;text-indent:22.5pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table style="width: 100%" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" style="width: 36.00pt; display: inline;"> <p style="line-height:115%;font-family:Calibri;font-size: 10pt;margin:0pt;"> <font style="margin:0pt 0pt 10pt 18pt;line-height:115%;font-family:Calibri;font-size:10pt;"> (1)</font> </p> </td><td align="left" valign="top"> <p style="line-height:115%;font-family:Calibri;font-size: 10pt;margin:0pt;"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">The aggregate intrinsic value is calculated as the difference between eHealth&#x2019;s closing stock price as </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">of December 31, 2012 and September 30, 2013 </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">and the exercise price of in-the-money options as of those dates.</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">&nbsp;</font></p></td></tr></table></div> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:35.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="top" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:35.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:21.35pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:21.35pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended September 30,</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:21.35pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:21.35pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Nine Months Ended September 30,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:35.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> </tr> <tr> <td valign="top" style="width:35.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="top" style="width:02.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:11.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:11.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:11.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:11.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:35.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Expected term</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">4.6</font><font style="display: inline;"> years</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">4.3</font><font style="display: inline;"> years</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">4.7</font><font style="display: inline;"> years</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">4.3</font><font style="display: inline;"> years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:35.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Expected volatility</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>43.3%&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>39.8%&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44.3%&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>39.7%&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:35.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Expected dividend yield</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0%&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0%&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0%&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0%&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:35.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Risk-free interest rate</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.61%&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.13%&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.90%&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.79%&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:35.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Weighted-average fair value</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.46&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8.39&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.41&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.02&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:42.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:17.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:17.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:39.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> <td valign="bottom" style="width:17.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:39.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Total Number of Shares Purchased</font></p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:39.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:39.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Average Price Paid per Share </font><font style="display: inline;">(2)</font></p> </td> <td valign="top" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:39.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:39.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Amount of Repurchase</font></p> </td> </tr> <tr> <td valign="bottom" style="width:42.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Cumulative balance at December&nbsp;31, 2012 (1)</font></p> </td> <td valign="bottom" style="width:17.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,397,803&nbsp; </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:13.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>14.22&nbsp; </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>90,991&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:42.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Repurchases of common stock</font></p> </td> <td valign="bottom" style="width:17.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,911,466&nbsp; </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:13.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>20.27&nbsp; </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>59,007&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:42.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Cumulative balance at September 30, 2013 (1)</font></p> </td> <td valign="bottom" style="width:17.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,309,269&nbsp; </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:13.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16.11&nbsp; </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>149,998&nbsp; </td> </tr> </table></div> <p style="margin:6pt 0pt 10pt 36pt;border-bottom:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">&nbsp;</font> </p> <div style="width:100%"><table style="width: 100%" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" style="width: 36.00pt; display: inline;"> <p style="border-top:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt;margin:6pt 0pt 0pt;"> <font style="margin:6pt 0pt 10pt 18pt;border-top:1pt none #D9D9D9;line-height:115%;font-family:Calibri;font-size:10pt;"> (1)</font> </p> </td><td align="left" valign="top"> <p style="border-top:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt;margin:6pt 0pt 0pt;"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">Cumulative balances at December 31, 2012 and September 30, 2013 consist of shares repurchased in connection with our stock repurchase program announced on September 10, 2012, as well as previous stock repurchase plans announced in 2011, 2010 and 2008.</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> &nbsp;&nbsp;</font></p></td></tr></table></div> <p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">(2)</font><font style="display: inline;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 9pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Average price paid per share includes commissions.</font><font style="display: inline;">&nbsp;</font> </p> <p style="margin:9pt 0pt 0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:446.40pt;margin-left:0pt;"> <tr> <td valign="top" style="width:446.40pt;background-color: #auto;padding:0pt 6.5pt"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-weight:bold;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:446.40pt;background-color: #auto;padding:0pt 6.5pt"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Note 6 &#x2013; Geographic Information and Significant Customers</font></p> </td> </tr> <tr> <td valign="top" style="width:446.40pt;padding:0pt 6.5pt"> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> </tr> </table></div> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Geographic Information</font><font style="display: inline;">&#x2014;As of December 31, 2012 and </font><font style="display: inline;">September</font><font style="display: inline;"> 30, 2013, our long-lived assets consisted primarily of property and equipment, goodwill and other indefinite-lived intangible assets and finite-lived intangible assets. Our long-lived assets are attributed to the geographic location in which they are located. Long-lived assets by geographical area were as follows (in thousands): &nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:41.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="top" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:23.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:23.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="top" style="width:41.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">As of</font></p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">As of</font></p> </td> </tr> <tr> <td valign="top" style="width:41.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">December 31, 2012</font></p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">September 30, 2013</font></p> </td> </tr> <tr> <td valign="top" style="width:41.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="top" style="width:03.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:23.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:03.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:23.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:41.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">United States</font></p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:23.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>37,037&nbsp; </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:23.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>38,363&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:41.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">China</font></p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:23.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>278&nbsp; </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:23.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>342&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:41.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Total</font></p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:23.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>37,315&nbsp; </td> <td valign="bottom" style="width:03.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:23.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>38,705&nbsp; </td> </tr> </table></div> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Significant Customers</font><font style="display: inline;">&#x2014;Substantially all revenue for the three and </font><font style="display: inline;">nine</font><font style="display: inline;"> months ended </font><font style="display: inline;">September</font><font style="display: inline;"> 30, 2012 and 2013 was generated from customers located in the United States. Carriers representing 10% or more of our total revenue in the three and </font><font style="display: inline;">nine</font><font style="display: inline;"> months ended </font><font style="display: inline;">September</font><font style="display: inline;"> 30, 2012 and 2013 are presented in the table below:&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:29.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:29.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:3.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:3.00pt;font-size: 11pt"> <font style="display: inline;font-family:Calibri;font-size:11pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:3.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:3.00pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:3.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:3.00pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:3.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:3.00pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:3.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:3.00pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:3.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:3.00pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:3.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:3.00pt;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:3.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:3.00pt;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:29.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="3" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">Three Months Ended September 30,</font></p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="3" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">Nine Months Ended September 30,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:29.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">2012</font></p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">2013</font></p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">2012</font></p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">2013</font></p> </td> </tr> <tr> <td valign="top" style="width:29.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:29.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Humana</font></p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>20%&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:29.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">WellPoint (1)</font></p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>13%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>13%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12%&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:29.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">UnitedHealthcare </font><font style="display: inline;font-size:8pt;">(2)</font></p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>13%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11%&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:29.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Aetna (3)</font></p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7%&nbsp; </td> <td valign="bottom" style="width:02.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9%&nbsp; </td> </tr> </table></div> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table style="width: 100%" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" style="width: 36.00pt; display: inline;"> <p style="border-bottom:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt;margin:0pt;"> <font style="margin:0pt 0pt 10pt 18pt;border-bottom:1pt none #D9D9D9;line-height:115%;font-family:Calibri;font-size:10pt;"> (1)</font> </p> </td><td align="left" valign="top"> <p style="border-bottom:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt;margin:0pt;"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">Wellpoint also includes other carriers owned by Wellpoint.</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">&nbsp;</font></p></td></tr></table></div> <div style="width:100%"><table style="width: 100%" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" style="width: 36.00pt; display: inline;"> <p style="border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt;margin:0pt;"> <font style="margin:0pt 0pt 10pt 18pt;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;line-height:115%;font-family:Calibri;font-size:10pt;"> (2)</font> </p> </td><td align="left" valign="top"> <p style="border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt;margin:0pt;"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">UnitedHealthcare also includes other carriers owned by UnitedHealthcare.</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">&nbsp;</font></p></td></tr></table></div> <div style="width:100%"><table style="width: 100%" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" style="width: 36.00pt; display: inline;"> <p style="border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt;margin:0pt;"> <font style="margin:0pt 0pt 10pt 18pt;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;line-height:115%;font-family:Calibri;font-size:10pt;"> (3)</font> </p> </td><td align="left" valign="top"> <p style="border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt;margin:0pt;"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">Aetna also includes other carriers owned by Aetna.</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">&nbsp;</font></p></td></tr></table></div> <p style="margin:0pt 0pt 10pt 36pt;border-top:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Commission revenue attributable to major medical individual and family health insurance plans was approximately </font><font style="display: inline;">79</font><font style="display: inline;">% and </font><font style="display: inline;">78</font><font style="display: inline;">% of our commission revenue in the three and </font><font style="display: inline;">nine</font><font style="display: inline;"> months ended </font><font style="display: inline;">September</font><font style="display: inline;"> 30, 2012, respectively. Commission revenue attributable to major medical individual and family health insurance plans was approximately </font><font style="display: inline;">74</font><font style="display: inline;">% and </font><font style="display: inline;">72</font><font style="display: inline;">% of our commission revenue in the three and </font><font style="display: inline;">nine</font><font style="display: inline;"> months ended </font><font style="display: inline;">September</font><font style="display: inline;"> 30, 2013, respectively. We define our individual and family plan offerings as major medical individual and family health insurance plans, which do not include small business, Medicare-related health insurance plan offerings and other ancillary products such as short-term, stand-alone dental, life, vision, accident and student insurance plan offerings.&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">As of December 31, 2012, </font><font style="display: inline;">four</font><font style="display: inline;"> customers represented </font><font style="display: inline;">25</font><font style="display: inline;">%</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">22</font><font style="display: inline;">%, </font><font style="display: inline;">14</font><font style="display: inline;">% and </font><font style="display: inline;">11</font><font style="display: inline;">%, respectively, for a combined total of </font><font style="display: inline;">72</font><font style="display: inline;">% of our $4.5 million outstanding accounts receivable balance. As of </font><font style="display: inline;">September</font><font style="display: inline;"> 30, 2013, </font><font style="display: inline;">two</font><font style="display: inline;"> customer</font><font style="display: inline;">s</font><font style="display: inline;"> represented </font><font style="display: inline;">43</font><font style="display: inline;">% &nbsp;</font><font style="display: inline;">and </font><font style="display: inline;">33</font><font style="display: inline;">%, respectively </font><font style="display: inline;">of our $</font><font style="display: inline;">6</font><font style="display: inline;">.</font><font style="display: inline;">6</font><font style="display: inline;"> million outstanding accounts receivable balance. No other customers represented </font><font style="display: inline;">10</font><font style="display: inline;">% or more of our total accounts receivable at December 31, 2012 and </font><font style="display: inline;">September</font><font style="display: inline;"> 30, 2013. We believe the potential for collection issues with any of our customers is minimal as of </font><font style="display: inline;">September</font><font style="display: inline;"> 30, 2013. Accordingly, our estimate for uncollectible amounts at </font><font style="display: inline;">September</font><font style="display: inline;"> 30, 2013 was not material.&nbsp; </font><font style="display: inline;font-weight:bold;font-style:italic;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 4326000 5361000 21000 564000 381000 752000 P2Y2M19D P2Y6M18D 172000 0.00 0.00 0.00 0.00 P4Y8M12D P4Y7M6D P4Y3M18D P4Y3M18D 0.443 0.433 0.397 0.398 0.0090 0.0061 0.0079 0.0113 818000 3982000 4210000 22389000 1389000 16.14 P3Y5M23D 72000 18.52 119000 6.41 6.46 7.02 8.39 41642000 33784000 2956000 2169000 13.41 16.68 P3Y10M28D P4Y2M16D 32911000 2108000 16.65 P4Y2M1D 5.57 21.18 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;text-indent:22.5pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:100.00%;background-color: #auto;padding:0pt 6.5pt"> <p style="margin:0pt;text-indent:22.5pt;line-height:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-weight:bold;font-size:1pt;">&nbsp;</font></p> </td> </tr> <tr> <td valign="top" style="width:100.00%;background-color: #auto;padding:0pt 6.5pt"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Note 3 &#x2013; Stockholders&#x2019; Equity</font></p> </td> </tr> <tr> <td valign="top" style="width:100.00%;padding:0pt 6.5pt"> <p style="margin:0pt;text-indent:22.5pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> </tr> </table></div> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Stock Plans&#x2014;</font><font style="display: inline;">The following table summarizes activity under our 2006 Equity Incentive Plan, 1998 Stock Plan and 2005 Stock Plan (collectively, the &#x201C;Stock Plans&#x201D;) (in thousands): </font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:42.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:39.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:42.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:39.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Shares Available for Grant</font><font style="display: inline;"> (1)</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Shares available for grant December 31, 2012</font></p> </td> <td valign="bottom" style="width:42.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,982&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Additional shares authorized (2)</font></p> </td> <td valign="bottom" style="width:42.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>818&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Restricted stock units granted</font></p> </td> <td valign="bottom" style="width:42.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(564) </td> </tr> <tr> <td valign="bottom" style="width:57.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Options granted</font></p> </td> <td valign="bottom" style="width:42.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(119) </td> </tr> <tr> <td valign="bottom" style="width:57.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Restricted stock units cancelled</font></p> </td> <td valign="bottom" style="width:42.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Options cancelled</font></p> </td> <td valign="bottom" style="width:42.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>72&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Shares available for grant September 30, 2013</font></p> </td> <td valign="bottom" style="width:42.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,210&nbsp; </td> </tr> </table></div> <p style="margin:0pt;text-indent:36pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table style="width: 100%" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" style="width: 36.00pt; display: inline;"> <p style="font-family:Times New Roman;font-size: 10pt;margin:0pt;"> <font style="margin:0pt 0pt 0pt 18pt;font-family:Times New Roman;font-size:10pt;;padding:0pt 34.5pt 0pt 0pt;"> (1)</font> </p> </td><td align="left" valign="top"> <p style="font-family:Times New Roman;font-size: 10pt;margin:0pt;"> <font style="display: inline;">Shares available for grant do not include treasury stock shares that could also become available for grant if we determined to do so.</font><font style="display: inline;">&nbsp;</font></p></td></tr></table></div> <p style="margin:0pt 0pt 0pt 58.5pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table style="width: 100%" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" style="width: 36.00pt; display: inline;"> <p style="font-family:Times New Roman;font-size: 10pt;margin:0pt;"> <font style="margin:0pt 0pt 0pt 18pt;font-family:Times New Roman;font-size:10pt;;padding:0pt 34.5pt 0pt 0pt;"> (2)</font> </p> </td><td align="left" valign="top"> <p style="font-family:Times New Roman;font-size: 10pt;margin:0pt;"> <font style="display: inline;">On January&nbsp;1, 2013, the number of shares authorized for issuance under the 2006 Equity Incentive Plan was automatically increased pursuant to the terms of the 2006 Equity Incentive Plan.</font><font style="display: inline;"> &nbsp;&nbsp;</font></p></td></tr></table></div> <p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The following table summarizes stock option activity under the Stock Plans (in thousands, except per share amounts and weighted average remaining contractual life data):&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 36pt;line-height:115%;font-family:Calibri;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:42.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Number of Stock Options</font></p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Weighted Average Exercise Price</font></p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Weighted-Average Remaining Contractual Life (years)</font></p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Aggregate Intrinsic Value</font><font style="display: inline;"> (1)</font></p> </td> </tr> <tr> <td valign="bottom" style="width:42.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Balance outstanding at December 31, 2012</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,956&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>13.41&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.91&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>41,642&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:42.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Granted</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>119&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21.18&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Exercised</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(834) </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.57&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Cancelled</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(72) </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18.52&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Balance outstanding at September 30, 2013</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,169&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16.68&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4.21&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>33,784&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:42.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Vested and expected to vest at September 30, 2013</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,108&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16.65&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4.17&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>32,911&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:42.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Exercisable at September 30, 2013</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,389&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16.14&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.48&nbsp; </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,389&nbsp; </td> </tr> </table></div> <p style="margin:9pt 0pt 0pt;text-indent:22.5pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table style="width: 100%" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" style="width: 36.00pt; display: inline;"> <p style="line-height:115%;font-family:Calibri;font-size: 10pt;margin:0pt;"> <font style="margin:0pt 0pt 10pt 18pt;line-height:115%;font-family:Calibri;font-size:10pt;"> (1)</font> </p> </td><td align="left" valign="top"> <p style="line-height:115%;font-family:Calibri;font-size: 10pt;margin:0pt;"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">The aggregate intrinsic value is calculated as the difference between eHealth&#x2019;s closing stock price as </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">of December 31, 2012 and September 30, 2013 </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">and the exercise price of in-the-money options as of those dates.</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">&nbsp;</font></p></td></tr></table></div> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The total grant date fair value of stock options vested during the three and nine months ended September 30, 2012 was $</font><font style="display: inline;">0.5</font><font style="display: inline;"> million and $</font><font style="display: inline;">1.9</font><font style="display: inline;"> million, respectively. The total grant date fair value of stock options vested during the three and nine months ended September 30, 2013 was $</font><font style="display: inline;">0.7</font><font style="display: inline;"> million and $</font><font style="display: inline;">2.6</font><font style="display: inline;"> million, respectively. </font> </p> <p><font size="1"> </font></p><p style="page-break-after:always">&nbsp;</p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;;font-size: 10pt"><font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:22.5pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The following table summarizes restricted stock unit activity, including performance-based restricted stock unit activity, under the Stock Plans (in thousands, except weighted average remaining contractual life data):&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:48.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Number Outstanding</font></p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Weighted-Average Remaining Contractual Life (years)</font></p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:64.50pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Aggregate Intrinsic Value </font><font style="display: inline;">(1)</font></p> </td> </tr> <tr> <td valign="bottom" style="width:48.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Balance outstanding as of December 31, 2012</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>381&nbsp; </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.22&nbsp; </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.26%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10,464&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:48.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Granted</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>564&nbsp; </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Vested</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(172) </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Cancelled</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(21) </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:48.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Balance outstanding as of September 30, 2013</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>752&nbsp; </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.55&nbsp; </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>24,248&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table style="width: 100%" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" style="width: 36.00pt; display: inline;"> <p style="line-height:115%;font-family:Calibri;font-size: 11pt;margin:6pt 0pt 0pt;"> <font style="margin:6pt 0pt 0pt 18pt;line-height:115%;font-family:Calibri;font-size:11pt;"> (1)</font> </p> </td><td align="left" valign="top"> <p style="line-height:115%;font-family:Calibri;font-size: 11pt;margin:6pt 0pt 0pt;"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">The aggregate intrinsic value is calculated as eHealth&#x2019;s closing stock price as of December 31, 2012 and September 30, 2013 multiplied by the number of restricted stock units outstanding as of December 31, 2012 and September 30, 2013, respectively.</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> &nbsp;&nbsp;</font><font style="display: inline;">&nbsp;</font></p></td></tr></table></div> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The fair value of the restricted stock units is based on eHealth&#x2019;s stock price on the date of grant, and compensation expense related to these awards is recognized on a straight-line basis over the vesting period. The fair value of performance-based restricted stock units is based on eHealth&#x2019;s stock price on the date of grant, and compensation expense related to these awards is recognized on an accelerated basis over the vesting period. </font><font style="display: inline;">The total grant date fair value of restricted stock units vested during the nine months ended September 30, 2012 was $</font><font style="display: inline;">3.7</font><font style="display: inline;"> million.</font><font style="display: inline;"> The total grant date fair value of restricted stock units vested during the three months ended September 30, 2012 was not material.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">The total grant date fair value of restricted stock units vested during the three and nine months ended September 30, 2013 was $</font><font style="display: inline;">0.2</font><font style="display: inline;"> million and $</font><font style="display: inline;">3.5</font><font style="display: inline;"> million, respectively.</font> </p> <p style="margin:9pt 0pt 0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Stock Repurchase Programs&#x2014;</font><font style="display: inline;">On September 10, 2012, </font><font style="display: inline;">we </font><font style="display: inline;">announced that our board of directors approved a stock repurchase program authorizing us to purchase up to $</font><font style="display: inline;">30</font><font style="display: inline;"> million of our common stock and on March 6, 2013, </font><font style="display: inline;">we </font><font style="display: inline;">announced that our board of directors increased the approved repurchase amount under this program to $</font><font style="display: inline;">60</font><font style="display: inline;"> million. </font><font style="display: inline;">Purchases under this program were made in the open market and complied with Rule 10b-18 under the Securities Exchange Act of 1934, as amended. </font><font style="display: inline;">The cost of the repurchased shares was funded from available working capital.</font><font style="display: inline;font-weight:bold;font-style:italic;">&nbsp;</font> </p> <p style="margin:9pt 0pt 0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">For accounting purposes, common stock repurchased under our stock repurchase programs is recorded based upon the settlement date of the applicable trade. </font><font style="display: inline;">Such repurchased shares are held in treasury and are presented using the cost method.</font><font style="display: inline;">&nbsp;</font> </p> <p style="margin:9pt 0pt 0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Stock repurchase activity under our stock repurchase programs during the nine months ended September 30, 2013 is summarized as follows (dollars in thousands, except share and per share amounts):&nbsp;</font> </p> <p style="margin:0pt;text-indent:22.5pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:42.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:17.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:17.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:13.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:39.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> <td valign="bottom" style="width:17.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:39.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Total Number of Shares Purchased</font></p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:39.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:39.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Average Price Paid per Share </font><font style="display: inline;">(2)</font></p> </td> <td valign="top" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:39.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:39.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Amount of Repurchase</font></p> </td> </tr> <tr> <td valign="bottom" style="width:42.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Cumulative balance at December&nbsp;31, 2012 (1)</font></p> </td> <td valign="bottom" style="width:17.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,397,803&nbsp; </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:13.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>14.22&nbsp; </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>90,991&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:42.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Repurchases of common stock</font></p> </td> <td valign="bottom" style="width:17.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,911,466&nbsp; </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:13.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>20.27&nbsp; </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>59,007&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:42.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Cumulative balance at September 30, 2013 (1)</font></p> </td> <td valign="bottom" style="width:17.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,309,269&nbsp; </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:13.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16.11&nbsp; </td> <td valign="bottom" style="width:02.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0.05pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:15.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>149,998&nbsp; </td> </tr> </table></div> <p style="margin:6pt 0pt 10pt 36pt;border-bottom:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">&nbsp;</font> </p> <div style="width:100%"><table style="width: 100%" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" style="width: 36.00pt; display: inline;"> <p style="border-top:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt;margin:6pt 0pt 0pt;"> <font style="margin:6pt 0pt 10pt 18pt;border-top:1pt none #D9D9D9;line-height:115%;font-family:Calibri;font-size:10pt;"> (1)</font> </p> </td><td align="left" valign="top"> <p style="border-top:1pt none #D9D9D9 ;line-height:115%;font-family:Calibri;font-size: 10pt;margin:6pt 0pt 0pt;"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">Cumulative balances at December 31, 2012 and September 30, 2013 consist of shares repurchased in connection with our stock repurchase program announced on September 10, 2012, as well as previous stock repurchase plans announced in 2011, 2010 and 2008.</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> &nbsp;&nbsp;</font></p></td></tr></table></div> <p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">(2)</font><font style="display: inline;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 9pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Average price paid per share includes commissions.</font><font style="display: inline;">&nbsp;</font> </p> <p style="margin:9pt 0pt 0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:9pt 0pt 0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">In addition to the shares repurchased under our repurchase programs as of September 30, 2013, we have in treasury </font><font style="display: inline;">209,925</font><font style="display: inline;"> shares that were previously surrendered by employees to satisfy tax withholdings due in connection with the vesting of certain restricted stock units. As of December 31, 2012 and September 30, 2013, we had a total of </font><font style="display: inline;">6,556,303</font><font style="display: inline;"> shares and </font><font style="display: inline;">9,519,194</font><font style="display: inline;"> shares, respectively, held in treasury.&nbsp;</font> </p> <p style="margin:9pt 0pt 0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Stock-Based Compensation&#x2014;</font><font style="display: inline;">The fair value of stock options granted to employees for the three and nine months ended September 30, 2012 and 2013 was estimated using the following weighted average assumptions:&nbsp;</font> </p> <p style="margin:0pt;text-indent:22.5pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:35.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="top" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:35.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:21.35pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:21.35pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended September 30,</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:21.35pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:21.35pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Nine Months Ended September 30,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:35.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> </tr> <tr> <td valign="top" style="width:35.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="top" style="width:02.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:11.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:11.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:11.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:11.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:35.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Expected term</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">4.6</font><font style="display: inline;"> years</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">4.3</font><font style="display: inline;"> years</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">4.7</font><font style="display: inline;"> years</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">4.3</font><font style="display: inline;"> years</font></p> </td> </tr> <tr> <td valign="bottom" style="width:35.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Expected volatility</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>43.3%&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>39.8%&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44.3%&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>39.7%&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:35.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Expected dividend yield</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0%&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0%&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0%&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0%&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:35.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Risk-free interest rate</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.61%&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.13%&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.90%&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.79%&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:35.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Weighted-average fair value</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.46&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8.39&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.41&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.02&nbsp; </td> </tr> </table></div> <p style="margin:0pt;text-indent:22.5pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The following table summarizes stock-based compensation expense recorded during the three and nine months ended September 30, 2012 and 2013 (in thousands):&nbsp;</font> </p> <p style="margin:0pt;text-indent:22.5pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:40.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:40.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:22.70pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:22.70pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended September 30,</font></p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:22.70pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:22.70pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Nine Months Ended September 30,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:40.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> </tr> <tr> <td valign="bottom" style="width:40.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:40.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Common stock options</font></p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>717&nbsp; </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>654&nbsp; </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,076&nbsp; </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,103&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:40.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Restricted stock units</font></p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>622&nbsp; </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,291&nbsp; </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,250&nbsp; </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,258&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:40.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Total stock-based compensation expense</font></p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,339&nbsp; </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,945&nbsp; </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,326&nbsp; </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,361&nbsp; </td> </tr> </table></div> <p style="margin:4.5pt 0pt 0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:4.5pt 0pt 0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The following table summarizes stock-based compensation expense by operating function for the three and nine months ended September 30, 2012 and 2013 (in thousands):&nbsp;</font> </p> <p style="margin:0pt;text-indent:22.5pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:42.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="top" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.05pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.05pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended September 30,</font></p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.05pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.05pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Nine Months Ended September 30,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:42.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2012</font></p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2013</font></p> </td> </tr> <tr> <td valign="top" style="width:42.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font></p> </td> <td valign="top" style="width:02.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:10.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:10.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:10.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="top" style="width:10.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Marketing and advertising</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>330&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>517&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>932&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,446&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:42.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Customer care and enrollment</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>90&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>92&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>243&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>261&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:42.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Technology and content</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>233&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>425&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>783&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,129&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:42.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">General and administrative</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>686&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>911&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,368&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,525&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:42.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Total stock-based compensation expense</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,339&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,945&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,326&nbsp; </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:10.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFFF;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,361&nbsp; </td> </tr> </table></div> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:1pt;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:446.40pt;margin-left:0pt;"> <tr> <td valign="top" style="width:446.40pt;padding:0pt 6.5pt"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <a name="Notes_To_FinancialStatements"></a><font style="display: inline;font-weight:bold;">Note 1 - Summary of Business and Significant Accounting Policies</font></p> </td> </tr> <tr> <td valign="top" style="width:446.40pt;padding:0pt 6.5pt"> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&nbsp;</font></p> </td> </tr> </table></div> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Description of Business</font><font style="display: inline;font-weight:bold;font-style:italic;">&#x2014;</font><font style="display: inline;">eHealth, Inc. (the &#x201C;Company,&#x201D; &#x201C;eHealth,&#x201D; &#x201C;we&#x201D; or &#x201C;us&#x201D;) is the leading </font><font style="display: inline;">online source of health insurance for individuals, families and small businesses in the United States. Through our website addresses (</font><font style="display: inline;font-style:italic;">www.eHealth.com</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;font-style:italic;">www.eHealthInsurance.com</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;font-style:italic;">www.eHealthMedicare.com</font><font style="display: inline;"> and </font><font style="display: inline;font-style:italic;">www.PlanPrescriber.com)</font><font style="display: inline;">, consumers can get quotes from leading health insurance carriers, compare plans side-by-side, and apply for and purchase individual and family, Medicare-related, small business and ancillary health insurance plans. We actively market the availability of Medicare-related insurance plans and</font><font style="display: inline;"> offer Medicare plan comparison tools and educational materials for Medicare-related insurance plans, including </font><font style="display: inline;">Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;">Our ecommerce technology also enables us to deliver consumers&#x2019; health insurance applications electronically to health insurance carriers. As a result, we simplify and streamline the complex and traditionally paper-intensive health insurance sales and purchasing process. </font><font style="display: inline;">We are licensed to market and sell health insurance in all </font><font style="display: inline;">50</font><font style="display: inline;"> states and the District of Columbia.&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Basis of Presentation&#x2014;</font><font style="display: inline;">The accompanying condensed consolidated balance sheet as of September 30, 2013, the condensed consolidated statements of comprehensive income for the three and nine months ended September 30, 2012 and 2013 and the condensed consolidated statements of cash flows for the nine months ended September 30, 2012 and 2013, respectively, are unaudited. The condensed consolidated balance sheet data as of December&nbsp;31, 2012 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December&nbsp;31, 2012, which was filed with the Securities and Exchange Commission on March&nbsp;13, 2013. The accompanying statements should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K. &nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or U.S. GAAP, for interim financial information. Accordingly, they do not include all of the financial information and footnotes required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December&nbsp;31, 2012, and include all adjustments necessary for the fair presentation of eHealth&#x2019;s statement of financial position as of September 30, 2013, its results of operations for the three and nine months ended September 30, 2012 and 2013 and its cash flows for the nine months ended September 30, 2012 and 2013. All adjustments are of a normal recurring nature. The results for the three and nine months ended September 30, 2013 are not necessarily indicative of the results to be expected for any subsequent period or for the fiscal year ending December&nbsp;31, 2013. </font><font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Seasonality&#x2014;</font><font style="display: inline;">The number of individual and family health insurance applications submitted through our ecommerce platform has generally increased in our first quarter compared to our fourth quarter and in our third quarter compared to our second quarter. Conversely, we have generally experienced a decline or flattening of individual and family submitted applications in our second quarter compared to our first quarter and in our fourth quarter compared to our third quarter. This seasonality </font><font style="display: inline;">could</font><font style="display: inline;"> change in the fourth quarter of 2013 as a result of the initial open enrollment period under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act, which began on October 1, 2013 and is scheduled to run through March 31, 2014.</font> </p> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The majority of Medicare plans are sold in our fourth quarter during the Medicare annual enrollment period, when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, we generate a significant amount of Medicare plan-related revenue in the fourth quarter of the year resulting from the sale of new Medicare plans. Additionally, we recognize a majority of our renewal Medicare Advantage and Medicare Part D prescription drug plan commission revenue in the first quarter of each year as the majority of policies sold during the annual enrollment period typically renew on January 1 of each year. </font> </p> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Since a significant portion of our marketing and advertising expenses are driven by the number of health insurance applications submitted on our ecommerce platform, those expenses are influenced by these patterns. As a result, marketing and advertising expenses related to individual and family health insurance plans have been highest in our first and third quarters, while marketing and advertising expenses related to Medicare-related plans have been highest in our third and fourth quarters. However, </font><font style="display: inline;">the historical trend of marketing and advertising expenses related to individual and family health insurance plans could be impacted by</font><font style="display: inline;"> the initial open enrollment period for individual and family plans </font><font style="display: inline;">that began </font><font style="display: inline;">on October 1, 2013.&nbsp; </font> </p> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Additionally, in preparation for the Medicare annual enrollment period, and to a lesser extent the initial open enrollment period for individual and family plans, we begin ramping up our customer care center staff during our second and third quarters to handle the anticipated increased volume of health insurance transactions during the fourth quarter. Accordingly, our customer care center staffing costs are significantly higher in our third and fourth quarters compared to our first and second quarters.</font> </p> <p style="margin:0pt;text-indent:18pt;line-height:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">&nbsp;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Recently Adopted Accounting Standards&#x2014;</font><font style="display: inline;">Effective January 1, 2013, we adopted an accounting standards update with new guidance on the presentation of reclassifications from accumulated other comprehensive income to net income. This standard requires an entity to present reclassifications from accumulated other comprehensive income to net income either on the face of the condensed consolidated financial statements or in the notes to the condensed consolidated financial statements. In the nine months ended September 30, 2013 we did not have any reclassifications from accumulated other comprehensive income to net income</font><font style="display: inline;font-size:9pt;">.</font> </p> <p style="margin:0pt;text-indent:18pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;background-color: #FFFFFF;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 170867000 128804000 834000 2076000 717000 2103000 654000 30000000 60000000 20.27 6556303 9519194 6397803 9309269 2911466 90991000 149998000 59007000 20563000 20750000 19912000 19096000 19711000 19970000 19310000 18436000 The aggregate intrinsic value is calculated as eHealth’s closing stock price as of December 31, 2012 and September 30, 2013 multiplied by the number of restricted stock units outstanding as of December 31, 2012 and September 30, 2013, respectively. Cumulative balances at December 31, 2012 and September 30, 2013 consist of shares repurchased in connection with our stock repurchase program announced on September 10, 2012, as well as previous stock repurchase plans announced in 2011, 2010 and 2008. Average price paid per share includes commissions. Aetna also includes other carriers owned by Aetna. UnitedHealthcare also includes other carriers owned by UnitedHealthcare. Wellpoint also includes other carriers owned by Wellpoint. Shares available for grant do not include treasury stock shares that could also become available for grant if we determined to do so. On January 1, 2013, the number of shares authorized for issuance under the 2006 Equity Incentive Plan was automatically increased pursuant to the terms of the 2006 Equity Incentive Plan. The aggregate intrinsic value is calculated as the difference between eHealth’s closing stock price as of December 31, 2012 and September 30, 2013 and the exercise price of in-the-money options as of those dates. EX-101.LAB 5 ehth-20130930_lab.xml EX-101.LAB EX-101.PRE 6 ehth-20130930_pre.xml EX-101.PRE EX-101.SCH 7 ehth-20130930.xsd EX-101.SCH 00100 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Condensed Consolidated Statements Of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Condensed Consolidated Statements Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Cash, Cash Equivalents And Accounts Receivable (Schedule Of Cash And Cash Equivalents) (Details) link:presentationLink link:calculationLink link:definitionLink 40203 - Disclosure - Cash, Cash Equivalents And Accounts Receivable (Schedule Of Accounts Receivable) (Details) link:presentationLink link:calculationLink link:definitionLink 40307 - Disclosure - Stockholders' Equity (Schedule Of Stock-Based Compensation Expense) (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Net Income Per Share (Schedule Of Computation Of Basic And Diluted Net Income Per Share) (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - Geographic Information And Significant Customers (Schedule Of Long Lived Assets By Geographical Areas) (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Summary Of Business And Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Cash, Cash Equivalents And Accounts Receivable link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Net Income Per Share link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Geographic Information And Significant Customers link:presentationLink link:calculationLink link:definitionLink 20102 - Disclosure - Summary Of Business And Significant Accounting Policies (Policy) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Cash, Cash Equivalents And Accounts Receivable (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Net Income Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Geographic Information And Significant Customers (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Summary Of Business And Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - Stockholders' Equity (Schedule Of Equity Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 40303 - Disclosure - Stockholders' Equity (Schedule Of Option Activity Under Stock Plans) (Details) link:presentationLink link:calculationLink link:definitionLink 40304 - Disclosure - Stockholders' Equity (Schedule Of Restricted Stock Unit Activity Under Stock Plans) (Details) link:presentationLink link:calculationLink link:definitionLink 40305 - Disclosure - Stockholders' Equity (Schedule Of Stock Repurchase Activity Under Stock Repurchase Programs) (Details) link:presentationLink link:calculationLink link:definitionLink 40306 - Disclosure - Stockholders' Equity (Schedule Of Fair Value Of Stock Options, Valuation Assumptions) (Details) link:presentationLink link:calculationLink link:definitionLink 40308 - Disclosure - Stockholders' Equity (Schedule Of Stock-Based Compensation Expense By Operating Function) (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - Net Income Per Share (Schedule Of Anti-dilutive Shares Excluded From Computation Of Net Income Per Share) (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Geographic Information And Significant Customers (Details) link:presentationLink link:calculationLink link:definitionLink 40603 - Disclosure - Geographic Information And Significant Customers (Schedule Of Revenue By Major Customers) (Details) link:presentationLink link:calculationLink link:definitionLink EX-31.1 8 ehth-20130930ex3117b0256.htm EX-31.1 10Q Exhibit 311

Exhibit 31.1

CERTIFICATION

 

I, Gary L. Lauer, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of eHealth, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 8, 2013   

 

/s/    GARY L. LAUER 

Gary L. Lauer

Chief Executive Officer

 


EX-31.2 9 ehth-20130930ex3126f6080.htm EX-31.2 10Q Exhibit 312

Exhibit 31.2

CERTIFICATION

 

I, Stuart M. Huizinga, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of eHealth, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 8, 2013

 

/s/    STUART M. HUIZINGA 

Stuart M. Huizinga

Chief Financial Officer

 


EX-32.1 10 ehth-20130930ex321c4c8a0.htm EX-32.1 10Q Exhibit 321

Exhibit 32.1

 

Certification of Chief Executive Officer, Pursuant to

18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with the Quarterly Report of eHealth, Inc. on Form 10-Q (the “Form 10-Q”) for the quarterly period ended September 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gary L. Lauer, Chief Executive Officer of eHealth, Inc., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

(1)

The Form 10-Q, to which this certification is attached as Exhibit 32.1, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of eHealth, Inc.

 

 

 

 

/s/    GARY L. LAUER

Gary L. Lauer

Chief Executive Officer

November 8, 2013

 

A signed original of this written statement required by Section 906 has been provided to eHealth, Inc. and will be retained by eHealth, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 


EX-32.2 11 ehth-20130930ex322becc29.htm EX-32.2 10Q Exhibit 322

 

 Exhibit 32.2 

 

Certification of Chief Financial Officer, Pursuant to

18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with the Quarterly Report of eHealth, Inc. on Form 10-Q (the “Form 10-Q”) for the quarterly period ended September 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stuart M. Huizinga, Chief Financial Officer of eHealth, Inc., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:  

 

(1)

The Form 10-Q, to which this certification is attached as Exhibit 32.2, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of eHealth, Inc.

 

 

 

 

 

/s/     STUART M. HUIZINGA

Stuart M. Huizinga

Chief Financial Officer

November 8, 2013

 

A signed original of this written statement required by Section 906 has been provided to eHealth, Inc. and will be retained by eHealth, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

 


XML 12 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary Of Business And Significant Accounting Policies (Details)
Sep. 30, 2013
state
Summary Of Business And Significant Accounting Policies [Abstract]  
Number of states in which the Company is licensed to market and sell health insurance 50
EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0!^3Q`*UP$``*@5```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F%UKPC`4AN\'^P\EM\/& MI)MSP^K%/BXW8>X'9,W1%MLD)-'IOU]:/QC2.63"SHU%FYSW,84'^@Y&JZJ, MEF!=H55*6-PE$:A,RT+-4O(^>>[T2>2\4%*46D%*UN#(:'AY,9BL#;@H[%8N M);GWYIY2E^50"1=K`RK[?9HII4'Y3N^GD&&@T>8 MBD7IHZ=5^'E#8J%T)'K8+*RS4B*,*8M,^$!*ETH>I'2V"7'8V:QQ>6'<5<`@ MM#6AOO-SP';?:S@:6TB(QL+Z%U$%#+HJZ:>V\P^MY_'Q(2V4>CHM,I`Z6U3A M!&)G+`CI<@!?E7%SC2M1J!WWD?QFL:/-A9T9I/Y_S>`3.3@2C@0)QS42CALD M'#TD'+=(./I(..Z0<+`N%A`L1F58E,JP.)5AD2K#8E6&1:L,BU<9%K$R+&;E M6,S*L9B58S$KQV)6CL6L'(M9.1:S9M:`S/#O!]]C&.T*>-K38N M-(L63C^%7758[^Z8,`BL+V!?'K:5'GC0`D+=>TJ0+=FTZ5F'7P`` M`/__`P!02P,$%``&``@````A`+55,"/U````3`(```L`"`)?]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7^ZBRBXL:NI3\(V(T M'4\4"_'L)MI<3_3_ MMCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X8<'%#U1?````__\# M`%!+`P04``8`"````"$`FM$*B](!``"-%```&@`(`7AL+U]R96QS+W=O:G;X]5 M4*`2#)=H+Y'L*)O1V#M?G.7Z?=]DK\Z'NFMS19.IREQ;=&7=[G+U]'AWL5!9 MB+8M;=.U+E<'%]1Z=7ZVO'>-C>FA4-5]R%*5-N2JBK&_T3H4E=O;,.EZUZ8[ MV\[O;4Q#O].]+9[MSFF>3N?:_ZRA5BJW@4C%)>T/0F]F82V\7',[1OC#2M#*25-!T@'$A:#4$Y M+,TJQJR2/C,P/#.844,G5-:[\B'Z=&(,W[UU,HW:BJ1A11!6)`TK@K`RTI%L M8"1+)S(,9.F5@@M%TM80](:E8<405BQ]M&)XM#+2F6-@YIA1Z1GBH4D_Z8:O MG,\QBF!I/`UTTB<_$5K8UWP:NL=UWONL"W[]B`&1^RP@LP-O/W'+_QSNAVDPCK'\LT5W)L M>^>N;3$9*,&EV(AD3Q$#X.N:IMB>C)1?L;9>11=+TF200]T;8EB#:/%)N M&!W;%V"J-:M=R/)TFG,!=Z\#-["=297D:V91MB2Y,`M([Z`.]?('OC\L_EF4 MXHVSM3XZ%::U>>>2JG7Q5RCMMK(""&!=WGKGU,1PWW7=ZMIOQE>Q.5P$>0?I MEQ6$YY3?EBS3.U0DO),T?)2&FVTXD[OJ@EM1DD$I9[R\$LU>!/*J< M<#"#9C#S/$E(M@U?EN$TUUPRK:B*7-/=!R6'X]_<_Z/ M",!O)W071;C`P1#)E&C@I.9&19^Q$A3X#`LEL\4A7"+?RV8(,YC+A(4+LH$9 M/&8?P(16<5\UG9Z9`1!*QU>6A?.89+4.7"/GZZ;S+Z96&4EC'B&8Y*%\*(8! ML%W%X+E-G?X>U%I9X[,-:&\7:D(^CJB%:$D0P4QZ+2C[^U,K!Z;2:V/9.R10RN.L842]%J/]8U(3PMAZ+6[[A:`Q MQX@PPEZ+X:Y./S!#N,!#5+R<*X#!:+P8NT3F4`D+[;!""XD_M'Z<3<^&(P<]$R)!%D0`>A$LCL57 ML7F5?7`.:_/D/P```/__`P!02P,$%``&``@````A`"/+5-0'!@``ZA@``!@` M``!X;"]W;W)K7XW.M[C//XX4=S M=+Y775^WIXW+UK[K5*>RW=:G_<;]Y^_/J\1U^J$X;8MC>ZHV[L^J=S\\_?K+ MXVO;?>L/534X$.'4;]S#,)P?/*\O#U53].OV7)U@9-=V33'`QV[O]>>N*K9J M4G/TN.]'7E/4)QL]/2J!_JVKU][XV^D/ M[>MO7;W]HSY5H#;D26;@N6V_2>B7K?P73/9FLS^K#/S9.=MJ5[PG\8(-TAK$@N[&'[\U/5EZ`HA%ES1:-LCT``?CI-+4L#%"E^J-^O]78X;%P1 MKLC/]Z?2^@Z2EAF0(B5UGA#"*R"\(F0E@-U*$A=L4!:3P;?$OC.0DRHBG]'G9&Q"* MR.>(2(P0PA&D,SG>YB;!4`*&%(G-#2&!`0G'!RO)\UL(0@V"+*3V(24=#FKA;R_/^4DBQRW!$.()I=P:S@WAUEJ<"?D M4DKNMF(23$G%=A81@J28'UF"YF28&\.$%(/V94IVFY5"4UKIU(9456<:@[Q" M83P8JYZ,!X)'H]:4F&4'[Q##CFUVB]36BR$&RSIE\?A2[/;;`Z!'!FV!ME=E?[9_/^'\QV@FD`//2M\5S'N.R4:6&4UUT6 MP.8>$,SV`&)T*EDZI4IO4=,%5ER(*=>4F>4#[Y3_W``"Z\D9,UN\B.W>DNMQ M9"ZN.0"[RP(4FA9_8#6M3&.PA)B()U_4BJ$+:%[!M&F)7MPR`7D&>M\WU2S* M+[7Y:8SF%\2QE?*<`M(HO%)L_"X[4&CK?&:_!6@,=(>K![2;$*J@[-Z+NP?' M7F]V#Z-?8EO3&-T]HM@XOF)J*0#>WZ8%4FJ6%RQ,[MP3F&]55\81=%-"TQ96 M$3>Z)&4IN_1R`;&GFP(R?RINK2"";BA(`*F(IPB4VUW6(-^`H:O#NL>Z8O[4 MJ#0W!`&!$33;&;<@E)]E$`LS/#<*YD^[3_,TG2*(0JL"AM0L>-]P[*T+*,A0SGUL%\*Y$9-[TCX+.#)QGG(KRV MC^\R#XZ-G^X0V]4T2.^0,/5]JW_G%)$$UQQ$NH6Y?9?)IV91!V$VA4R#]*'` M((#YI]*<>1:63'?Q^=MCW2?TQJWMD@IA#``I9 M(N<$$3/C99-RE)W\?H[8_RE'*XF9,$V"!7X26!KG%,%%9)0P96GYR,(\HP]0 MEE.N=)X1A%=A*1RSK&7(.VE9+0A@PD\,,T>2>.6,-[)-U>VKO#H>>Z=L7^1U M,H,2&?^+5]T97'6K>V%O'(";YG.QK[X6W;X^]0<[?DOQ]#\```#__P,`4$L#!!0` M!@`(````(0`+-E9RK`,```P,```9````>&PO=V]R:W-H965T4]8N7.PAUR%MR2K:[A;NSQ\/[Z:N MPT715D7-6K)P7PAWWR_?OID?6?_(]X0(!QQ:OG#W0G0SW^?EGC0%]UA'6HAL M6=\4`B[[G<^[GA35D-34?H!0[#<%;5WE,.O_Q8-MM[0D&2L/#6F%,NE)70A8 M/]_3CI_=FO)?[)JB?SQT[TK6=&"QH345+X.IZS3E[/.N97VQJ8'[&4^*\NP] M7%S9-[3L&6=;X8&=KQ9ZS9SZJ0].RWE%@4!NN].3[<+]@&Y32SY6\!,$TPE%\W\57*QH` MLT(4RWG/C@YT#3R3=X7L03P#YS.96L>%]3548)0F'Z3+X`44'.KSM(Q0,O>? M8$_+DV:E-(GK7#1Q8$K69XG<0>F;G6^,.=A,R<\*63Y`NG#!;ME<(=3][Q4[ M8\@D$R.VGK>ZEM@0UXHX-!>=74LLD_Q:H9D8H*$)>AM0BJ'YM!J$V*Z3TDPT M360N?WU7D=U5Y+<4!A\L1"_D;3XI7KBP>9<>"X/87/U*::9#E^)D8D;7>C1` M%GFF1\-X:C5'KH,0W^&*3[W;%I-CDBM#47-=*:7`P@"$/C<\=3HGUG7AF MQ7%J^N=6/!A[PN""HTNOVVTN*3:YPHE=+Z69J/,RL*C7>A0^%>::,STZ2:S< M7(\FT5A'@T=.)];1?[\/99+-99\@2J.XL-VE:SV:6*F9'L1:(89"YT84C=MI M8*7_@R633*P(66VR4IK3ZY6BU'Z]]'B`]&U7'S,]CM,4C^M7='H[#06V1V2_VZB1Z_0V[)\AL`;8[TA8$8T.KZJGA2\TF#>EW9$WJFCLE M.\C!2K[[E[MJZ%OA&0P,\-VW[F=R&!S&N4L`9K&NV)&O1;^C+7=JL@5+Y"5P MH/5JFE,7@G7#YW_#!$QAP\\]3-T$1A'D@7C+F#A?R('C,L&ULE);;;N(P$(;O5]IWB'Q?+( M-J5]^QW'A-I)MPYB)%_3@C/!=G("`'=TJRP\=*_F2G MKX3N#Q*J'8,AY6M6/N5$%)!0D)D$L5(J6`4!P%^GIJHS("'XL?M_HJ4\+%"8 M3.+4"WW`G2T1\I8J2>041R%9_5=#_EE*BP1G$=AQ%O"-_3AY6\75$74& M_V<5/"J1&Z6R0"ERP(6`\CPL8R^: MNP^0T^+,K,9,$MC(ND=4!I5NWB\\Z_KVEDU/J/*!I8LOR);IZ^5*]>$K6(7? MG[O2"Z!]\3,,=4PDH1U:/D8&(ILQ88A8=L*/V%$PM)@9?9;:P:TT$QE,;!/K M-XG\36+S&F'Y@T#,#^!C$[E)1"\1,$)5(/J00'6+H:%MZA&I)TA- M^)ZL254)IV!'-?Y"*-5E]3*9;P+U8!VLK_P9/.['ZSE,\F[=O6R`2=KB/?F. M^9XVPJG(#H[R)BGDE>M9K"\D:[MYMF429FCW]0"O3`0&"70/&ULG%C;CJ,X$'T?:?\!\3X!;'KNS+]T!GSKX5)W@JFR^O):%\8)KFI-J M:Z*%;1JX2DF65^>M^<_?3Y]7ID&;I,J2@E1X:[YA:G[9_?9I6F:Z]JR:'K!94(7Y(HK6#F1NDP:N*S/%KW6.,G:H+*P'-L.K#+)*Y,S MK.N/<)#3*4]Q1-);B:N&D]2X2!K8/[WD5]JSE>E'Z,JD?KY=/Z>DO`+%,2_R MYJTE-8TR7?\X5Z1.C@7H?D5>DO;<[<6,OLS3FE!R:A9`9_&-SC6'5F@!TVZ3 MY:"`I=VH\6EK?D7K&`6FM=NT"?HWQWHH%"?EYT7KC;6"^0T[3![CEF:QH`)'!%RZ"$L@XPW MZF^,,4@,B7L$*Q](&G1!MF1=+M3]_8KU,EB0*,,)Q>?MWX&(B,,<$;@B))I# MI$S$<\2$1!#JSH5ZO[1F+Y0%@0DGM?!"62G'>!.,+\HX:!&1%A&K$().V,CC M!65!6Q.2.7C.67JBBCW'K%K7HM"310K+KBME*9HN^VX@VW.Z[+E.,#Q;T`;U M>EP;"Q*U^;8]\+??GSW'P"8&_;(\+2+2(F(50M`9S'7JO2'BJP'WN>>-5FRM$D^# M0W=\'PG"6$,CG1;ZMRH+$H7YMO0]V7.,JH!:1*1%Q"J$H#.-BOB#<7TR/!M:??[#J0JHQX2Z2&Q$B*J91V#I%9O6<3[##B$AP-B MW@AT(*5:SJ.`1'J66`D1U;*V05*K?Q$AWFQ,:_N.;_N.I.UB'?F\[#BXK1UW M]%[7L/+H[BV+Y/8Q%L*7JS%)_!_R6)3XM?3M\0F\(T` M&NMR$&]E0R2=L0>8D)D,OARLI`8@$I8=7W8^&[#'<,<-QOF.Z^/3,Q\N2UR? M\0$7!352^ M+[*2U%AXK"4-6`K&:RQAR0^^:#G!>>=45SX*@L2O,6U&<;RO M0/=+.,%9S]TM+NAKFG$F6"$]H/-UH)>:Y_[@0*7=X:18N7?A8I>X M_GK9Y>G9$R4Y?.,T?:4,@V5`F58`]8T\*^I"K+7#V+[SONP)\YTY. M"GRLY`]V^DKHH910[1@$*5V+_#4E(H.$`HV'8L64L0H"@%^GIJHS("'XI?L_ MT5R6*S=*O'@:1"'`G3T1\IXJ2M?)CD*R^H\&A6*=HL6K!<`',O3(=QZ#U?U)!HR*Y4RP=%Z@04)[G M]60^7?K/D-/LC-EHS-1U!DR"3,BVAZ@,*MZTW_CG$YHNNQZAR@>2!EV0+5M7 M!'5_NV*]#.5DRD!S\WV;-R`F8GN)2"(3DEY"K$SL+A$C$D-H9`I]7Z`"0_.- M:A#&5D8W&C,986(S_.U51'H5L7L/8>B#0,:%?%^?`J]<2-[08RB9F-%O-&;6 M=6D26];MV#H-K1Y.QU84!E9==X8YF";#FPU%<,P^KDB!;45V3VI,TBD*T=PJ MZ%:;)UHPLCHM'3M'*)X-,7B88XB*S'IV!Q'B948N#%4`)I\$B&[7/HZT-.R)OQ`MJ2JA).QHQKU M"/(Y[.I;:!,N8(3!)++V4[B=NGU_,,#MT.(#^8;Y@3;"J4@!E($WA71S?;_H MA61M-Y#V3,*]T#V6\!E`8#@&'H`+QF2_4"-P^+!8_P4``/__`P!02P,$%``& M``@````A`.0Y)>M\`P``1@L``!D```!X;"]W;W)K&ULE%9=;YLP%'V?M/^`>"_?^2!*4C6!;I,V:9KV\>R`DU@%C&RG:?_]KG$@ MV*1IFH<`]KF'>\Z]QI[?OY2%]8P9)[1:V+[CV1:N,IJ3:K>P__Q^O)O:%A>H MRE%!*[RP7S&W[Y>?/\V/E#WQ/<;"`H:*+^R]$/7,=7FVQR7B#JUQ!3-;RDHD MX)'M7%XSC/(FJ"S

U+S MEJW,;J$K$7LZU'<9+6N@V)""B->&U+;*;/9M5U&&-@7H?O$CE+78EO.<@`)IN\7P=F$_^+-T:KO+>>//7X*/O'=O\3T] M?F$D_TXJ#&9#F60!-I0^2>BW7`Y!L#N(?FP*\)-9.=ZB0R%^T>-73'9[`=4> M@2"I:Y:_)IAG8"C0.,%(,F6T@`3@WRJ)[`PP!+TTUR/)Q7YAAV-G-/%"'^#6 M!G/Q2"2E;64'+FCY3X'\$Y4B"4XD<#V1!*$3!:/)]",LX8D%KBU+\'&6Z,0" MV;?H;[9";,:8L:!#EFW$%E-R9NT`V=>7P])6X1L)9#4 MZ8**]75=[IHV?0F6Z;?O7:D!X.[TF*D.$6-#<#*$&"3I$-$CT>1`Z]PN1X*A MC+WL_9'AVTIAH*F#1&[7)\$+&\SK<@\BP]J5PO3U M17%D*+R$,5Q(+F$,GO029MR]2],)2^QVG1)LZCSS-BMDI3!QU"PZSPGCJ=?_ M&;:L#7@4FDUK`,)XTJ?S#+[4@$?1F4_3/?Z(;@DV=`_Z5V%:W9W9C2GK:Y/) MM&6]( MM(")$^L!TT%`J@5,'2V?.`[[`9HW\O#5VTZN?W8EV/1FJI=RI3!^T/3W%/I; MGU]K\V,G,M9'HLU/G$$#:_,0?_Y.*EWJ?**VS!*S'5[CHN!61@_R[!%"6MUH M=RQZ".1.8HRO_!GL;\/Q!(Y1S;C;!<`QID8[_`.Q':FX5>`MO,IS)K#8F#H( MJ0=!ZV8#WU`!!YCF=@_G50P[I^<`>$NI:!_D_MB=@)?_`0``__\#`%!+`P04 M``8`"````"$`7$L`L_P#```K#0``&0```'AL+W=O"3@):L`(DT[W MO]^R"PB8="<[EQ#@U]Z420NWS<$6=<.23`65A>TZ3FB725Z9R+!J[N'@^WV>LD>>GDI6M4C2 ML")I0;\XYK7HV>4ES50[/(B;]\4J6F4Z>KKH>)-LBM@W:_$ M3]*>6]W,Z,L\;;C@^]8".AN%SM=,;6H#TW:=Y;`":;O1L/W&?""KF`2FO5TK M@W[E["Q&WPUQY.<_FSS[EE<,W(8\R0SL.'^6T*^9?`3!]BSZ267@G\;(V#XY M%>UW?OZ+Y8=C"^D.8$5R8:OL[9&)%!P%&LM5,E)>@`#X-,I`;BQ8Z)]RB6E::0GT?+R7P01*6H@<3L2N%XA^2#0ZP+AV@42 M:A'?">6/S^-L%*^\>$S:9+MN^-F``@-YHDYDN9(58-&,$?7Z$&ZKR>JER2# M=$FN)@DQ8TD:(NX1NB2P:BSI8RD2#-4Q7GF@K3U"C#_"!%.Q<8_0I4#,6(K, MH/]N&??NR*"-":L;DN$OO>D/1H@)53I#CRZ6CH:($4%'+($_D$Q2"()TD;=3 M*(-TD1=^57D18E"D2PGQPW!0H!`Q(GS5"\95%);KE[Y"!AK]+W+.B;)E2>BUD-N M)U<&Z2(74Y\BQ'0B7>C#&B!&P$2D?]E9$Y$`TD7>=E(&Z2*7FDC$]$Z&%KD( MP`)$`'Q>]MI[3A)H:[K*VU:J*%WF)5>X43K04B6<.I3J,CO`6.=[NYE<.37N MD(G]?=)TJ*.YJ:@W)NZ>@#J.GO(.,-_/D('?\0X[_%249DVDJ#D=\2JE6 M!'&'N,L\V30I>W+E>%A`2_R_!_S\P!@5 M1Z<+,3)!0Z4'6AG&2@^P:A:)P?V=](<\DH8!=N#0,>2N6]PV,6;EM=J M3-KQ%H94]?4(?TH85)IC`7C/>=O?R-%C^)NS_0\``/__`P!02P,$%``&``@` M```A`+&VNF-W!```>!```!D```!X;"]W;W)K&UL MG%A=;ZM&$'VOU/^`>(\Q&'_$LGT5,&FOU$I5=6_[C/':1@'68G&<_/O.L.R: M'6P<]R68V3.'.3.S7UE\^\@SZYV5(N7%TG8'0]MB1<*W:;%?VC]_O#[-;$M4 M<;&-,UZPI?W)A/UM]>LOBS,OW\2!L>.(Y(#RV,QX$=6P,B. MEWEIX4M&>;E5SCX;I$YT>@V*196GW6I+:5)_/O^X*7\28#W1^N'R>* MNW[IT.=I4G+!=]4`Z!P9:%?SL_/L`--JL4U!`:;=*MEN:;^X\\@=V\YJ42?H MGY2=1>NW)0[\_%N9;O]("P;9ACIA!3:'48"<\@`/AKY2FV!F0D_JB?YW1; M'9;V:#(83X4&6F@LR+*!WWE?^U%LX[U#OI,$$$C.U+8UQ342H$%@1I%TK MP\7%]WW3*5(8["W0I(5!":FP$33E]792.M#)U.$]F]\+)*0M@P@-%4++4(:+ MC-'09(T4A*J`?FJKZ(\>P=#V[0R/28X#B8%VTU48FZ&$"J'#5X:;+I%"T.CA M,^WHL;GNUP"=EC8D1$?H3T=FC('$^'6GC69$8ZA&M0)EN%`2T9%"4`4P):@" M=XH+T)U&0C\J@G1N(#%2Q'A"1D,Y^MQ*PYA`UHK@MBR%H+(FIJS^MD(PU4+R M%TB,U/+DTKD?JF%=$66X';I"T-!AYOVOBJ`?53$A;24QC0J/MI4<[:V((K@M M2R&H+#S&D'7X_E1!)ZII2C1)C-0T'=.U2HWJPB@#KN&=F16I41H])(5&[T/O M]?<5.I'HQW2UE1B8G:W%8&8J#!5&:U"&MA,ACA2&*G%ACWA<2NU%M$Q(KH,& MU"]&@[0:;>F3HT$=/;@_/MQ8KMQ5C45X0CNK`@=E;(XA)I2$<<;IN/BY.;K2F.-%7@2I`4Y_F>3P!A`[@CKLUR)471'1;C M1./B-MM2VS^[:C2<9>I3=WV<"KJFL&M:=TV183)CPHVS%9/:XA\]/R*-.7_H M;A>X$H/-T&HG@&I3 MT:RC2*-4^.N+HS+AU:SA`I-4)*]:\K2?LW+/0I9EPDKX":]14YBVVBJO>!"0 MNN-U1N9P.@=F8E_CI?"*/?#F<`R^@O?F<-3MVE_<$1"-KHQ`V6'$QQ%'?QSN M?<=XS_Z,RWU:""MC.Q`T'$PA!Z6\.X(;/X&XQ'`!X MQWFE7O`#^G\&J_\```#__P,`4$L#!!0`!@`(````(0!5B9+/"@,``)`)```9 M````>&PO=V]R:W-H965T^QE^?!6Y.B5 M<$%9N;)<>V(A4L8LH>5A9?W^]70WMY"0N$QPSDJRLMZ)L![6GS\M3XR_B(P0 MB8"A%"LKD[):.(Z(,U)@8;.*E'"2,EY@"4M^<$3%"4[JH")WO,DD=`I,2TLS M+/@M'"Q-:4PB%A\+4DI-PDF.)>0O,EJ)AJV(;Z$K,'\Y5G: MU$)%O'@^E(SC?0ZZW]PICAON>C&@+VC,F6"IM('.T8D.-=\[]PXPK9<)!06J M[(B3=&4]NHO=S'+6R[H^?R@YBK8W#]P@'&=Q=$:UP`A+O%YR=D)@&GBFJ+"RH+L`YD:9SJ/5>DDJ:%0D MCXJEY@(5`MKSN@Y<=^F\0DWC,V:C,3,+M9C0,R';!J(JJ'BC9N-_3(]UUR!4 M^T!2JPNJU=?E0]\_[E@C0P69,KQ[,\7-!Q`3L1TB0M^$1$-(KQ*[(:)#8@CU MAT*G%ZW9"%5!8,).+P*WE\)&8Z9=C"EC.XJ(1A&[:PA#)R32;>CU1BKPRH(B MME[SP\#,?J,QT]JMKCQWN`U%T*7;%2FP MJ2AP>[;::`P\O%7=T[P=142CB-TUA*$O-/6IJV7RN M(0R=<*7=WD<%-OLX=*;&7'*F/KWHS&[PT)E&\-"9>@+J`5$0?B!;DN<"Q>RH MIIL'_X9V5P_>C;N`6QLNW]Y^!`.YWG?:`QB(%3Z0[Y@?:"E03E*@G-@S\!/7 M(U4O)*OJ.WC/)(S"^F<&;SX$YL'$!G#*F&P6ZM9OWZ76_P```/__`P!02P,$ M%``&``@````A`&NR@@9M!```LQ0``!D```!X;"]W;W)K&ULG)C;DJHZ$(;O=]5^!XK[)8)G2UVU%%$\[MJU#]>(4:D!8A$<9]Y^ M=8@'TEB$F;F8&;J__"2=GP0R^/D1A=H[25A`XZ%NUNJZ1F*?[H/X.-3__ M20R9`TTB+X7+Y&BP+N@8HC0;[`$;`RZXEY##4?YG];56TNA_`9DW*2%BW40:T/M;WJI9 MW9;9:G]!I7E3Z3U4OM$5$RHH!@3=OW7&ZE7NC"'*DU7;]E)O-$CH50,'0P'8 MV>//@]GG]>5U;L"]7M<9"LP;_>*MLK9`,_#&^ZAE-@?&.TRH?V/&@NGHVH.Q M9&)2)!IU&;&+-T(BTR+1;L@B3A%!(K,B@47F101WUBTBZ#X+);$L$O@VJR*" M;K,N$EADHT:VI8@!_GF8")Z3;YB(MY)-9/7DF1L+I),]E-QX$QRPBR+P=,HJ MTPJ,4X&956#FKYB.W!^W`K.HP"PK,*L*S+H"LZG`;,L9R3&PHG[#,;P5=PQ? M[KD=QB*0\P<.V/L68Z;DC_+MB-.2+T0@YPLT>R M]I)C$#,M)`>0A"4"ML9$G#J)BY2>LV_5'4WAM"C[]P2'@P2^0NHU@`^4IO<+ MN+'Q.&X<_08``/__`P!02P,$%``&``@````A`-Z"MS*[`@``"0<``!D```!X M;"]W;W)K&ULE%7;;J,P$'U?:?_!\GNY!DA02-50 M=;?2KK1:[>79`0-6`2/;:=J_W[&=T$!6O;PDV'/F<,Z,/:ROG[H6/5(A&>\S M[#L>1K0O>,GZ.L._?]U=+3&2BO0E:7E/,_Q,);[>?/ZT/G#Q(!M*%0*&7F:X M46I(75<6#>V(=/A`>XA47'1$P5+4KAP$):5)ZEHW\+S8[0CKL65(Q7LX>%6Q M@M[R8M_17ED205NB0+]LV"!/;%WQ'KJ.B(?]<%7P;@"*'6N9>C:D&'5%>E_W M7)!="[Z?_`4I3MQF<4'?L4)PR2OE`)UKA5YZ7KDK%Y@VZY*!`UUV)&B5X1L_ MS6/L;M:F/G\8/@F3W(OO.-."' M0"6MR+Y5/_GA*V5UHZ#;$1C2OM+R^9;*`@H*-$X0:::"MR``?E''],F`@I`G M\W]@I6HR',9.E'BA#W"THU+=,4V)4;&7BG=_+<@_4EF2X$@2@OIC/'""9>1' M\=LLKE5D#-X2139KP0\(#@V\4PY$'T$_!6;M+(;Z_-\96-(Y-SK)I`):0C<> M-U&0K-U'*&%QQ&PM)L%HQ`131'Z)"+T1XH*^4218GXL,WQ2IDZ8B@]5(;WQL M+20Q9=;&\K.-B0"HS,<%Z"3H]%D%PGA>)8M9G&&BJ<;\-<1$(Y"<:WR]@QJ< M8;`[=B=,_.F;MQ:S-/T-EV$<3N/Y)`Z'^<7;1!><\/?KTN"YKL7TO5N+65A= MB_FI.H\&R7+,G6B*/Z))@V>:XEF7MA9SJE7BS>(PG#3',9Z$_DO&PO=V]R:W-H965T M&ULE%G;CJ-&$'V/E']`O*]--YB+-9[5@MDD4B)%42[/#,8V M6F,L8'9V_S[55(.K"X\7OPSC[E/%J>KJ.D`_??Q6G:RO1=.6]7ECBX5C6\4Y MKW?E^;"Q__G[\X?0MMHN.^^R4WTN-O;WHK4_/O_\T]-;W7QICT716>#AW&[L M8]==ULMEFQ^+*FL7]:4XP\R^;JJL@Y_-8=E>FB+;]4;5:2D=QU]667FVT<.Z MF>.CWN_+O-C6^6M5G#MTTA2GK`/^[;&\M(.W*I_CKLJ:+Z^7#WE=7<#%2WDJ MN^^]4]NJ\O5OAW/=9"\GB/N;\+)\\-W_F+BORKRIVWK?+<#=$HE.8XZ6T1(\ M/3_M2HA`I=UJBOW&_B36J2OMY?-3GZ!_R^*M)?];[;%^^Z4I=[^7YP*R#>ND M5N"EKK\HZ&\[-03&RXGUYWX%_FRL7;'/7D_=7_7;KT5Y.':PW"N(2`6VWGW? M%FT.&04W"[E2GO+Z!`3@KU65JC0@(]FW_OI6[KKCQG;]Q2IP7`%PZZ5HN\^E M[ M=UIB?OIT;[,N>WYJZC<+:A@RT%XRM2/$&IRH/+NP6K?S#`E6-I^446\*Z!:* MX^NS#)^67V$]=T.`U<3US%MT@&B2@<"&*.`%7H\ M"F7$HHC,^\4("?JJ4!P3/K#E`RD9,"A"`5"*]Q.LP+`0)'NN8-00`@4S)GAE M(I(!,29X&'C7)!T0/+]PF_GD%7AC0QY&9JXTJ<4("?O2B8)@Q8)+<-X;\[ZE M!L)S0H^M5$HLC+1#3<]GKL",NH.T_ M0EN!&6V/T48(T@Z$X*6"TX0VQ7M.Q&D3O$$;]CO-]KQNHHP8?<8O1HC.>B!9 M6TAPFM`W\+['%C$E>(.^>GH@S?#^'E5@1MMG64<(TA8B%"&+*T$`(6Y8K'QG MQ3-/+`SJT2/4%9A1#QAUA&CJCA^P^03G"7-JX$\B30G>X"U`;.;GO$X+7;J+G"77#0D9C2[8`2JE]$8V?+&&J,KW0E9XTST/"6/ M7M$B%)+7.K4PR2NEFD\>=IGJ?DJ448":8#*;4PR2NE MFD\>=8V2]QBY6#VAP:9`\B`Q$=O,B090]C\P2:F)25_)U7SZ*&X&?9:I6"!& MT_>%$[+22C2"\C=L(M]UF->4VI@!*.&:'P#*'*1K?"3P6&7'ZND>\@^41@SO MEB-D?*(91]XU2D<(?Z812L3FAX"29ZP!VVIQ[W$H(4_RI]=$S],5H#KKW]B\ M[PFM4!(VGSP*GD%^TC:I9@HG\!D@Z6^I%NB:?6H22H]9I-3"K!ZE8O/9H^89 M[%EIQ((*IQMXD\U+=%._;1@6D3]YXN(/0TE&D%+!_UJ&U=&#FM3*;4Q`V!*VW_,"]2' MNQ]\9Y)3T>7-,=88Y/5!>%$T>>+7$.B9U[5D6K4UW41.%+'53N][,0-^2)WE M5)U7;&/&&H-1NM*3C'^B`73!J#K+,)B\!5,3D[Z2/K)3YKW&2Q1,8\`\"=51S075=HTX._/Z3@]V>Q*($D(]U_E)8UU5[[93/60'V$I0',6X/>RE0-_@4AUAC\^"9NO2EH!*DE MT^;6FP*U,0-Y2+5=E%=XXQZ2&$^'DNG0=CJ4&D,F)R5SI#I46ZM4[$'&LXB@-PV>(B#/[KZTG]Y?ZD[.'SI_SW"85L!G]B= M!8#W==T-/U2PX_'=\_\```#__P,`4$L#!!0`!@`(````(0#NEOR5C`8``((; M```8````>&PO=V]R:W-H965T&ULG%EMCZ-&#/Y>J?\!\7T3 M9G@)1)L]'0S7GG25JJHOG]F$;-`E(0+V]N[?UX,G8>QT">F7["9^QOBQ/;:9 M>?SP_;!WOI5-6]7'E2MFGNN4QW6]J8XO*_>O/S\]Q*[3=L5Q4^SK8[ER?Y2M M^^'IYY\>W^KF:[LKR\X!#<=VY>ZZ[K20;.OF4'3PM7F9 MMZ>F+#;]HL-^+CTOFA^*ZNBBAF4S14>]W5;K4M7KUT-Y[%!)4^Z+#NQO=]6I M/6L[K*>H.Q3-U]?3P[H^G$#%<[6ONA^]4M?7XYU4SSO@?=W$13KL^[^ MRY7Z0[5NZK;>=C-0-T=#KSDG\V0.FIX>-Q4PT&YWFG*[Z_JKAG[>Z)]@\?QJ]:<^`K\WSJ;< M%J_[[H_Z[=>R>MEU$.X0&&EBR\T/5;9K\"BHFS``/IU#I5,#/%)\ M[_^^59MNMW+]:!8N/%\`W'DNV^Y3I56ZSOJU[>K#/P@21A4JD48)K#!*A)S) M.!1A=%O+'"WJ":JB*YX>F_K-@:R!9[:G0N>@6(+F,S.TX\+U/:K`42OYJ+7T MNH!%"_'Y]A1YC_-OX-*U@:0(6;C.`)$4DITAVH%:K3K_,*P1=$E^1NCH`:,+ M+7`6I^5#V/\[8&<6>A%CP9Z77D,XB6M$Y%.CU36$*F"('<=Q>AJ\VW$]$,.@G MM`2TL.F1ZM&,&'-G:C#(+$Y\'BPJCR4K=XK(I3:=YD).`4)8KJ/4=">?G(0" M^[Y=ZA>#SS!F!H/4$B%8=VV="-_+IU+#M$VK, MM+37N'*Q>/@A$V?C8F7$Z!CA12S=DX1GO""H;92>KJ?3Z>'W9_08V4BU2]#4$,Q:@'? M2ID1G\.R8.05D4?0RGD1L0<0V,KO\=+]?#HO[/Z$%ZL1J4`,\GK@@AL_H07,RPU&(R8Y'9E1!PO MKF)FCQE^/IT6=G^;5CSXRX0+,4A+<+LS88LE+R[* MB-%L'P;X2S1,+N)R0RORWZ$E[QH_>C0=A/F#4X,9FX1O0]1M2#X*(;&3=PTB M/9K.6#$?1`P&>JK>:][,8^[/;@$4!U@%$`/(`7)(;$H.DFQZ8DJ-9N3X*&(P M(^10R;L`Q3588Y0AQS180R@EQX:1:<52XE`"GY>7L7CP'NX^@QE-4U0S`E&W MM>2C$$I6#Q232XS4:!;)JS1%C"GY<7#U+F"4&$"2\+D2RL M(8>2NVM`T:>?G-Q5FMH3A$B\A%7VS"A!4H94IA!,J,&_'_)<@91MR'Y*(1&\'\-+O)Z<.&'.JG! MF)&,S1T9D;(D4$3X8#5ODYWV2#34:,KKKH$%[B2N,I-9G!H,'DF*B(DS(I;\ M"$P1,;PVL+36MR+:`M0>1-:>1EIXY8$W`H>R>2FSZ_(I7 M+:E8PCD]'+>SWQ51V\6:@#,^XL7Y^,EW]RNWWF M/JBZNKI?)NZ/SWK=]A_T^U#QPD=RDI#@XXVT\]Y;U+/DZB6?E;0O,,NXT]'$&OLJQYC?@E0_1 M[Y-[M]VS;A>,,A@,1][,SU9Y3K:LDZV)QL_:[5Z_/>BYW>NEF*XNDF66ET*. M,BX#&_#'Q-L4W<7K=);DT1GV]R;+_66+Z.HV6Q50,$4+"F"6%$64E;=)?I<6250LDW$Z37TA?IF,*SGM MNYT:6IX6!8;^W/LY+FXC#!B-^4?RUU7Z/IYA&SVZ@F+41464)^,$C:YG'HN] M3*8)>&`2I5":\R0JXP_^_ISGR3).)U'R`9JQ`#4YN"PR&FL.BF6J[DROLA*< MN;G->0Y]FT,ALE,N9DDET8H62>EV]XYTC<)#O5E`R=^D6*)N$.SAJRR;W*4S M3TC51,,]F]WX)HVOTUE:IHF_)16EE_%]B,SX/5^!RJ`Q21B7T/JRX.MDD4S3 MX-;)"_,X_RD1<3+$=XE2[6">O$\6*V^'%=','LSL(MR.UC=K0\.WV:*]0W\B M@+?9;`+C_$QVMKSW>5D):T%A=2=T.IF`VMD"+$3V:Z<+PX=@868P'E$)*AU7PU$Y6@61Y[F">WV,;T M?:+EQIN0,+[,QJ%`N&6-VL(6N[QYIN;%25PK707!+"-HEF1^#3G17D!?.H33 M4.K'VG,`A;`".$'9-"J4DH28K_+Q;4Q=2&)GBT4R%E:]2\O;*%OEBL#0)Z9A MM,RSFSR>8Y`%=,T8;U+W5J/UU&C]%J0RNDMF,_X_R/<^A=(,]`:=2_5B^L(L M8+"5.].5A<#W.O9,88,*OX0%2JA-H/^GT.[U?8-%I;[;2:TG'\984`2W0)F3 M"!8BWD?;#W9VZ#Q;EV&$GEW'RK9;M(0T+_02/!@*#1*NQMM M$Q!8Q3(-?7U;Z2NJ\W@"S[Q,BY#578''YZ#H&/99=C99Y-ELQNWR9I^,;Q?9 M++M11@)\609:?0552D=(#3Q/%^):E9`/M[_3.5V4ORDM#/9/7=OAOJ#(1SO5 M1"?W#TSR;1_H]B)O;2NEF;7J?:YI_%K1..NB[6BI=?H-8B6WD"EB;LROH_H=!?0ZF*')W\! M,X88+]2WNY;==`\]M=>S[*[1D7Q7,1?BK_2]N!GN4*?51(NHS*"%(0EC>,+T ME2HFR.1?XAH*ER""C*[O#1-"R&W_'IE>)E#-XU23A0)DI5$QO-6C[.;-V6YSET4;H4 MY_5>.2&!S=`.;32#`^L'7MX&3'<@[JOI%%X;B0F_1<0A8M`@W88T%O6UA;H!V7>AO?!Y#4_.;E:HZ@ MZ9X>WY=&$YWBA4OH?X3B8X(M.ESC#,X1\(\1TKD3>&`W&S"TMQDVH1>U(],U M=JB:(4FUUPQSP1638IRG(B4DB.GM7W__+[4<-.)_Y_B?XF\14`(@E=TG+TZ^ M&,.;RB.$TW-`HCT^R5_#JU)-KM(Y-.C;Y"ZZR.;Q@K].XWDZN]<]\,$+Z;0\ M64.HHN?H,?K7W_^'=C->W+?^]??_Y3]-(_W/NX1_8'S\M"KP]V=1"IG$JY"" MB;#%8@83$A6(.(#`8&6W@H.!`Q'E"2JCW)X)#.5D!>2P%K6Y48'.77!?X$2[K!'@108[G'@U3+/QGHN/= MW5U'DZD#'>@-_3,-VXK^^0]OK$^SS#=F+_^?K/?;9`+EDR>?<+G,;WQ>+.,Q MA!R.79'D[Y,G)R(AGWK3SQ'8P[^BN@(V01IH*/7G5U$M<421?\GADL:+Z`8V M[:\K*&/M?ABEX^D8[%:>XBUV`'W&L$O@"?I8[>O[-O\?N`8T=[Q<0CM2)_%? M%3:2+HR"DN=*B;8BPPGM/!%J/5E*A:#J>9P# MW2)X9(W>)%_=J%WI0).]6^418J(YMAIFHZRA!K,BBY(%D=D"GB.#ITDR`^D` M/\#!%-[XU]__VR*YV#B:);+7#,D;[@2<<8-Z8HQE#+H271^-YT(43C@U6G7.6 M+XFGI,JS/,MFB-C3N%,S'U4"$R)=GA`.D-"%4@^T1FCX"1V3*\PX1OY#'!$2 M!1NMTSS<\BK-HZ%3@`Q(\Q"I!V'_=HMTT`.-4UNG4B9X%_Q*8/ITL8`C&"$^`[;'&`>0SSQ"(OKW M%?'OF156M/;G`R&]3<>W$:]W MGGH.GQ__I&[,TSGV3&`' ML$!J"RN@AF4\=#.[%QF^CR;`##*!RV",L#[H.D@MJ1WL0K9\FF6EHFK.4)9K M`:16S40FHI0X(@C;C=UPQ0V5$#7)3^C5*$!(FF1,N$#-`'(_5+3@VOT89BM3 M["HVY#PMC$+,N`92`G>"':(38Q31-$YS,>'&))#XR=<2WL$",R6DP(;JL3B*H5ZXS!DB@V MFF'^1*C)]0L43R!8$&UK5F6(N-[`8C>;JF]&L@HYK[S2#P$:"6 MB,*.*8@<$Z%\5*RN"_`^MBV"2\)B'/Q@)C1593=&P7+^GH8=6"UC*IW$4;@$ MML0<+T"[3^P>V*1#T%'W7:,U;Q`$F:P=Q`]7.'I2WP=N'Q00W"&Q6=8M4N=QNACJ1O8P)^XIIR@[$(^)[<4+!) MF$R6$&OTT0IF?2+B'8DMT/-<7WUM>=/UA;OK6UL]I00ZL+"KXB,13#BLMBZ@2& M.JL.H;0N0!A!N,)$Y_%?,CA%:R&FBL1$W\![LQR^3O<)G"GP$U=;Q7;(^--[ M\TC-)6(+3+LV@C95XV-9$;L'RH)_C31F9MLQ`HR->=?&FD*7ZO%Y4U@YSB`Q M3$Y66@[IZ>R.B\T,\)4_$$!'M6;!9)2[)6M68#+Q-]`]FD+H=2%<#EY)2 MHEJ5BN8$)&_"YXS_V/4":.U:]XC^;/V,EGHF##&OOW&&]?VCPD`=8'*'+:@Z MJ4+S'<+LH35=:U=YF\4%12'E3A9KLX(>(M0F)+U66^1Z4>ND]S- M52A]3WJM:?!"=!E8>0>:UN9DF+62I2VCJS$Y^KIY`66^SNX@A[D*]&%-2F@W MEA(#J4%S[/A^,]N+6LI8P>L"1@1(K]HZ$&VC':)B"@^DZ%#>JF0;!-.W#H!N M7$DX6=<8V+*EA&Z"W51JT!`=;-"DM&5_,V@9EL,FX-T/+-@1_O^X)8GS(NE# MY#3G2\K>:BF,A5KO6CT1\"YZ4P@FIE.C/LA^VAOQ^4_0/#P&"U)*`4HB*PBY MP5Y8C^T]4:]P/DIRZ(1C`5R8`=G1.I]!`.OQ*&?4/&\N3A=D08O4+`K<=Y$J M;KZLO9&M&]PM+G_=+RNT\3=*43QS>!P@(T8[G2`3#TIP\BM0!A.[E",5R+!_ M0I]=);89LE2:76$MPA6QGB28O08>@`-P]`/S!)\`CTH4JD-K>;-"H3=U/$2# M.P56KW!*RCN,Y0QE'Y(R5MLJ1A=][U`/2G9"90)Y!T5NQC_5P&,.'"6HVX0"M'05]/0;JO7W>[NY%B'LUK]E@4(?6?G_E`D&IDG%$9BF8T=$><@2V=Y= MZR=4&/!VP.T&B3"!3E-!--!%ZF-N#>73;`T$A6724']T`G"&K,JV:35#Y`UV M5M5&B;U0R.`-XX<%\P+M8DD\F^$Y_I7DRYS53M<(T*D"X-\"/J%B)<<3Y52@ M:/4Z?1!5WH[S!SH/)RWE95AH72D6Q3?(+JA$Q!BQ"M0=8E.X^Q:MM'.*LFO$ M4F+9X?V<[EXWWD0F2992:)$KP'S5N#<4M"'ZF M$E>BX`3F'!Z].DSTV><&DSBXU>N-_.?Z)`DE*4`)O_]AMW4\#/0S.FH='?3< M_D6]_("4%#.:&5#)7$XVP7XBS2E`"OTP>`G*8Y#<-XW`G>#_$X'@^[ MAN96',\J`&33J;M>JQ?B]T&K?Q`0`R5.`:*XHC]L#0^/_3D=M@Y&@6XO68%= MG4ZB-U)ZARY#;9K=BI.W]"`&XD'4WV1I1:A_84]I&)VSLN;3L678`;I:8ZM2 M<%L4AT"/P(C"5%.MT%E7^"\U!D^"ZZ7QA`2L.Q4/%].*>J/1L3J%*@]$%:+] M0?W9<]IIFVDG7Z,HJNGJ>B4]79PE@Q_D*5F7TP>MT7'`EEG\PAQI MBU>PJ-R^2?2\[YW>/>X%Q.4"5:\\5D7! M0FVU^,D*[$+5&/.,C(ZC$`>D4_$3M=G&5B#FQ!A%5E4<69W[KH)Z47YA$`&* MDL5:]01JW"#865&L!`)0`LU7F@5:*D/0`4JB@0VA;(!)5)/+@PO.K@!QJ="8 MWH:X"YO[I./IZ^NKS6I(D52=C7!U$H>K:8]US=$"#L?R"B9+U@]5B6ZZTX>R ML!\J[Y'C-@SE,L'X`N`:E\S1H(@-X3E*>T(>ZMOJ')>:A69=E[_,^:_H5`_U MRAP!P:F)L7=>SS1OF^87UY7IAV_U-/.06"5KO'ZK=YA MP$?J'79"'M6P$]+3@T'K*!1Y?0^#`@W&4*@JJX">X!$P;NE.D^L&#!4G%XC* MAIU>@)(#,$8OL-=Z0\37V6DRO=;@.$RI7B#J!-L%9M[OASNAYHLK,45IEQ93 M8#$KQ,RLP)F-]6%\A&/4=I.4I,&L-TMJY41C``^,$932E!!QST!. M]HTC5!19_V.B/S8+T2E##VIYTB MH&`UQ2,S(]F-I_W.H7G@3M$U-9RR#14]GQZ@O^_L55:U7K,.HPF?`>>AQBC^ MCXD];'O7>A7;3?(C&M_&JVYH!<.LUV@:;:CQ\T8.)PTQ0E"?AW$8=^,'QP%M MU^_T`U8#EU0,#P/*ZR#T4&ES=[3FB6Y7[TQ^>N:]0Q;TAH^^A M.Y/'59*X(J5,<<`!8N$5.@3E!)M8]VS">RK2[A/0E7GK1(><.#G>B#@;P7`9 M/O!X!K3Z.D_=@XY]/I!+X1)U\A$`8I;SH3G]:!P6#%L+;$7EL,ZUTML8-ZPM M`$X6K.`%V8!QU_>D;K!T^DX,`JR`F`=U\`CQT[*Z3TC7@6`D0O\2,F%@F"%U M%II#`?Q2%4`R'NJ4X-;S*H:V%/RI4F+F'<2TFC/JK`W,=.'_NCW:42?^PJN4 MA'!U==@.B]QBA1OXF>0"U6OF>*=3%V+A!IW*PNUD97>>@LJ(P$/9>,Z$F",8J/X$@N<8Z+IV,H MIL2A:ID^_,+EX+R,@K?HXJ[D7%NU8M3%(,AX.NA69$3ODN$$1`V-HOID4()_ M?,O#*]&A`4]VGJ-%0*CBJAG79JJK'XTO!!UDYL[9'5:SZT3G>J]0JJ'K:VN- M)6DVCR=R"P''DM)$1_J`F%/,CQTHN4.Z*PS_7[=YQU5N"[:@.\E2'>$Y1 MD@O"]$:#(50JJ,Z27'O,"2$:?N6`=DW`!16>1;%AF@A[I&I#*N3U+LM_XI[H MZQU^%8(GE6:GZA M!=$UAN4]#SJQAQNLHGD"J9CX<=?)I2M'`4B_>:'[:?8![6V5/<",:XG>";/S M$/%ZPK="YV3IPM,>3A>"W%1VJ`:\*=XTTN0`+=2.#3&`AN($@4-!.PIP./XE MN_MT88#!Z-<]JE.Y^XGL'2^K'3RL0@V+(!^V!L@U'W<' MQJ&S/_6`]01"AE&W-0I!9W9^XM'6!D4+[=9 MBW]=(T!6T&#M)J-->JEF9*&,[&C6$$,@'^U"PB".CX23`:P59"27J%JAAO'D M$41>E&6JY@-@T0DJYW`IB3K]IM,+`?)836V)9DRM`:4L%0Q'2.6DU-A1%9DR MHSXX8M0_,+L@3HH8X"62Y+RX$;D/7,3"RFA`;Q+Q);"^V7V"Q6"*O-^TP%%W M7K-$<\PD,Q0T"V/%?KO[2/-J@@UL_A@W72'Q`'L0P&98K+1GL`AOYA:';&/M MSV($9,0/(//=@5DB3YDMSPYY]L5ZGNTO):0[JT5GGRZW M+<=VU^,T9=,,0BGQ([8-.V6WC?DP[L->OKHMH1*@#ON5,H2H&V2+O7D0%ZIK M5W.5/OW<*-YUO7\EQ^6_5='+*W&TUGC85:EO65VZ>_-7YI`CTW5N7T-@C))+ M\G\8-/UP%/ZA&N=]ALB<=PA[A1;#06?P&T,$JYT'H\YQX/%PV-3Z*-"Z&G[" MZY(@M-%]"I_*75S>@R+1[7/,@'RIG3BV(SS)0.M:7UR+O$NHHE"$Z/`A`H/U6]RA` M4Z3+0L[215!CNZ,?AARJ7JL?\J?Z*(D*5"*P4BK@@2A?>-M^N/-!1BO$(;W6 M:'C@TW?8&O0#%#E`B62`H3Z6=0"FZH/L"'`0:\H)$RGL^1AEO96)!H,`T0]" M7#,*U93V6L.0)(X"G8X"\M8?!ASQ?HB\_4&@Y;`?V+:CXT!+U.'U0[KA.+#! MP>PI\IBA_'"_=1":`RK$6.]R%;ICO_[;M@J[H538U=]P67H+V]%Q)K@4OD)8 M_',V2>0F25:TT9/C)9*,83_.3UACO2KF]4?ZS+N>M0=5%-@LN&R'`;ZB>Q<( ME8Z/0DHNU'(8WL-^ZS`D_O9LDB&5NR7'^#9-P+P=A$WY<-09!EH/>YW#P.-W MP+AU1+7V^#)X_@4)<10%$$I=XZ-/N]);YM,X7=.T1Y;!6$M$!7,L% MOA(`2&@%C46@9Y9=7]\3I=%9"L0DZ(7$PETX>3E%0173$U7F0D(<;53Q404Y MU0"/^Q%7JH#F3[#2%@[@XN"PE(SAHC6`8LR1(1RQM]`RUF$&C4J>5X93N<-K M('`F9R?EJF\$+GQN=H'HE\"V[`>%:`@1Z;W+511NF=!`(Y#6LWQI3^'OYXI( MR+BB%\NB2E:4X4)=,Z=USKC&F7)^W&+;OJ)+N7M)$0&](OA#<,QP%!H'RT9- M@I,-Z'>&!M=VXS2\7*L#)9#5?K/`,23YY^[M/M'>`%2B/M\=5:O2@@;;@P2][I3QTF`27WH=88C[G5)MH/7/&/'B1"44!U MO0S`.!?87]XPA"\BF!LC->*%6Q'^@O08F<#"7)]!3M5W!NKSJ.%L#9/F-&L3 M=P9WUE%5Q=JB8KT.ZCS]ISTW:("E^NIJT9]:X![SOD'H#CHK/XG+AS6)ECAN M@1,'*,J=SZ1#0]$+ZR507!!4\?I#*8)7N>EJ,#T;R&Q] MF?5J@RD/-RCYE[?P9XWB=HMH#^U5FR9/5`&2"K_2:1U/:M5%=5Z`SJ]V84^A M/I3J(=M":T"%8,*L`AB+DMPXK["W:N>M==YGG_N3"F=9`HB6*WZ;$*YPIS[L MY?8I(NUYU$@:49%FN?]+=7:=C);AIC#L'+BNSE[N&/UN(.SJA?SM(4XB!MH. M6H>AFJV7R2)#Y4WC/(VF:990Q3Y:A=18U5T!X-_142"6Z!VWAH-`2(CV1\$, M"9(JH?,3;RU5*Q8"+BR\Z&U!M],-X`E(#`4"F&XG=$3MI5**7L\&40L0K`DO M"H$]!_T``G,40FN&1X&6&V815C[N;AT%PKM>$(T(87J]$!T5?E1G>,2[8]K2`PRRLIC69Z@OW5-<:V^: MU=GL6S7I:L'@U+I1VSAM^-Y['J"UP2+PO-#!AEXH20TT-?1X&()81=Y"*4`K^\ M`Y+0\]3?\;S1G]R4Y^JH->ZL`B[`;W'HGI%<6O]XIS3>W*2#;[J&IL=R%=QW MAN\,2)0"IX4"?F.92MP98Q@AP. M5BOL09>U&QPJIQ"[6XOP9!M?W<)?B$'[;AUY#MYPML;9."3L/8EKJ<%#VF4C<&1N5;1A'7[H5S" M@'(]*.%0<[.CKO,S=W85AF$,JK2VB;AT57]`@K$JT3I,#S%`0CX/XPY?KW"VQ6.:7B@E MVPOEI'LA8+H?@KQ_P,GG\PPR'ZI'"F:,>WT/]";7A:,AM0GJ>`.^Q["A>.WX M4>&_!,&;+K$D.[0L)NQ3""OX&"%75 M%RFM"UK(YTRB[(X?O(5"J]H'T#&/BKMUZ;X6Z%FM?;?NI&V@C[.J8@JRI:Y/ M-3I?3C)"Z\MUHB@%Y3W7O!1>L"H>8*:@;+Z]DB(OM!IV^?CM!&R!-625A8)FZ!_\AM\%Z_?Q?SW- M'=!BZ[NIOKX0$Q&Z1EQ(=(C?>H=P'%E&0@+"'BZMASZ!RVS,!5FFOF\-!A/+ MAKM9[P!!&;\?XK%45A6C#P>_P90IVH.!,U,CL$]Q7-ID0]8!2W6M9?W"'CN9 MMT@WP#]LHE6C,0^M<(]B6/EV#\QU"NTF#FP5'$L&WEP;0R\6573(DLFQ!]ZC M9M13129@]KSYBI\7`%OB9Y^RH+E[+RGP7U%^,ASJ3O0]-4SE5HF>T-EU*01< MK)\E\LO'KS_]75CER>7#O@P9/9=O1-Y[MOIE[4-4[Z;5UQ==OYO8JWR`_%QQ MJX2S;J/:5Q#D,EZ\%+G`\A8!PJU?\)CH[QC6'W-+G5_P_]]H, MD$Q?'2_?3^=];NR`?==OKW3'KK\4&,QKSER%^(X-57]KXC MZRS59_1.?2X3YW[494[?L8BY?FF*-[\:#2X@%OINH$M)L=#?`44?TI?JX*(Z MT!#NIO;[N3[#MFF"KWGN]'NY+@$LJ890*RY:\ER#*;;T=E-O\GZ@F#EB22DJ M&]UWZR5)S5MHQ1`KTC5(W+JUM\EHMJCF"B4.%ZP_0?95JG3U$:8:T)ZYW,RN- MGG]W^3)Z&C`TXXZYO;;WF),*:.<=IB-:P5/8VQ;Q!J=,U34CT$2`LGD1E6AP MN4RJA6.:O"Q>.5MWO!^7GZ##[=O^?4/=M1)_EQ[P;CK`6.0H:]_]425XY`"$ M.I%HB\GI&16BTW423-^OLF<7L/'&0JC>5G)[G#H<[O8EE*0?:XXI(XK`Y!`Q MF(.]<&V5N^6]JHS?0X[AN%U=F7,_,N&6?VT:3V"Z+\G4/2:H<[RZ\;&R:C7& M-<][YHK"H0,(!Z*,1V%[^UXX:MWOJ>F:"G++>^V;CU6]]L(,)V%MC:\T>S MPM81'LP2>UP$^7`V>394I_GP2024*_+^E-XAG(9[SR]^IL\#PNLP+?O'P9:& M(H\Q_]UW>*_1/GK7`V0C+9J$<*_)[A[;[I?(>4>/]9%CM=__M#M]D9_1AGOK^`V1Y>1M[M!^X)&.WA% MVLJ^LY;OX7P:ZJO!`H::*KYSJ1)JV6CD0HT?;->>];7:!MBOU798&5<-K7X? M!77#GLRN>(UY#((D-9^-\CF#IP/&.'*?"/E(W$$ M!09HYD/TKV/(ZN8RF?JQ']W>]O)5,KY= MX'K7&WRH$F^>@3%8/+'MM:]P.#5G3ESFR@PY@%NL'_GV;:^N):JVHOW`C1Q9TP#,K`KW2[6/LIG2N/W.I01'%Q7S'O#;Z?1 MXZ3[:D1SMXD#F%,$$-_ZS96LZM.EJ/6M@@OS*LYQ2@-U4Q!:G5W9)+%XFWZ' M*"@H&`H_1+Q!2&V"<+>Z_.UY+0ZO2^A,/K%I<)5D5)\>GF'\JIJ/(O\ZQ@7V M]WB*;(@@@O(UJ<:%!+)>C6VM9LH`-?(K**(A>2]2XSNF0LG=T:JO=U"A30NM M&EVAUFE[([D@:VNSURSV:FP56-D&+6_=VOH7&\V:/7`,ZKA&-WSX\B="IP?QZKZZT=\]HUH6O*.GS6QE`LF\T!UVN0<]$"35'0$F6SYD.EJ#L[1;][9Y:O68F/I;C4 MND!S""Q1W)G?/'?VP>75]R^>JWVQPZT3^'-]<-[7-=M?!BO'?YSK?[XWSZ:Z MMHTL?V6Y@6_/]5=[JW]__>M?76VC5]?^_&3;D08D_.U%S[O- MV3+P-E;D/#BN$[TR6KKF+2\_//I!:#VX`/5E8%C+E#;[K,>4+J^\G>>Z45;;1GL_&BN#[-+6OS+A]5]RO) MPL\QY5XBP?75.O!S048C4!-JZ_+9#[[Z)OX&S@#BX6W75]M?M"^6"U<&"&\9 MN$&H16!ED(]=\2W/CN]86*[S$#IXV]KR'/4`TJ4Q3A,')-,(K5"8/1++P8K5,UC\+9.)XC>MYM=$?QXM)42V7-%Z'?G&@ MPS:\,EL1/N'CPUPW3<@A@WX?U4H-UA&SV:(/_$[&[&)\,LE&YLB<2)6,\\5# MNR'#D2E3E34,S?>3VY.I4SZS,NF2-'RJ","`DZM%!T*W(KXG)OX[A9^!BFX9.IL(-5>DWDZE1:9(`[.$>1SB'3$;.+=/`=D^=T(U^"CLFGRIEU9M7)^6'E MM>>3[2I7=-!4#-+9%4=98_<7IMQ.B(Q-K0>UXT.5U9W-VPU6N/23*N9PJ+#G M1`TLRQAL(?$YKIN-*$=C''/!E>LK&-Q&=NB;\$5+/M^_;F#$Y<,X'`.E%]]7 M<_=C:+T.ALS[Q1IL`]=9(8K'!1OG)77VXN+.7-PQO@29*(H2HJ:YF'1`].YF MMI"/=#%COMJ3*/[0A'^2D;X?XS_)1$WX;R%-ITE6-&2!S.AID8/S,OWSR6PV MFPXNIM/IS!@-#(,I^2'Q:,=?V2\V3M5(4],A@C$@F(VFLXLA`.D;4\;JI`A& M`&`R'D_'@]G0@/]9JNH>@6R=CG755B4(%%F5(%!D538U("/U)9$"LZ2*8Y4@ M4&15@D"152>2,_!$N54)`D56)0@46955J1)C%58?%,I#$*Y@4C%= M^QS@2#6^=GWEVNL(1`B=QR?\&P4;%"B((EA4O;Y:.=9CX%LN?.RE+=*_%2UA MV1E6F.=Z].0LGX$9-R<7ZR9FT16'+.L9.)HP)D9_8HR'%_&`31)KSUXY.^]0 MNHQWH5^"&E&W]8(3'?H9D\0=\IGU'EHA,9]@"V9J9FG!!N`3J4L(MI`A8[[* M)"HC:2$F(VD@*"-I(2HCA$Y1<*6:7`4[V/&P;V#3G/;[;-37V%^*"1+@!1Y3 MV^90G[5-"C1:VT94IZGR(+\6/)$:*#3KKH1E M($S2-GNJE2UW+7D"Z:1RUQJDRJ^2$@(JDJ7MNI^Q1OCK.BM+8*;O^NIE3?9. MP88VW%R$6[/P(TRG)Q_C$B3^`N*7-1J6-M*LS<9]_;3S'NS09+O<&`MV%:?M M\V\WK';*O[.E6L]F*`(R@`@'N MCTQT`.ZI`@&,)%,$X*`Y`H!3X15MXF!`LAGX0,X2^'?%$G),*B7'LD,IR](O M\*^0TN32;RLUDWP+CIZK&;Y4`&C%LBS%JDHQQ.P0:;D*X$N%"DSH=>5T>3#7 MD/D=Z"`'H$PA).ER@"`-5&E$GE>2G`L\135R([$.(4Z!J4@U!("C!`(QQ$!1 M_SN@&!3UP-0;%'7!%`+7!U=G":DQ02W!]9"*,``>)5&1Y^L!UV.<4`T$@JH, M2;QAJ"I%4@RJG3>-)5#)_.L-EW;*I1S!0.OS?M]7+ MNG8B=5`V:`)::?-X]!2/',$6;"Q%AM+X1*J%C[G@W*GV%(3.+S#(Q"=3EW#! M#G5\DCEREO3*U]#:W-LO,!2-E\)>UJT$K,&4\X?)=5UKPERZ?EI@$;!TC2)J M)6>#^MJ)^3W/X">W:SVD%@1.[JC&@+I.,$AW`4DA@I'[EM0$'69=(FJ426K] MA-CH!*$AE5O3+("Z?4NVAL)$F:UQU*:..10"4IG39("[&FAO>=!;:?B4!$[@ MUO>:0\C#_QM`R5P^6):K^X^J0)KD#>E::L1<=NW5B+EL_VB:TD@^+;4"/"VX M5VN8D`71_>.>))TF3+^75J52-",-#8UYMB^I64W:O;HDV1)/L!&.9Y.MPW1F MR2ZP2+3C:>#!CII>U5"KW+,@6JN2L7`@2E09UUG@:E='`-4K[=CLQ3L5KH15 MJ8@/0!46582WT,!T)(P3Y(6UU*'7%8^%C^RU:+"D5@=G$XU4ANH=>AH MU\&[5(W!^!*F5)6-^E#BWM66X^.OE#FUXYOHU%L#(AKBK54W8.;-I:+BE&Y1 MJ<-Y*&*J\F<+A=5%8(.*EW?[HS`=%0:RRTL:!E(SF!0?:S,C4UI"P(87Z?YU ME"W?/D*:X_;W"57ID$]QI9W"L3W2J`,L-!!:IC,>7EW)RNOJJ$QR#%Z(S[50 M:<9G.NFVE)(GJ/'B+$9=*UL_BD\C.6HJ$&!6.7RI6@21Q2=552*3O=`L#QG) M$IPUZPJAHWS]J$Q+$/*U6HU9^=@4,G);?&]?@]TC/":?$1-S`&LL?!*;=NUS ML;YJJUNBHJX1M8V"KO&]-0]K;D'I3MY2)5U8C';BM=Y=5DT?FP#:C#U.&&D5 MY4ZS[3)=&%"PQHA/-ZFL?HA&I7N^-!6>$EDSG2DT+GO[BO#Z.P_TC8Z=B#,J MPEN;#0G$4WIE?!;:49%;<]#=9&FC!P:DKZRTZ7UE M5P*T%VM;V/(>!5%:-:MPE,NG"%MH$!]_DCHY=)0&Z5Z44D2'/<2;VHLRDIV' MFY3$Y4I[*U/@Y0C!`SN+C%H=HE.EJ^C"H5#L=Z7S"T4@V/-P\`0<.4^,/TTL M>UY.PQ<8P5L?^[_5SK3W2XSY+)?@.O+#SG'AH&1\$`YUO-QMX8S.F_ABLH^^ MBA9DT%C[0]S+2FB!XS2EE?500]A]0FG!A&936IG?8EP16G#46F-:\,QQ+".\ MZ(2C!?O3F^*")@DM7O=C0=T;179DS^D3W8/((K@HK=R.N&)":('(36GE=@3# M45H@H#+F=N1U M/Q;4_7Y&Y3U^*.CQ,97<=O")Z`A'CB(ZBJGD5N.]?"3HY3&5W%Z\?QN"_AU3 MR2T%](A$!OP@+E%FHQ&O74-0NS?6*LVZO,-@/R,"`UX+C`;M1$4)W+QO7\JTH"%\U?%`\(\<;?2Q( M[@]!D.F(IS"$KR*`?H!W9,/KMS702U(0<`K"AX2;D,EB@5\5[#I\EA@!2A-(G M>Q>%5N9_?$@-!17S"4^.S6CP*2)^#U]ZS&U2?WZ"@V)3)>)PC<0.UM`BP/^T MBX@:L14A@M,*(D3NG0C.'$^#F".!L(1(!'!X0T9B+Z,(TOB+%?H8+5SH[OEH MB43Y41A0_:]>\E.$F=XC?(L\.U\X&P^`HE;VVMJYT7WVXUS//_^1G>8/SI3< M]:/S)8@8B;F>?_Z(KTF`*(8)*$@W'[=P]#[\U7:A,]?_?7F<.S:?]F M>F:,[/'9;'QS>S8V%C>WM^:L/^PO_@,J\UQ_>PGO;&_Q2GO/8@>?`Y'+K0LO MO@\381/PG_-K&SL]$!-CSFE0K1V^)AS)^?;#NZ_B\```#__P,`4$L# M!!0`!@`(````(0#[8J5ME`8``*<;```3````>&PO=&AE;64O=&AE;64Q+GAM M;.Q93V_;-A2_#]AW('1O;2>V&P=UBMBQFZU-&\1NAQYIF9984Z)`TDE]&]KC M@`'#NF&7`;OM,&PKT`*[=)\F6X>M`_H5]DA*LAC+2](&&];5AT0B?WS_W^,C M=?7:@XBA0R(DY7';JUVN>HC$/A_3.&A[=X;]2QL>D@K'8\QX3-K>G$COVM;[ M[UW%FRHD$4&P/I:;N.V%2B6;E8KT81C+RSPA,S*A/D%#3=+;RHCW&+S&2NH!GXF!)DV<%08[GM8T0LYE MEPETB%G;`SYC?C0D#Y2'&)8*)MI>U?R\RM;5"MY,%S&U8FUA7=_\TG7I@O%T MS?`4P2AG6NO76U=VJ^>?__J^5/TZOF3XX?/CA_^=/SHT?'#'RTM9^$NCH/B MPI???O;GUQ^C/YY^\_+Q%^5X6<3_^L,GO_S\>3D0,F@AT8LOG_SV[,F+KS[] M_;O')?!M@4=%^)!&1*);Y`@=\`AT,X9Q)2"M M.69EN`YQC7=70/$H`UZ?W7=D'81BIF@)YQMAY`#W.&<=+DH-<$/S*EAX.(N# MUO5D"53,+2L?VW9`X8NXS'"LY1 MZMAUC_J"2SY1Z!Y%'4Q+33*D(R>0%HMV:01^F9?I#*YV;+-W%W4X*]-ZAQRZ M2$@(S$J$'Q+FF/$ZGBD".S1P1%H$B)Z9B1)?7B?-AOZ'&(KA\1JCX_M\+H>SHX;.1DC56#.M!FC=4W@K,S6 MKZ1$0;?785;30IV96\V(9HJBPRU769O8G,O!Y+EJ,)A;$SH;!/T06+D)QW[- M&LX[F)&QMKOU4>86XX6+=)$,\9BD/M)Z+_NH9IR4Q>Q,O91&\\!)0.YF.+"XF)XO14=MK-=8:'O)QTO8F M<%2&QR@!KTO=3&(6P'V3KX0-^U.3V63YPINM3#$W"6IP^V'MOJ2P4P<2(=4. MEJ$-#3.5A@"+-2[\JIB4OR!5BF'\/U-%[R=P M!;$^UA[PX7988*0SI>UQH4(.52@)J=\7T#B8V@'1`E>\,`U!!7?4YK\@A_J_ MS3E+PZ0UG"35`0V0H+`?J5`0L@]ER43?*<1JZ=YE2;*4D(FH@K@RL6*/R"%A M0UT#FWIO]U`(H6ZJ25H&#.YD_+GO:0:-`MWD%//-J63YWFMSX)_N?&PR@U)N M'38-36;_7,2\/5CLJG:]69[MO45%],2BS:IG60',"EM!*TW[UQ3AG%NMK5A+ M&J\U,N'`B\L:PV#>$"5PD83T']C_J/"9_>"A-]0A/X#:BN#[A28&80-1?F#R`Y+<&ULK%G;CJ,X$'U?:?\!\3XA MY-H=)1D-X2KM2JO57IYI0A(T(41`3W?__98Q97"Y39+5S,/0?3CGV"ZJ3+59 M?WW/S\:/M*RRXK(Q[='8--)+4NRSRW%C_OV7_^7)-*HZONSCK>I: MIO&^$>5G:S(>+ZP\SBXF=UB5]W@4AT.6I&Z1O.;II>8F97J.:YA_=5Q^?[U^28K\"A8OV3FK/QI3T\B3572\%&7\-N8W>Q793Z:U73 MST9U*MZ",MO_EEU2B#8\)_8$7HKB.Z-&>P:!V%+4?O,$_BB-?7J(7\_UG\5; MF&;'4PV/>PXK8@M;[3_UGS-(TDM>J+O)_.&T%<*U M%Y/5^PT0>$LU8(U\=&!-MFO7!];,1%*X3K8R,N6R%<'QL12K29*EP? M&_&Y%<+UKA$MGA--BKEQ'6_79?%F0-W"4Z^N,=L%[!68L=R:0H;RYR*R39=L MD&7,Y!MSV9BP?)!74"$_MO/)T]KZ`5F=M!Q'Y2PF,F6'%);#S->E@$NGR+*_' MX1PH_HXC,W;(P.F["&@E'C)0XB.@E03(0$F(@%82(8/&"!9S?XP8&6JQO_[I M6(Z`PSE#,4(&SMY%0#M[#QDH\1'02@)DH"1$0"N)D$%C!/5U?XP8F>31E)2_ MPSG/LV97&H]LLBWM^/V9*$^7"DAB>E3@$P&M,LH/"=]>R$\UZ@FD$H/7TOVA M860:&C(SAW/@26A+#!GX8%T$M!(/&2CQ$=!*`F2@)$1`*XF00=,'7D'WQXB1 M;Y48YPS%"!DX>QP]9*#$1T`K"9"!DA`!K21"!HT1^[N`O/+M)6L=-1TE M[MI,1U.*5AOG=-5&4F[7WN^GW$Q.?Y=:T!?=;0N?6I!9!+;=<"]X`_7<\.F!4UV/*8*"(E\@VH4'@H*B M4"!:420H2K1@4?UH-2<]][R:;2:D:49JQ6E)76'++]X=WN]5P7PZETDNDG@M M+4=C^=_2^Z(4.I\;;/U=FTEM?=EV/!J3KCM`PI!+B*2[)Q>A0F,K5SYKS._/ M9=[&PR:.J>&PPP-X2CUHIT*N"GDJY*M0H$*A"D42)*^/-=6]]>$YXX/G'3;O MS:67C++C<0[;=WM)0?X0VK5.P,(0NBKDJ9"O0H$*A2H429`<'-9-_X3@\*:\ M'QSEW>G8G$2BLY0K<=>QNN@((4*>RO)5*%"A4(4B"9*CP]KAGQ`=WE7WHZ/L M0`X<&(/#K\2)^?M^9I>4QW MZ?E<&4GQRH[KX?ENUP+&;PES^)C0G.*3.XZ]@#L+5@K*G27<:0X8E3M/^&F" MW(%O%M\FGWJMX(Q5'<-GWS@^P9W):O>9CSM9P8GD)SZ3%1P[JG@X6<'1(N"6 MF"A\PKC&Q_3WN#QFE\HXIP>(V7BTA$VTY!]!^"]U<6V.L5^*&CY>-#^>X&-5 M"N?'XQ&0#T51XR]L`/'Y:_L?````__\#`%!+`P04``8`"````"$`;4?78YX# M``#R#```&````'AL+W=O>QQ M)O./+T4>/'.EA2QC0@=#$O`RE9DH-S'Y_>OQPRT)M&%EQG)9\IB\M);SDT`#J6.R=:8:A:&.MWR@NF!K'@)=]92%BDH?W8JTCUW!U-.N^I#* MH@*+E:U-25"DLR^;4BJVRF'<+W3,TJ-W?=*Q+T2JI)9K,P"[T()VQWP7 MWH7@M)AG`D:`:0\47\?DGLX2.B'A8EXGZ(_@>]TZ#O16[C\ID7T5)8=LPSP9 MMOK)WW@.H5I@%B#J&9/90X6\!L4`M<3I)&] M6#J1F6U,1M/!Y&8XHB`/5ER;1X&6)$AWVLCBKQ51!&Q,HH,)_.\/]]]N,CJ8 MP/_1!/RN$X1V-'6B'IAAB[F2^P"6*?#JBN&BIS,P/)\-&`%J[U$/D/2TX-B:17PVRBHJTB."IPW8&A`8`C]05",()A;)%O:"^VXD1>W MJQ@U"@<$LM`&P74R@B5Z/3/X$.A:XQXW[I;0*L8MQ<15)-<4#B&8M`FODZ$X M)C#Z9D:F;MRE5;3);EQ%TE6?6UM))V8.J70E=R@0U? MF+TW!Q1[;*<*LS5@)0Z;5R9)5W*![>XM;"CVV$ZVELU*'#:O4)*NY&3BE`&% M_:)_XFJU1^'RH&GS15[))&&])_J]8[%;\SD[=7+MA5`/!3M3 MM)G66S>]G49TU-J]+:?M*&VC5'"UX0G/$6OBTXM#7#`8C74IKC M"39-S=?*XC\```#__P,`4$L#!!0`!@`(````(0`B8I;5308``/T:```9```` M>&PO=V]R:W-H965T9#]/6>>SXB1T[A*>//^J] M]YVW7=4UQ>'=;%O#GSI_^2=__'YUU^> MWIKV6[?CO/?`PJ%;^KN^/RZ"H"MWO"ZZ47/D!QC9-&U=]/"SW0;=L>7%>E"J M]T$X'L=!750''RTLVGML-)M-5?)54[[6_-"CD9;OBQ[\[W;5L5/6ZO(>72Z^;`]-6[SL@?'X:%NC?BK]UQG>OVS5O MO[75^FMUX+#:$"<1@9>F^2:@7]9"!,J!H_UYB,"?K;?FF^)UW__5O/W.J^VN MAW!/@9$@MEC_7/&NA!4%,Z-P*BR5S1X<@/]>78G4@!4I?@R?;]6ZWRW]23R: M)N,)`[CWPKO^]I#+,1F4*(\`JS M*R4XJ4119"OE"B.R"SAI8A!$2FP":7D^H10/H63SB(F3*4),&J'M4:80FH82 MG&A,QK9.KB"4!624R>*Z]P(,B6^N\)2ZCQC(-QV%J>U*IA#:?26XJ)(K!/4> MIC&]%\EU.P9":>G#@F@/HXCXF"(F'C(MG$]C0@&'HV%S#XFD!">;Q&*N$)0" M[`E*@26B!MW()*%'61`W4\1$`PO&YH0$CLZ-=9B2W%\I`Y=I*02E%=NTKN>5 M`%,NB>UMBACD\F$V(9YF:E@GE1)<=ETAJ.NP]=X5$:%'640*`0-`8/^\#B'08N2H&57@I`%F\QH M%.2X04-++O/0$(>(:(HDF2(H!=>W.<-6:E7>*=D#J02Q$*O69!01JIE$F%30 M,)187=)I^365K+2"B1PJM_?%H$5CXAQ(L.E**B$;,9I;THQ)!76N4E$0)RJB M39*HW$$%FRL8U8L7T4:0,@1)*E,X^=J%+9,`DXEJVB>[3E`4Q&$BNN7C3+#' MVDS(G"E#D&3"9B.:@9E$F%10!_[K)2)F9!7DBL14A`GV43')+SNV#;89VU>9/U3AJ`3+T;/+1)A1D@U\"M4%,2A(IHG MH7)'LF'+M:F0!I(RU9=/;D4Q::69!H%C,C#GU$A%STTU.^5$)WV<#_9?BT_L M]!G5I*_R4:`3'R4QU1P^"D3C$YXY`-R.SZ!%FDU,FXT$F34JBFFV:9#FHR4G M/K2T:8C#YEVG@/#,*2`F;:[3(P:-'8 MT/(F03.\N&!Q1)(QDP!(&]U@(GKN64F0N29DV7(-<4(E.BW92'>0P_YL;R1: MXT($X.%<\W;+,[[?=U[9O(J[_`0*KI;B>P9P2+UH MH"-L`1?$8)G(5_!FXIP\#1=P$WL&'\($9^2?PA@&XC,C:9C`2")&`CTYO'PX M%EO^1]%NJT/G[?D&"(U'">R<%E]?X(^^.0X7RB]-#Z\=AJ\[>,W$X7I[/`+P MIFEZ]4-,H%]&PO=V]R:W-H965TKA^M5N:@L/K]6 MI?6"&2>T7MJ^X]D6KG-:D/JPM'_^2#]-;8L+5!>HI#5>VF^8VY]7?_ZQ.%/V MS(\8"PL8:KZTCT(T<]?E^1%7B#NTP358]I152,`C.[B\81@5K5-5NH'GQ6Z% M2&TKACE[#P?=[TF.$YJ?*EP+1<)PB03LGQ])PSNV*G\/7878\ZGYE-.J`8H= M*8EX:TEMJ\KG7P\U96A70MRO_@3E'7?[<$=?D9Q13O?"`3I7;?0^YID[+^TO_CR;VNYJT>KSB^`S[]U;_$C/&2/%-U)C$!O2)!.PH_19 M0K\6<@F$H(-L1!"3CFA=O">8Y"`HT3A!) MIIR6L`&X6A61E0&"H-?V]TP*<5S:8>Q$3U[H`]S:82Y2(BEM*S]Q0:M_%&%YNK$$3C"-_"@>WXNKXFIE2I!`JP6C9PM* M#W;.&R0+V9\#/BN:JV.\$`Z4DR1?)TG*!%AR2_+*:!-.%^P*9R2^8]0-, MZ.F8C<+`/JX\<:!#D@XBT6;CZ^[I)VB,XE4PMMDES0X2H&),@4(X22 M>UPL7>S2R8Q]IN]@_0`3&KOX1)DMU#>HG2!(.: M[`LV+)0$P_GI)=>/#!'6"C/I82(]PLTH(AE%;$<1Z2@B&T)H&D$P?8WD"1LO M*NFTM"$1UX,P"8U,KA5F2"N%\(/V1'K.DRYE8I@-I;>:.7!BW3O5S+YCE'RF MS'"]1G#CU_2!/OIQ?:23J8]Q%M8*\W@';>O8=`C9L.`#H`>8=-9'$:C6TR&D M?^CI(#HFRBUU4UNV[\.8PC,%48 MZUM_#C,'K+M7`\R4#3K@[X@=2,VM$N^!$CHR=`&FIE+U(&C3SA([*F":;&^/ M\.4RJZ!_F"Z]^1U7\```#__P,`4$L#!!0`!@`(````(0`(FX<. M$PD``'@I```9````>&PO=V]R:W-H965T%5M)A-J6(2E-^]^/O`_=\:BZ3K>7NOD= MR3ORR#O*UNW'K\?#Z$O9M%5]NAM[-]/QJ#SMZGUU>KX;__4I^;`:C]JN..V+ M0WTJ[\;?RG;\\?[77V[?ZN9S^U*6W0@LG-J[\4O7G3>32;M[*8]%>U.?RQ., M/-7-L>C@S^9YTIZ;LM@+I>-AXD^GB\FQJ$YC:6'37&.C?GJJ=F54[UZ/Y:F3 M1IKR4'2P_O:E.K?:VG%WC;ECT7Q^/7_8U<3U93\#2_>V^`@\P[*.F?+H; M/WB;/%B-)_>W(D!_5^5;:_U_U+[4;VE3[7^K3B5$&_8)=^"QKC^C:+Y'!,H3 MIIV('?BC&>W+I^+UT/U9OV5E]?S2P7;/P2-T;+/_%I7M#B(*9F[\.5K:U0=8 M`/P[.E:8&A"1XNO=.(")JWWW`O];W,R7T\`#\=%CV79)A2;'H]UKV]7'?Z20 MITQ)(S-E!#Z5$2\P1BXHPA1B=OC4BM.K%!=*$3[ULF]6\_ELL5J"K0LS+I4B M?.H9KULJ%(Q8*GPJ1?^ZI:Z5(GSJ&2\J3N0.B0V/BJZXOVWJMQ%4$>Q!>RZP M)KT-&-,[+9WM]_Y[6P][CD8>T,K=&-R'76TA7[_0+Y-A.R6RYC$5O[O:1N;:6,![9ZH3D5"7N1 MWG5&8D821E)&,D9RFY``P/GB!@#/NG=6`%J!&H+DZKWE):"$+H6D%^E#PDC, M2,)(RDC&2&X3$A)PWP[)Y5Q`8>&Y7O%6DF#6%T'(2,1(S$C"2,I(QDAN$^(5 M'.O7>X7"U"M)@C5Z1>S"L6?;Q2/4G]_`,B['#=7H#(J`II5#J[YFR*38:EGG M]N6I4)A.I8OVTJ)+>H?WE&6?[(9N\'FLWNI=I^W M-2P1PCJ0D0$T76(1#YZZZ&RW)2)N2[2>BF9MYOG+F>MR+V%F`FL$/=Q?O'0[%"GIV(4FIE M4*JD)*(KAQUYQ\I1VCDB)/)A4BOK6#^LI."CE_("EIM*"NZG7BI8.DUFC"T- M+`)FU-N9:'31?*JEJ/F@SQ8:&+PDK2W]N0R6-RTI7(7@VK)\=%(V]*24;[KO M2".JZ/2AL9(B^(Y@GV(4[%^`O\6N6]/992"4Q5PJX5(IE\JX5$ZDJ'_8 M0EWOGVKQS,JWONK!8"O["@A63@6$6@J$+2DGD2,M9?K?6".JZ&QPHJ6,8JH1 M532[++(ITU)&,=>(*IHVEH8/FZSKPR=;,I(>"I'>=^6VBM`M8\;,X$2UPF>Z M6N%,I*1($@TJ.MUCPA73JV;,N&(^K&AFI.%S&LH?5!=O''V)L)JMP)CV500F MU%)T2\V:5/AZ6[I2XV%%IS=+M)1)HE0C.J.S89F6,HJY1E31S$C#Y_2E/P@? M[SU]A(4T[?,4"LS72R%'$4A&IZ1,EQ_Y\P,G/;SZF7Q1E28NAOK93F9%:IA9UGF<*71&N@:KXH6 M;Q0#B?2R3/K)XT@-.\LRAP-=%O9(5]\P\$C%MDZBA;FS0R5EH8BCF*.$HY2C MC*.<(.J?TV!A-BP"\1W,.W_=P]\MW+25"`K4/M^<@S]4BE891QS%'"4!1#B[=9VYW8"1TM=&Q%',4<)1RE'&44X0#0?V'%8X+M_@\#H1 MVVZ)8`;M3*BD+!1Q%'.4<)1RE'&$KSF)!!.+D/[)UY;D6RS'LGDNP_)P:$>[ M^A5?28)^[?ZVQ_)]J6TPA1>FQ&,2&YG!B&B2V,@<1L17A&QD`2/B8F8C2Q@1 M2V4C*Q@1#Y;."+S+]>!CA!V^A7>\1/ZYW-_`NQP#\@%,,,`?9IN'P8FWX/F@ MX^#WH-OK#?QH.C"Q!\&%GQN'1L!I^0Z6Q\\E4_;D]XA>._M7#R7 MOQ?-QN_I4 M11UN__'[YO7BM]5NO]Z^W8V"RZO1Q>IMN7U'A>O MV[?5W>B/U7[TC_N__^WVYW;W??^R6ATNR,/;_F[TZ\K3=;18'^G/W/-Z_[U:+Q\YH\SH.KZZNQYO%^FVD/_:V69[B;K/8??_Q_LMRNWDG%]_6K^O#'YW3 MT<5F.2^?W[:[Q;=7ZO?OP62Q9-_='^!^LU[NMOOMT^&2W(UU0['/7\9?QN3I M_O9Q33U08;_8K9[N1E^#>3N]&HWO;[L`_6>]^KEW_G^Q?]G^S'?KQV;]MJ)H MTSBI$?BVW7Y7TO)1(3(>@W76C<`_=Q>/JZ?%C]?#O[8_B]7Z^>5`PSVE'JF. MS1__2%;[)464W%R&4^5IN7VE!M"_%YNUFAH4D<7OW>O/]>/AY6X441N^K?:' M;*U:_^F)@7&CCT!C3*QM?7TYOKJ*`[G6JD\@XH5?C))A=!I.K M:^7CR,TGQHY>C5T8G&)'7KL>TRO?[^8RG$V#Z6=WO#:6]&HLKT\SO#&&]'I6 M4VF1=DVE5V,7!3:^1V+SQ1C2ZYE]#&CT]8104U$/^FEQ#?JI1/\YK[D!3R3U M'V-Z8F@#GC[J/Z>T=ZP70+>>DL5A<7^[V_Z\H$V*6KU_7Z@M+Y@K9[R2=)C[ MM?71TJ(UI;Q\56[N1C32M'KVM!_\=A\%U[?CWV@-+XWF`36!5,2L4`M6N4U\ MD/H@\T'N@\('I0\J']0^:'S0.F!,D>S#22/Y5X13N5'AY$`\,+#Q#;W8L8)- M$A^D/LA\D/N@\$'I@\H'M0\:'[0.$+&CV?=7Q$ZYH?U<3,4;&:P'K5&KOI^O M4RF)>TD?4"`ID`Q(#J0`4@*I@-1`&B"M2T1HZ;3X*T*KW-!&09._#QLNTL<62`HD`Y(#*8"40"H@-9`&2.L2$5LZ445LAW,0WBB5N@LA=_U!DVC2 M+_882`(D!9(!R8$40$H@%9`:2`.D=8D(#Z4-9X1'J65X#"'_SIR;]8M5W(O. MGS/NI=3R7H9P.PK@7 M\;1)@*1`,B`YD`)(":0"4@-I@+0N$=&D_$Q$\_B*46H9,4TH8AR,&$@")`62 M`7`3)(SJGPRIM35L5Q3!"EB#)$.:(" M48FH0E0C:A"U`LGXJ>3,7:W'YY(,D0YHL(@ M9P,MK[=NY'V&E&A MKQI1@Z@52$9:I6C_?Z25%^^TT>C&KO98/8LCU73:/0H(KP*O?XD5V"!KFS#J MMY;,JM03!7+C3*VIK(#=U`8YK6FL:K@UK160&QG[ M\[+@`--@@VA+=:?-1"[0V*@FMO,)HM3ZXNYFJ,H1%6A8HJI"5*-A@ZI6(!F_ M\S+[`%-[1I24VC0[](M^HYI\Z2=/@BBUOFS\]!T=PQP-"S0L454AJM&P054K MD(R?RL7=M3^PFU(QTV^G.G47I[Q&W;;Y57=1'.8B\Q#-A ME2AY0N\93=(QHEO?3.XJ\5"TV*J=5^Q M2KKW#T)TW[#A4? MT%-&=DO,&%G#'%'!R!J6C*QAA:AF9`T;1M:P%4C&C_;E<^*GY%[\#!*)!%0C MH58YDRU!E"+*$.6("H.U4$U0C[LG,F8W34?3R*]&C(KV$SZ\$D9R??C5"*OL\LL8 M65\Y(^G+KT9897V5C*ROBI'TY5*-F-83&`NMU\361"2.,A:E%[1:3L:%]ZI29@:%:66O,@R-K2^BK9$/KJV(D?$UMH=&UOD9?#1M: M7RTCZ!%%JD+/M9:C*$14&N>"DGL;CD;R<)["AJ-5GR3[D5')LPSV(*-R]Z!3W.9Q@F6%02(Z6C6=?/1)/+:Q,RDUR-IX-6#&MW;#],E]"KQ/ M>>0^,EXJ]W9GTR?+1&1ZS2IY<]J&%64&]+Y[BZ;"A]Z@A M8Y7=V'-&\H[>-"M890U+1M+0=DB&U<^Z_UQ8,1F?&$0)I'/4>T\D8J.:T(805#//A.T)8P;`<-OPHK"IO/C9;3WLL0A]2A66JD9N*&I6# M$D0IH@Q1CJA`5"*J$-6(&D2M0')NGI>WT^,7")9)TNWJB(U*Y$N@2E&5(

7!X!!5'3R*HL1)8A21!FB'%&!J$14 M(:H1-8C4KVNH":$[I(.E?RU#?[M_L]H]K^+5Z^O^8KG]H7X)@YY,W]_V6/], MQ\-D-E=SE&("5[[0E>Z-!__*](I_V\._$M"O?NC*TK\27<_5TY&!^T0W=*4; M%;"AME'=.V1#;:,B;^#*A-I&-0I>H1\D^1H.\`?5Y"$>SNE[ZNCG(:);#_"O MD_E7&I(!@PFU:(A/*8I#G'H]V&GJ\V"7`^JR?E[F!9"^A#%7W[/`-M'W*N;J MJQ-XA;XJ,5??AL`K].T'NL_0%4K`YRDENVA#N?-"6F*^K;3$-7)G1ER(:^ZC0O!J_0-YZH/T/>RH"&3-N,^Y#2C\>\+YY7 M[6+WO'[;7[RNGFA)777O!.STS\_H/P[F'8%OVP/]?`SM0?2+&O0S02OZ5MR5 M>LSPM-T>^`_JR+C_X:'[_P$``/__`P!02P,$%``&``@````A`-(-NC*V"@`` MLC8``!@```!X;"]W;W)K%KOZD-U M/_Q5G89_/OSS'W?O]?';Z;6JS@.R<#C=#U_/Y[?E:'3:O%;[]>FJ?JL.)'FN MC_OUF;X>7T:GMV.U?FH*[7>CR7@\'^W7V\.PM;`\?L9&_?R\W51VO?F^KP[G MULBQVJW/Y/_I=?MV$M;VF\^8VZ^/W[Z__;&I]V]DXNMVMSW_:HP.!_O-,G@Y MU,?UUQW5^Z8+F-]O-\?Z5#^?K\C[IRW5@#7[ MX%@]WP^_6,MR06FWB4!^'#Q5S^OONW-9O_O5]N7U3.&^IAJQBBV??MG5:4,M2F:N M)M?,TJ;>D0/T=[#?LJY!+;+^V?Q_WSZ=7^^'D\G5]6(\M4A]\+4ZG=TM,SD< M;+Z?SO7^OZV2Q4VU1B;<"/WG1J9S:>2#@E->D/[S@O30#_1GPEOYI,GUE34; MSYFW'Q2TQ)/8AT\]RNJ>->]*?/)9"^$E??C,F!D6(]&ZCP(H03,"(C1$ M$=L$C@E<$W@F\$T0F"`T062"V`2)"5(39";(35"8H%2`%A":%'Y'0)B9^R'] M50;-0H_`8ZMCT43?*5WK*JM.I8L2$`>("\0#X@,)@(1`(B`QD`1("B0#D@,I M@)0JT8)&$_3O"!HS0Y,EC=4N(#C5<:6/HM:I=%$#X@!Q@7A`?"`!D!!(!"0& MD@!)@61`YVR9ZHS:/%D:S@BB,M%JV6@AS46("D2EAO18L&VI&HOVG'VU8,O8ZW;S[;&FA8!&0\\*-:7S-#]E M\\VM&B*.U!"UZ%K;HL[&^N)BL\PW2$N%V$+F(/$0^H@!1B"A"%'.D!#*1 M6LIJ.3.2!ZG4$A7*$.6("D2EAO1`LIWJ_Q](OM^5C?_($DAL*E0#V:+KZS:A M,K8F9@P[!5%EAYNA,@*Y',TE\A#YLF"3O1E;4_UA@500ED-$$:*8(Z5FB=3B M#S-JEDH%\;`,4<[17*X5A=3JKT8I%!$(+6$^5#84OV:C(T,4B2U1,&8 M(VH;@1*!/FR)5-I26\*8B3.I)GJ=&RD,3.I)9Z8XQ,+CCY^ M8BFTU,:9CN4+";W7L%/^!?,^4S?.CRW2YIJI.1!7U'"L("TAHH(V1\;,8LQ2 MCM02!5V.%G+E\Q#Y`C7O!)OY)T`40A M\A$%B$)$$:(848(H190ARA$5B$H-:;&8F&D;=B2B5Z:T`EWX\K&QI(](CF@. M53N=7#;:R$DMT>EL1`XB%Y&'R$<4(`H118AB1`FB%%&&*$=4("HUI$>.EHX+ M1M&$J1OA:9&RQ*VXEH)L1`XB%Y&'R$<4(`H118AB1`FB%%&&*$=4("HUI,>" M)3G4&>U_'T4\7:*<26FOSB)GC")C"[.26G(4=04%0A\A$%B$)$$:(8 M48(H190ARA$5B$H-Z9%C"1@U(R=W(H7U`965U"&!Y"+ M!3U$/J(`48@H0A0C2A"EB#)$.:("4:DA/3PLMW)!>-I4C+I58-M!'#W&MG1A\A'%"`*$46(8D0)HA11ABA'5"`J-:2'AV4F+@@/4S?6(([D MYGA%6_-&2R(;D8/(1>0A\A$%B$)$$:(848(H190ARA$5B$H-Z;%@^9$+8L'4 MC5AP)!M^-0%D(W(0N8@\1#ZB`%&(*$(4(TH0I8@R1#FB`E&I(3T6EZ5`)I@" M$4B-!=>2R$8M!Y&+R$/D(PH0A8@B1#&B!%&**$.4(RH0E1K28\$.PQ>,B_;L MK"TA+5)?3$\`V8@<1"XB#Y&/*$`4(HH0Q8@21"FB#%&.J$!4:DB/!3N17Q"+ M]@"OQ8*?Z65"?D4WM9L57B(;D8/(1>0A\A$%B$)$$:(848(H190ARA$5B-@U M=MDX;2S::^GM_>-]=7RI5M5N=QILZN_LROGU@MZM=+B]#_\XF=.%^.8M`D@6 M)&E:'B0W)&G2\""Y)4F3C0?)F"3-_`82=B6_V76#9$*2YL4.2*8D:7)S()F1 MI,F"@^2:)$UBRY#0;P*^]#Z%'.OWBPRQ'*-AYY&7'ERPACA+*B2]9QALEE/1> MLI0V2B@YO62I9Y10B-('G0)Z&W@.1!GX3>Z9$'?1+;FI,'?<./WFV1!WT2>I]% M'O1)Z(45>=`GH1=+Y$&?9&5-J4Q?MZ5K`=1W^B0K:T9>]_5<>A=.7O=)Z/TW M/:=/0B^KR;<^";UL)@_Z)"O+6MKMXF$,0KJFM&3WDK"_T=6D);N+A!*ZCK1D M]X]00I>+ENPV$4KHH@YYT#<-T.4<\J!/0A=RR(,^"5W"(0_Z)'2EACQH)*.N MJO2+H;?U2Y6LCR_;PVFPJYYI>A\WEUV.[6^.VB_G^HW.`?2[H?I,OQ5J/K[2 M;\,J^NG'F.6!G^OZ++Y0%4?=K\T>_@(``/__`P!02P,$%``&``@````A`"EN M0IH4&0``V8P``!@```!X;"]W;W)K1TF,B:W`]DS.?/O#ZBHVB_RW)'#Y?S=[/+B_W#[>'SW/IP M^>WY^.MU_OTIF ML_75_7%_>UU_?7A\'CSVW>Z[W_-ES>W MK'OX!ZB_O[M]/#P=OCR_(W57?J!XS[NKW15I^OC^\QW=@3/[Q>/^RX?+7^?7 M_7RVO;SZ^'ZPT/_>[7\^1?]_\?3M\+-\O/O"WPZ'WYUH_=DA MZGP%O8O!!?_U>/%Y_^7FC^_/_WWX6>WOOGY[)G^OZ);OM,`Z+\7]W=N;I!);OXU_/UY]_GYVX?+9/MN,Y_M%AO2\MO^Z;FX M'H^W/^?%YH'55Y)$I0L:/2^?;%^M]K,%G.ZYFN5+(,2^AN4S&?O MMJO56H=[H'^OOWRZZ"$_@8EFW?+9+79#O=PY.J;T)'^GCEN6H3# MN.GOV\>]"TKH;U"R>YW5YC37O.O=I`MN78C;CMSR?)PU]#_<=2;3YEA7GBMS M^I_0-7F7;%?SU=I-EF-=:7KY`1`"B`ED`I(#:0!T@+I@/0Q4::EK>3O M,*U30X&")O]H-ESF0>B8;4>1T;9`W&Q9X"R8#D0`H@)9`*2`VD`=("Z8#T,5'FH33B#/,X M:6T>3Q:#>91BVFS.4.RDM>)`:.#19):HJJ[EJH1XESSN8R>MKQ7(D',YE0'(@!9`22`6D!M(`:8%T0/J8*(NYH'V&R09Q M;3-&"UEQC(;Z1%_.[?2QZWV"],YEXL_?[FY__W2@Z4-"$U-B08E02(]\OD"1 MDUWPR451Y\SADH-4&M`R#IWSU7+TIAZ8VT;C@4T,@/+(<01^UU4C\"BAR!:M M`+L/NO24QKFDX492ZQ<&Y7:@,P85-JS8+`'1BHDNMQDO%RSEI98TMDAJ.TII M2[G0?<:@0J2/!^61L=1NO%P85)!:#_GO+ZOU2YYSL?*,\3AQ,X,#4D9:FWP[ M==6O\USBQS.?RX"U?Q>'$QV<53D+(7H\Q+IT#RA#EB`I$):(*48VH0=0BZA#U"JD5D]@] MR#E\L74'2U/[0&2WH:=V)F-!ZM MA\,V']>"5(0R1#FB`E&)J$)4(VH0M8@Z1+U"VEAN9XN-Y;RX7@Q;^PF[^3TQ MGOU)V":#%R6J!1N.S;$77]BPDO-VT4'<>-'OCVO9P](@%:$,48ZH0%0BJA#5 MB!I$+:(.4:^0]N)YN[N+I7;*>[30^Y)LEL&#HQ2G<%G011T9Y8@*1"6B"E&- MJ$'4(NH0]0II^[DL(5X%)Z9^2#UD9GUR48],NDY&,Z2(,D0YH@)1B:A"5"-J M$+6(.D2]0MI8YZ5*":9*`2W](PAWR)D&1"[B:90ARA$5B$I$%:(:48.H54B; M82HY2PB^OB)RTG8=>K2(ZK(@I2NBC4ET,Y:*UZ'7M:+=3'+-CJJ&*FR;&,B?,U2,HA&U,>#,*EF*U(T"&UFFU>>6)J80+K\E:SL5G]D!DEC M0VCS4KK$VY@T,Q-=;*P\H"7U%_4+XYZ"I;0O)#\=!E&R>ED8U71'27V&CC5V M;+CCT7&U+*7']=*>;//F$[[`_#@)2`UJ`]N,E]*5[=:8-!-=XHO0D?X<\\6D M>K,NRJ!^*6>2%:(:48.H54A-[X7-HH^;=!#7:4Y`>GIOSM6>`E2T4S&U&-J$'4*J2MZ1+W>!]_4Q'JBD@3EAFI M>;LU-DR#%*TI]_#O%QL>,]$RSMB`:)8=M;$?D5D0)CB5HHO55XAJ1`VB5B%M MXZF*8;XZ\S!P@=5#0&8BFQ"9!BDW/IF46Q,/,]'%IL@9G9C-?EQNVX_42SST M<5ITL?J*D>YH(EO-4K(,&D'1%>W^T;*44K^3D*A=9&LGMPS<%CND)J\[W*`, M!!9!0&H1[$S<3$/'E9:Q>3G[S@$XM!3\(O11V$&Z"5!2\63TY6#R[ M,TNX9BGIV`B*.J*#)LBX6I:*U=-'T<9#)>T+TG6.+YRX MV8$]BDK@U#V,(JD(98AR1`6B$E&%J$;4(&H1=8AZA;2QR*3*6*\^+G(G"]9N M'JWX;'[TC\_(0P\Z$Y1UE\PDW.B!N5KGC!7E2R.UHCR*7)8N`&6(H6TL2B"*V,-^\/J'4W:,S_RM'":S&KPR'EOC+/)S,3_-'2, MK)TARA$5B$I$%:(:48.H1=0AZA72IG6UQ1GST),[B##+,R&<7&"E*",I3*$16(2D05HAI1@ZA%U"'J%=+& MLD7*"6-A->(23+V#IX@R1#FB`E&)J$)4(VH0M8@Z1+U"VE@N=7U]S%KZ3#>. M60%%T3Q%E"'*$16(2D05HAI1@ZA%U"'J%=+&H5TL8ZKP188@G`*'KXPDC.*3)$.:("48FH4DC?C$W'W1,)E M`#+T%%&&*$=4("H150KIN[%IL3J1>M7'!]VYD$UH/*(#&IG<'KDT*JH^S"E/ M%G317.*..:.XX]R>X!8L)1W+@-13MF0F!S]#,5N)%%U1F<8=E)T1$`=QG00' MI,Z"DID]"PI2+F>*+&//@D37:)GICN:4I^".:A^,5Y_;@K&(I/2XY M"]+&_9(3Y"YG*3X\Y;0D8Z^AZ<7,/DS%I"])&(83I/@93F*LE(D6=G`>D/*YOWR$2NQ8 MJ8[:"#;+?)L1,/E<>62F@CV="5+J(4LR-REJ)KK$%$&].OR9F_!;<$>9-:4@ M67`3L6)2O<1:;4.7`<:QPMKP=0]"5CZ1C#/0@.)R!U&&*$=4("H158AJ1`VB M%E&'J%=(&]%FH,Z(&_I2,%GE>$:RPF0T("JN?(0Q![[<3$Z.@J[L8WI@YV5[ M*\SV`E)>]%(1RE`J1U0@*A%5B&I$#:(648>H5T@;RZ6"=BF$S^J>>>*[(658^JRUGK3'X\T@ MKB=F0&9B2FKI\QZ1&NV'*$=4("H158AJ1`VB%E&'J%=(V^^\7)D^%&T7=D#: M?HG)@E.1$OMY7=%:SU&J0%0BJA#5B!I$+:(.4:^0MM]Y>3=]]!?LYU%\^!*D M(I0ARA$5B$I$%:(:48.H1=0AZA72QK)9^XG%BNGY.J"HF&`L]<8,^4XVSQG5`.E%*-QH*:JF`I M;5+)N@?U):JON.-1]35+:?62'&J3VJ3>EFROFX.8ZZ\#BL>:)#:3"E+N,]&C MP9+$Y`N9Z!)+>_7ND&_L.&'I($6[PBB5V/.P$M57/"YY%TK-2`UU(8<5VJPD MI6+7V\SJM)@$RR,]@1=F.:9K+Z5/$Q9FH65!BG2)68/Z./^=,&N0HL44F=6L MHA+55SPN=>1K_5&SE)K`"UE^VM)3Q4!\>/6Z,X@8^3I#E",J$)6(*D0UH@91BZA# MU"ND[7=>1KW!C#J@J+!($66(H6TL6Q&[59!\I8/ MZ6TPV0Y(5W8+NQ^*%,><#%&.J$!4(JH0U8@:1"VB#E&OD#;M>;G\!G/Y@/3) MS,)D"JE(B?V\+NK(*$>I`E&)J$)4(VH0M8@Z1+U"VGZV5#@1![$F<,?'[F1+ M-OL4488H1U0@*A%5B&I$#:(648>H5T@;Z[PR88-E0D#TM(CG3!I05,YDB')$ M!:(24150]-&!&J4:1"VB#E&OD#:62Y'C*OM-F>HF9/N2*WUB%!7?`>E:3) M&,7U9[(TLRYG*=G+"D0E(ZW+5*D52XFN&E'#2.N2DG0(&BU+B:X.4<](ZY)Q M:5^<5P!ML0!B1&M0"J"EU%N^`!(I\877I3^1LS254XX="T1E0$:7R7XK[%@C M:J9UF4RPQ8X=HGY25_0*8>V+\XJI+193`>EUL3)[3RI2X@NO2WU)-EF9!95C MQP)1R4B=WEA=%4O)7*X1-8R.ZFI92G1UB'I&+^G2OK"UVHD8A079-B"U+E8F MU*0B);[P'?5(6T_6X>>F&Q8<&X]BD\X$&6(H6TL5Q!%9>2)XSEZZ^X9MP&)`5!RD@*]@Q1CJA`5"*J$-6(&D0MH@Y1KY`V MEJW]WG3"L<62,*#X,7M`YG#!GG"(%*_A'%&!J$14!117B2(59_QF#VE$B@?1 M(NH0]0HI2^]LX?@F2P]:=&@,*+9T0"^>*60BP/>7!Q2=*10B-7VF4(H`JZD" MBK[+4HO4]'E+(P*LI@TH&DTG4M.CZ46`U&C;GU. M!4J5B"KL6*-4@ZC%CAU*]0II8YU7R>VPD@M(9ZS1J[=]5_8HE:Q-$9"SE#S'*`1)1U!?LI16;^J"BJ4DI:P9'1U]PU):O90*_FB$I63T MG:`CH^]92JN7TD#[U5:%;PM`6"SNIHK%M2DJTB!%[WWB19XQ4E6F?95D'J2B M+Z\4W%%TE8RT+A/7JR`5;PC<470UC+0N*02"UT*I*U^DZKBCZ.H9:5V2N&H7 MV6+Q;2["&G+GD5Z1&SE6"RO22[D7VHUK#99,%G3IS\_85U/F?$69TP5W/*J^ M9"F*P>,@D@VLR/&&>#;5W/&H^H:EM'I8D4&]C+[CCD?5]RREU;^T(EVY%V>J MUMVO^WC.SE>-<08;4%Q;(LH0Y8@*1"6B"E&-J$'4(NH0]0KI-4/!3QGQ>+J_ M<^(F@?)(UY;P'I8ARA$5 MB$I$54!JSX,K-MBQ1=0AZA72QOI;:LL=UI:,XF3<2YVH+4-'DN)=(T=4("H1 M50$ILTX.PN0@#>IJ$76(>H64I>S5Z/DZLLC8S%ZN+R.) MT=+,HH*I8"::)#,:9\YIG[@O;H/OM# M`N3D("7%&*T8S_0C1?O2!?(H="6/`B/W3:HSAQ/D/NA*[@-&OII49TH?\A5T M)5\!(\=,JI-2QSC&E3SG!"Y?(L55QWPV5F618\Q<(\=`<46."2QV:;*5NFG8 M#,@QT)4<`XP<,ZG.'$F08Z`K.088.69*7?2Z:W\@,(I%5>,$(\=,JI-5;QQS MJDI\Y=Z.5>)\YIE>2+)R_:G`*"7;`OG+]]3?3;*OU29_A0O(&B1_!2;JR%^3 MZLQ(R%^@COP%ZLA?D^K,<0 MJ=TM@6.<^3#UUR!W!K$]!5,0".WAMN2 M*Y!;7W,%\O3D%23&\?;:MHZ_W5'.O,9EMG,XCI[ M@M':]'TC.5J(P,B)P,ACP,@]P,@]P,@7P&B)`2/#`R,KQ\R8U!6KYVQ,OKC5 M&Y-G]`YJGL.T#0$CTP$CTP$CTP$CTP$CTP$CTP$CTP$CTP$CTP$CT\7,F^[J MZ=M^_YS=/-]\?'^_?_RZ3_??OS]=W![^>*"53E\AC/#%X_[+A\M/Y('KP0UD MH+'+V+9U;4/`MFV;Y-I]:VBBUV9!+4/)`7V6U#(\2X&6%;4,8<"V;*F%/F`R M<9WMFEJ&+V7;/JO=M7NAQT2?]>S:O:IBJF5.+"6TK MT$+7H3>43UQG07:CUW%/M"S)/_1U M_(D6=Z-3G%1-:II3`_UJZ(2FA'SCZWX[XH1FKB]XH86\1KLO:J-P,KNF^#$U M9@H7LVN*#U-M%`YFU[3^I]IHN9,9IMM^G5__.CD7Z:8FYQM-WDEYNM6I-?KK M\OK7%U:\F[A3%MB1`>@1/-J&/D=P[3XJ@"WTT8!K]_0?6^AI/SETJB7=[4C; ME$=K:G&'9*CMTXZF#3U"F&JA-46'XU,M-*/I)!A;Z`LDU^X[(MA"WPFY=E_[ MP)::6MPW.;"%OKE!,6*J)=W2G=('2K!/32WNHR;8\FE+HZ;/1F%+GFRNW:_K M80O]*-ZU^\D[;*&WB5Z[=X5B"[WZXMJ]V`);Z$46U^XU%=B2;C9DG:GKU-3B MOAR$?3XM:4+3NR:F6FA*4R$_U4*3FM[J1BU7XP)^^OC^Q\W7?7_S^/7NX>GB M^_X+[82SX<5QCW=?79;F__$\N_+BV_[F\][^E7(F?M%BB^' MPS/_PUW@Y^'Q]V&W_?AO`0```/__`P!02P,$%``&``@````A`)F-3A^5!P`` MTR```!@```!X;"]W;W)K%;Z4XZG?;NGE,()2H0E*3;W?_^9F([]GC2%%;WLBR?C"G]Y^_'P^A;7M5%>5IY_GCJC?+3IMP6I^>5]_?7]-.M-ZJ;[+3-#N4I M7WD_\MK[_/#K+_=O9?52[_.\&8&'4[WR]DUS7DXF]6:?'[-Z7)[S$US9E=4Q M:^!K]3RISU6>;=M!Q\,DF$X7DV-6G#SI85E=XJ/<[8I-'I>;UV-^:J23*C]D M#<1?[XMSK;T=-Y>X.V;5R^OYTZ8\GL'%4W$HFA^M4V]TW"R_/)_**GLZ0-[? M_5FVT;[;+\S]L=A495WNFC&XF\A`>'JXWQ:0`4[[J,IW*^_17XHP M\"8/]^T$_5/D;[7U_U&]+]]$56Q_+TXYS#;4"2OP5)8O:/IEBP@&3]CHM*W` MG]5HF^^RUT/S5_GV6UX\[QLH]QPRPL26VQ]Q7F]@1L'-.)BCITUY@`#@W]&Q MP*4!,Y)]7WD!W+C8-ON5%R[&\YMIZ(/YZ"FOF[1`E]YH\UHWY?%?:>0K5])) MJ)S`IW(R'_NSZ0)=#`R;J6'PJ88%TTO&@= M>\6#JJ&31_2R\F`\U*6&%??MP0]F]Y-OL$HVRF;=8T,M(FV!2P+=QBY(7)"Z M0%A@`BEV><)B^A_R1"^8IXYPK8%)/'"2TA9Z2.R"Q`6I"X0%2%*PN-VD0MBN M_1M-UPH'P98BM9K3H-?2Q@=?74$=DZ@SZ1)C)&$D9438A"0'6]!-#KO(E2L3 MO<#:AF719<*7IC(:2K.PVCLBL!(JT:+;DF2FT*/L6\Z?"LT MIK=2I#UVB%\4'TX?7,PPF2O7&_JAMY0DI-G==-FUG2[JC'1!8T821E)&A$U( M?GR2#(?<6M.8%8*@[75UZ\R\ ML>JFGJ.$HY0C01!-!L\E:WU]D(P\Q:!KZ9C6V,&P)F&'(HUN.Q1SE'"4R$)`)5C=IGY@)0K[QDQHK MZ6<^B!+:*10T6NB!RMG9TN40`WM4Z0.W>G*ROX,%;AE%K%J#'`?4"Z M1NA3JT1;F?,VU6C0O=!6U+T1C71B\&2T2OIS*QB=./.E$)P6UDR$-,?(EU:! MD;NQ1G2@L]839446MO)UU_4%T>_+R$PZ$\ZY_W,SP?6`+Q%=.:'1'FH;2"O4 MUM9\L96CK*"E6%;.!D[,'76'3!4:=B^T%75OCC,Z7R@$!E;.U_+\7N^SFX24 M$Z2;2V0K`:ASV]J,.(@Y2CA*.1($T8Q0*#@9!0M\@G"M1/.EY"!9=2K$+AUK M()V5+EVL?%G3D7"4HP(XYBCA*.4HX$031R MU"A6B3Z('*V=R"6B6GGF[+,HZ*QT?C%'"4+7@4+F\(XT,D=\S%'"4:3;1T7K`,*$!6-.^9FC#R-M!>4S5DQK:BM(P%C- MC!B4\EI;65I3HT'W0EM1]T;FT9)^H!@N^K44<,&@$5RQ\RK=EZH7)` M(ZM)Z!HU!H-F+$4L3'@ M#7+I&3-?PA/S'GZ[A(>S/?QN"8]`>[@/4<'SQ+XKX$J>?VY4/CB#'Q9\3.2' M2WP$Q:_`(R<8TW<%A,8R!@G0,P:NB-XK\&KYL7=68")[YQ&+TG.'-035%]/C M;/G8/^VS);Q:@5`GW9S`*^5S]IS_D57/Q:D>'?(=+*=IV\8K^5):?FG43^&G MLH&7R="!X"TH_/%`#B\@I_@"8%>6C?Z"-^C^'.'A/P```/__`P!02P,$%``& M``@````A`/R;4;*W`P``3PT``!@```!X;"]W;W)K0EBAN+AHI/91G$9U.%U'.1!&Z"&LU)H;<[T7"GV5RRGEA7!#%,V8@ M?WT4I:ZCY-02,5>,^#]068LJ6/; MAU[X7"1*:KDW$P@7N43[G%?1*H)(NTTJ@`&6/5!\OPT?R?J)SL)HM[$%^E?P MLVY]#_11GG]5(OU=%!RJ#?>$-_`JY1NZ_DC1!(>CWND7>P-_JB#E>W;*S%_R M_!L7AZ.!ZYX#(R2V3C^?N4Z@HA!F0N<8*9$9)`"?02ZP-:`B[&,;4@`6J3EN MPW@QF2^G,0'WX)5K\R(P9!@D)VUD_I]S(C8I%\NF]LP,VVV4/`=PW^"M2X;= M0]80N,[)16BRO)8D9(=!'C'*-ER&`>!KJ.S[CI!X$[U#-9+*Y\GYP.?%I_&( M()LF)4BCG=)P>6ID=$9D+!>F\N0,;1@Z#!/[,,@\ACO]&@X/@5^;!)DU\5T& MSF?6\IDW'AY1K):UQ8)TU,*.<4S'D*J4PNJCFUP;S,*TN^[A"JF.@-P@Y50! MN#5#1"K3`*F.,M@QFL63Y3W;I73IAO3MH5W4"MM4[.MMZ=T)7VK"ZZ*I; M7]V.F'-UX+_P+--!(D^XFE)8[AIKLS8_4CS?M<_6CVZ=CII?8)TMV8'_P=1! M%#K(^!YB3JVN*;<0NPH'0(Z:OT*[ M_P$``/__`P!02P,$%``&``@````A`&'FWW2I`P``^`L``!D```!X;"]W;W)K M&ULG%;;CILP$'VOU']`O"]@;ME$2:H-JVTKM5)5 M]?+L@).@!8QL9[/[]QTS0,#L)=V7$)@SQVONZMKVY**5ADM>,56]A.3]J?UQP_+$Q?W\L"8LH"ADBO[H%2] M<%V9'EA)I<-K5H%EQT5)%;R*O2MKP6C6.)6%ZWM>[)8TKVQD6(A+./ANEZ?L MEJ?'DE4*200KJ`+]\I#7LF,KTTOH2BKNC_55RLL:*+9YD:NGAM2VRG3Q=5]Q M0;<%Q/U(0IIVW,W+A+[,4\$EWRD'Z%P4.HUY[LY=8%HOLQPBT&FW!-NM[!NR M2$A@N^MEDZ`_.3O)P7]+'OCIL\BS;WG%(-M0)UV!+>?W&OHUTY_`V9UXWS45 M^"&LC.WHL5`_^>D+R_<'!>6.("(=V")[NF4RA8P"C>-'FBGE!0B`7ZO,=6M` M1NAC\SSEF3JL["!VHID7$(!;6R;57:XI;2L]2L7+OP@B+162^"T)/#L2XLR( M-P]F0/**8]`ZPK-U]&.'A%ZL%Y_ZN2B^R<4M572]%/QD08.!/%E3W:YD`5Q= M$I"A3\M+68%T:)(;S=)P0<`22OFP#H/9TGV`]*E0\:TE1(9GI/O5%![3<6&0;7_1)-XVT0$S8BKXEA3=`ZU!@&YR88B8S? M*5+[C462Z+P$BD0,BKR*XG.:&G."YJ'*ES()K?JN3&H_0V3L&9E$3"N2$".& M!,V7B-3WHWFB7%)N[6>*-+<)8E"D;Q@3-%XB$3#ODJC]3(F!D4?$H,29N6G0 M"+_]OGNIU`0..%/CV_NZ\3(5FAN[!>'.#GUB=$+2VB]2:5P?KQ^$I+TFFGL9 MM\;T4S+Z--JC1!_'1FN%L,?_][+"4WUX^@VJT.I"C-;2ERH,)YGJ4>:I#(/+ M1&H,)?U?J7CJ#Z6&H='WFV8MN.K&6LW6.Z-ZK3@:X3A0,K%G"2L*::7\J,>> M"`[5_BN.9!L]DNGYQ?SN+^"JG'Z_(=KA60\"+E#/J0^$T\U];K\,S%TUW;/O M5.SS2EH%VX%`S]$SDL#)#5\4KYL[?\L53%S-WP-,V`QF%,\!\(YSU;WH-/0S M^_H?````__\#`%!+`P04``8`"````"$`Q1B6E@@$``#X#@``&0```'AL+W=O MW7]SSSWIA47!0[ MG\Q"WV-%(E)>G';^]W^?OSSXGM)QD<:9*-C._V#*_[K_]9?M5X!0 MJ)U_UKK.7#'B_DWF1VL`T#:;U,.#+#L MGF3'G7\@FT>Z\H/]UA3H!V=7U?GOJ;.X_BYY^B!'B%5V_I6B" MQ<%@];/IP-_22]DQOF3Z'W']@_'364.[%\`(B6W2CR>F$J@HP,SH`I$2D4$" M\.OE'$<#*A*_[WP*@7FJSSL_6LX6JS`BX.Z],*6?.4+Z7G)16N3_62=BDK)8 M)K6G6,?[K117#_H-WJJ,<7K(!H#KG"Q"D^7/DH3L$.2`*#M_Y7L07T%EW_;1 M>KT-WJ`:2>7S:'W@M_$AC4<`V30I01K=E,;+4T=&9XR,Y<)4'JVA&X:.AXG< M,,@\@I[>#H>+P*]+@LP;?)N!]9EW?!:-AT,47*8316=H4I?8/`P;8!O:.DT( M#0/3#6W(KPC.W2<%P(4FC:;@E:7;?$*636(.XZ4;]G:MT=D-55E,MQU<"-ZE M=!QUJ9]QVR#I-Z-#:#8T=HLOUA`[A0I=> M97$[M!KO$($M,)VR\7:#U::'03%Q=KO09N@B.H&26=D+@V!@@GJV>D(>?D+J M+DDAE808X;1=JTTCI'HRV'&M(*V6\,E=9=6T*%6U*;A*47OT@KC MW2-2R<=0*^A=6F&\#717*Z)&/*U65%X3SBK\;)@^W<:[1ZS1!]!%MQT],3`[ M-EQ..#1HI0(=K:U-SDE(6]YNY)Y6W%9VN#CTC]W:U.F6O1O8#_"_^!7PY-];F3G*@>%CT[?/-P0Q8W_ZP.<"),K*`P`H8J9$W%-_8:6W0 MX-Y1QB?V5RQ/O%!>QHZ07VC$7]J;BWW0HH1.PNU#:+AQF+]GN&$R^!(/456/ M0NCZ`5O;W%GW_P,``/__`P!02P,$%``&``@````A`(IE.P;$%@``K7T``!D` M``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`"B`ED`I(#:0! MT@+I@/0Q4::E3>AGF-:IH4!!BW\TV^)BHPUW'80.V784&6T+)`=2`"F!5$!J M(`V0%D@'I(^)LBUMSLJVTUD&!THG/9B0;_TZD/GH[&D@&T?4I6@+5Y?RP?K, M;2+/W^YN?[O>T[S0[$P,84Y!V8=JIT2/()#A>H-,ZLDBGL/9)&3?<5'-EM8;O=`B7GF4P$P/R*7Q\99V>$!.6@\H$/H3 M#28\3AQ,QZ/M'E6)N*GPW4^ MGB:TLF7"5K*)ZD&Y+2I>0N]RM)G?Z.C*HZ\STK:;6]OYCHF6>FE"7=#__X\U M;!WQ6#TR=K6.Z7)&FI"Y\LS5"YXYH5THO3;0_6B/.-*V6G`G]LM["QQ)/L MT6(1W-2NQ+$Y]AJ)A7I@;M>(!W8X\,["MA./QJ/54-[[L!:D(I0ARA$5B$I$ M%:(:48.H1=0AZA72QK+;I@LQJ_FPE[]B-]Q"9V%[#+,H42W8<&R.9_&%S6KF M=K8C9M&)&U_T:"[E2SHHI2@A*$.4(RH0E8@J1#6B!E&+J$/4*Z1GT6[M[RV? MQTU?9FAQ(5OF,(_7LR`5IV40CT<9WG0RZ<8H1U0@*A%5B&I$#:(648>H5TA9 M.CDN;QG$];(,:)7(%H$H0Y0C*A"5B"I$-:(&48NH0]0KI(WE4J*W^W#B,Z@X M40EHX8]'W5E,&A#E`[R,,D0YH@)1B:A"5"-J$+4*:3-,I7$)!<.W%TL)YG`! MS:."+2!=+ZU-2IRQE.0H>4!+E3VM3>Y:B!1;OD1=%:,X.LS69B^H64H&T8AZ M"3ZSM4E*6Y&B06@SVPST\/Z58*H9D$XUUY+P^FTL2.DB<&T"8":ZV%@Y=U3Y M]-Q,3\%2>BXDDQT&4;)Z<8QJNJ,D24/'&CLVW/'@N%J6TN-Z8?=V)CS&\WW: MK#P_(#6HM=F*TN$Z'T]U_;LQ)LV"%.V?,A=>_8*V*:G#<"Z"%'F?2&V,7Y0\ MB,M1?86H1M0@:A72R]OEP$<$4TRR769..9*[1'0WQC-3E@H5_&9NUG_&`A*` M->`L04I6<\[J7W&62?7@ M+*"^8O5Z7.`LT+'AC@?'U;)4K)Z>DAF/G]1(6TL5RW8)>\>^#KR(9:Y MKSHHXY'EO)A)4!H6_35+Q;NG;"+!,8(F.C(/2!*-#%&.J$!4(JH4TG=#N\\Q=^/$S=T$ M)$-/*10-4H(R1#FB`E&)J%)(WXU+;ZT7C"GEFQX-H,@`=^@1.1\OVS1(J=.N MY,*D:1E+R4%3SBCV'#BA*EA*.I8!J6.RY,(X7252-%1M&I?YQ:9Y9=GZ1#&N M?.8>J60NN;#)7)!2)U2)?0XN$UULTGRZHTG3"NXH66#)'6EX+Q\`5"P5![8D M^GA!&\OE=$<8RZ>`RE@!J4'!$=+<2ZEL/['1-@M2\1$2=Y0"H$!48L=*2:E[ M=FOYB'L>Q'4D"$@OD)FD0GY?8*EPQ@.+/V.!J"IF)+->("H92<>*T=!1W^Y4 MCCA;'OD@D5OF)AXR4C,/AS!!BJJVX1`F,5;*1,OH(`%1Y&26@BFOT]!1/3B1S$R5G`4ITL7WG3.B?69T^61FPF_!4K)J M2D'2<68/"RN6TNHEUFH;VC35VO!M)QD+3%\#HNV.;SQ%E"'*$16(2D05HAI1 M@ZA%U"'J%=)&G$I?UYLW/`K@"B^[^#RBJ_GGKDS%%GKHBFTF^Y@>V''9'GU8 M"*/Q2,TBH"QTC*1R1`6B$E&%J$;4(&H1=8AZA;2Q7-[W]FUS$=+$Z,`H($IC M9,E[J0AE*)4C*A"5B"I$-:(&48NH0]0KI(TUE:N^HV);C`FKA+2%W76O62K. M.R6@A9TY:(HJ-NG&\Y$C*A"5B"I$-:(&48NH0]0KI"WM$M4Y:*;Q"D4"Z0DM,SE.(%%NZ M#(B>96%4B50\"),9U2)%';7!;'9[N-IS8S8K(B"=P24FQ4J#E,LP(V.9P)*) M+K[!G#N2%XT=(1$K6$JKEZUZB%LEJJ^XXT'U-4MI]?+!@S;I3\F5Z1@9+!U0 M/-8D,85O&CJZCWE&@R6)^3`B8_7BM'E`SKG&CA.6]H-PF>\HE=C$N$3U%8]+ M=NR:D1KJ7"H<;=;7TN>WN39FSTN/]`*>&W=,@Y0N0>;&T3+1)0LXJ*=4;C38 MA%F#E*HD[%,-):JO>%QQ%`+U-4NI!3P7]].6GLJQXXKW;87*$A/N@%:2R*6( M,D0YH@)1B:A"5"-J$+6(.D2]0MJ(+G6/V'&Y]Q)S[X!H%F5%)W.)ACY)%"EVA0Q1CJA`5"*J$-6(&D0M MH@Y1KY"VGTW'7]DQQZR;S7"]]"@JX5)$&:(<48&H1%0AJA$UB%I$':)>(6TL M"NW*"UXQEA,WB9='4567+@%EB')$!:(2486H1M0@:A%UB'J%M+%LX1%8A*1!6B&E&#J$74(>H5 M4I:F;\AH2Q]>EH.X7I8!T;[*9D@#BK+S#%&.J$!4(JH"B@[W:Y1J$+6(.D2] M0MI8M(XFEN61!^!NMS"NS4ART#0@EV^/R5*R,)\J9R+%QL\1%8A*1%5`RJQ^ MJ&80DI8.OM&@KA91AZA72%O:Y=88`(ZU="@3),FZIN]Q../3R0<;+`V(4@>7 M4M"#*"8^9"+`??*`Z$L$C`J1"FI,1ER*`/>I`E(F]P-\<30-JFD#BD;3B=3T M:'H1H-%HV[L$/+;]*R'!Y^MQDK8**;P$RY211(D,48(I,6. M':)^4M=2=B0]%\?55BNLK0+2?F%_DB45*9D+K\L]Z"Z3N#0.E6/'`E')Z*"N MBJ5D+=>(&D8'=;4L);HZ1#VCEW3IN3BN3EMAG<9(^<72A)I4I&0NO"Z]EJ.? M!!D<*L>.!:(R(*/+Q)4*.]:(FFE=QM%;[-@AZJ=UB>_KN7`5VQ&;JR_PU.;J MD?$+$Q[259"BN#0Z`1R&92REEY$)#SE+R9(L&!U47[*44F]_\Z-B*5%?,SJH MOF$IK=YDIRU+B?J.T4'U/4MI]1)']+S:BO65/&`L3-E5KE<>Q6?1CRFOQ[)3(L+"/CETS5*'SD)$AA=OABA'5"`J$56(:D0-HA91 MAZA72%O:%IV'?7B-U65`Y,-BXV1E]TF1$OMY79'SYRA5("H158AJ1`VB%E&' MJ%=(V^^XPG&-A6-`]"0Y6R9%E"'*$16(2D05HAI1@ZA%U"'J%=+&.JYP7&/A MR$CJU)21G"-EB')$!:(2486H1M0@:A%UB'J%M+%HIU99T[L>9G`_>&<*OH#B MAQD",F=>4N8,*6LF4KQ2"%242!9F-2F$2D>1(NH0]0KI"U- MH>LG6-II,3NV1\K2'KUXU)6M1P&^OSR@Z*BK$*GIHZY2!%A-%1`]:L:H%JGI M8\!&!+A/&U`TFDZDID?3BP"IT;8_KDY;8YW&2/P_#2@:8H8HQXX%2I6(*NQ8 MHU2#J,6.'4KU"FEC'5=(K;&0"D@74M$/(/K#'I8Z6"MD+$4+=BRWDI6I37.6 MDJ>K"T'2$>JTDJ6T>E.N5BPENV?-Z.#H&Y;2ZJ6"'2S1LI2,OA-T8/0]2VGU M4K'J>;6%U/M"/=97ZX!H(4139&K=-$C1%Z#8R3-&JJ/]F9X\2-$S0]RQX(ZB MJV2D=9FX7@4IM2'XT4?C:J9U27T:9LUWC,;5<4<95\](CTL25S5%&UN^O6N* M!BUZCPA(>R3\H$^0TW" MZ#-ID(I0ABA'5"`J$56(:D0-HA91AZA72/O,<;7E!FO+@'1M"5^/$RD.0QFB M'%&!J$14(:H1-8A:1!VB7B%MO^-JRPW6E@'%M26B#%&.J$!4(JH0U8@:1"VB M#E&OD#;6<;7E!FO+@.*'.@**'^I`E",J$)6(JH#B/0^E&D0MH@Y1KY`VUD^I M+3=86S**DO&`7JDM18I].$=4("H150$IL_JAFD&8'*1!72VB#E&OD+8T)8`' M-Y(W/;>\<5K,/A)0;&F/7JXM@QH2$"/[/E&I5(C4=#57B@"KJ7B`,II:I%ZH M+46`U;0!1:/I1&IZ-+T(D!IM^^-JRPW6E@%%_I\RDA.H#%'.2!ZQ*!A)QQ)1 M%9!:NWY<]..&;*<&.[:,Y(H=(^G8*Z2-16FP6JB'#X(W3MRL2(]4)FM+AC3T M<[]Z=RB1#:IH<8Y2B?W-Q%QTL6$*0=(1\N22I;1Z$PTJEA)OJ04=4-^PE%9O MBQ26$O6=H`/J>Y;2ZE^J6UPI]/;/7C>A8)1GO*X#HFG.6DHX%HI*1UF6.%"J6$ETUHH:1TA7] M#J"OYEE*='6(>D9:E_BTGHK7RKLW[PE)T^V-H3."\A:\HZ[?@C@=/+$J6 MTNI-I*I0?GTYI[>P#EDTM"SX_:RFY6IYN;VB!US(:4P+??5FZ[Z< M,M&RHA9Z@FBB97VQ=8_+8,O5>K:]HKO$%GJLA?H,B9P=P3JAEN'E#M!"=TJ? MWT]HVY`V.NJ;:B%M=(B%+5?SQ?;*?]QHKT,M[K?SL,_U@D9`/\DRU;*DEB$, M66V+%;4,!ZJFY6JQWE[15ZZFM*VIS[`L3)_K)8V-OMDYT6=)UZ&M?:J%M/GM MSVJ;D39Z0]%$GQEIH[?>3+5LJ&5JU%B?(A+:$UHZO8&V? M.;50%)_H,ZK?OB#K;4U.*^BX,M]-T;"EU3+>F:1DW/7F"?FEK<4QG80B_[V+I7 M>6`+O8%CZ]ZO@2WTRX=;][N&V$*_N+%UOZ>!+?3[&5OWZQC80E]%(QM,+:>: M6MR7N+#/]9+;\]'3Z&79/VZ^[OJ;QZ]W#T\GWW=?:).AER'3^<>C?]VV M_Y_G\#JW7_?/])IL*OOH_<+T6O0=O4[FXHR$O^SWS_P_=.GS\47KG_XC```` M`/__`P!02P,$%``&``@````A`,W+2(J\`@``#P<``!D```!X;"]W;W)K&ULE%5=;YLP%'V?M/]@^;U\AR0HI&JINE7:I&G:Q[,# M!JP"1K;3M/]^UW9"@&Q=^Y)@WW,/Y]QK7S;7SVV#GJB0C'*?/^ZO5AA)1;J"-+RC*7ZA$E]O/W[8'+AXE#6E"@%#)U-<*]4GKBOSFK9$ M.KRG'41*+EJB8"DJ5_:"DL(DM8T;>%[LMH1UV#(DXBT:@Z+LBN`=_/?D3R M$[=97-"W+!=<\E(Y0.=:H9>>U^[:!:;MIF#@0)<="5JF^,9/LAB[VXVISR]& M#W+TC&3-#Y\$*[ZPCD*QH4VZ`3O.'S7TH=!;D.Q>9-^;!GP3J*`EV3?J.S]\ MIJRJ%71[`8:TKZ1XN:,RAX("C1,L-%/.&Q``OZAE^F1`0.`$JX6_B/_/XEI%QN`= M462[$?R`X-#`.V5/]!'T$V#6SJ)_.@-+.N=&)YE40$OHQM,V"I8;]PE*F!\Q MMQ:SQ&C`!%-$=HD(O0'B@KY!)%B?BPRAB7\O_TFD3IJ*#-8#O?%Q:R%+4V9M M+!MM3`1`9=XO0"=!IT<5@';/%%A,-,+,$-EKB(E&('F_1IV48K`]=,F/_)E& MBUF9/H=A=.Z1*6(V#?OG&D_4P9D:JWN]=1H\5Q7-5%E,;%4%B_-KK:IQV/>C MJYJ?>HNQM8H7Z_-KK:IQ.(KBU>#)JK(#R-[/EHJ*9K1I),KY M7@^7`+P.NW;NW?H)'&(8.+/]#.:AV7>'`,RCGE3T*Q$5ZR1J:`F4GK.$0@D[ MT>Q"\=[.$'SF,&=F/&9Y^UR5UA,5DO%ZA;#M(HO6*<]8?5BA[]_N;^;( MDHK4&2EY35?HA4ITNW[_;GGBXE$6E"H+&&JY0H523>PX,BUH1:3-&UK#3LY% M110LQ<&1C:`D:YVJTO%<-W0JPFID&&+Q%@Z>YRRE"4^/%:V5(1&T)`KBEP5K MY(6M2M]"5Q'Q>&QN4EXU0+%G)5,O+2FRJC1^.-1/E!T*!=6> M@2"M*\Y>$BI32"C0V-Y,,Z6\A`#@:55,=P8DA#RWOR>6J6*%_-">1:Z/`6[M MJ53W3%,B*SU*Q:N?!H3/5(;$.Y.`QYD$>[8WG^%9^#J+8R)J!29$D?52\),% M30/OE`W1+8AC8-;*@K\J`TG:YTX[M:Z`EE"-IW7@S9;.$Z0P/6,V!A,AJ\-X M0\1VBO#=(2290D)_"-E-(8$7=A@'9'9:(8-CK3[TPI^K>-&JG89:O45'WZ9C M8R!16RV=G^W8D(P-NYYA$*+_/R%J)VBI7JJAKT8Q&DS0PXP0VU<1R:N(W37$ M0"<$TB_%]1)H\`I!RKI6PI,:&,R\;4:\"/UQL_7WO2B8!\/\)&8?GMT[1OG9 M74,,M,'Q>;LV#1YI\T]=^VOX^Q[X>CT!,#N";N&F(@+OP7 M<1H\%O?[;)K#8S"F<(LHFN%A8;;]?1RX\V"D/AD`?'?NCH8(7`PZBG-K>'[H M1MTKC#0S]\U8K*@XT"TM2VFE_*AG>@!Y[ZSFNMG@&`X]S/F1?8MC./M3>X)C M&`%3^PZNK=;N=$1P;33D0#\3<6"UM$J:0PBN'4&!A+EXS$+QIIU*>Z[@PFC_ M%O!]0&'\N#:`<\[590$O=KHOCO4O````__\#`%!+`P04``8`"````"$`"NTB MF6D&``#_&0``&0```'AL+W=ORWK8CLQ;!>Q;EN@"RP6W=UG199M(99E2$K2_OT.15+D<%3'"?I2 MU<>'1W/C<,RL/G^O3M9+T;1E?5[;[F1J6\4YKW?E^;"V__F6?+JSK;;+SKOL M5)^+M?VC:.W/F]]_6[W6S5-[+(K.`H5SN[:/77=9.DZ;'XLJ:R?UI3C#-_NZ MJ;(./C8'I[TT1;;K%U4GQYM.YTZ5E6>;*RR;6S3J_;[,BZC.GZOBW'&1ICAE M'=C?'LM+*]6J_!:Y*FN>GB^?\KJZ@,1C>2J['[VH;57Y\LOA7#?9XPG\_NX& M62ZU^P]$OBKSIF[K?3S MZ@/T;UF\MMK_K?98OZ9-N?M:G@N(-N2)9>"QKI\8]'[?+X2'N,Q9E7;99-?6K!=L`@MA>,K:IW"5HR53Q-P_)^UGN M(&E,Y(&IK&U8#VEIH>!>-L$T6#DO4"2YX&PIQ\6,4#)813#9R`1B$TA,(-4` M!UP<_(1H_@(_F0KS4UJXE8!RW#.PH+5>PK;#16\YQ06M(J$$)!\K@&$%B@B0$274$.0<[QW2.-9%W5B93 M@=J&LA@\"::&+UM!NN;N0!G<)4A,D(0@J8X@=\$UW=WK.63DWBMIS58@?5?O M-T\HD+NA6"."Q`1)")+J"+(86M7M%C,RME@@RKZ0(!%!8H(D!$EU!%D,#4JW MF#>[">N8W;',G[8U/U5&8N]#4^.MCFE@1P2B.<(1W^.=T/461B^,!H+,7TQ$ MDH'3MU-W%BSP)DT'`H@@-]D?\;S4A((/V#[SBP0 M;RBN6.BH*"2"HTHRU1%D\?U[+&9D;#%'/-A;PR9WO7L7Z4TR* M!`DJ2",9YU0\O$YF+[E%.QW55L<%"@AKO7H./U2JO0B.E(0@$YJ#/HY"*%B> M.N@B">&%1EW'2GX(C5QX/Y1**B&LI9HRC@0[T;5J_E@D^%@`QX"T:\N.!"@C M7#3^W(P$9[%358N7635"RP>RQC+V:ZS>*(U(Y,*K\JED8?F[P50<+S8L7(G7 MM_H")?'6D.#RD0/>+&W="LB?#U!(H8A",842"J4(PAZQ$4'SZ'H_<\5`H5O. M(5^5,`&IHR-DHQ_K^NI\B2@44RBA4(H@ M;#D;'6ZW7`P:NN4<\G7+!4NWG$"Q2Z"$0BF"L.5L&M`L_UB;%%.([I"`E/6A M.PP>?#*AXXUBR#*+!:3E+U&LGTTXB@$ZV%TV2FCNOE%BC&T1A+0Y1T#($;%0)3V5"WL(6\[&@-LMYT,#ZL-BCD#33F#,**$K6+!MM".) M'%R"!<6G6(&:2?JN$4NM8.C\B82NRJ>2A>75M($"`ZE`@?E0!?UGLB%VL@C(:RE6CB.!#1ZO40^%@DF8D2"0WCD M,7]6A!YGO3'R2!:0M:BJF817CF#!&U5P;I%/Q^752(_C]4M&'H^./`+21QX* M112**910*$40]NA=(P_Z?QS8,;+!_@[6-K M`EC3%YJQ9NO!>R#6(VL\>,^H6KA8PH]TNB)9+.%W-\7A4%Q&<%S1;^"8`[O& MOH%K^(=1J^!ZOC^#B!]@[,@;MN#$6$0>(%2C0=Q"I/I`.<,;X/K]DAV*/[/F M4)Y;ZU3L(6G3_FJDX1?X_$,G?CT\UAUX&ULC%1=;YLP%'V?M/]@^;T8"*1M%%(E MJ[I5VJ1IVL>S8RY@!6-D.TG[[W>-$Y8TZ]87P.;<<\^Y]]KSNR?5DAT8*W57 MT"2**8%.Z%)V=4%_?'^XNJ'$.MZ5O-4=%/09++U;O'\WWVNSL0V`(\C0V8(V MSO4SQJQH0'$;Z1XZ_%-IH[C#I:F9[0WP<@A2+4OC>,H4EQT-##/S%@Y=55+` MO19;!9T+)`9:[E"_;61OCVQ*O(5.<;/9]E="JQXIUK*5[GD@I42)V6/=:26&TU96+D(X%H9>>;]DM0Z;%O)3HP)>=&*@*NDQFJXRR MQ7RHST\)>WOR36RC]Q^-+#_+#K#8V";?@+76&P]]+/T6!K.+Z(>A`5\-*:'B MV]9]T_M/(.O&8;=S-.1]S[`""XHT49I[)J%;%(!/HJ2?#"P(?QK>>UFZ MIJ"3:91?QY,$X60-UCU(3TF)V%JGU:\`2@Y4@20]D.#[0)*D47J3)_GT_RPL M*!H,WG/'%W.C]P2'!G/:GOL13&;(?'06=(Q>7[.*'CW)TK,4])H2=&&Q/;M% MEJ9SML.:B@-F%3#X'#%_$`S5C))0QJFDOQ?YF-F#?69?="]E%39.TV3I9)1R MEFARGLA[G^!L_#NA#T+. M=\]K^,)-+3M+6J@P-(ZN4;T)!R0LG.Z'(5MKAX,]?#9XCP&V*HX07&GMC@M_ M!,>;&PO M=V]R:W-H965T[_7K[>CL,+BZ'@]7K'Q8OV]?5[?#G:C_\ M]>Z?_[CYL=U]VS^O5HJ5/'K>[S>)` MO^Z>1ONWW6KQT`5M7D;AY>5TM%FL7X?:8;X[QV/[^+A>KI+M\OMF]7K0)KO5 MR^)`]=\_K]_V[+99GF.W6>R^?7_[9;G=O)'%U_7+^O"S,QT.-LMY^?2ZW2V^ MOE"[_PC&BR5[=[^`_6:]W&WWV\?#!=F-=$6QS=>CZQ$YW=T\K*D%*NV#W>KQ M=O@EF+?1]7!T=],EZ+_KU8^]\__!_GG[(]^M'YKUZXJR3?VD>N#K=OM-25H^+[R^'?V]_%*OUT_.!NGM"+5(-FS_\3%;[)664;"[" MB7):;E^H`O3O8+-60X,RLOCC=AA2P>N'P_/M,)I>3*XNHX#D@Z^K_2%;*\OA M8/E]?]AN_J=%@;'2)I$QH9_&Y/HBG$V"R529G`@N;,]@8T.+2)'26! M4_ZY-CQ,`CM.IA?GU66DAVTW"Y+%87%WL]O^&-#20@-S_[90"U4P5[X\_G5. M^AGQWH2@F:!)E,2]I$\HD!1(!B0'4@`I@51`:B`-D-8E(K6T/_P=J54VM%#0X._3-H;< M&M&IW/:2/K=`4B`9D!Q(`:0$4@&I@31`6I>(W-*^)W)[_.3`"Z52=RGDIM]K M,M:'"[7JQ9J$XW[Z)T!2(!F0'$@!I`12`:F!-$!:EXCTT$GA$^E1:ID>36;3 M/AFQ(>YF$X7>5I+T(LYS"B0#D@,I-(EL\66OL9,@"B.Y>E2]B(NO@31`6I>( M)%);11+U+GVASER'Y_7RV_U6GS&/C+V(=F.]1RL3F5M-W-QJ,G%G>!1Z6TW2 MB[AQ*9`,2`ZDT,3-;:]Q<^L57_4B+KX&T@!I72)RJVYR>`+Z9&Z5B:3";=\2B\#+QV)?WGW*Y4DS#JQW[6:]01BSR\<9?WG[-'H4DPZSW*7F,\ MO'I4_>?L46OBU*/I-HQMUEVQR_5=&W0P>EUJO/&P;FB`H,+%%5(:HQL$%5*Y#,GSJKNQ/\ M])!3IQMOS!G4K;9\O8E"[WH3&Y6ZL?=9#J)+.3035M%2WZNBT#N?IJRRJT=F MD0T$^YQ5TGXF*U&PRMJ7C$[6OF*5M+^6]C6KK'UCT8G:MZP2]DX*9;^J>\0G M^E5?.Z@('KCWZEZNNMJN$[%!SHA/4)4BRA#EB`I$I4%.B16J:D0-HE8@F2QU M-?A$LLQ-PDV606(1B;QC5ZR^0I`K1F*0D^44488H1U0@*@T2^>NKREU=8V"# MJ!5(YD\=_]W\J1-8.%7?";[S52%O88&Y.+BIU.A*#G-O&XY-()7`K4@8R4#O M#)"RRDZ_#%'.2'IY.VG!*NM5,K+UJAA)+V^#J5EEO1I$+2/I91=;V2V4?M$M M'ZSM2N[MC0:Y:X!&SHA*U#?"2I=$5G:7MYA5YFU<<:!7ESZI@ITI816NPX^7M5*E1B2R?8Y^?95^@ M?`*D>O`@-+5%6(:@QL4-4*)).E;B:?2):^R(AD:22O(&/8 M"(W*KI()94E-*&=!3QG9)3%C9`-S1`4C&U@RLH$5HIJ1#6P8V@IJ^R8R1C1OM@'PAJ?LTK:>VM\P2IK M7S(Z:5^Q2MK[BS"KK'W#Z*1]RRIA_]YM)/S<+;.3>_UJ+IYV2,9&Y4X"1"FB M#%&.J##(G02HJA#5B!I$K4!R$JB+U_F+2*CD7K(,$HL(W$9,H,B?#G10BJH, M48ZH,$CD#^PK#*P1-8A:@63^U`7'S=_9MQ'Z#@]2J9%<3R+_-F("G#2/KU3*27N_<1M21 M0'3+Z8-8)_>&M;D9BF$]AK[0*F<,)\9K3,.O7X^C,?2%#G0&;,:!]EN_G)'T M@KX`KY(#K5?%2'I!7X!7PX'6JV4DO=[K"W5C@RE"9]/S_UZB]DY_V='HBHX= M3IJ]_3(V@;/NR2/]32HC6N.=0&\G3(V*&LJGDHP#K5?.2'IYVUZ!7B4'6J^* MD?":V(M&5_L:O1H.M%XM(^EE#\9R":,9]?_VC[+PYH]&,S%$)C!_C,K^724) M#:*!:/MG`O/'E&BWZ(P#K5?.2'K!_`&OD@.M5\5(>L'\`:^&`ZU7RTAZO3=_ MU#7.GS_!Q/Y9[+?M&^7^HV^_0GT;=.]/C&P28X-F=N%-$*4&.AJH<46&0 ML^R5J*H0U08Y)3:H:@62@US=^-PD?K`A*+DWH#62F_,$%ARM4A.P'[UP&D]" MHZ+!TJNB"-8@HW+7H'/L\[/L"U99^Y+1R=I7K!*UGWBUKUEE[1M&)^U;5DE[ MNZC*?E77SD_TJ[ZEBDF@D?.W[S@$E"!*$66(LHA[J5P1O;XFMAL\D":(4488H1U0@*A%5B&I$#:)6()EI.B.( M3)]>FR,E]X:E1A.[Q<:LLGM;8A!]F<#Y2U&5(A5"I5LX+%+HKN#G_70 M4(071H.<%L4&B>>&0N?[:GT(MBJ;"FU/@8PR+M'F,+>!=IR&_E>NA56Q5RF0 MS`Z=@D3W_Z5'JB+EXHT*C41V-)J,WWORQ]C099-KGAID8[RS:,9%NVGZH)P" MRRE/E"/SI6X^YV]YD9)[B=%()$:CJ6UW8@(=56J0H\K8WFT\>!7H50HOV4!U MAG8;^-<&A'+QVJV1NKWVBVPX]:X#,9T$5*`ZH_>J:&HO3V8&]5YVH!P-]*X\ M&=O;,I]?08&Z;,[M[,@64F$#G_)HB MRA#EB`I$):(*48VH0:1>M5-MU%75R=*OSNF7AC:KW=,J7KV\[`?+[7?U6APM M:W638[6B`H[P+V-J1G=N\PJ^'\_I?8`C1B%5E6Y"1SZ)+JF,8U[Q M;$Y/_F)$-IO3T[S(R]FDZ;^*@OF-ZU?%L\K=K% M[FG]NA^\K!YIT-$[CK3;[_3;FOJ7@_DZZNOV0&]9T@Y,K[+16[4K>I_B\H+$ MC]OM@7]1!?3OZ=[]"0``__\#`%!+`P04``8`"````"$`+H,^\IT'``"H(``` M&0```'AL+W=O3U,Q+@)]:[5:WU&K)N?OZ M_7*N??.C.`BO]W6CT:K7_.L^/`37Y_OZWW^97X;U6IQXUX-W#J_^??V'']>_ M/OSYQ]U;&+W$)]]/:J3A&M_73TER8\UFO#_Y%R]NA#?_2BW',+IX"?V,GIOQ M+?*]0]KI'N$-`(N-MKD7^\KS\:S#6Z]>;#7>J@ M?P+_+5:^U^)3^&9%P6$97'WR-L6)1^`I#%^XJ'/@B#HWH;>91F`;U0[^T7L] M)V[X9OO!\RFAPUT4OM5H]9#OXYO'UZ+!#%(H0RP"D@?]_V).P>9:'KF:^SJ-B\(9 MTT3]]M`UNG?-;S2Y]IG,&&6,LL1$2O"9Q-5.=3#3@:D#2P>V#AP=S'6PT,%2 M!RL=K'6PT<%6!SL=N`IH4GCR&-',_QTQXFIXC*1WQQ(406MK`9$2LLM4!S,= MF#JP=&#KP-'!7`<+'2QUL-+!6@<;'6QUL-.!JX!20"@-_(Z`<#64$I5%TQX- MRA$8"QF#4G>^LGIED4DNDD<)R`R("<0"8@-Q@,R!+(`L@:R`K(%L@&R![("X M*BD%K?M[@L;54+*DM9H'I&MH(1EG0N]%+1?)HP9D!L0$8@&Q@3A`YD`60)9` M5D#60#9`MD!V0%R5E*)&NW1IJ567'G(;XM)I<*13QQGIY%EO(DBGGY,ID!D0 M$X@%Q`;B`)D#60A">Z^T>0ED!;W60#;0:PMD!\152@O343-;NMLJ;RS07DK-S!L0$ M8@&Q@3A`YD`60):"*$%;Y3)%0FYWM0Z\-D*T@W6)<.]#CJJ3D>%[BEE;0^YY/Q0DNKG M4I=J5[NEG1D6A93LN,P0^4:BE43O>F)=Z%(]H:7732$EU6\E*IZX^]`372E% M&Z3B^R(ME&<-/S.K>?27/U[#JTL%(GS5"J$NS-[<)`C;- M5`U(.)?JM+3$.2NDI`UFAI32R$)DRXYT*LW5@Q%.(275SR4JVZ5=SRP**=EQ MF2$U,V3H?4^L"UV%J9V6=DK:%%+RB5M\XNY#3W2EE.J<3JN?Q[$\:_C!_A.S M1MP#T".DG6-#H%*NZ>@+<2*EBHUVFB$MLVA9:E9(R2>:&1H4FYR%R)8HO==- M2T$'T3Q#FA':I%\44M*(989*:23S1#'&==%1B;ZA9<]-(275;U']3J)"O2M1 M*4$814HJAYK?!WPBU-GU@1IJ@93%.>'WP)0S%#1%-$-D(K(0V8@<1'-$"T1+ M1"M$:T0;1%M$.T1N"95CP4_YGXA%=BF@QD*@3E$63>C]1QJ+`DT1S1"9B"Q$ M-B('T1S1`M$2T0K1&M$&T1;1#A%_.50X1\1"O.P1[P`N?O3L3_SS.:[MPU?^ M(J?+:]L-C_O:)IT2=MQG=G%;P#J/;.>2/7?9(AF+#N,O<2FZ0 M)IIF%3T,ZE*IBS9GQK=>[$.[+^/;+;;0CLOX?HHMM*4ROF%B"VU]C&]LV$*I MGRRH<@SE=K*@JH7R.5E0U4(YG"RH:J'T2Q94M4Q'C$X::)DY8G2Z0&Z/&)TH MD,]'C$X1R-U4)%,(V\JH6*51IY M5-R%<]1C>'R"=]-DV/;5I\9GU&%W`H;_49 M7;HA=_J,+MJ0K_J,+LZ(-_,'T'OBF_?LK[SH.;C&M;-_I/332B],(O&F6?Q( MPAM5Y_1^,TSH#7'Z]43_$>#3K46K06>78Q@F\@=_0/X_!@__`0``__\#`%!+ M`P04``8`"````"$`U5!QC/H'``">(@``&0```'AL+W=O7FM6Z>VZ>R[$9@X=3>CI^Z M[KR>3MOM4WDLVDE]+D]P9U\WQZ*#/YO':7MNRF+7*QT/4WK^OMF54;U^.Y:GC1IKR4'0P__:I.K?2VG%[C;ECT3R_G+]LZ^,93#Q4 MAZK[V1L=CX[;=?YXJIOBX0!^_W#\8BMM]W\0\\=JV]1MO>\F8&[*)TI]7DU7 M4[!T=[.KP`,6]E%3[F_']\XZ=U?CZ=U-'Z"_J_*U-?X_:I_JU[2I=K]5IQ*B M#>O$5N"AKI^9:+YC")2G1#OI5^"/9K0K]\7+H?NS?LW*ZO&I@^6>@T?,L?7N M9U2V6X@HF)FXR M[9**F1R/MB]M5Q__X4*.,,6-N,((7(41)Y@LYW,_6"ZNM^()*W#]_%1\802N MPD@P1_P)1`VX"HC8@3D0B@70A&N0G$Y\=WY M8MFOQP5%V-#]K.$J1W2OTUP)3;@*S6#B+N?.O`\:'7+*4ZC/R*CHBKN;IGX= MP3:')&G/!2L:SAJ,R53D%E1ROI6;D)3,R#VS\_EC#>GH+:STC)21= MCSGQ`^V$DKE@*%5"8`CY!275](N7YPD[U+JG:ON\J6%VD',#*^1!&>;%F=G` M[G)BNLO):B9JM[OP<>I&2D"YRHGIJI+A!\#R,X4A+! M2A@.6ND9"BE7'[R11%C1.H)B;5Z%1BIJ6ZE$V%;P1B18AV%D\^-&ND%)A44M["VJ^Q'E%.(I&*%\VG4@J;7[X1 M+]::7(C7M_H,*3%8Y(RJX/`&!T:6<]T(Y.EJ'%(44113E%"44I11E".$=PQK M20R_+U<]1S0PIG\<>3I10R%EH(BBF**$HI2BC*(<(>P?ZR\,_S[[;"':%#.7 M?->JE1M'-3,ZH.D#+](RBF M4@E%*44913E"V#_6RQC^?:[(\X8(N2V0]C%T1-L$NUW5:M>W^P`MI3-9*4J4 M""DC15*M:)JW]E>FI:2M'"$<'-8V_>?@,"-6+R"0&1R.5F[?N;HSQVI](G"5 MF0GT/HD%TCJZI>D[YD0(H"B],TY&Q\DOC(/#Q?HL(USOU`+>E:&D$8V:?KX* M'8'T]HD$,KR*J51"I5(JE5&I'$DA_Z`Q_X!_O31>=X%PY[.T=D`HI:`DJ'WB M+:U$CJ24K_J$6"*L:"52(J6T8BH15K2R*9-26C&7""OJIA:'#TZ^Z]/#9=)6 M^`2"%#8"8Y^.0M&'/LJ0TCTN?VZ7YO46C(<5K5XRH8KIL*(U8D85\V%%/2(. MG]5>7MY=+FTC!;*R3S>S?6!"*8675,])A(^;!UNRC,;#BM;;TT1*:<54(CPB M"1\9,1]6U"/B\'VH2W5IERH1RKX5V;Q<$6??BFQ>8=[,OD%%LGF)8BKF=7G$ M3,]>+E@^K*AW/0Z?U02_DWVJUY6C;5C:P7XV'V(HBBB**4HH2BG**,H1POY9 M?2SK@]SY!.@[GHI>59]/&_:Y!SR=\Z/\B[7VH;CM0SQT?5J]53-A4Y@U\^II M,3VK>G(DIV5E5NCRV]:T=''%T6(=F7'27STMT16:T>)(3DNGGRA'_+8U+5T< M\+18J+=0<>H=?L@77@C@MWH`0,W5G"G;X:V];YX\EOW'!T)"\MX:/.G1.]^`@O)2@-S;@Q:`3#HP`KVD&-!P8 M8]!6&*SA[3_52((UO,RG/%RLX14ZY'OG4,#UCT#CROP9QX#JA( MP:\#SL5C^7O1/%:G=G0H][#\L_X[0<-_7\#_Z,2KM(>Z@]\%0(;`%U_X'4@) M'UMGK&;OZ[J3?\#04_7+DKM_`0``__\#`%!+`P04``8`"````"$`[D1K?#(! M``!``@``$0`(`61O8U!R;W!S+V-O&UL(*($`2B@``$````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````````G)%!3\,@&(;O)OZ'AGM+6=5,TK)$S4XN M,7%&XPWAVT8LE`#:[M]+NZ[.Z,DC>5\>GN^C7'2Z3C[!>=68"I$L1PD8T4AE MMA5Z6B_3.4I\X$;RNC%0H3UXM&#G9Z6P5#0.'EQCP04%/HDDXZFP%=J%8"G& M7NQ`.=;P+,\O\(:`I<\<-P#4SL1T8B48D+:#UEW)0"Q?C\U]V$55[E1(&_VK'MS=>+]KL2_LU**P8X*!SR` M3.)[]&!W3)Z+V[OU$K%93HJ4D#2?K\DUO21T=O%:XF-KO,\FH!X%_DT\`MC@ M_?//V1<```#__P,`4$L#!!0`!@`(````(0!5QCTHRP(``/8)```0``@!9&]C M4')O<',O87!P+GAM;""B!`$HH``!```````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````)Q6WT_;,!!^G[3_(PQ,LZEL7#LS':K M=G_]+@EM4W"MK2^1?]QW_NZ[B\_D8EF*8`':<"6'XB;I3DC`J8(2. MXYP*`R3:+I`[H+5H$\JUB*$&:CK#<$$UI](BK=JL MG31C41FKXU]*OYH"P!H2H4&[V`R[MMTQ'\3]?F.!(Z]EZVQ,2\B"GU3.X'_. M.'$?49-L@\6S=V68]D6 M%%<-F3=Q-C*-%-:2-)"E.#)*\(Q:G%Q1027#A&T,:^E;\!Y(8A%9'@)I97K/ M+)F7)=6K]#%/K^:&2S"FB2OA,\ES-S-JBG14?VY^S_D":T_:%G3)F#O^Q"KV M6BB1X1_=H.S*Z?H>__$2TBE=[E;`1I4Q6-2Z,9J`3I.":K<6WT'--*T*SCJY MD>O0G(?[I7#+U\BP5PLWQB$&1OR"%>FDU=7$9^>2QF?O5V@/=6^UG#KY^R4Z M!-/>*1\J^6.-I==@*1=N75UI2+!)9',!Z:,S%#]DCV0.6MMCW.'[S_GW\+?G M#`Z(Y^L!F#,G9J>$?3EQUO`F"J=O/\2=$W_INW/BQ[ASXL?LR8GW%_LR5A9, M.E7I+9?8.S@5;QT![^"N/CO=[UV_^\'EJWFJINH:>\GZS;"[2)J;-<-6M][? M+I`[?"YH43L9%76SSM8V'S?J%\YS^XR+3P;'O7X/'R^=-1)M'VSQ7P```/__ M`P!02P$"+0`4``8`"````"$`?D\0"M&PO=V]R:W-H965T M&UL4$L!`BT`%``&``@````A``LV5G*L`P``#`P``!D````` M````````````!!0``'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`(U:(B82`P``G0@``!D`````````````````!2`` M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`+&VNF-W!```>!```!D`````````````````-"L``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`.Z6 M_)6,!@``@AL``!@`````````````````ID$``'AL+W=O&PO=V]R:W-H965T&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M``B;APX3"0``>"D``!D`````````````````C9P``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`-(-NC*V"@``LC8``!@`````````````````O;,``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/R;4;*W`P`` M3PT``!@`````````````````OM\``'AL+W=O&UL4$L!`BT`%``&``@````A`,48 MEI8(!```^`X``!D`````````````````B^<``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`(S:LB84`P``M@@``!D` M````````````````N`4!`'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*#$BD(>#```[#L``!D````````````````` M1!(!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`.Y$:WPR`0``0`(``!$`````````````````GBX!`&1O8U!R;W!S M+V-O&UL4$L!`BT`%``&``@````A`%7&/2C+`@``]@D``!`````````` M````````!S$!`&1O8U!R;W!S+V%P<"YX;6Q02P4&`````"H`*@!8"P``"#4! #```` ` end ZIP 14 0001333493-13-000082-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001333493-13-000082-xbrl.zip M4$L#!!0````(`$AV:$/AFU%6G*@``-ZT#P`1`!P`96AT:"TR,#$S,#DS,"YX M;6Q55`D``WA`?5)X0'U2=7@+``$$)0X```0Y`0``[%WI<]LXLO^\4[7_`U;S M=FJFRCI(2M9A.UNRX^SD[23.VI[:MY]<-`E)V%"$%@!M:_[ZUR`IB3ILB;(. MD$02.R()-AJ_/M"X6N=_>QEZZ`DS3JA_43(JM1+"OD-=XOW M:E:5^%S8OH-+4C@IZN*%2%T+N'J M<&>`A_8M[J$0OHX8C_!%B9/AR),M".\-&.Y=E&0[RA,V*R_<+:%J1$@J"?4% M?@$UQ(X`[0M5`IXX\6WB7I0^0FOELX#.LNIMZ[PZ>VU"N#I'^7R$&:'NK!X0 M&A,?0=,_1$"UX=]Y=79W6A#[[EPQHR9)NXE"Y]4$\?-J#,(;B!CP=X((_+8, M-2$QX-]Z2."?9;P;DF8$B14IB56++F)=?OAB_X>RJX`+.@1WUWTA_$&JY\._ ML.>-*/'%%SQ\Q&SO"$J0<%\ZZ.D-N!6YEPY^&7G$(3$OR"50+G+]<3,ZR\TH M?9#MZ"RTX[RZDN2,B>H\%ZD$:Y5KS0T$:TE=M]ZOZ]L)]G>?0!\4.4X'^JZ, MRW=U<[28?PV&MF]G7+C)1FB1=K'(O$03;#JN8'4?6P@Q MZSXV=R+5?:RR`FTFAO83@9JZC]V#8,W-@B?SJ(+5?6PAQ*S[V-R)5/>QR@K4 MT'WLX?K8S18!CBE8W<<60LRZC\V=2'4?JZQ`WY[\OZ*^`[Q'96\)_WXYOL2^ M,QC:[/M,O%=T."1$0A!_X)=XMC>9]\E3\0-;*_K MNY_L(?'&GR<[*KYYML^SH4?KD(NUZA7HUFG8.SF9H!\SL07\Q5DN66L"DX)= MQZ&!+_@M=C!YLA^]U&:P5&#BA^Z?:5ZT?E+R-;0.J_GK$<_3G*7ZBG[C9R2J MSXVB3Q'7BJZ#&AW4Y,8$WIX,U2:@3>#P)G#$Z>/9[NL#QSO3,G%_NU0V+VJO M3+PS+?0VXFI,XNQF4[T2FAYU&9/QTX!A':?=R)1:WI>F;QV)I^F)G%(VJZGE;1TRJ*3*L<8,=`ES_<]&8Z M?_1#[%$Z!C'7LLF];5HV[;<,E9IF3/S6=DW;<)M'%]AQB1<(\H3OL!,P(@CF MUR^.%[C8_<3H$`QO%(B0UDWOVF8^\?O\&V9W`YOAR_%J`G-]^YV@SO>;D:20 M$9^T1U1FG?@R+,796J'5KD!JI\[BEU:[HJB=4N<5M-H52.W4V<)[!\)U`P\# M=L.11\<84&)/Q,$1?C(]G$08Y!)2ZWH>=6*P;[%#^S[Y`[O?0HZN*!?\MY0:^=*[=P,K#RIZ-N3/3H.54I' M58I#U3D:H.-0-;54B3BT0&JJX]`LQ:%%4TP=AV8N#E5G]4?'H4KIJ#)QJ%+) MRG0/YWWIB!Y;Q*'U:R=GL/3F9JT MQNY;8\U]'J\\^CE2!?8KSL=%:B&BPG20D,/M)7B+^6R_$8:=(<="4:Y'-T.Y#V)DGQHG$[1&&*; M!PQ'8RI@1N#SZN1>1%V^N8I&8XF&[-Y)9P0?-Z51G]((TV\D0)#EO@803-B" MSH4L$\*$T[II-#N_WWV0I?77R]ZH*I]26JXMX MV0;0I/MZE>)RA7)8D:H>Z#/^.5^#)#$C?!UZY:MP0"+S_."7?^!QJAJ2;O]5 MBDL5TN&0^N&)Y7#BB]\$0O9J+O'G]7^I1T;2UL)'D9DB%SMD"%9P4?K\]1,T MN'5J&E:].QCN)BO9^()Z?K!.Y3EDX` M,,+%GG3EV$4AE63E$\S5F- M]\R6<-^-AX_42U75]:_WOT8US-&(2$??6N4X+,#N=%4SGN3DJS1I%K8N:)*9 M5*4RU&NUZP8H-X07;]6Q'1NSYJWEHED_3Q"%#VW6)W[9PSW1 MJ8W$67S-2'\0W2C)M_[\PY_^)%\4!#E_P*0-4SGK`6[D7)GCK MW),AJ.Y7_(QNZ=#VHV><_($[R!B)*?60O'PVJ<$E?.39XPXBOJPA\9XQX>HG M>S@Z\Q_YZ$R^7)4EDLQ61\FK1)N?B0N0@U'^-2(#3X4$%SGR6T1M5SJ'BU*M M%%[SD>U,KN/W'RD#$98=ZGGVB./.Y,-91+A>/ZW4$UA.L9UOKR^C:12!Y MTO,OXI0LJ$U\.TSM&:UM52]WNB)(LW"$"Y.I$2(3Z M)75J4=&6@-E%;3,%KR\C_U8%X=M=CF@/?02=#Y<#+.,$R2XR9#\]M3L\$C&A M6OJWPZJM$T0#AAP)'4[8J".[+"ZC0N`7XE^(ZX=AW(#LB>6*@0U#7O\)A\6( MCWZOW%50GSYAYLNQ0IF/@`AE\!"N,!LQPC%ZI+X;N0!@*J2$?'`=_&3Q=218 M.$P>HT<"#CE\)2P9?F)X%#!G8`-%N\]P.#B67(-/%G+?CUSI1H_C):+T$?Q! MV&WR"NJ*3(C"9HQ@V7B(2`"3J&U]F_B@3`QYE/,8E&<,H(8HH;@$XS?8AT9%Z5]HB2B06K0(^V)U,7<[`VAF?^S^:H!]Z'/G/T M,_A",:`!A]?Y+YV#!ZQQR..$7G?3^!5D5ZM`7=O'KX]4"#I&P[W_L,^AE7-IVR#OK1 M#@0]BV,W`]H\'P.>;1#^H?"G4FNL,8WY2F0OU`,-Z0R("Z;UZJ!HI^.B=0'A M1E*L616SIJ6X5HI+H?V\3-XK!J-=,>M:#,<6@[8&+08MAH13:FFGM$\QI)SJ MRF0Y32>Z;?"A]<'5$TQ0J?<@.TUF@-=+Z`5CW(R0+010ACC,9>H\UC MQS'09#ZR03AFZ6TYF6:EOFM[X=0C+OJQ%OY10%#A)'D(0B>::CWP"O#2G'GQ M0M-CFEOJ#F9SX[$J-6T\^S6>Y$)1M.QSV-TGJG=D[5SW8ULXO=4&5#39'&)` MGBND$WXNY$$5Z%7OV;.HX\M>7KN2@\"\>G2N8=;#=16W1D(Z=/)_O2S>9)O56?N35M%?)`RBUS*.>!C/;)J66N\T!Y M#:=4F7[=Q$*^),^M]*`5RT>"E'1L"D_6*C6)L8^`:2_8']-;&=:)==K(;<"D MBC]2/UQ2S:LH`O4^8IZ\.9%FZ\0PVD4->78]3D"G^PY\[JFPO5>/L!TL"GK' M#*P)SUT:R.-N[S`C/<+;^Y+;/@5US+"I7CMIU=>ZO,R&3<6:9U)4OPONB':[ M9I=31]1NGC0;1LK0*[I4,ZU+YC(4_`NC@,M$*(\HP.$14#"%H9?L)^@#-RPE5A/[ER2QG*;2:W3JSUQ_BT42@V)"@$UGEP0,HMB*CH@.JUHIXC5F6>=A,# MN:+#(>%`3XPD2+/@O8N2$;ZTG,:@.BT\ M96ID]W'YD6'[>]GN"\U:J5S5IG$$L[SB(BRYD@D@W= M%4SP9E*<*'EQ7L4#,"SYK0ORYWJ6(Z_KNY,UQUGZBWM0U$N/.M\__/D'A,ZC M=VN7$?8YGF/J8\#"?#D/QD,$U<,]G?*X'C?3,!IF@LDU5;^; MR^967+9:IG5`)F,HK223Z\5M6FVC?G@H4W+9:ENG6S'YV7?`:7+\$4?_?_;! M[%F`W2]A;B8(->)W^"[ULVQ:5D(_-V=B]YRG!+ILM$]WSOA'W,/@+MS;_7B# MAO$6QRLJWRFS*0%N&\UW%8.0Q",.;>WHS$N&ZSO8( M+_+<;-06>-Z0AYVROI$37F*]9BG`^D:JLLAZO=E2@/6-_/6219H'8OT6<[AT M!';O!,1MDIE=*KY16_3BVS"TOT9M9Q*+#DBM-FUE*X995[I16UF1L11#O+-1 M7P-Y`.BF=P=#\3!EI2\FH11_7HE;=$O[]7'T)3Q^]1>E^/,)S1*9QWF+9B-8B?E82P!HXT!BZMYJ]/3I3 M,683'#,=.#=R%^YMM`EWE[&;<=HR$L%%LII4M6\W0CLUVXT=5+Y=)&@T6J:Y MNZ:GK!VB_-;:RN^<`78##]_T5DR6S,V8I`'F0SS5-YVN24S[+69GC*^CZ&%%W4VR4-L(E$DUY3.)ID'*69P_YL6@[8&+08M!J5VU&DQ%&&KG2+9K](N M!1<^VLI"IK)@BQ#6J'YO4V23SDQ!/9Y/,UAYW MG4U2(>/1V23537UU@(Y,9Y-4)J[6V23UX#$_6JZS2>ILDEG&.:^#='7.QFX2 MW>ALDOJD;>:6,I0[9JNS22K6N6BL\^2`E%L04=$!Z6R2Q_9.FQB(SB:IHFM3 M?_='WE+!Z6R2.EY2T:3S(@O M4Z43UVXH.VY(9Y-4*IND%'C[#R?. MV=TZ9Y/!'`0K]\RT5!O;[4".QSY9NAYXTZI8+0W\L0ZX:Z4_AM)KX+6WR1/P M*6=7,QA&;3`.V7,LM*W MJ!BV[&2WU7X#%?FM%]A%=\(6>SKGK9S'WXU4,K_Q3<5E,>5VO5G-DYK5W-7N MVYR:@HXNM:_1ON;]OJ9U8IU:ASC4I&*L=-1QV"9F<34@OIV-"$FU256E3FCO MPQ?E[7BEV=S9B2/ENN1L3OAHWZ$"X-IW;!#&U,VBQC`[/%TW.M2I[$-%-(J> MJ--#,96E<]R9'\MHY#8**L#,CZ(ZK3V.RM(Y[OQ/L[;6XRS$3M&E/F*]X1'K MM*>E5QZYOAO8#//NDTT\6?@397]GMB]NJ>?!YV>;N?K(]1Z^]+U9J:L6\.M3 MUUOU"'6STE`MK6OQ3N1ETLJL=G%V?Q[,=G8Z!;6MA([^75UAKXZFW3KJ48;" MCGU)B&L5`/UL_))*]'DUW0SL@(KE;L_)O2_EC@YPH&6U.1]Y'Z%Z0Z.3=NL@ ML\HJVM#.LMP>8DZY"WS)X8WM(1X;5B`&E`%)%_ULIO.*^0@FCV\^+6/M MC2=C2S*WF`M&'+DEEPLY=1#X1/"H.\)N,8Q'N=[GY\9I_9=BF4VF^IR;D0B_ M4Z-05J)8%_.S8;0+9B/YZ%HSOD4Q&^4Z%],H:FB6R3XF8^:2M\UES<+. M`F1[)NV=22V.,Y66TWT&]1/32/M]@=MM,P@Y)[Z+?=&QMG;1N]]DL,G2^-QS M%!98MUP^)<"FG]S)$GHHB3?.DR/K-%(,M+)Y4R"F,*>`\BPADM*\325Q7=&M M&JUTJIKT1\BJ5QHS6J\LC,R4;32O:^XF&.X)FO=Z.Y>"A0HH[7B!BY&0^TH" M-H[C[GA>5`QL@1P:>+)]G*)'[-`A7DF/]-`S1BX6F`VA?A<)*NO@M))^:6KM MVN0"_-69-J=V`%,]:K0J6W\WBS;_/)F_F1?SO_'1_]I^8+/Q3/>B54+K!&P; M(S\(XQW:6[$0(DV;2.P`!;KFR!5!^@ZC2B7\?>9_?NL`KA1&G]+Q+^R@B2K)PAPC`R9ED MM)OB%FK-CR\`07U9;]8?6)DS*V@?>2)N(+]9T`>;"EN'!MCVQ``>0H\;FI<] M&@$G=C1\Y\'CD`@Y!R8&$*;W!X@&#,F>=X@9%(8Z!1CG$`W`WOK8QVS!UH@? MOM$CC`OT7S!_,#:0^W`$6A7VR^%3^`4\3!Y+[N+WQ(`P]]7W.##B3Q]7T!7U MGS#CV!N?R`!@8(/ESIC"+R/,"(8V@HN$Z,"10"'P+#UHA,`^..+789H!,8=/ MS.8\(\OMFVM]HGD+#5]\;Z[U%70_(""1F7(LV_=:C0CCIRW\F#.P_3Z6;$L? MN<`V@"9M%$F7B\!9!)Z8>%/B$T$`23K"/L(^`Z\Q!"-#4A+43;CR'G:EF-`W M`%86^,:HP(X$.<2KVP,M<\-(XPH00EU'A/<9!ME)H0!55U+F$QY_C?0Z+"U+ M7KM!)#1T*X7E$(]$ET`*M&5`G`&$E'WH.N#>C2.HM)JX@XI$!MC'7C$4$`O\ MJ5%\L1F\'N]ZJ5>6NNSE'GLC+Z3PMO.C.=&I8QO:_X'H`*P`5.T+=L$D6>B/ MP"KE)PX.]A4S-L/KI@$K*X0Y$,#WN47_\V0.JF+%X20;(WN[$MD43CZ>X'C68# M<%WF\0`Y9F#SO*ED!?$CT`&P&;N`G71?!\B`,>77L!/R((=DW:`T_7*>0+Z1-WX!>]FG[(6T[:8`+/`6_#/ M0P)@P#4NJ'97#2#?NK@E9>0`7`_D^A^3<%M_3$D!"/\,*B@-%VN44>@"(D7V MX7ZW=D@8&J4$?)9WBX3\BFV)?!:JV&"RW(ZV+.:8H4C1TD\C3=X31B-IP"LI M.\T-)>2',_/#-YM',CM>X'L!MY74W$"P[Y2;,K,N8H&K17;(_F9Q@AO2Q*VM M`,)_5WI8[LU1\H9-GGLD8F*3'B^DNZW9[LR)DP@E:1$N\%EP$G!WVG;W'/*O M_!L(*6?LE]`GCYL>*'1[#J9%PV@WBF,/V(E,0CY^.K2@3&M.77UVHO6D32[^ M#D,!,O_TGL'9@T&)B(BI%>*J"#P?O)?EGJ`!4/`9\4V26`^@;@CW^`OFAV6) MF"Q'?,7GS9FB)9*4@8M$:9Q4_.;#R&JX815DQ7.SXNYP#%X%8RC,-Y(P>!5C MY(B(.`%XP$4.#4/0)?2`?5W='GF,`,8%H@6`*W.VV.>^;\;@H0LV16*B)>L= MH*]D-EN-S5O3L$."8N)"2&8Y-!W#(QCZ\FZGJD^?$"YI)[A'\"(F9D/M6 M,+!+1,#0I@G3%/B6`?RRW.P1IA=&:;2Z&:@8;S#B"T[RWI%Y)KMR=T(:MFY& MDC=5(L!:V1-)KNU\&$NEO6&V]A84!V,(][R;(&"3!>8F;Y:;2V[)DGUTPS)L M:3'%[S`84NNC>\N=B:?AWH$-?R!V\#N!N.'%?)JZG4]3KW@U$[^0[6C+/K"H M:8,^P]=7U\;5;\J4O\!==?+,DC<.TK@42$:O,,I.S)["2!WU"J1Q*9#&K<,( M1K_@#H;4M,V;Q\<`@L*(?G0C&!U#VTPPLJW75Q\CNKB6N3]M0W83WG^9W8/+ M:4H.;].`DF1]I-<$=^_,>.YG,(LV%2`A]D"U:$E;;[ M_?'S!];QZ50UMCM>3HCMKL0+F*DLO\QN`^_)9AE?N.NCRXJ"X&$TO'&M][,9 M>X?TQ#[X"HAT99N91O>5T8RA+-HJA>J;D21U-T/Y5-E5B[:4R7].H3$H!K$(2A\J M.(PW[AD830FA!C9[C.'H_%I*&ZF\X!T36H(IK;\) MK!ZH0/3L"*H`5=#/A%1'81<]`=5>V#N3<&JO"C#:$0]VT3,9"#O"CB0C+NQ] M2!!5VBGTM%J$R0E-3T1&FCK46K%;:`5%-7TDT-T\H%3Z!-_-0^F]:U%K=R/+ M4AIN]92C2>\K/\L8G?(E>3BJ&W7TI5U?^LPV)ZK)E7"TK!>8Z$/-#CJ]F$:=M^ROZ6G4*?H; MB1US5U?.P>$H(K*?/)R@'IK70_8_474UT@+8R,U0B:JQ!VM(F2E[2:EU*2IR([!)) MJ8YAW2TJRDQ?B:BQ!JEH.E!&B]25Z)06K_25$A.[4I2 M"49.ZND0K+4IJM82$I)0ETA(P/248"2D#PS5Z&QRJJ,TU'VDVT!#K4M#"48] MZF"DCOJ:A*H[<2N-SIV*6I^SR?)/4D`BVH\4E,`I]DNOSA-1$4UFEY2A_$LO M\DLMKCA`W%O'/0*FCH3C'D,?:KFYIW7IHQ;S#7),*SA&P,R0 ML"!..4/)E2`YLFO16GI_1]I5-Y+'0INOKQ3^&.EX6F6[V]+V'W__&YV#]7V+ M%]#YY9?9NFSH@QQ0&)H*5[!?['=JR[ MO_/NI_>:S/^XDF+73B[\-_S"/K"H:8,BPM=7U]K5;\I(5B:R+*<]>*'5*K*- M2\EF&+)V=M%2V+1MT;23HJF:,3$N!5M!V::*,BXL6D!)&`?+;Q%8XN%T2T-OLU)0&_,_\9V0"W)MEY??8SHXEJ6%>-J1^R;\/[+[!Z4K"F9^M6W M!57!]'3@ZI64.=NO*O(D2^2CT!Y(/!HJ2BF)X_#ZD1#_U8UIPM@0,2;X$LUI M\)6:U'YB'!!^IM';.`A`/850/5"_IBE3KOY";=8C9GXCU31=KDO*6[)DU]6" MWDA1M4RY=ALI*4A^?'0N1DDY-MC5952Z/IIDBI/55"6A\D,T,J;9AIY+IG@1 M.S#^)L;VUEOX`9T#*<+(G`S8__)"9GA?9C!05\-.24>*DHW7+7E^@"$VJ%%P MF&NP08TXM\2V/KIOB6]'Q*D&K:JI4WG/7[/;*2M,@9!`'W'B+2[+'W$8+;]#M$/W+=NG-#SN\9R'^_5O0*&@L>,O">9BZNX'G.(O-_.D3/R@HQ\"@ M]1[*%V:A.5$<3WJ-XJJA?U`7IIH.H'AC+6S7#B,FWQ,M:)+:?CC?3S0_D>`[ MC6SWD>,)D_C(#N&O8F!.-;51+,LEUQ1-FXHG=CL9?C_L[R&2U0E>U9HE^(91 MK)?@1Y-FPS=!P*R%W[7]3%PS8V7!MP"&-E+$$[N=_*XBE#40O**HS48<#<-8 ML-R+=N)&<=\HV8VJ,5>-#'C MCJ/T8>])X(('A>M2I04KFZA@P(>Y177/W>H0L-D^K_FH8L-OEMD/V.$\7E3V MQ6=/"+,9KF.0YR*@PZA]HG>MSZ*;6;LASS6"'+X+GW:MRX);6;L1SS7^'X9\ M':#O5AG9)1`_C!*+5X].1YJ\%\!FA8#'FBI2[JG(DTG.EFJI*E:,D6QDM9A= MM'NBX0(]528'1;G'VX79H1U^F:75Q:#S6\^QS67R_^NE.T4&G-_2M5KK=41; MZ[:2U5/)ZC2VA"K].UEOMK-2[]BB*[Y2I)5?\QN=D:=># MYUCID]C%KUBUFVTFDG+T)&\FW08T!)$X+GRIUD\_``S]\(CYDPN][N94(J"- MA4_<)>B#06^Q^3I;@.SR@_38U%YZ(`YQ32J%8L!Q(0%S@+B2T;VAI*=\?E MV`43/B,IHN^HR1O;++_3E+359[C"H@&T94DS(%`N;]K8[M-GM@M/MXFSW5\` MF',O_")Y<2#=N&X,5R1Y(LESI0]>L`"SO?Z_-1A+2H(4A>-R#:3GN6W.N7@S MVX%KG^UHSN_?$#^'#-A_#O-N*@'U+^R0;P0._WXB@3G?/)?!RL!-\-NQS*W> MA',O=@!'"BH@O$^`P!^Q:S*'V$B0'QXF8$!Y.;[D>A%-V)^`.>1`;"@56R[9 M&,^46-K9K*QYV2E3IW/RQ`Y/I*X$1..3(%$E>UQ@A])@DF9TE M^YIYO,6O2X8HN!V\Q_8=&@XD\`U^QS]N;FX'Z4;V$;CE8DL&VYVQ];G,%H?2 M#6\/'L,H`HQR*5D>,[&51TK0+'-]9J^9C^"V.?.\*+'+@*9+\1Z6&TFX(`PF MAT8T$XW$G];T5!5($(L)'!)V/B4?E<#_BS)2S43$<-H&E:S+R$/)A?O"D`3+ M]4-GQ`Y8?];C*%,"_2WK5,0SL=:O79H@O0KTV'R'[4=0*%XX%0_C?9G@7^QV<#N#.(ML_AJ"]W&^XDW]LQ< MK10I)QCME3)G-\+>#L./]T#J3\1A'G@3O25!P$:[WXD3TY?ZJN1X^Z6-Y/&! M'"=;K4?0(A74\F1O%=`%Y2PRS=;EB3YM&M`<&Q>,QX9R'C&3%\T?79.MVJ?` MJOQGG>]LQ\I4RR%[MB!GZD+!5Y#7NB9/)S5VXFP&K6C:R#@0M(B)G,F$QQ-% M.?2TW(+!+--S>2JS!I3V\IO[#R_<=(&ET)-B+>^O(L]-(&^U+=:S= MB@*6JZ90Y0/4SB1?.78`C[LP@$4+/48'!I]7/I>==)DT_M4.OP._L0_((U7* M5`@)_*'%WRB;`;B M?(3IPI-MQ;SH[`,/OC^Z(8@+S[AUR+%W(L;>!C?R<#S9!O`X+G4BN.&T_!"N MWRT=[/E1%,:#"U8%I5_<(]5EAZBI!J*6HG;W[.5&3>T=:BE('[PXR(L2VW&J MGRC=L01-;ICT'L&TOF95^[Y_;6ZZOY`+OESKU.H!:NEPD*4W$E# MWMN'L)H0Y6;GNJXK]2-14(B)O)\A>%$&OA]RLM*FWN4SLB+OY[OWFBLC3,E% M,B-#.=1,55E*+H51)J.];5=K!*:HQ2HCV2@@RSLZHT%`KW M[R&O2]R1ZT3+]8E9-%^O3??>EY22-/7/6BHZIWO;QF6W45*.`K8%`T-I.0"V MI!JTMLUS]]^JO-!2%9$*O*90CIAX*8D^0R!0!T[J5#V-TZ:QBH(58:H<^CLN MEQ_`TY)RG3HY:KS'Y-L-E12AZ";XZC2O"`!:'.8$G5 MA2IK39,+(%6G1>42J@W+.2K4W!5>X)$<0K02LU`!WA8(J[.9Y%_69Q'QHX0D MDSI.>@K5ZROYBO\=^L1<_9W>GYZY9'J.0_R0OEK]\FOR8%T?#?4M<-=@[W;V MA6.K(\_?.TAJ_.J0%U-O+H:/6<5R8HK4NB;)`3B2&_.BZ62M MU`+"3?[$4/+B*(Q(4M.\*G=."Z#_0OD22[Y:)KDXC!_^H&;$:J@#ZL>!.2M06HT8A83FY>6;&_8:W^N'=+0?K$P\_96NJ[FR>F?%P:K9I(T"LB.7+OJ+`-I,59>RV M9/70WH=L?$V77:P;2Z5A:P&VNDF>26"%3/J`SIRDR-UVD[N.=17`)K[OV.9Z M[0(OPT\/4DI%6-!HSD!KTY*?-LG*=#N#\=-[YF;*AV&^=!@\(UV"9F[6.3,E M/7"F8/;RHG;_8K/U-5XI1W[E.#)\-))UVI'>BC[2/Z?44?F0=M']%'])%Y M^H4^VCZBWU?TD7G.@W[EMT8BII1(''DK]#3Y_!FEIEYFK;0#_0Y]`NHQKDZX M$8!1M[+X#DS23WQC#;DI;?$$,^_YJR31>N$WNGSEF_3)XSL2O><[$AUH\B&0 M_I9GYY_L%G8V..I',K$.PRAM!H7'+W3"IIWP,]L53$P?[/PPJQAB#[/9"JUK MW%5+N7RVTS;C\V7UU[3/LX+,2J/AH:ME#X45E26"KS4P%J)C-.@86O_"1'0- M=`T<,]`QT#$N,F84G-:TM2;MTKZ3)V7(R\%?76J$;YC)ZM''EGOQMB](;B5> M;B#D_7Z;)_R`C30BF$TCC8AAY4@C2",MMFFD$3&L'&D$::3%-HTT4B/D74VT MU)`U6ZW%ET;G3KE\CA?L;#40'%^L".PKK2TH[33>';5OA+>?YHST@?:-]"$Z MO,*:,]('VC?2A^CP"FO.2!^86+E`IFN=6E'4L^=6-CN4$@5 MZ^3ZV]4FI:IL;*@._0`CI!8!C+PB+J\H8QUY!7D%`Q@DFO,2C3X8:1C"(-6T M$V!D%G&911N,)LHI9NEJ]J=-.S/4L1%#ZXBKI=G2UM(3OFQ!>!%>$>!%\2`Y8]-+>U43OJ.LM;!?7$V&D(C#>HL#;47-&>'L! M+Y(#6B_"*QB\&$J@.2.\"&^[X$5RP*3'"Y4WJCXTJJ0]E,DE5OHD.P]32R)/ M-""/5')C?JR*-]M9\".%<:8#'1MA(S1"H/N+,`8=+290J:#L7*R:K[G%BZ*02/` MR!@B,(:FG)RF=#7W@NML!"'=YP&U'ZKW7\`IKSD@?:-]('Z+#*ZPY M(WV@?2-]B`ZOL.:,](&%+6=71S,;V/HT2"I7N`Y_^J'*B@X=O.1YS:W7'.[_ M=BG%-)@\EH=R=U\V87`D/+S(,<@QO7<"Y!CD&.28BARC=G>_;.08X>%%CND# MQRA3++/!,ALD,D#[1OI0W1XA35G MI`\LLWE9'2TX0^N=[<01M7I2/2/:^8G=9Z2.(]Y9&T>`^VK22")HXT@B[0!8 M6)-&$D$;1Q)I!\#"FC22"*98+I#QNMRY1)_C!0WP5"+1?:6U[-1IO-&^$>\N MXXU\@O:-;Z-%AU=8JLM'9]=?X@JH5`"/1](%HE'%W-WI`HFD% MP$@T?2`:?3#2,*9!JD&J0:HY,]5H@]'DY!9Y78WB MVBC1O079242\T;X1[R[CC7R"]HW)%]'A%=:2%T=A1%S6H7YD M;&K1*9):9<2;7*,P'4S'2R@IY;N"@&W5F`D4+:32&:9`[AX47F:"USZ..3,4=7LROU[@NLZ@WF5P(:1H%MLB^3VI?8M:.6I%M" MS[$MZ2>9_].8'GO%86>"O,D`:-S9^`58,V6T9E0D+>()6I\J!' M[Z1*&;@H]HP4@A0B(H4HTX$\[>X")*00I!"DD+-'(<:H-]6X2"%((4@A9]A) M03F9V.U)6@:/1MKEJ!+M>S>">".G"(0XVS6]!=T4Q'`M_O1#E17]5\MV MXHA:/3E)2;02OSP:_/D,JA%P4:9PI8#R4.[+QGF=FWYU!6!D&F0:=`1D&F0: M9)IZF$;M;BT.,DTK`$:FZ0?3*$5WM4G^)`\.W7_8ZMO:_'7=G+_S^%6[B57! M?:^O%'Z3=,2*=H3RR2.]?@@H^7Y-9A$-7A'GF2S#K*(8OTJO,KM5I33G"!K' M?-=V+>J"D97>S3B7K!^\0*+$G+.]=:(YA?\"2@_4:&`Z>2]Q+4D MEU5;_3][5_O;MJWUOU_@_@]$]@S8`,?3F]_2M8";IKM]T#9%FV$?`T:B8]W) MDB=*2?S?WT-*=FS9B269LBB9&[98MB3^>-YX>'AXN"TQ>Y^=P0W3XH^QN)X; M.-NEAO8_28"33@FD/\@\(KSPD:D5?[J##$TW$",5?#`[Z)&@*780)786`8,!Y'R`YBST'S(`+)<['G+5`2N$3^COAF!]W%$1>:=$O@)`QF_!I3&L^@ MR^2)A+9+22I<\&&M\4<2$KC#]F(GV4G(GH06YG'$]Q"RA]*PZ<[FH17VB`OR M.YD0.T*/'/P4/Q!T1X@//8_<<_X&]X%TTWCEG;>'+9.TZ@3="K M#A>!;0<^=2G[.56Y2>!YP2,#\@NG0A!3`$9_O1!O1]8S%/T@G&$OMVDI8EG6 M!KVEMU*H+VMC7^(+Z)KV\\K^\K$+V<3S4I_H[9EVQJ_I'-O+Z_3Y=(R'`=S# M)"\&DZG!(/[SFX1JB2>QZ6+M65(!QR3CN)C@N/0EJSV[= M;"D`M0(?YO%BZCH@BR^*E5#)$N*#ZF:W)]OT0``KQ;!.W-1L6X&K M)KP2>LEHK^1>R7W+::^,O61";RG:"Z=])N;6ODF$J;5_CQST&V:4P![S['4E M,D;B#=C!1;]$<&LM7&T3/R)A9?SBSR:!F(N[P'/2\E,L&HF^L(@=15<\C+8> M%.M4L.H@^5A4EI/'6V\KI#6B39S2&GCZ*_PD2FE:/Y"=_&;OW=.>`ZHC"-=# M`4O@M>@A6W\YB%]YITH',DL&=9(D'T0I0X7*8)Z>NZ;40:F#&AM:HPP[0F5* M&6H8&]2L1,U*&FK,!.K:*2W!-'[H4-*L%M*50$M/7QD$6IGG-GCV,M"W#FDN MZ)OO9(B,[GG-^][R..27Z^?T!'.6CE[!T<@RYDE)MS%+[UC#O6=<-=:3:=4> M4"7/>>39$'3NM))F);O",4J<3]HC5\)\:L+<:H>\7>(L-E3>2G$N M[H\GET6K,AU0SV-#3@Y)]UBAWUN.I"'51XK7IX(GUSF&UB]^_RVFY_<8SR^N M<.B#QM-O)/S!*L'<@-"]]P+[[W?__A="OZ]NX]5LW`?RB5>.N<%/WW%$+J%1 MUX_A^>LY"7FE&G+U9$^Q?T_84]?^):;3L>^P/U?_Q"Z,2<2/#I%X8QW].<`W M8*C)HL^'HB+\KU-_"_^Y/A#5@]G<"Q:$?"<>/.-\=O&=Z_$B79=Q&,+]&[#' M]/9Z<@O4-O5\A!X:EK6)=%][A\/+3T9=&_2%P/M!P@?7)MRTO\>4.)?!;$Y\ MRGG,Z/_1"QX3)K&K/^&.F^`'B2*/C!]QZ`@5[O/12-_9J8-1UM'YHIHQ8@P] M0N?!M$6+OUR'?'"I[04T#D'C_B#!/7B,4]<>AP33SX%__QFLHC.FE$3TDY\\ M12_!?XW"Q?7D0S!S;=+Z4C]+,!8RSAB-[^3!^+'Y`O^;Q!>QA1FIB0$1YUE3;&* MD*[S]NQ31&;GFF;J9P4L]6W:U.W&F^GXR:6W9!I-;\QE^RQP"[^)X;I7.X^;OC#U?9QC:O&0"A76=^(,R78BZ8VC#:Y.V_6 MTGE3:.?_8J4Y`]>/)._UZ(5>[YR%MDN1RW6QH"*/:N%J3RA72RNR44OG7QJ; MRG6^(8IL&J^;K\WI@V!%/IZ0"^QB,44V=GIAE5!9,#>[&4"'X<@.U8G"\8N+2,;UA?7 MR3_@#2'VQKXS=F:N[]*(07T@5T_L'46F_/NCZJ.1N@):!:$#NATNV)A"OP8^PQH&G@>/ M?F*[.@F-1"KO2.]O\J]"W#43J)S-T+7!Z$0(5,Y6]4UM<"($*F)WW@ M!<^+**L\I"(2\"Y-AEOE.ZTEQF7/4DJOPU55HK-]F6+JX*I]!U=95K]KK1%7 MQ,%5JW?6ESS[8M5_U._V-C-;\V09[DL#;<`Y507W;;W"U5+4/'+EZB`BR$*< M5#\],4/S!B46"W&;UR3*B0IEAYUV":_?0;%?+TKF@:O1O?IC*7?O MW^UU-4OFO3$';-_M:KWF#_9++J[.T##VG*&A];H#Q=%CG**5FR6ZUC5D.[?^ MQ%FBF5U-ZKH%BB6*)?4<_P?&2K&A=C9H>G>DV""7@;*ZNAK&:]<,Y4U)P08V M7*MYAF*#8H,R2A*>G]S(:%>OVZ^>2VDC=9_UTIJ`EC1,.]T`U@FP0/;HB&*! M8L%I!J1:2G;9`U#-)7MK`D[-98'R=N0CN^R1#$5V179E9.0E^RD$B`XZSF`_ M6Z2)"8WV>$:FT35%\TF&<[?7&57W$=PW/.GU2Y*'>L7S4%=9I2Q'M!2'&SWE MJ%/[RL\R^OMT2>OV15-=Z5)F%P/\)$J5U#C7GG'.W!=XM[K6-I\./(96*>>F MP&A#[K1M81[98H/[9C+U^@W"::T MLC9R6!M=>:.UZ8#D&4X-]WP:'H1JK]SO3C%3M%=Y9CLYY6'F_U6[_+X[!"4CQ_)1F1%YFT-GT.ACB.=O MSY*_JS*$:T4*)UZ`HPO6R=6ORV*>>D<;C)ZM8(NC3E4J2]/B3NWE1`O,ULX( ME8PHWP3PU;@.E=":IWS&UP3Z3U-:`EBS9N7D4Y-N)!["JRT:4UKHU.GRU MBU\UVKGAP#J)T)4L)NVTPE3*.#4K2"69<3+VNV"-#5$UUB`I(]0F(R1A>$HR M(V1U>D:OM<&IEIJA]E.Z"6:H<6$HR4R/T>D;_5,-0HD.W*)^U:&HJZUC/4\C M!"5QB/W8N_-D9$2=T26]J_U\$O&E!F<<*+HWSO9(&#J2SO;TK*Z9V_8T+GS4 M8'NC;$PC;(R$D2'I;(PUZEJ";(R$$8O6VIA3H'6S]M;)2/PZ[0H8W[UV)1/X M22[QG4>R;UO^ND-B$N2N[Q`?.CXLJZ.YPB,OU"Q:89]+A/4Z#A'9"N?`+2B: MPC4O\(U]!VT%>/:^V8=/Q9]"LX"70":\!'+QYU=%DTLT;6H=Q`KMH4=,T13$ MFX1``>S#4SB*HR!)PG[]IED%#DQVV7H`A^!32@*F#J>0R]BH"T( M*_*"N[L%&#E$GN;$I_`$>PM[GDZ#,)I@SZ,H)!Z\S&&/TRD.R?D=IG`YQXL9 M2`/M%N_6*Q6TE'04EP[S6-+1`::'D0M2L4#!9$))A.X6"/-7WA&?3-P(I(7& M7L2>FH3!C#,E)"Q5&MX2P5M8MF`PX=\OL<$C!(?VE+_'#HD#KP%&!O']%'V` M9Y."XWK2UZ[\!JQ)QO9#'#)>G:SN;)N!S1W0*IM0ND+>I8J MQ5X;"J^+=$W!"+F,15E_2C1J-&U MRC?:8?V?)Y;=6W08$<;@@T?P$U#V&W:=\T\^NL1S-X+KU.+;`=,31DSXQ,M$ M<$+?80_[-@%J$P)C%#IU.=\N,]H6.=>Z)?IVJ)Q;ARA7E7)^,X7!%.$9S+&` M'<`!A#T:(-O#E+H3-R'Y*^_C/.6\8NRP,9TB=BHZO(HBF/5-8;0/$P\!B`=< M#N8@#GRX7[\7B`KW8S1Q?4"W^M7UV>_=)HV/SUA1,V$7$M.UJ?4RZE&LUYN- MP(O>GNF)[&_A^&UU\XI6!*1\`)[CWA!=^$02^R=U):/6/#D M>FP!K5_\_EM,S^\QGE\D169N\-,'E]I>0..0W``QWGN!_?>[?_\+H=^W[KQ* M'/SWJ0\/%H&1[SN9O#V#@1,S9;_5X5_F,-W>!+>C6U/C%VIFD[T&VV>0"P02E@PX%5,:Z48.8Z+G,O+J-O](]# ML*+`M$$I7'QPAVD<__O)']LV'YN^X06+EXF4-4,?:EF(K[6X/1*"?@9P2",1>56=W4A4/^0"8D!"?H.WD@?BR4QN9H MGP!G&A>)M2!MS<%HRX(>!O9J-O>"!2'?DTG$9Q??P>0C]H^RI?OPC5,#L++&-CF1Q5QP+3V*>4+(*K`7I#VNCG8IZ(EP7\+ MR1RF?NEH*I+>_=Z61_%JVP*1%J3NL&<R4#,=^\Y'(MB` MF&9OF('Y8L,'(BSGVYJZ,K*]F.43_!$$SJ/K>1M0Q_3V>G(+;#;UG+.7D9YE\/XFA8#, M3\#!L)>E7U&,:^83"/TC@AGL-/`<$M*K?V(W6AQ&1'W4-[5-,NYK\&!X!52D MKVO#H1ATZ6AT&+D,;:B-7L*3ME`"09&IL=8WR@+X&OBV""I8_4Q`8V<;Y6#D M)T7?,%ZDQ$LHON#P;\)"M2`[8^>!A)%+X:H"A\,*T"HVO9 M7DE8.,EI8['A]#K)4MO([ZLW=,\?7#\D,'D3N_F"K06Y=KIH3Z@=NO,HS:5X M'P--"=TNNB2B+1[2_ND):&R5R-8A_R'8BZ8=!)Y\%_W"%IZ>7WCY!ARI.?87 MG>?O/KS9N&'Y_(LW/)*-GX)PX]>8KO_Z*W(I7_OR"&8^1XF5V(!_1C2(0YLP MVD\Y/K@G=0W32E@@?*X3@V)T$!<2-TVMHJ`L'KI+&09?IJMQ3)^(@WZPU3>^ MBI=DOT`SZ)'<4?@18<<)DV=^*;&FL\77Q\?';DK=KAW,RBP/'[3(]!J@E:,M M';(OQ'%M')8$5CSIX!5$WSS,9L/,$MR1D`'ZM0RIV.IO/`,7$MG81_9A)T,BJ3O-*W8:J`P\4V+HZBB_X"?4G7U]&, MCT%'JY?Q5*9E`85]]_PV&$ M/J!YN#;Z.&%\GP`J#J);5DV?\T"!J""Z0).(V%,_\(+[19+O0'P6R:B$+X+.O/H\+HS;8,,8EU[=0%(1ZQHS#PX0LOR9)\41>Z:$QY?@1+;N'9 M,]2=P:LFBS1=)B1XQL>/)`$#?B-/2<9MB)?Y']#&'(,'!-X&3Y=\(-L-4NRE MXTFJ3DP*YF'`,G2Z)<2!:0LP&#J=9(1`)U.EX;@)Z-\6!ABXF%X6;ZRGE=`H MGI:29B<#[3ZX0$S7CI@.7P9>/+MS<5/22@HY7G7G$FS[Y!F?G427F$YY(5"' M..\7?X+\?/(_+O-^QLP("U]`.#>U3'PS/XY*\!==^^WINE%I!S[Y#X1&U3%@ M9`YRX=^!HQ+\11G0'YB]*O%?+]/BJJ&_/NKWS#SX=^"H!'_A0,%@D(O^>?`G MB2B?`RJ4Q%9_6T*>6RH,HER`RM!$8BBYSM\?;JGZX80H*C"9;*U7,3RF.1T@ M-B!//GRTDY36;P&,KHOD_ZN4.(F#3,Q?.$]W1N;?%2F%/R*]>_6=;TH";WOL M!',VP7H6&A:&\1T<.O2PX-=S3:K_QW[,IJOI'B8^-\!INS`WQ,]-TV73*)ZS MC&STZ(+;[0-=[F/7X9YWD(2,V#P,>H"74<"0+).\EU,7/H.'=\>S.)E#!BPS M@4\\0C)-)Q?+JNT!-!*E5RP`Y=(5%GCU/[$;R5?/N9ZN(RK^3R4`6T4?$47?4I?P*9K&]LW5ILQUK;? M$>2X#FL,3?$#VUNR$$F5DBG#[&#^>N,QD['K21(2_N3_Q3;.7''E2YPB4@A/?QV/=O:N MMPYD?U.;V%9>636NUTC7-]>9=[17$E#)=4(MXZV*`U3.)^N;E0$JYY]9FED0 M#[-]:1J(H)7YH6YD0.QJHQR,`JS1AD8I%)?KX\`SV3X&(3@S?I+>`(8RQ#[% M?/O5V'?XE<<9-W;^&].(&5;PC:\G-VPKM<`)YW:7A..MCR8EL^Q:39.2@95, MR!#;>#,$4+EO81P5C`,G[GLZP=/31Q4S>&KT-_$48E\(M.B[*K.J7A;^PR M@?O6G'@A(VF_GY61_2V*@%B$EH9V*,+`)L2A'\-@QA7SFN>,T*LG$MIN&H83 M-N!JNI6!NZ=UD6"+SI;[O2QMBX+=+<7@"QXHE_JPET7V8E,'@2JR5Z@_&)0$ M!4-$:@*N)Y\#__Z&A+.TL,IGMJ'L^LYS[W,D&Q>VHQMX"Z"H!GY1^10&/TG3 M(E0K\;,/(:-+N)LO#*N=9]S/^H&A4)5=RC%K;6? M5S6;HJ2*"/&\M(0W6_#BUW2.[>5U^GQ:L-H./`_/*;E8?GB3O!C!F[OP\C=9 M@)L)":^<^14%\^R!7\/N4+8C+38.7RM5_[Q0LLIF2\$#"5EAN(NIZSAD,_>C MX%E@^6MR;2Z!ERVH;G9[6OM8*89UXHK9;^N09G3-H2)\U8170B\9[97<*[EO M.>V5L9=,Z"U%>^&T3ZYS'QS/2S+HKKU MT-AU_%`54Z4#F26#.AUO?%+*4)1.?F(K65?KZ6G#[Q`AQ=L$ZN?EU6R-([UM!Z5IJ6>3(UZT+[\_[DDV=CH*19 M27-;I+EC*GENC#Q+EZ`JG3Q;YFB?-+?5+175`XE,OA+GD_;(E3"?FC"WVB%OESB+#96W4IR+^^/)):ML MD7W7\M=]Z1Y^$,ZP5\VA&_(<6":^Q,E+)50NL6?'7OKT5W:L((Z"<.P['X@? MS%R?77WRMU[+6-B"\BFI#4A6C8Y7366GS>GI72\:0TLF6U^KM*13$@HJBF:4*!=WO+*^UQ=0V$+]C#6,!8J MQ6A,)9A6N(E*-91JJ#%#*892#!FKAS4U)TW&"@7O,77MBV.-\#5;,C'\V,I- M_E][7[;D-HZT>S\1\PXXU>,(=X1*YJ*UW.Z(\M(S?S5/^`$; M:40PG48:$4/+D4:01EJLTT@C8F@YT@C22(MU&FE$L%20(@9:6I5S)CNZ>K&P M2^N%TS)Z0KR[Y.*T:WVDD_`*J\Y('ZC?2!^BPRNL.B-]H'XC?8@.K[#JC/2! M@94+1+JRT(JJU1Y;H2%\-KT%)8;C>*814HN$'C%SA3BZ$741+49YBO3^5H-H M!.0XX;*5:\JPFE2?TMJ!*",V`HR\TAY>4<<5I7='M4=>00=&<-$T2#2#WDA' M%P:IIIT`([.(RRQZ;S11+U'*2<3H3YLR,U21B*%UQ-72:&EKZ0D76Q!>A%<$ M>)$<4'L17L'@15<"U1GA17C;!2^2`VYZ:>]IHESQ.SQ/A)Z*H'B+`J^DZHSP M=@)>)`?47H17,'C1E4!U1G@1WG;!B^2`08\#.V^T07]X3MA#G5SBI$^<>9A: MQ'B@OG%/B1OQLBK>;.W`#PGFA@]O]Z(P"`V7=:@;D9)*9(H.SMF(-[D%?]J; MCI6.;(TMJ^&B*#0"C(S1/&-,>@-]A(S1"H66%F!T.MI,(=/>6#VZ:[[C&BZ* M0B/`R!@B,(:N'IVFR!I[P7,V@A,2KA,AWC(/N.T(O7<:7F'5&>D#]1OI0W1X MA55GI`_4;Z0/T>$55IV1/G!C2^WB:":![9+Z\<^LE MA_G?+B68!H/'2E^1=[$)G2/AX46.08[IO!$@QR#'(,>D#]1OI0W1XA55GI`_4;Z0/T>$5 M5IV1/G";S6%QM*"&UEO;B4)J=63WC&CU$^5G),D1EU;'$>"NJC22".HXDD@[ M`!96I9%$4,>11-H!L+`JC22"(98+1+PN5Y?H0[2@/E8E$MU66LM.4N.-^HUX MRXPW\@GJ-ZY&BPZOL.J,]('ZC7@CWL@GHN$M:^BEDEA8,VED#,?Q3(-520J] MM;)(W8C+B!;%/$5Z'3D:N5LT#1Z.U)2AM.>O<8&J%0`CT72!:-2QO(D>D&A: M`3`231>(9M`;Z>C3(-4@U2#5U$PU>F\T.9HB3];X$*:6$9S)6AI/;2T]28TW MZC?B+3/>R">HW[@]1W1XA55GI`_4;\0;\48^$0UO#+\B#?RB6AXRQI\6=^) MI`WZPW/"+Y&R#G4C M8E.)3)'4SD:\R3,*T]YTK'1D[W!9#1=%H:4%&"FDS10RZ0WT$5((4@A2"%)( M62]DK!X]5M!Q#1=%H:4%&"FDW12BJTW"NT'*&BNZM"X/+FX+#R\R1VN98ZA-D#F0.9`YD#F*^AQ# M>1=[D#F$AQ>9H[7,,1@?]3EDC:Y4FQ=8&S087_%I$/JVR7Z,][Y$KAVV)-P2 M>(YMD9\4_G^-R;%3'%83Y$TZ0&-I_1],E(<$@@12^T*3KB&#((,@@R"#E&40 M!1D$&009!!FD-(-H1RL+R!J+V8B*C8=G1&+TL[CFE$C,5R\TG)V'C:*`6G`I M65(__HJ8AF-&CL'VOUPJ'K/;,DZ2I0:_6UYTY]!S+*L":;:,RH2$O$$JTY1> MA]:D2BFX*/J,%((4(B*%J-.>,I7W`!)2"%((4DCM7LAPU)G=N$@A2"%((35D M4E"/!G8[$I;!TDCK''5`XULEHO90%"+>OK41Q!LY12#$D5,:UW$Y.$58>%&A MD4(D0UQ2"FD/WJCAR"FM05S6<$RU)Y8NDZW7=DUO05<;8K@4?_JA*>K@I64[ M44BMCE12$FV+WRD2_%L-HA'P4*9P6P&5OM*5Q'G23;]D`1B9!ID�&9!ID& MF:8:IM'DW8N#3-,*@)%INL$T:M&L-O%'X\ZAFP]+?SVVM\7U_(7AE%.H<_:V M9*U?KK4V[4;\6'CGJRN5/X;L5\I\MTG^PR\OHN#ZWC"6-U_,.;4BAWZKQW/_/[K7_]" MR"^[GAW,X4GL?][]-[+!(J@;!NOW$A.Z`!\^T]FKJ[>1SUOR385_-$75OWWU MODV_Z0K_G6E7/'/P=(PT\^)?9O0)^IG]IW8'1B58RP#>I/^\3)^#V@,N.K`RIOM M7=>B$F%.730^68LZGQ'C["O'-@^NO\1[H#ZPRN/-W+8LNFZN!>D_1W!IBVO= MFJ;W-=$&;!&E6+/?I$[[V@#%T+08T!I0#"B&'"E-D)3J%$-%R\U"^V&3OEZC ME,3>]R\XCS4HFFZY3](`C1J-0,L%M.A.3AN`[H(;<]:>.?']&.ARL#1`.-K5 M83EI6G]0M;VZYID^96>(`YW7CTOH+&4Z_Q?*'+,+$>A5N/7LAZ"HYE(,.6#613J<>Q$J1W M1N(*B61SB0FY5$@+>QY(\)&]C3J^S?)()1>!>??L'&'&Z7FUA]HNX-BP+4G= MF,=5+I?6[[T4<7U"N+V7VK@WF!S-8X]6(9BKWPFL96`@X98YA&,@==H;':_F M):L[)4KX]10+>0^=>2+PXN\T)#/H11TE2VL@-H&#M4(%,>IPF&K!ODFV4O6> M/AI*ZS")PD?BNTNBL8H@4-?A\\A&(N-)3U6G775YJIXGD%'=CD]20,P(YL1P MK?@/NCKHUH(ULVJ2O>,,K_8EMSH%U:3;-%!ZD\%1RFNMV]2M.).@^MUQ(JIV MS4Y2(IJ.>^/AT0Q*&ZY7_!&S#13)-G`\(\"^;`+O%DO'>Z+T"_4?;)/R/`2O MC8!:;[S%DKH!SQQPZ\`CDFP&GZGIW;O0"^L3]6T/K@O@7%\1^RYBCYR#>H_8(_;(.=W`'O4>L>\B]L@Y MPN;0$CUZI&G]<=WAH^I/8E>5DF)XY%0]"RA6;5B5[O,I*[ZFC])_Y6'V]W%T M_=UV=+U[L;^RDFP@%P5:34-6\X$M255D-%T8W,I69)!C<#N6,F:WF9YY`EJ$ M#<.-VVE-B95VCF`"G5@7O\(,VH8(ME$L;9(4WIT`TD)C::6QX$""`PG:1A4# M"6HPOT@/2@W3PHOHB M/32.KZS!C4H.P=<;SGCC+1:>&Q\W)=Z2'3&M(UN*@-1>C7#:GY9`P.V7PN4D M&*OC:A*CH!T(X?4@XL@\[6">T;"BU-_2V@$2#1(-$LWY909ZRGB$5(-.CJ2( M(_>(S#VJHE\BV:Z(0:)&0W2G6,5G&H2^;8;42L)$D6O7DE*W!A83;;.94,-& M'=PD6R+PD7:T\$EKAVB9=1O)!,E$.#)1>]KT:&;;3M.)(,J,[('L(1Q[:#UM MJ"![M%"[D4Z03H2C$QWH9-+5H$N%Y2F6%RMO="PG_*5",H+6K,#8LLC2:73: MI>L5%382T'$2S1@$W[6,#(0,U``#30<55:25EH&0<)!PD'`J(IQ!3]=P-P^Z M/,A`R$#-,-"PIX_JK^(X8,7ETCC,)18C=RJ M\P6W@5<5*0U(?."9QF^7ZD;@$7A9@4>J:;3X%"H]LDV'@$>V08U'X!%XI)JV M`E_)OD#!XT/:H*\,:PX0G;W"456]I?:712LIK:8K`3123%#HL:BL)"^W?(M6 MT[35"%=,4/"QK`NE-;"L3>-F65O)IQT#%F;6Q9)/+;.->FH'"NW,H6F@:>"P M@;:!MG&I8:/@=*:%^[8Z,)&_YWR16[T1<204`0EEH%56M0_5&PE%:L214$X@E/$$/91V MJC@D%"$U&XD%"04`0E% MZ^FC"5)**_4;*04I14A*&1Y?.Y(U+E-)7)*D_XYJWS7CA88#5WCF]^L[(Z!L MX\QB2=W`"&W/)?0'^_MB\9HS$D5I\+OE17<./<>21(LJGR+"BQW.%%0ZC4:@ M=?UH!+JUSI-HQG`)YTE0'4<&$EDZC3+0=(#[=)"!D(&0@1K:)]C3-7D7N40S M!F0@9"`AI=-D9L">7OAD5OS1`"@VGY;^>JR,DNOY"\,IIU0G:=2&K:>JE;5^ MN=;:M!OQ8^&=KZY4_ABR7S'SW2;Y#[^\B(+K>\-8WGPQY]2*'/IQ]FZQ=+PG M2K]0_\$VZ9>YX=/7+&+T)AOWK?I-UWA'ZY^370KZW=.SV)I MQ_;$1)Y\CNUCC7HV;DQM5GF6*2C7+V)2QTFXZ]654"@%#._9R\WVKBM9T8BJ-NU/JR[:7>DIT/K+GZV_ MR7N@/E#/X\WX^)5S-Z#/M#T;RI"D19C>CJ]ZM&B'TS MV*/>H]YW$7O4>]3[+F*/>E\+]E7LSQ!]-J%?;#:AYX(DB6A*31^2M[P!U.]\ M.S^EP#E%>8&6$V#'QQ29L$:]1KV6$6O4:]1K&;%&O48?_]3I5\G5XR)._MF+ MQV?Z[-#O8&F`A/2K(QRE])6JA57+Z84SUOKC=;13Y34M,PM[C!M[YSE6[EG3 MM*U?YSZEY#W\,`_(.]>B%OE"ER%=W%&?Z$JO^GF9Z&./N%67T82$-*$/<&%5 M%H2CG!RC7`F/\,S"\VB7FW:I*:IVJ>'K3.&)8%ZE9=?,!`K-I7IST=';$\_; M0]L0PC9P*,&A!,VEIJ&DX+0'!(=S'ISS""$A09@-_:SV#1R(+ZHOJJ\,^*+Z MHOJ*B:^L"PHM*/+WCP@>8US*E191'`V>LU:GSZK*\R`L^_)OCQ)/FR>H MS:C-TFCS"+49M5D6;=:4H]HLJQ/>Z!3H%!?\3^HXGSP;KGJN_MP-3URP_-JJ M+B_7MR,"@)IN&"3W;&\-(]1FRXILGI\Q10U&36Y!9J,E(R* M+(4B']\MN^%TQQ^+UB3BS;9=B[K0ZTE9#3G)5]USF#%K^UI%HE-*XZS]3O@% MQ\KE9`_PL[^LM(0.%\.!$ZU$'\5:079V+P,B@_F8CN:/DJKJ\-D:]MM)FCGF M+W.RNUHWNKP`-HJ!J_P_3+R'VU2T26K6C*WM/"L57:YKJ'4*\DT#>M)2R&G$ MD&U[6O)M3X83>/`4TXDLN,L+Y]0GIN'[-O7AXZ-++7+W1++K^\57:`HTZ^CY MX@V1O5C9S6&JDR^:4E4;7U;J[&G<%F-E`$MX^&;]V:H?U@AT^R%#U=YXP+5SD=3/K* M2.3@!58Y+1"'&DDHRFI$5W,,4-'Z$Z'7>R7&7AT)'G^5&'O4>\2^B]BK:E_# ML5;(2IO">[28JU-P/[7=R]'"#POMAE=X;[/=\*+V(KSMA5=XMU!8>+O@^8T& M_:'(GA^_-Y][OY6N8*7U$LJ*K,(2%:6$]B'B]>$^1F$0&BYK>O7"$WTL$4!V MXKN>:"WW;$,;^X):U[4T)QJ+&6JM;V4J0#HES*MV_M[G]X;(26_@R'9;F";Y`_#B0IFZXCSK3]F"W"RO#<=P34J\E0-"C(!X,_*6FDGM6K5'ZBE\MMNK;#B?OW`GH?6) M6M7I(N'&+;G.]>]T^U"=-_+D]C4-]?E47R"&7!`%WXVXD`K>'.2GC+I_JV$L MW1G1%%(V#9*/JO0&H\$E$HN(Z(]6$&$FZ;^CNCW3O_L&3(.L=L0R)3L&/#QN M(ZT=HMNQS-+I)>YV^3^(-^+=3OJ0=!&\`766U6.L9')U.9_Q#QITQF44;F[U M7!UK/TO&]AV(3\H`,#HPB+CLB`L"L(A.8VM56E:WL56!QC=L`=QQVN(W5KI; M102W45-E\QIEBA$(Z#.V-$;0:75&O+M)'P)ZBRU59UE]Q59ODOQ"EV&R2U+A MNR3U2SF19^SLT.!WRXM8RJLSW$CAXH_C(>XK:\>@(*!/*9PV:_WA$-59M$$8 M$9=QEZ2(HFF2>@8];3"Y2"&(_(EIU_,7AE-.I4[2I\Z5@BB<'!?T-4U@/%J% M8$_("9V[.DX)733MLYJ^YB(E':H'YI@"%C!G_M"OG1W)>^!'\NR` MF(9C1@[\:+&I"(T3LW,-_^D'S$.F+^$2QPO85"5@:7G)TK=A"K/G;!>!65N//7))6=9@ZCS5 MF[*:Y,A@?]Z$LI2R4M<-53TG\_5VU1QQV;/^W-:5Y*(NENB:/_+CDOT9B)3; M^M#J6;DDZ85SI)^4/+G\0'LL,W="^/'!Z:83=6O]\41L%Q-3=9\\E9OV!X*' M*MJ90/3DB;2"Z"/Z'41?K2'1":*/NM\&]%45T4?=1_01_0:89XK^OJ@%`P2< M66/:V$M/GS%;WWV6-I;M0.*A]R0J68,$!1R.!!,@)KMLG?FD>61)FD?VW0_J MFW9`R2>V2H9FU`8SNO@4$DWG7J`4S&A.."H)BWXIT]J;@KGXOH2M731=G9^U M]71!>(G\R[NG9Y@S#A=>?*I9"R:9!\!FIO M-#AZ3%C6R7"KTC+5EO]=Q#V]@N5D4M6IM$.T1-E59(6W_8.Q@)MW!:,83>VK M1\\8HQ4(.`L0<7>NS'BC?B/>,N,MXI[;EN(MZ\2U964HTMUD'9F\"A?E>3[1 M!^?F%!9M!.C`.JT,`./4M0L$,^P/Q]+.744S!/EGKW(CCCJ.B,N.N(ASV-8B M+NLLME7+KS56Q1'^5*@`'N;S\VLIBC8"X,*K\/#B[%7^A5=UTJ^P4`):0;>G MKC+CC?J->,N,MXB3UI;B+>N4M;W'9R]1F:OR\[.25N;2>NI(W@W%N#+;"H!Q M;MN%E5EUU!_)NZU8-$N0?WXKG((/^AH>GVVG?B/BXHZM`DZ%A:,>7>^-)P,\ M/"OH1/@/&O!J<*Y%Z`]61@T^A!YY@*^;FQ`?F-%V=0$&9L.*O"XJKO(*#V_[ M1VL!9\*"D0R;!U=7/QRMH-NS8,&4>]!7Y=U^+[-N(]ZBCJ@"SG\%(QU=ZTW5 MHZ$W66>_+5@(3D[=\H+!C2X`BRBI)EW1GC[!U5\C5BC M)0C)/2).A(53<+T_D#>6++=^(^+BCJT"3H>%HQY-.\6QWY@0QQ_9'&WS<>FO MFPHU76:G7N,NV*Y%W?!&T_K#LE/*D_1JP]Q3!6+TP8@?$-!PS<@R^ M(R`@(5QNV;,9]2G;*W]'PT=*74+_00TGG'--_^F'IJC3EW"GXP5L$WW`*\LN M64%,]H@MEJVR.]YLN]X5W\FP'<6IMR'LG0PLFA8$C?L/[;/=:_CA>@$\_42\ MN-XNPP5^"N<>7&D!V$&_UM;MH:25UF]H_(L5;Q0CW4VRW;)5U_,7AB,*^R[7 MP89WOKI28YK8[QSD<2#Y#[^\B(+K>\-8WGPQY]2*'/IQ]F5N^/2U$5#KC;=8 M4C5;,[0?[/#I*\/Y*V#WVH$??_WK7PCYY=#S/AE/"X#X]M'P MK?SS6.4__I+;((@6\7?KSR8F=`L^?*:S5U=O(Y]?_4V%?YB=?/OJ?9M^TQ7^ MX>K79)#*.IL;L&*9QY[,BL`2WV2-QDX=Z8Z,:BD-QU46LV$K\8G`X7&,94!O MTC]>KD9,&-">O=QL[[IF'8BV;X^1^K`_$`%ZDHO_XF[X'ZX/,] MWLQM"RQ_S8C+%+F,">QD_CK-9]^6(\RE!J(%PRJ08S5RJVX>NPV\B$&:3@"/ M&H_`=PMXI)J+`+\O5HE*CVS3(>"1;5#C$7@$'JFFKGQ(4_OZ ML.8`T=D+M&=&?:#?P=(`"0VOCCBI->R(JC2O;%EIY59NXY!I;?+B]S[&K;WS M'"M=;/(I)>_AMWE`WKD6W5B7J7X!7O2QJ*PD+[?U!*VF::OY`#]5931=&,LJ MV&V4R/E2H]MNN57&M/.E)<(!MC`H(:VT:!M MU'&02G!_#TT#30.'#;0-M(U+#1L%9SPMW-I54I)M"MT576Q`5JMQ00'![<8R MF738HN(B*X@%+LYAD1CD`1>)`=T%B;!%Q456:!9<65=K6Y$$+LU\3OU%-]8I MI*H_)>)>R#8F11GT1UO:?_0F\D0-/T"K:9W5(,!(2RVAI>U5(*0E6:T&`49: M:@DMC9&6.F,U"##24DMHZ3+>DJSQ*N%+]F71J@?/,4+;L<.G;HPG[8CCMI;L M!"N=,M#[^K.JLE2C+G?+,Y((7J2*HU2A3_L3I(H6Z#+"BU31L%L<2[-LO70X.0 M^$9(NQ$3P?!LE\*S2G^DRNNV2*3+""]21;-4H?957/1M@RXCO$@537L54XF# M(1+I,L*+5-$T58RGG8V$M&!_R)^\;=2Z-AZH;]Q3,C-LGR$==20>TL;3:W^K M7C0B4IEP,=U1?S"2UNV1:HE"7H"1:;K`-).^/D6F0:9!ID&FJ=VG49%ID&F0 M:9!IZF6:<5_1"D:"XH_&G4,W'Y;^>JR.C^OY"\,IIU`G:=.&D:=JE;5^N=;: MM!OQ8^&=KZ[4.+?,?J7,=YOD/_SR(@JN[PUC>?/%G%,KYX=/71D"M M3\;3@KKA[:/A6U]"S_S^<1G:GAO\83B1P?ZZ#8)H$7_WE4'\%>3]VH$+?_WK M7PCY9?O97WUJ!)'_Q)_V^NF-8P1!=A,QH>WPX3.=O;IZ&_G\%=]4^(<5J/KV MU?LV_:8K_,/5KXG29#W**5`LQ]A,F#"3S['BKQ'*QHV))2K*LTSSN.80DSI. MPDBOKI0K_CE8&F;Z.3'LN'A79MB)P8$U.<8RH#?I'R_C]X"J*&!1SUYNMG== M?8I&,0=:?SH1C$C6(LJE")[P?_O*\`@!K;_$>Z`^T,GCS=RV++INIV4JI\7, MEK9XC]U6,QR,^^H(I7A4BO4[3"/1'"84`XJA&3&H>G^,8FA<#&@-*`840T9* MP_X(/:4ZQ5#%W@KA9R7EXDZGBNGLB%.GYQH-RJ9C0P8BC4C+-BF0!FG4:41: M-J2%]][;@'07''1]*JR#SN]]C)MYYSE6.SWVW<5CFY-6;NTX7E>[L/R^>J'A MD`_1XH[ZQ)L1OBP:D$^1;\[9XFCU4A5]U!%+J(7'(>A2L#0`?.WJB!R@L57+ M`:UKW;IND[,BGWS;A/\:`,X2[(P;V?9&AJ/AD>?:SV?9X\[RY;(;(YI>-TUO M`;T+V9#VF2Z3T:R0\$WT2)B=:D>*+DS',,%&C5"\I::E'DL M*QO5U1[1%%4CS]7S.+*`)[K;Y+J[;W'4TZ?CWD31J]HF+=S0)([M7"(2)*1^ M5S,DM73W],X@M)!B:I"&U$%?.[I_&BD(*0@IJ*I(MI!B:I""IDIO.CUZ6DS6 M&88H*PNGF,AJ"W=XYO<.!K0%,!VM-U75WF!46?X(X49P46854([A%_9XML+LUPVE.4HZ0BZVQ`G(!% M^?6&+W09\@4'HBM\G4%OR3J#!K];7L1.=Y]A3^+-KWNZ,NUIH\I2/PDW4HMC M->*/U<)AC1.%+@3YU%%?K2PCE/Q&(30!"3K$=IJ#JEYID-074@?3WG0ZJ3UA MU"C1+]8)HL.GHZ233R^EJL-G:RB]`0CN?+M\4JD"D!?//W5*NJ2UWPF_X%@* MI>P!?O:7E:95XL(]L%43,(]UC>RTP`RS3&X'AY,RLGFYH0D;K+0IL%UZHTY6 M>K.K847;M1+OUH1LI?7+=:6W3L%>"$BK-H'MR6V0WTU'LDUTAFOMFO.:GAO8 M`=]4&<3G!/QL^"TM=R%9^MZ];RS@)2XPJPEW MPN6KMZGQV[0>,0+R"/;#_G?ITP?;BX(=3X-^!+EG02O@[K@C"N^(IBB3_M;X M5"6N),-&[D9ZSW)`?J9+SP]!M][: M@>EX<#-M.&_CWBRP>8F>D<>SL,=U4G+`\D[5L1R4ZP/QOJ23@\&H/]A%'>N= M/1!>W_:_LF?N6W#(T]*H/UR?1NV395YTIT\DRN5US)^1.%V6QR9S!=.+`51*N5E76@`W6.A[.(;.P0QFC$2N[6JI'_!577P M\I;O?=L]#2C^Y,R5+WYK-M7H\:F#X[GWUPY,5V"B%@0T#-(9"'P!OA?("$3` MF@Y3"G#`PB?>8OK?R%ZRT;Q'[CW/>K39%`*^]\(Y=(X)PBP]?TB`_(<'AG.88X$S0]^OB%G M.9!==S,:2G6]@Z;5_ECHS"'E"AD4<7M:F.QZQT%KO3\1;8FG`CE6([?JEGRV M@=?TOB[:EA@)@=^]UH9*WXS2(_#(-C(!?_YL5W0WJF1!J++AHTM.PE/I-)H> M101AE4Z),JTNVC=-V\KG_&T<\B\MN[;G%6HU^&(8#HY>.'H)>"*FU5:X M%:S&H0R',K2B@E:TO<<+![:N#6Q%HT@-YWJI0CR7X[NBD2($MS.QY];`VR%B M:-(UZB!5-`%W09]E]S%[`=V62@Z0U>NH_(MMJ;'(E]`(:;'=;JUE_&JDTOJS M?"(NBPEWD$\?]Q2]HMQ#TIH">I?(-<@UYW/-I*>/CN9IE]57:G0>=HI9O)G; MKM$.#TFTH*I0V='JX"+9LJ-IXZ.Y"UH[)+9/5A M*DP8!/^.ZO9H>)W)2WDT@B8)PJF8R-)I-O*CJT-IO:`.1'X$U6ED')&ETVS\ M9ZP<99P-WRG^V.[C\]6?BFZT.Z$\#S;<)PG`O\A/GV@ M;D3)S//Y>?9P[E-:,CF`"W\5OXLLX(IY0"C@WE!*`BW)):;JY-$(R#UUJ<_. MZY.9[RV(F6*?'N,G_#0^)6MKGGWRQO!]FUWFTZ5/`U`BH&?0C6<$L%UX/F79 M#%CJ@Y#794^13Q[6=>!9FH0$MA7"\8'^.\H.G6'.@_;E/-@]CD_[4]'<6$Q[ M4,HE`V]G.)!/E-6(KN[)BM8?(?;-8(]ZCWK?1>Q1[U'ONX@]ZKT(J3]:.9O0 M+S:;T'.1QT0TI:8/^Q/RXYRBO$#+";#C8XI,6*->HU[+B#7J->JUC%BC7J./ M?^KTJP.I)++L+CIF=Q$@N\M7OES\/E[!?<=7<-<2OE0_+Q-][!%_[QF:D%`F M]`$NK,J"<)238Y0KX1&>F:L#[7+3+FO*^+=S^,)$*Y>>0*&Y5&\NQ3+[H;>' MMM$=V\"A!(<2-)>:AI*"TYX=Z>]PSM/!.8\($A*$V=#/:M_`@?BB^J+ZRH`O MJB^JKYCXRKJ@T()4QO^(X#$U9.@3<4.)<,D+U.FS:G*E",CL4N5*06T^19LG MJ,VHS=)H\PBU&;59%FW6E*/:+*L3+GR.[#^IXWSR;+CJN?IS-SQQP;*OJKJ\ M7-^."`!J1FW M//"C&XWXZR=I9YYK'7'BA9ODRNS\8,BF<]JLHC:C-DNCS1*[\ZC-G=/FX]PL MJTLO?#C]EH:N09[K'?'"!9OLCN6E>8S:=$F1U>,KIJC)J,DMT&2D9%1D*13Y M^&[9#:<[_BAFG:]#AQFSMA:8O\S)[FK=Z/("V"@6J_+_,/$>;E/1 M)JE9,[:V\ZQ4=+FNH=8IR#<-Z$E+(:<10[;M:RX"XOG%.? MF&E],>_1I1:Y>R+9]?WB*S0%FG7T?/&&R%ZL[.8PU4ADO@=')Q%M>U>#:[1[ M[6)VW[0DJK:^K=78T[AA\S:D"*0(L2E"1XHH:7UQ?/T0A.=AB=E;[S%P@X"VW.SLK5&&/KV710S<.B1A?$?5N:66K9I M.'`SB,ZV(OB357B-&T7F?#2"'X/(-UR3$GB3&_":N\9RZ7L_[(414KBPD'KR M%HZGQ>]Y5K+<[GA2YEU)\5]S&\I.5P#N`0S!DIJA_0"2[Y,6J-K@@JJVG;X. M5:VDJNF;JO8G)1:=L2S0#*W=>L34!O"<41\\1]"=X`SMZY''N6W.B>7!P!2F M0S4)%JP0^UT40$L"N.@]?[1/KWWJ\'+C.Y^6;Q2\.![NX5?;<0P?VNU[5F2& M`0DB>",T.YA[?G@=4G_1(ZP&O'5M.&QT9,.'X?2(8\]HCSS83%UZQ#!-F_W" MGQV$$?][7P/Z;1K*VM36VX"9\EMJ)DG)U90RBQO!#%2\A.F840#.\%I1^U+F MJPU+\%CQ6P"9_;[G\4:6(=LRPE`O.(*H:JE.Y9FR1V;`>`8;3^YL-HT(/:`, MIIH7'M#^-N@/"=B9PX8T+PHYCP$#,;KR(C=D6FI2^X$["G>&P[BJ3V(K:FK( M*7YS^.B=8:G%;PU*O.T\-AAL9QD]00G.,>URMJ.7:>>Z[91X:ZKLQ>\<%;^E M6"2@[%N*&^T'+XU@5#0"J4HIX@%/S_-I2D`Q\>UJN!%NC],E&;L*WN'.[1UU M;/#[N<>_]$)`SH;6,RXW/<=A&@H2@0E"!"[+HPT>IN$^97.'#'8;7%[;A>F2 MP]S(QI@4>!Q@]YGFL!&)M9$&(9_%\2Y%;MHI+HY%+"$02S/-Y3--YN6S!OJ` M>\Y)+G&>:CMQ,[OXQ@9UM,TRCNWZF\%!?76EQCW8:EQV)_^0A.1(_L,O+Z+@ M^MXPEC=?Z/T"].PS7<)L`T3UU@Y,QX-I`_T*;O-KQS.___K7OQ#R2W;#'&8Z MKXV`6C#Q7U(W,+A6FO!^N.$SG;VZ>@N3#O;E-Q7^87;U[:OW;?I-5_B'*Y"\ M'5_(ECS8%Q8UF;H&KZZN]:M?![HV4A0EU\:=KSR[67J^6?K19@WUD5I1LVY] MF)7=4P;\ZZ?5)9^,)_;5[:/A6^_^&]GAT^]N$/H1^S+XR,CUZ]QP/R[9(X+? M/']&V8K1[^XGT%?/(K;UZNIWL(-K:.7PZHRN;_9<.Z7?M?3I4F#^'1X1!CN1 MU*M$V,1*GUQ* M[39:+0Y8)^O5>*C)C=7'E1OZ)Q]9J77[0'WCGGZF"P.\'??^#<#G&V88&`L,2G6DKSAOTR&`>O5NM9G-H$H[VX.\Y"! MX2O]2O`ZM>5"`#5&H`IIU&$;1*`RC6H;4'?'7W=7Y'5L$%&+D-.OGP;_GKQ7 MMT>#?^@Z/2$(`=G-$TP!4S3A_>`X\Q@'G MJ4I'16=L.1CH-=/E>N,%0:NXMQ*CI7<2K>(N"T=+GXZ[B%9QOR5!:R(+6I_M MX/MO/J6_LUJ6,*>KDK4&L8\WKG7>NLQT4E&,\4BC&X!FO`N:D]5FP!=* MFT&FS'3I8^IR4-^T`_8"L&/?=@/;Y(:NYK%1=ZK-Z%&;8`>((03R3^\9]I4+J:S^()X4F M-D&<]/4J8C@B@)C;:[0^%UD;-R;%9M[;.Z/5T:!:UV5ONYN`9WK>#%/7QY.* MMMS6*-]FL4';L<%%>Z]6LL6I M4LC.4.YX\V\\38]WUWCLJUR[;N_O?7H/#M?^\5Y5SASOM:E:T1&1<[MU:72K M&"B5BM:X"C;ZTE#5.5P,+PG?Y4:1PFVI*,;->;)"FJRN'P65-CAMB8)>.F([ M[`^+[/*JM!L50WAPME\7?IK:5XNXB-5U8@=Z<\^QJ!_$!W5`R;?>%&0GN`N9 M(3LGGC\SGDOH&B=5BG/WKW)E)MGXUS)FGI*+2=/Z0_@JG^31]7P`^^0$386S M/1X^E;]ZM%HJY^,IJ6^/I+G=R'O*,B08RX#>I'^\7.7,[16I7%*RCM4?>ITAW7;)GET6[$-2ELIJ5 M`9+?_<$+*='C%#\__6#,\9)\"8%K$EI:_3!]26*.:@;C.M2V($U5@W@URAI_ M%+.D4\L0^-*S08EDDQ]G;-4-([C/;+T1DEN\F@!'8?6!\1@*:%` M<<$K`)7F&6PT11DEZDQ^=TW`PWZ@O"D]HDZG$[)J&T\F!-Q&G: M6**?51?>[.[9VY<_D^<\#Z@7!?#0X.>;]9PO]8U&B76Q?E+_?9@6)(H!YK@=:*JK\)UNNC* MU^@J.&:VTLKT:?UF=L[8W4K;"3S'MLA/"O^_IB24J[06CS<7]J_BO=8DVVS- MD]3Q&7J)K'*;9;.Z:KH-EQ4_*7E@+'=C3>[W_&C`5H+(2YGS;H/L;JURO3>= M:)>H5BZB#550()2D_XYJKUR>G70B06)8JP-;FT7%A!T0)2LZ.E$G736>2@:@ MRYG/9QJ$OLW6JN`R%@M@"Q)!/!Q1JQO&(]SH\WPX&OS<+;-IU9B3K*9URTH$ M&V*>J^JT8S8BQ]!BLO3]CM,5LQ%N<-'4KKIFK1QC6F8NE4;V!+"6<6>C`.V. MI&45.K)Z&RT(I6GPN^5%K"=G6)!P(\Z@IZE*03,Z?]N`7IJBSUER*;\TOO:[ M@#7*"T!9KKIX5ER\@*JN[;;1!VSC3/JL/0LC=10-/QN:<]ENHUYHZ%,CB/RG MQ.].XJ+AW`B)Z46.%1<"OZ.FMZ`[GV?/R",K_,F*@2;U_-@[`J]$,;"+U_IF M_PXG?`\5FG_GS5^3Q?P_NN3_&FYD^$\KW5/3&I)L7Y<;G]'Q9CL60IAILSIN MO#9OO+N,W;)_=UE+%H7I8#7GSX MF27((U_2L0D>$X3^,,%;)TNX MDFONJC:?:Y''Y)`"C%/\E`+QTS,S_)!!%1U M^&P-X3?`#7>^?=X9@88/`(BTY1)F5..)V/-@W'1YJC"5:7\@>#2VG=LN3T-? MZT\41!_1[R#Z*HQ-&J*/NM]!]%45T4?=1_01_0:89XK^OJ#'K$2<6>>7^D># M_K#NB77U1WC:-GVN='=&69$U?>[J0Q8GCV.2R4Z;&B0HX'`DF``+CT#0CV!I MN"P[SA'P:Y@#HOG`W6G6()*D#2)IWB#"$P>A&;7!C"X^A433R9G.=6HZ6?XW MDDL`1_[)UK*>/U'##WY&&HU+1I97E2298HE?!,J27V'#1QEE[$^5D+ M=@"_-AR^I<5;I=@DQD7.T>^>GN$Y^HW#)KWI<'1LZV]KAZV&#>02P5,A%?J, MP2G6ZEHYZ6_5D\WN!4TA9=,@V?"Z$T@V%S*%2\PY4<,WTM+TIZC@[51P'%X% M'EYWKEP**9LFC_&IO='@(L=A19P,M^KP^-_K2DPBXIY>P4Z,J^I4VB&Z`B,0 M>SQN/[SM'XP%W+PK&,7PLC!(,BVW\*="!?`PGX\UV6:PN/`J/+PX>Y5_ MX56=](='=T"A%8CI9"+>R/*(-^(M[:2UI7C+.F5M[_'92Q3/J?S\K*3%<[2> M.I)W0S&NS+8"8)S;=F%E5AWU1_)N*Q;-$N2?WPJGX(/^\>*GJ-]"ZC>#+`P[."3H3_H`&O,>5:A/Y84EZT//3(`WS=W(3XP(RVJPLP M,!M6Y'51<957>'C;/UH+.!,6C&38/'B()-/"68*(LV#!E'O05^7=?B^S;B/> MHHZH`LY_!2,=7>M-U:.A-UEGORU8"$Y.W?*"P8TN`(LHJ29=T9X^P=5?'+!E M11PGP0)SSZBO'HU8HR4(R3TB3H2%4W"]/Y`WEBRW?B/BXHZM`DZ'A:,>33O% ML=^8$,K', M?\I!EKIGRK,,,M[A]=\)OX"P,[:)>;VZ4N+/P=(PD\_9`_SL+XLDFLN%DNDQ M*.F&$A-]%.L(V=F]#(@,\'P=6E4=/EO#]@V\Y\ZW-S%]F3/[JW4CRP.\<8)9 MY?^9+-=KWY[P3C5[SU:%JY6V+=>5S3H%NKH1.:9Q!>R8/_3KG!(CJQ=F9_7" M'EB],&('Q#0<,W(,OB,@("%<;MFS&?4IVRM_1\-'2EU"_T$-)YQS3?_IAZ:H MTY=PI^,%;!-]P"O++EE!3/:(+9:MLCO>;+O>%=_)L!W%J;+L,%?@KG'EQI`=A!O];6[:&DE=9O:/R+%6\4(]U- MLMVR5=?S%X8C"ON>U/SZVLJ,,?1"PR'W+&D]UP0R,VP_,4=0D=B84K5YB+?J M6)'/#(WI6SCW*>4:[\)C"6A9.`\(A>;OL`&-/(+B;?L]1QNJ](?%;R*`F`/- MYJTK\5+PI:JT_J@[J4^QN_25@/Z^N MU/BA!P@JL]:E<4^O[WQJ?+\V9B'U;PSGT7@*=ME_M>:^T]XO3TMBN;"5+=B< MS)DSSW&\1VZ7L8,<+>#=\,2`J2*X-'P/8VS/D6N'Q&#*:8=//7B4Z43\K-^2 M^C,V&(%?[88>6.@8N,GV_.QKQ=P^P9K2W2V)PW=,09*C\_.S(7 M2^]/INXP+W>,94!OTC]>KB9V,.]ZELP#X@#!]F2@\*+PI*^,!`M)K*W0EPL5 MY=7G&.&LO\D#@YP!?=S,;0O8=*]F5:IS5 M47\H6E2U*]BCWB/V7<1>5?L:CK658[^QJB.G1UMR];.(2WOVXF>G_=3V'R\3 M>EAH-[S">YOMAA>U%^%M+[S"NX7"PML%SV\TZ`]%]OSXO?'*Q,V=YUCM=`4K M3=E?5F2Y37$F=4/J7UAH'R*^VOQQE;RR>N&)/I8((#OQ74^T%KC[SV0U]OHV M68W]G*W&OLFMQOZ3K<8^?Z*&'_R,YM0&NCH!?PZDG-"VX^S;; M3/I[MIGT#[ZEJOB.HLVMN5WU*5MP:'IG]FR^J75K/^ZEO,HS\F=+>&1Q1T132-DT2#ZJ MTAN,+I/"5D!_M%4%2/_.SG?447ZT+7N-OE_R#> MB'<[Z4/21?"VUO\3T&.L9')U.9\Q+H'0#9=1N+G5<_7\FO6BL7T'XI,R`(P. M#"(N.^*"`"RBT]A:E9;5;6Q5H/$-6P!WG+;XC97N5A'!;=14V;Q&F6($`OJ, M+8T1=%J=$>]NTH>`WF)+U5E67['5FR0O462F\EV2!VJRMCG^.![BOK)V#`H" M^I3":;/6'U97OU-.=4:?LKV(GS+L7FR7I(BB:9)Z!CWM>%69#7\T_E@TQ[BX MN4X[6=`!]#4M7S!:A6!/*.R0N[I<70=M&`O(M]J\27Y(C@_UY M$\I2RDI=-U05"S)E$`IKI[%!:,*8 M)*]9-UB+X!J6O(^_CU4Q2)*=VYX5ET%8[^"):=!%Z2[\OPE#(_7Y]4=Z6]PN M3R@3L0>>[7H1=1;DT,^I$E&,(>-;JP0F+J1Q"C*N%Y(%O,FW#:=$J\]AZ.H[ M7'_ED.VCUB?K1-G*(?HYE6$.#=RGC0_[BKS5-T[P&_-9$.(GL8MO;%`7VXS[ M&)>(^$R7D6_.@3?))]\#35H$*](;3#.?D

Q;5>ZNU4F^F@LU@:M#&U[Q[@>\R[VGY-8, M&=#J5!_TV'3$6'"Z+NM3F%X0KMS)5#8P;LP-H$#.^+.(CP#!LAX<* M'CW_.R\:8RP9NY28W)S`56>YZ)>G8'[E;Y[/7$&FV]SEB_RE!TK26[?@/-:Q MP)D=[6.ES.'TK=BY9'E$L%6"\XL&Q&;=5XZ5G).FS-*XKXJVUB.B%.M? M#1V)MAJ*8D`Q-%2/1N^/40R-BP&M`<6`8A#Y>+M<8LBM_^]M0+H+#KH^%=9!WUKA;J7' M7FEJC@JDU71-F:]\W]V';,?XEW@Y/-T)4D/"%=%'';&$VN$R36()HI1UI370 M/O&=VI\,.]Z6P(VL3-$F[>>S[''[O%('C!%-KYNF%^_%A"%MM3&XD/'(ZFY6 MF"_X`A'A-]&"':&S']AYFSC%AQ%FQ]56-IJ=6RM:V.X,3Q0KMZP?C!OU].FX M-U'TJI(B"#20Y\'(GVCJ8$!;`-/1>E-5[0U& M(VE'<%',`Q>3.S=XMV032Y/TH_2U,5)/YZFGEF%5".X1?V>+;"[-<-I3E*.D M(NML0)R`1?GUAAWGT]NQSB!I'O%I3U>F/6TTE7:D%L=JQ!^KA<,:)PI="/*I MH[YZ-,:'1M$*`A)TB.TT!V%-E1.7.Z>]Z;3^7/!I4FW6":*SDH_'2*=P"N\U MU3MIVU>!=-*=2RU_<#@I(YOS\LYSO>$IR@XTK'!2^JP-%TE*?V%(JS:![2@E'%EEW?1V9UHU`O(( M]L/^=^G3!]N+@AU/@WX$N6=!*^#NN",*[XBF*!,1,M57GFT^*^?`V3B?FXY< MUYP+<-=.]$,W;>G]H:;E>[*RD57FN)Q71*:;AE.H627O2+?UQPG8E^FV_CC; MH.V:3F1!A]A:LAT$8`Q!1S)$MK'-O[N$J1/GK#@G_BYN6V6XW)7;R)A,8/SN1SSV$FQ])XTEU$GR\)P+914#\TX++=:=O[Y+9@T1$. M(TMR':>)AWN+8S'J#8>CGJYLEW\\&4;6O.)W3WM#==I3IX/2+UY/WM[;2E3; M;YGA;9W8B)_$+MY.['[]FEO@FUPQB_/RNF\7YHAUTUNR9P=Q$8*X0L;*)F:> M7[R^@);X'TFA`68?"V,]C7"B@F:N79[ M$JG\9K396.>7`O M#SQJ/`+?+>"1:AK-.HM*CVS3(>"1;5#C$7@$'JFFKQ]7?;L?6S@GFMG&^4E>3E M-EVBU31M-1_8@E1%1M.%L:SD)ML=-2PT;!&4\+MW:5 ME&2;0G=%%QN0U6I<4$!PN[%,)AVVJ+C("F*!BW-8)`9YP$5B0'=!(FQ1<9$5 MF@57UM7:2I(BU1NP>/>#GR&K`?BR"<`&_=&6 M]A\_WOY$#3]`JVF=U2#`2$LMH:4RZ3Z0EMII-0@PTE)+:&F,M-09JT&`D99: M0DN7\99DC56,<.G[HQGK0CCMM:LA.LX-)`[^O/JJK,@+K< M+<]((GB1*HY2A3[M3Y`J6J#+""]21<->Q0"]BE;H,L*+5-&X5S$^2A6R1D': MM&L'Y&5;U+7(DTT=JQNQ$`S]-@)P@W2DR.NV2*7,"#"R!;(%*C,"+`3`R!;( M%M(H,P*,;-$&MI`U*B+\WI#/=O#]>L82[]HL7P\-0N(;(>U&3`3#LUT*SRK] MD2JOVR*1+B.\2!7-4H7:5W'1MPVZC/`B533M54PE#H9(I,L(+U)%TU0QGG8V M$M*"_2%_\K91Z]IXH+YQ3\G,L'V&=-21>$@;3Z_]K7K1B$AEPL5T1_W!2%JW M1ZHE"GD!1J;I`M-,^OH4F0:9!ID&F:9VGT9%ID&F0:9!IJF7:<9]12L8"8H_ M&G<.W7Q8^NM>=;)=B[KAC:;U687;?&D?U_,7AE-.QTY2L`V[3S4MZ]"R2`?4 M25D&.JFM7^>4S#S'\1[!8`F'F@31`AH#3PS@5L_\?GUG!)35^EHLJ1L8H>VY MA/Y@?U/B4Y-IID6LR.=/@.>%O*BUX5K$985Z%QXOU$NW"_425M>-7\B*6)'G MM@OW>E$`WP0_WU0*X_EZ4`3:G"6E%%BH-SF#2@A&49YE!A5+R:2.DQ#MJROE MBG\.EH:9?D[X*JY)EO%5PB-`$HZQ#.A-^L?+^#V@0@H0Q;.7,8PQ6ZW3>)G@ M[$#IJZ+QXUJ@O/Z"8>MO\AZH#U3Y>#.W+=#/O8I6J:Y5Y85H$HJR&M'5O]ZD MBN8!=@5[U'O$OHO8(^>@WB/VB#UR3C>P1[U'[+N(/7).+=A7L;5/].B1IO7' M=8>/SEGUX/<^QN^Y\QRKDB`1`!$L#1#9\.H(J2E]I6K#VETK\<+BRZV/Q$'6 M"POP*P^SOX^CZ^^VH^O=B_V5E>3E%GC1:IJVF@]L2:HBH^G"X%9V35^.P4TK M9:9GEO*MU$XKV)/1B)VRI>%+C6!8>KG,$(:VT:!M;)4;#`3)/&]Q_>0%&HND"T6@]95Q9CE6T!.0>P1!' M[A&9>U1%OT2N>A.)7[:-!Z-MF2*TD3!2Y=MB2()%HF\V$&C;JX*9:`&]R M_J4=39W8VB%:9MU&,D$R$8Y,U)XVK2SGLY1T(H@R(WL@>PC''EI/&RK('BW4 M;J03I!/AZ$0'.IET->A22722I/^.Z@[!?/5"PR''R+>DOKP)=P^BUR3_SKS?"P_V/7R@\"$FW%? MK3\2S7/`VH/'!KUM.8(_HH[DDV,UT05\9UAP@.GN%HZIZ2^TO MBU926DU7`FBDF*#08U%925YN^1:MIFFK$:Z8H.!C61=*:V!9F\;-LK:23SL& M+,RLBR6?6F8;]=0.%-J90]-`T\!A`VT#;>-2PT;!Z4P+]VUU8"Y3=#<6LEJ- MJP4(;C?6P*3#%A4764$L<'$.B\0@#[A(#.@N2(0M*BZR0K/@RKH4VX)"@.\- M_SOEYSK9N4S#>J!^:`?PN9[`K&@'RO!TN[#;)84[VJ[KE:5A%<[#$F);=N(^+()L*QB38X6ED=E5M(Y4;$D4[$HY/"2=VE MB<6T8!//5VK.76CN_1,/Q)AP?6>B,*+%E.6G)N%"Q9HNKZ\CMWHCXD@H`A+* M0*NL:A^J-Q**U(@CH9Q`*.,)>BCM5&]$'`E%0$)1>ZIVM+:YK!&9%NR.^3MU MJ6\XR:&JA>W:02^@/]O?%XC5G)(K2X'?+ MB^X<>HXEB195/D6$%SN<*:AT&HU`Z_K1"'1KG2?1C.$2SI.@.HX,)+)T&F6@ MZ0#WZ2`#(0,A`S6T3["G:_(NJ80N7P2G5]P_!3/MJG^"7PH%=7*G\,V:^E M>0Q(_L,O+Z+@^MXPEC=?YH9/YYX#"A.\^V]DAT^WKL6_?,U"1Y^,)Y;X)O@* M\GWM>.;W7__Z%T)^R>X&@=LSVS3<\-8T0:58QN5/H,VF35?WQ`>W?H2?Z>S5 MU=O(YW&H;RK\PZJ!??OJ?9M^TQ7^X>K71$>R)N?T)99:;!=,=,GG6,_7*.0@ M?]BN!5VZ42<7EGZ^%EK\(';QC1V"W9AG*T@.IY1JE&>977&S("9UG(1R7UTI M5_QSL#3,]'-R?\(?0`Z.L0SH3?K'RR1$.QCU!SG\,WFLXU&L2%OZS-R(0$;] MX3IM[Q/K.:.`05QC`8_[X(4T8+KXF^T:KFD;SI?0""G7_A4]&>MF>**T^?WL M!40EU^1+M("V/Q%O1EY'`=P0!'P_7C M[A;]!S6<<-XCO[MFGSP/YY2L'OCFY1MOL33\?7!-`&.@"]_-H`F@ M*/:#;46&$_0(5Q*P=`UYI'@WY/T12N9>^I M9;,D@N4:QE6@JA9]<@SWD\^9X([ZK$$_EX$*_+@@6H"G2&"0(O4+Y?.$S<+]FD) MAC,'+S1G(_S[F$I[)`7XVJ<.V(+5VS"9^)$PEH/[`N/M5KMX*_KD3[`7DVUA MAU-D0;F;&@V$[QAW88\C'ZLVW;3Z(O:V$F+W9C/K9P_FC$ICL`"@[]#PG M[@BU(I-[SH#"`AK@@XL2<*R.M:P'7YA.5)+&LJ;=6@_@FACW=(4\^#(@,>XD M\39FWW\R_)"\)4L_-_I8?G0?-ZAX(_IES93?_1&HD0*HH+J`29C+*N$$'J$N M&^$#$@'A>\2B#JB"O]+UU:@P?;FM0TQC[5@N`:$.-4/?<^$+!Y0)GK;7%OKD M%L1*`)_("7M`W&`-"WC4+$YU$80^-19\_&"ZR!3"H3_X3Z$/9A;K`;QC:2S! M5;=98HP`VKW]PL!PDO$D,2>F!4O?,\%`^B74@5D+"!@ZS7816*R3B='P=L., M8KL-,'`QNRS^LJ%2PJ("/C#&6`%V;]D1%=L,F0V_\9QH<6<;_6)S;^&=/,FZ M\QJT-&#R8F,6-(F;UWG.Y5?&Z*89^Y#,!,"^K5B#F:6S`!RGSCO#B6*>0,3>(G;\V!/"N4_C M),,N,_4%]&(.-`*/M;;?JO$+V>LSW3ZM!48P)S/'>PRR]Q9Z6X^QU)(F0V2/ MFW_D&C">P+N8_[FW'>M@PG=&@NA;:O*7K?165Y.W/L(5%@QN#W`_=ROX6!R_ M;/WILW2BGN]O/-+Q,9![Q+>NR]R&SW3IP8@$H]!O,!T%M;W^?QD83]3P$Q3V MMPLH>FZ;<]Z\F>W`M8\V&<=S^`9=U["F2S6-A!P"=>+GEO M`/NNGLM@9>#&^*UI9JXWP=R+',"1@@@,WB=`X#^1:_(!-6O!Z?"P!J9>@LM= M-Q:;,T`=3D!L[R`L&L^TB1,+L=-.F`)@^T]>=CXA=>\\+8[WTZ7\C MF_7E[FG5$MZ0V!D*Z4XT8GO*Z.E<(+UXRAT80-IW?%0R@L*,5#$1,9SRH!K6 M?Z(@C%_F4N;7L=E.^M"98?O<#T_'42:$9(::=VV#59O9%:NN++W`CN6S=S"T MPR#Q9/DE'KBDB4=:7)OX-/B)!-%=`,;` M!`/`VI[%C#,3KQW`9"-3'=;^O;JCE_'WJZ?1JH+#,HT"IWK&7Z@1L)F?'3Z= M[P^[$==6T,*=`98CDUU0RX4=,D4-27_%?X#;4A_CKF/_Q+.;=_:>U]`&?.G/_?!&7-A5A]P M!Q8FVYSJ5XUB-@?3Y[FUT?/.^M=XSKH*A*5@I1PE#-YFK66*ZG7B[27!ZH]D`6DR$JV!'RGJV M"\,*(`FCA9NKL9)R7`0FEU`S&7-TV/KF&QZF M,L,U-Q>&;M?*AF+VP'CPBZ_F'GL:68/1&81EVHX=?X1'I7[_';TWN!__T0P] M9C5J+S="`?;FG%J1$PO(C]S,*+C?3Q(&'O211"_@2B^,_WC^1M@V#=+Z;$7& MV6=F5L1=`*8EV8U&[+EMJ2A3#5#=+/I*'?O>9FJ86]+A[X/+4Z;T4G.!-]BY ML&\66STQC&IZP&;L\LP/@+9YCZSMS!78CB[&7,>6ADB06VV34NB'9=#-`^:Q7$Y`T$_\N#=OV/M3`O/R8D M'QK_""(H#5<:54_GXYO=6B-AYA\;8+.\6XF[GV_1,EF0C_4HIS'[%(6$3\LD M),Q[PFCD_QIP+;CIZMKK-APTY(?JV_K%YI[,FA6P*5DR,V+JMMA7.SX].Q>; MM<6"5"Z;GX9KSM2I;I/G[O&8V/S9"^CZVV"F[$2QAQ*_$2Y8,N?$=S<7$TYH M?VK?0$@G^GXQ?:ZFR'-0+1J$ZUY<')?,>28!'S\=6K!-6RM:1]X>OS,.(.09 M"I#YA_<(QN[W2GA$3*S@5X5@^6R.%8+Q6DS`->)KIO$^&]P]/@N\>RKADYW@ M7ZWO/<@W+6Y)&;B,,/&3RFR6V/2L$_PD,,R;WG#.P3D0;\='# M[8X#P$$2I,H-5(PW&/'Y1WEOSSPS7J+-3TB#6F8DI3=EXH+HSN[`O)1R\=]: M'H_:Y_:'?@E!JH9O!><%A-[-9O$2W\HU3<.[CVQ#6?Q>P\TO&`3IJ\$6600\ M7FE@'NY]9,=K#TD`?3,`#=Z^8X`O/LO\(CYK@&='BR@>.KUPGL0]MI9/0:== M&B:?TN!'TI9TX8"M=0'-A,QIA^N3!E3Y8D)M?F72Q9EA9A'=(JL.G/=B%Y(O M?,`["CZB3WYW3PV)ZTR:ELU7_V)_BH68*T2EQ)8U9CC3=/]XZR(D^_/E"'3* MXZ1S&AMG.U@"D;63(6OG.&Z#;Q]GWU3MF\Z/<6A7)((!GO_$-JBR+RQJV@![ M\.KJ6K_Z51TKD]%84914:()J[,C1UN@32;*H'@+?@^"B%IO^=C^B7LK M_(!,P'_\R,,,P;L?,(6S$W,]];#+1H,WVSO1=S2V4&-V=":^A&T(?1=/5@XV M6,LW^+B,-64\VF[RUBO+-VM5=BJDZ2[#9:JZ)<`JV"S1L,=6G=* MJS[3=,/N)]^[!R_]-@KG,'?^'[5NXS#CSE9.X9^52-531#JZ^E6/#SMNMO-H M&ZIK=PFA0[M'E;3[*YN71/X3O_?6C'=*W,8AX3_@`5PK MBL8.?)7NR"#?$8U9>E\;KSIQ:H,.=.,##Z!]G,5T]@_J6(7&FWS[?O_P&]/C MX4A7]#UMW'[;N4T[B=9YRZ9#=:I.!U6T++XH+V8FJ?-PTZ?CR5[`CN>(\NM)@ZGBC(^TL+M M%JRW^4\^VQ/GR,0CY333;YE72\MOTNQG7YUA=L2PT=.Q(P!FA1:B3L>J>DHW=K>D M\DZ4L@Y0JO%)UG&A3I2T#%T5J1/EK&(RT$^RBD.=^#_7U[\E^YW9(0+6FNOK M^"?'=K_?I)NA_PD?R`_^5?BTI*^N^*J*1:VKY%O?8X&I>1@N;UZ\8.<]?]SY M3M_S[U\`!>DOV,\OV(57_.'IXQW/7'LJ?#9"ST\?.O=9[W]*70`M_=XQ[JBS M<@VT;\Z=K#TZ;?FMO_X*PS?3Q\"?1YJ=7/%B9ICA=?K$]'86G]QJ1/(J M[]55BNNU`NXP3V?!`FD;K2P&@+X'`%T$`/0+`##<`\!0!`"&^P$8[@=`H%:. MLE9JYXEILD=,$Q'$-&F%F`ZTLBHQZ>IN,<$4KWDQI8W8!<"T(CK1QKL!T,8" M`)`V8A<`DZH`V#.@:"(,*-J!`65<%0#3/0!,10!@>@$3V#.B:B*,J-J!L:HR M$]A#@IH()*@=(,&J3$#?XU7K(GC5^@&ONC(3V..M:")X*]H!/Z`R$QCL`6`@ M`@"#"YB`LL<$%`$`2!M1JPF,]FC`2```TD;4:@)[2%`3@02U`R18E0DH>_P` M100_0#G@!ZA5`;#'%59$<(65`ZYP90#L,0%%!!-0#IC``0`$:J56T:1=V>.O M*B+XJ\H!?[4R/=TS:5=$F+0K!R;M50&@[M$`500-4`]H@%Z5!NSQ5A01O!7E M@+=2F0GL<=@5$1QVY8##7AD`>Z9LB@A3-N7`E*TR$]@3MU)$B%LI!^)650&@ M[IFRJ2),V=0#4[:J`-#V`*")`(!V`(!151JPAP15$4A0/4""!Q:9B@&PQQ%2 M17"$U`..4&4`[/$#5!'\`/6`'U`9`'M&`56$44`],`J= MLMEDLW$)1&N;$GXL'/B>51ZA[O6_OES]RI,@WM_[])X=);3=T+==MFOG(=Z. MRI+`.69R<(LAQV6?XZT_&"^%0BJSFS]&V6>F$MW2C)LHSR>AO;9^,6+(7) MTK&S)`NYM`Z``\\CS/.KLC>P'4+P^-RNNV)O6\^KVO_EQ9H,&A+,<(=@WL2' M`-F)OR2C:T",\'14V0%&.^!99H)X=[B?'7=(DYJZ-)?3E!_8YABO+F0YJ]G! M"';XW(MX'@RX?/4V5(D[%G+4_. MFR;ITHGWZ,9&R:\5I"^3'7V)JW/$W!0G2SBI6YNW"=+#\8X>_LFJ2'DVRQYU M4M>RZP7ID[JC3\FIE:3F@Q/GU0*Z<9\_X$6P:LJQ@;IRA`=X1>(+`H^V`YV.6L`J&VUOEI9I/@[X:(A,PC.SL M6IS5(P@BG@M@E=(/FC,BR8G>WUV6VX`-+NQX(4^P#0_P6%)@U28 MGI%G$`;IF?O]SQ0$6/U\GX?UT[)9Q1"6"0JT+'QDV9#J<(72%/,T.4N?.$Z>'N>MLGAAHEV@;WSW3_@`W__R@L$)?_Q_4$L#!!0` M```(`$AV:$.*BGF8A`T``">P```5`!P`96AT:"TR,#$S,#DS,%]C86PN>&UL M550)``-X0'U2>$!]4G5X"P`!!"4.```$.0$``.5=6W/J.!)^WZK]#U[F86>J MEG!+0I(ZV2ER.T55SB&59';F;YL8S?D>N\4*'[H<) MW_C]&V04X.VSYI M+:_<^B-3Q!^ M75M316:D9#0RIPY1_>G&! M$.$5MY38B`!Q\(%3!]N"J!O3$>A?Q@BHKAEBF-^>^R$T:(Q,QQV#H3PFV@I/ M:(B&C4Q=-_8+9'F5#X:W=#)EH#;AX,%]N&DF:+?04@?[3+`F'S\X]&/'["F& MV!K8'>:60T$9)'H5_][_Y>%WTQ%#]8C=LRSJP<=G9"'X^LU!XD:U/04T^I\0- M"NXMP_3]3'S*Q48#$$G;`%Q=]CQ MX`Z/B&UME9TKLD,C?45TQ,SI&%M],J1L(E4!'5[PB$`>8ID0!SWN@A:,K]1^ MI&3T"''=[G$.3[&;^:H;T^E!KK-]]-F[8KX1X7O+I M0C,7@82]_!:[8E#(PR#-JQO+?N'SLFMCO6_#[]SP>Y>``))#K=!`CDC&*`L[ MA8]-9EQ#D[_)M`ORYY%I3D7*V6X@Q^7!-\)]VO5FR\^^?O*__G-AYJ!GQWQ# MCLS"0Q<;A2EVZS$&%DS4SV_SYWGGK'5YUNQ>7%Z>GW=:W>;EFN9K7M)C81`F MLX+^X6/$<<(IK=^BP;W)PJ/K&$@.Y(>,3J+F\P>C612G#$(P3(]JAL=!'SH5 M8YE.S?A`>#1VY94IPY1!B+ZNM8OA*#Y=Z+FW)F-SF,_]QW0\I.!.2S9LFM-6 MMW5:"DZ3F(NRG1]J);P@FA/!@R_EQDT0.0S.,R/TJ6Z7FNH[-$0`P7XU9PNC MI#*=('$81&<%Z//<*37/3PQ-36S[N3W$KH$[1DSGD:PA>1B\YP7J\W]:SVM&')4-W-\IL3+'[I50E4C-@:02 M<7HMYJ2R&=LV#/T,H)=WTJ0/H!(Q]BNE]@=V'`5=P>4J,92HLT_*6:E)Z1/7 M)",,Z?HR3MS/+,<3NY,IA.F(5HG,W'A\HL]+3?0C-M^P@UV,Q))_=-E;07*Z M6,%@DK/S:,,0@UW(=L^*]DA=9M9]51-7I993GLRY6#;06T@)-RXUJ4DZJM=1 M-`!6@MW[R=2AD2-V`+3OW%2Y`^(\']8]S\.B>W#B&^&?S$/V-Y/]0"X\ M&?WU@,T=E<2V!T!==GR5F%\%\\9G](Z(EQ*+XQL?`+DY`%9B!B8GE-H16-'Z M@/C-@K`2L[DU+*G+([%M2TUNGNPX!5HEUC*U)VO1AF'0IZWN>=%KEGGXU,15 MB2?L+9U,*)&($JL%-IJ5CTA-4F*J`W2@56)N\RK*LSPV3V4SVO"`^-0$EQIJ MZV6@]%D4VQ%DWYN,0$;/(<7W)IZIRF"QX0Y3G!5B)`KV&1^6', M:P&/E(O5X<'PU9RIUZFR]')`OK$+Y)683?5L&R_T>C*QW2>WYA2[IFJW1-'Z MD(C/@##G;.I+8Z/X^5,JHE-?$EKG15DCW=:MD5X-9PR&1FA`PQ^QF+QU$WA* M"$R4*.*&7;Z>(.*/0NE0F[#KGH'K%CT;UF!A_99,1U.)/'N%X0&L`3>+BXD' M><=@BIBT&+]!0\I\@X`M$+^?N\J5`)`$4X-^HSYQ$4-@]=4%>`$E)M;K?H)1`M-N))3$95B4?>LIQ%'`UAOR/F8KXJ;E$P MFBQT,!3G@)DM!&?F7/$,#$X:N#69>%?KGH@$7"PJQ=.H)5-Y%O.CW//.A8+$ M5V2-"77H:"[>IH995#)_"Q,*#X__^0?I;+Y[HMI$2A0Z&-)SP,SV#DY1ZX-BNO:= M$AJ>)R3?Z.\!*N&V2U6B3K`I<5\)#<0&X?*@A1%Z_(Y3/[M!SUPU9@V M)]5*/,#M@D=D49YLS5^92;AI29*(+?_R*;/_"\FM_^Y^TM;L?@8+6[\+UB]Z M02;C=NDGFB5GP"E!`<3J"%&MLH?3G&4/,(RQ&*,AII]UIGW5:3?CG\J)Y5M#+>L,ALL!K[V?6&'(N]`R4#$@\%`7N M+%V4,&!LRUHTJ&QMD$IL;HI#H`#+$Z/O&,+`S?PWN,'[9+DBWH-0^2ZK_M6% M-YH='(77;&F./2\ZEJ(>JPS,;TE3+.\I>+.%@]-BJ`W>G,PV94F1.@+Z\U@@ MV[U>F$-`4FUA:5`E^ZLF1T%U"MQJO"VQ[V7,@^0^AP$JL9%O,1B6BW! M,-1+@'HPBQ5;&B'@^Y,KIL,+:S>4_H#_>AP3Q+FH-@";L+@UJ6S"AT[[=H8( MJ"_W4J7"8GWRCO@V&]8Q'93/73YOPUK7')78['@RY[)`Z97V+#`;0\K?SE'X MC'X'Y?.9+0F.>LR6QDC=!R]%66<$I,RD`:GM"7LE[Y/I"1^CJ^@;HAK5OPJ+ M/6!B$FN+IU%,!^5SE\][&NF:HQ*;K0#.0LB6KUG(0]L&4DU^/T/,PGQ5BQO] MX;IDN9!)+IJM[F5)Y["Z=,8$E%PVJ$0E9K#B_X+8.Q:_XQVWV1Q4<2^*4\5? MPJ*O]`6YKH-Z'R:SE06^N^K_"-QLO[:JQ$M+]S,+9HVOYLPO89-W7*P=]!]V M6_5Y#&ZW<_M4:GKV0-DSFGK,&@-<>61G<-YX2IZM%CP"I\EIA-14J13Y-2#R MX0V&CY2,7A&;^.?3/HJT MDX/^_K5X#VZM6P-&,@)MC)4ZQL^!0LNWYT3+3?%?C)]]Q7XISWMU/7!.QN;@ MAXF_B*$G6\B15Z!3@M;A.Z`%=T`Y9]P*'D)'7*G@5&)JE-OOU$('QFU&H"5[ MBWF;*!Z]EC6"=W89P6,:%!R[HP826876C[7&BQ3Y6[/`@7]V9J`9UT:3*%N^ M>*##6]P/T&:'6>K#_J/X M\E2#)\2D`=963\`*GAN4FID<6Y!XW&''`UM%Q+(%];-F:S.H0X_^;R@9T*B@@."B4CVDG>L@&-[R-\H[5;%\VB%W-SLKT>4[:WP)Z?)$G5 MW&+9V73\?0FI<<^%!^`;W+60Z+Y2?RM?6=2M*7]0Q.\&?3%'F6NIO9$$_49P MI*INN\Z.U!VT39%MA_@3GT1"E:MESD/+K!L^K16--,YAIKNAE+Y<)YBE#0 MD!H:"Q6-F[FQKJ0AM2PX,Q'G^"Z6'1(+7:/-"BE5(4#7_'=LHQ5/`[*RJ33H MAF/T27`PJ%B@80DU*SOIO'Q12,5PJ!YE?]@KL>^4#_]"BB_PSR&PTPFVL/*P MC-T.LOQ[\9QH_3F\_`I8[O02*`PZ`MH`N> MD!B#,T8Y'R(&P?T,W*!'*,`M'8HG6UX)QP?[[8.VU>VU.V`LQ.3(-)^>GMI, MR?)0M.U0SS#"V4YM+D>7>L&TW;:UN',6SDS)$;`L\]#L=JR>_'2TMW_4Z8#! MU4+R2IHR1,6B&)&'>SD?D'P0?M**`9S>,]RF;"0U.STS$FS-)8^F'"6DGWJ1 MK&7^N/I\ZXRA9QN(<&$39ZFEADG3L_K]OAG<78C*Z5VQD(VCV3?G-Z4H1T<\ MF.HS=6P1.+/0!)`IH;X9D9BA+AE6U^A9[2EW6Y(N`(X9Q?`&#D&`]4C,)O"D MQ9$WP%)"X[%V%"<=_J]CM)_\Q%Q!U/N,W@KJ/,PIMB5\7'^MX_$ M3-'E^AA>#X-[002<46\""0^L.I^JC_!T=CV!3%XAHPN?..K.1RALA'D+*&#? M;BX3]L,QM+$82R_X3+E!A9FI!,V:P9C5D?4%BDNY,CWX%;+;L5PK2W@#(M!' MA'TAEU)PBY]/'>R[T+U@U%.0?1$@OAZNC+(U;W7CJI#"3Y".F#T9(^>2#"GS M@KD'Q+U%(R)W"<-IJL(6.7+KN!CY#X,J:O[+\H:X:-\FA" MNFSFE&4L8\N+=E*UU^T'1([E$,SQ[Z'A(GG:J?.K!<*)X@0L1D%$F%+4#&7, MU`%J!+R8Q7"I9Z,UT:YJ[P8J'-H^%AMCC=3K!!OP87C0NX=L3:!)U1I!VABO M!RU0"`%)%A%!:D%^EE.'`)24'F=HG"0X%9#(\V-Q%0D%)?YUSF M*Z#M='8#)Y0)N63@8(KXCAA#M"Y*_P_-*B;[^;ZW;_7W.P>'_?Z!M6?UW^_M(EJC?/6_$JZI-&L0P5X`JJY,EZ,!]A$P@+K^%>=]5F+"GQF,YU;I"*5E1Y(=1O7(M2B9R2":KJ2#RZO#J'73& MA&(ZFDD89Y2(,@XMH;137_8:]64)-JIS8S6;\B=(9*V-@SW$D^[A0E7>C[#, MKEQ2=ZYJ M)FED=]H.^>DL?8"L7A$N?E]?H\V4X\L/H'?7VZMIK%02I7&H1&\-#].H#`A2\G`['99.GM@MA\8#%AL\7T&966B>C6!JDHXL4NO6.H[B&OBG$\\#+=5+6 M+FSHN)TE"<'/)Z^@*\M1?$E<](AZ@4MB6EHLBJI<$K.K?I=$)-[;=+3 M#-D9RQ?49\4DQZ5T>%EZ4X[C=FAW.#^WI>@Y:IY"F:9L4Z^ M^"I:KH=I#XK25DR^O!:'0BD'E3!&^P7T%3)UP1Y!J^P22JAH<9ILMYP2]NCF ML-4.X!6TW=,$ M]7E^7Z%GDS^L7C5:@_UQX/4R`RVWUYLAKTHW/#L.X.W+L>$U>2?2ENY;Z M3U)]VN];>BK5MCKJ[C]]SR9V=L6=O*]#7Z\P?A;E0A)[[2V,[Q#C"96V9;.Y M(J)#`5:>T!7XM7/Z37("W7EBZ-@LI_^6):E#T52>X2PK:B=Z`$7>-I"XK4-9 M4Y[2!'3=2LZ5-"QA45''K;1V@_\`L)Z!&;_LWSQ9?:D_-LCG;=E&V2@RXNHZ MG$!;!$EY0S=J7APO_H9>?OD74$L#!!0````(`$AV:$.'C;(?1#8``.,Y`P`5 M`!P`96AT:"TR,#$S,#DS,%]L86(N>&UL550)``-X0'U2>$!]4G5X"P`!!"4. M```$.0$``.U]:W/D-I+@]XNX_X#S?A@[0NJ'?7MW=LSL1DDM>12G;BDD>68O M'!L3%(FJXIA%UI(LM6I^_0$@^"KBQ1<2E.>+W9(R@[C]S^\^X"V>;[_Z?W[KU^_ODLI;,9!W_G)[ORF_?[=Q^HO MEWSF)/X)??SX_O^\__[#QQ_(OW[ZG__ZTXM`HC'][)O,A M(H\X^],W#0)?G]/H79)N".:'']Z7@-\4D#^]9F$+^NL/)>S']__Q^?;1W^*= M=Q[&6>[%?HU%AQ'A??SQQQ_?L[\2T"S\*6/XMXGOY>P+:>E"4@CZTWD)=DY_ M=?[Q^_,?/KY[S8)OB`P0^F.:1/@!KQ$CX*?\N,=_^B8+=_N($LY^MTWQ6DQ% ME*;O*?[[&&_HQZ$S_$AG^/B_Z`S_PG]]ZSWCZ!M$(7]YN)$R]&-K+([TOJ`R MHC_=$FI:=.+7',&4-D*=EXWIYZW^_?XRC/RM]08_K^ M_,-'[HC^A?_Z;X_D8V)*Y)/W7+L?+@`9D%U#49-*K4(,,8L)B/1$-7U'*2H@ M]"L#<^';$R>/;\@_,QUC#4!@'>B0+-2#"@I.%TY(4.D#!44,=K129-A_MTE> MW@_="G?[/V><43RST_A;'U+5=D MQH#.>AUY&P'=)W^W_S6%!):?L_5'J]]3,'/G@U8PB`+9MLY[G(8)"3^"3\17 M*#3R!`[.7H4$GQIN"PC$@@44R$VY`"9Q7(`HN&T=N`XSWXO^'_;2:_*;TY5: M"0FG!Q*B3S7A!`Q$%X0TR+6A`$<4'C$$&'THE-),(UJPT#HA(%RL%0U`0+WH M4*'5#.XNK.K&4^K1C.+C\"6FF(,Z_>#M1`"`&L_]]5>26GUD$8_5KRPGH?'2>M*EA$06V^_$O MB5-)O>@F#O#K_\5'*4,=.*C/+R&X_?U/@``40$B!3`,X,&+0B(#;TH'+0YJV MHA/Y+D`.:E\3=&27RB"#LZH/:B(Z*L'!6R&@[5T!5^&"D@>\3]*<+F"YEPL# M034XF*-0DG_B+X2P$&Y#08C4>W"-J9!0@6576Z[#"*>71$DW22I?1DZ@H'1# M2&Q;)5H@`)H@F%^F``P4E;"6G42RVR7Q8Y[XOSUN/2*&NT-.3\EI-"O7H0(9-;`=.$6Z6U^'L1?[(=DN)UFH.)/O MAPI\TF3`EO#L28$'=QJE):H;[21QED1AP`J!+KR(EM<0_<,XSYPXP%YE&2%% MHVBG0#`J)2:UJ3QM".MJ(IJ^>Q3"@%`)-4LU1H[3#-].0RFT:O+@STA#.["0 MBBHAO*NO)X!`:BND0KIYXUH\!$A M*UOEEUZ:'DDL\A8[P%YSSE4>VABE1@"(8`S9: M@8P"WGX\HR6F&^IR%)16.#!&,8#VPA8\/0?VK.`37F-"ST7;I?DN-Z#-H(!;1J)(&% MT1XEX4VE$0):UQ4%%1T58;#5-JN"A@D>^Q,.O=S>Q#DA*GR.<&655Z]^=*"% M'#\G2?`UC&3,FJ'"*'P?MIKZ;X)GW1S,B>HHV748ASD^OPU?B!.MQT%EJ M?+&Y^U7G^H'7W]O0>PZC,`]Q1C9:K*9RFT0!<9]TTY4?-;4ZYN@PNMJ7O:8V MF^):U_=^A'44KX'.=LM98X`_L+US/KHN>Q*%-"L74R&`*YU!X9@<&E*Q^M5A M-1`!B['*`]=[[TC/3,V.ZD^!80_IQ:2+CN?;D&`'\R(RY$?R^P(:3D6N=OLH M.6+\@"/6Y:^C\!)V#?!@%,>8H:8.:9&LJY,A12+-2@]D:^DG.WKH5323HXO: M,X[Q.AP664DZ+O*Y/GOI;YC>7.-'=*=!N@86H+.BCO"JFZ(,$*:#HIH::1U9 M47&&7FC)&0EP,EKFEV\Q>N87-C)Z80/12QST+U$C&`J+C%E`P-/DL-F2_WL< MDJH4=UYHG:0H>8["#:.<5NDPG45Y@G8EK0S!"UYPFH<9_3G#Z4OHX[*FAX#3 M#X1>D2?*WP0&S;K@A^7.,T9'> MP"7T\5]1\)@V68P0/1[Q&&G^T2=L!$^0Z:*$D&#'L()29==/C4A@0[=!*1(3]L2@MH MX',FX]A("@UXUF06!TE`8NU9)3V,U<&G3;KS#=&>3;K8Y=V!3KL_K M`%?]&)/<+OUQ396U9^P26'"%5I^Q"P$AU5I[5-W2;.@S]CZ$$X!SI[2[=X+? MO91^OR2^0VG[WHGZ1T%B'O*N:]VQ0WFMM0,&=(-50F[KLNH)C/U[J4("!)TG M6,L3=E(#=%EQ/*$6#P*"@/7S\*)[+PQNXDMO'Y)`0Y;*ED$#'06HB6^=!8A! M[1\&J.CH)D4J:$3O*YR',?(+!#B->4JQEQW2H]:[B0!A]$1.EG;3[*)PSSA,T\+H+M/=P!CRE<[>BY'$\L/>$](V7K%_:?= M(?+R\*5.FA.6'HD^XMTS3M$/'\X0/1Z!;`\P"XN?L,\Y_,@X_![.(3W@W`MC M'%QY*>U5D*U\OR`9!Y_P.O1#6\QIW MZCR-,*"\BI:)MF>1@@-X%PTM@NN8'`,U4-@[TQ0)ZG9I7RYJP`DKEME.D)O4 M":6"OP-4)HL(K*J1FW^$J4#N4B!S6+2L-]G$X3_(*A<<4EKI26MOBV1F4>H; M82]`&QRS,MPD/D,Y]K=Q$B6;(XFP?+H,\KKA)([H\\?9GJZ=:;8-]YUR8N)! MPQ<6D5FNWC4025&?)O'D\]I?+Q+A`PS-6@D=4*@"";``0FV'0!=]-<05VRCX MLM[R"L!EDN5T/2JKUS6!K@$>4*FO*4.MHE\=DOWR7S.*NEZLOM)!$8O65QP5 MM$XHR^_6XK!#`@-5(20@M%T>U```J`WJS"X(&S-VMLE]RWFV]5+!$TAVHMX! M!,-I:76%A]C;JHZLN.E).-0AP>BQ&2M-Q59C6-=T$W(ZFO19=M=NP@W4Y2'+ MDQU]VBZEK5BO8L)*1+<,8C4QQ`'8:)DR4FV^=`@P&S(SJKKQ%]F*L1BN7!Z; MVS5^39)OU1J7.?=I\A*RAZY]/BV]75K(3$.&KFYZAC'M)T5& M3HE?]B)V&34+Z2MU/B4'>?L]V?=Y-!OZ=9N0L:,($9&=S$8VACGMTR:>]&2< MQM;S$`0E;97`=Q%T0C)WEL0Q9OVI$C]D+I'>*4TB<4Z6,ZQ'-]Q<]9F.,6O<2YX8B.@W9>&-/ZIQ-HRTYIP,>JN:'.B.,` M>J)1+#04!;!E(4N#1BS/O)AY@7>..-LOX!_-N=^O3+I\2]G5(0%6+1JRTBA25&/9K$@W($=5K M5TATN?+\_SJ$10OND[:K0,]43L&4EA>[V;IFSE&1VVF#P>7L1.2>INV:,""9 MNRX!PEQ8D;4M`8%>[S,CMSC%2!1)9P>.-NI29UVRO0D)?'S1)5IX8%&#P1U1 MG-(@*,=@=5SLR)OK"MF%P"CVU%1;[L#S)8F3-@?J^%B'!-B/1\M*IRV/%`.F M.X^&'$D1!'\VY%ON(+\#[A1?F\$U^41TYQC&!\+07:7Q%YAL__E]D2?ZV,G5 M*PGIDS0(8R\]WN1XQYI>$$R:PV*R(!$3SM3EMC/-"%FR.ZL0NV6_LTP'5#H\ M(R\RO_[,AE6^XF-G]P`M`7:F0:L,69IO?GGH5NCER,.VER:\\A7FHLC/*B4H M@(;TCE+BNYZM`PKDE21TB!Z: M.)=<@[7C,1V@\06GSXEZG>M')?(B9AW%N;OO1`^A\G+_/4X?M_3(5UTC*0<' MZ@NO(;_5#EX":[\+O)(0H0+QY9Q@((:BN$!F)\*;@`?`VLU3ZB^\+/0-.>6P M;NA[BW"5LC-`<$UO4-%1D1*VH>0,W`W]5E$^'YD&2U`?0AM+$=EX(%I%B\^? M*8)#MO@IC`YDB31DMX)VPQY/B%=9)`<%M\D6'296R1'BB[ M35/O.X9U'S",P([&EL.<>\4X*&8#T:-_IKT9.F1%I5^ET,ACC>H@+^Z8,J\* M"GN.X;8J2X/(7@,XJ\0PH9MV)9N"?+ID?.7CH*X1-E,,I44F]-6H?UQ9BL\?UI+\6RCZ(FMC/"!&N/;\K42<=\'1I$$WTSFD1=5QK=+7D> M[EN:L_[N#-$UA*P59)0SM,KS-'P^Y.P!P#Q!]QY[TP,ZV3@5Y\7N"C#T5/4L MO4Y2XH+BXB4A__B4>G%&^Y\D\2H.V$^%@U@%?S]D.;VIH^E:.]=D@/55LXFN M4Y6UC7E1/W'10,-['JB!+*?FEE/*& M5+QJ%">CA/[>V\&HH&O`?HW?K2R[;74?)5UW]( MC0+5UEO/1KO!MQP>H-6WCIA>?5S)$(B-X43W5F(-E")6IQ7@X.)(G]:^B:N[ M`*NJ=9Y&[88,!%96-9#ED]JKGJ-`%&@-(E'1.JONI`CY7ED9OF1/R0.F7SR, M<*N&ZBF91JGGF0KJI;3YQ-9^9FWZ>0#>:)N+"<$#;]54-%I*R\GHY9>J8C9A M/_ET[=CS&='SL7&]L#9,P+Q$^29[OYIL+1:,O1@RTU1]#8IU+3:BIYL_YUAE MC$_PRBNWB&/"[*!'LN-&]?DG3+87M$=,MSV.&`1*^[MDME6]_CN`7I].+OCJ M-0B4MO8BLN@+TNA\,&&[JW87AHLD^8W\]Y"%,I*G;J)!]IUT!/9_/@9J#6*WJ]0;X$W=B8CG"?K M\^>205_%H,7T%"\5QL%EHT^:+(\B`09*22E);R6CA)#VTU`*,CH*Q-ZLHC79 M.&BWL,/B/FPC%A<2C='79?$G7/S_)BXCK@=U5T5#1(!%I1=+U8)BA`6SF/0@ M3=A]D6T^M^2WN-DT-<5[ZJ9HQ]2B^R+OQ5C49A)($FQO/;*)S3AX=HC8,0'] MR:_?%`["-2$&TT:OSSC_BG%,M[,']@@`'X<&1VFC6V.S`R2-G1#=8M/*F_.( M/@9"+R/8[M\Z1L8E+BJ1R=X+51N7!]@&BF,8JWA@'X\]UP+[F$B7F?H]`6\? MYEZD?Q+/>`"P2^4]63RY9VZ(#7'UO!=IW6,9YL)HK^EFYHRUE&.ZV7BZ$3"+ MUF5SY?NLVOT!^SA\H>>JQA(2H;JBEG*VU`K9Q7-`%65$F?GZ$AO5Z--Z^A\+ MGF*\H6>2JKS%"-8J+E(I%Y!F=$\"%B\,U&W!]&BNF(^8';7IM'$<,!L107*3 M^;9$_([Z<(X[3V@TQF",F"JIK_J/5]$1>)=3N0NX]XZ#EI\*SQ7CD3!DMO!P M)`?,1TA1SR6'XX*U^!K$4D7]7DP]I+%<[?91#0,:C+I8F0'C$E)F9E1 M%7?WZE)Q!T/=?EP6#!4WZ/+FV<`2;FM(9-)G`-=O9XALSAS;X=L8BBXMG0KP M;WD7B.^$M>!@37=GX-2$/W!+O(E?<#;%O2GE0$Y9I@'+!A:J&,452]62*%@G M.883*GOO'?F%EE7Q2AQAD-A4?KPG1.?T12ORVST%D,R5KZE89L6I M'V;2QP,,\(`",E.&6K&8#LE^&&9&D>BQ,897/$R+.72G@W&RG_&175U2&H8W MB\]P\&J21YR^A#X67UHKVRA=K=W=!4D5/12^6\Z)B<,4R6)Z`I`S8"T(LD[@K`HO=X M]\@$.VY,("\QA2!:GF',@/:]P7AJNT\0L3%9-QL^ M*J+#UF^$$=-HCHSJ8'4U\]Y1ZQOF$T=.Q%'6;1:Q12:Y.@Z?0KU.T@>\YVFV MN_4E"WQ8$*5)@:D085.G>I9$:5,Y%EC*5$=21_]JZ.PTBH7.F([@1<>*/:,A M-'%V[M:W2;QYPNF.WY*]I=4P=\]1N"D>#9>(H]<(,&8T@,FF/?5`MVY8O6D3 M:24?@6HE'>.I^&9-7;$Z8JE@7'%3YG/**#+B)5 M.CH?YWYJ=%Q*U.%4J&D:?VV0$P4]HIB9-XN[2[9KOEN3T)X"BC M_828$M,"$O:/^NDM0.45LWC/;CZ=5CI+9-=O"*`G-0:PV7ICHP>^_4A,G M=+'E;3@6XYAJJITE!))#BQWHB\OG9%V[3Z+0-^@CKT``Z@:O9:'5TUT*;;\S MNX:4;BO$PV[GI<=6?U"BHN@QW,3A.O2].$?UH*@CDS6) M$-#M:R5QXP/'`&@I,)31JK%`WP%@V@L,HU)X)GI6O,C4&(GIIJ`AV]SOEXJ< MBY/<6C!$V=HV=!"'35&XU@T;P6UCU"T3??6S7A,=M<>E,:QN]P'#->!#+6'F M1TEV2(LCP.HI/J8I%N_]E[&,"7(`:PVWDC MHL<8,*]']":PJ[.-82J=I-50.!KAB3*,$BG=M`K>!372^:'& MBXPU$GAR3[$U06<""GB@HWX=`ZUS?1FP_4-\-27=$WL. MCP@"K]>>6>=?S)!SS6YVE=L`,;X>$,CGX>RAZHF@)"#`\7L&O); ML;D$UGX,KB2DHS`_XV23>OMMZ!.]62?IKKB6<'IRN@^9+-,5&%ZE((,IRMOE8&6#;LY2P!Q?OHR0OW18!`90YC^C_AS$_#??5R+C^/A]/J"_I4X]WZ MI*K@6/Q7MV:8(L-H?S_6FA9AAFG=2OJ0U=$\ADP-IT8_*VH]CNA7_G]P.YJ` M0V)5]X2V\L1TPL/S1^QE2>Q%87XT,1)#'("C<5-&JI-P'0+,P;<958)`JD*S MK?_2(^WEL:(^K![/#^3UL*\-_Y,F,?FGC]DY19^UL?\P4%?%AK';OC#6;PR` M:V-#"!3DD+ZV*B5;`[FWFD[$-:T&B?/HB%9!LJ>O:#5$\)A[<0#;M.31W^+@ M$-'2`.'MAR=50=O008`2(8-8;>5$>HU@/STR@+SN*L('H<'N97E[I5/P]"L; M"]Y(IV7YCK.\$K`\92A<$2TH0-,6D/;!A@B/>S-7!\K&J$`A@IVX9:L7+XSH'-=)^G/JQ?E#$D7DW[3S61_/ MT7\T4$\RE'F!9^D[%+2G&4:O4F6+(5$U)B(#(38JHL,B/JY#WNCM"\'48UF5 MA`N[$G&GN&;S6=[8X]ASIS)\8.C=RUB1B'>.[6G/V:^5_B@%8%,='0AV^<2&B(^7_`69Z&?HX#1NXO M<9AGK/?LI'ZD]RQN.I6!PNKC87I.X9R[&43_0-]3S\5MC1E^DO)YEB0WL5(^;$WD*)"N@%#.A26G>)S_7P M^8C8$`Y:[2A.Z<:",=AH+RLTQ,;?[U-:S;9SPBP[UZR89VH&3W_QH@/S8ZLL M.^R*WPV.'<9,`FWD4XI*%SD,G\&)P&$L^<9Q`Y^H"`TZFY9J.M28ST$/9$-P MQ%%=>V'*9-)P6VI9N>"AC-[<6$6,%O*ON_4#]I--'/Z#2).UM&,7O\V=U>3S M0?NMF00H=F$33P;HS6;A1.G8RAD1GU*Q0ZKGI8CUS*B8&K&Y'?1TEH5:NKES MP8A4MU.[6K#ES1E_Z2-+JWB6FG5B*MK;A"_T%[8IK<)@U?E"( M,ZVI1%$?;8T=$>B$:QJR5>WZJI'9B4;K%CLM\*B&9S>2Z03P)UZ_8Z%H3L`< ME(P34>"E%_F'B"\*7XC-I71.0O`G'">[,*8_W<2=Z[Y]J_JFF`0ZWIM25+*J MP/$S@%8-3D6^IJJPFH;^6$W$*@T;4]'^V8++\]#^"$9NM#211&F'8D5EM]^\ M+/29:_H41@>:\W;LDGY=9A7G84!I)-[S$?N'E#VEUU(L:H\J"5Z?2I!@3.75M"66]/6N6T)5L,HRG&<7Q_IVO4=<`/;4Z?W1 MHX&66`YE7E!BV7I%7CD(MCU9V$=ROI>]8Y?&#H6&RL2,2QU]!1`6.M M<20K8RL^-"V'8(,W&D.17]5=>\H)P)V&(](!O.A]V#WC]&[]F--4V$W\5^+( MME]@2,92>,Y5O,MAU>?$1AAJ+0IT=@`D2A8!]5E,BH^!/<(X@B(Z&_!WFT4/&4`^S':SY&D5]Z:7HDBP2K M0U%PHT*"^^!Z5DY508X!HB0ZM M#S%D2XKR2NTJ#NZ(8T[KF[49?>3YD*:$+PGSAKB@SU::,29XP5*-"/68I0E5 M'7VKKDW3=95A-RY0$ULB`YPA/@2,&4W"75I??3\OTL,)XS4M`OI)7PE,=KLP MH^?7C>OL4GLQ0X%X>,R,C?J9,34\T*-B)D1U5Y0:J]DS@>:_Y[0$:7)P45QH MGO\:S4HZ2WL'<9E?FM*WW*F&71S%)=!E]3/.?3UHM!%H_>DR]J%1DHV@F6DYXS+VU=&<3>'+Z0;=LH)2ZXQ1G6 MFG\*VN;Z,XVT-0M16G=#*-:D`^L6,7Q%FJC6@-)2W_KFE[Y7AWR;I/0^TVI' MRXU9#9*":@5ZLM>H"C##MG_WW($O\[JC@?O\9J@=`Q0A`9_?CN4MK[O8E M=U[-G2?D;FSTESVRM$6`4QQ<)^F3]_K7,-_2%U[#>$-^(?9+4@\V=#BH"&T< M^^V8:]A8@%'4&(+%RW6&&D.BIP0]$I1L?63WG!J#H[OG*-QXPOOO%J*:N1FG ME[Y..::_DX4T4/'&''+(&G)X/B+,+R-GM/XAX]J0$]E\K6<"/!]L]:6IJD$8 M)W_&42!Q]EHLF)#!D)EFK*!!L1XD&-'3#5Y;?9#.4*/JJ%!*B@L3%XQD*"L8 MBNMJHX*AK8`A=_HB-K8MF6S?P@H7M860H\>'+OB=2$!]NB`:#^Y$&Z,1E`_J M?-A,'[""8&FK(UX7#/F&[-"DP&T8XYL<[V1ELU,,#&19DXFD95*C1[5O2Q.1 M+([C-(:CL1LZ!6)S+-%XVJMTIS_ZU-]#.]W"#,U0?).8GV:NY1BE$2/3FZH@ M5*Y[]Z]EO?LG$>.>Y:>OXD"950.09X:\E@B*G/@C,1?,1/7#AS-$DVDS2N4Q M]])\&7+YA'TNEH],+-\OV.&O@B"D*%[$Q5,E7^?Z#*H9%^KV]4* M\]?Q,J__KV>OEH)J?J`S%>L";!-G>,:"$-2@A!>4Y(V"DK,B0F;7 M/PN"IG65/Q:2CO'&R_$\H?(T`G\0%XBP('&F]>,%I\_)3"O(-$+AB^O=(<_H MZ\QAO.'ZLLC51,CYSVF239YE5,VTL#5"+[1)E@/Y-,OQ_#H>YG#R4C=.?T-F M7IPW[RW$LC)RJ9ZZ-\/-EA2MUQF6ZYFUJ]5UDJYQV*@+M;Y>"BA8F"*K`I?7MGDL7Y<@D'L_KN M5OQ:S+K`TI>>`I3ZY@LOHNX))?5`M"W=&RF$F5E*+I7%4()OLNR`@T^'E-!7 M+$W%B7CS_=.K5YSZ82:O=ADP$.#=V4$L=^[1]AH%YD[M`!)G=:/E7"X$O%/) M1VK_%>)R0[BB8T`1P&*:KWA*Z*]L17;FTR\SX.LKWBGC0-.Y%Q<>]F-L5G?' M6XKPS3XCAMYUI;^V%U+.OM4=*7"I_VQ(#S>D1QN+F$6;R_&S?*E@[2+G=*B" M>9;I.:4"F])%=B99G"^4<`#G]!H$+=OIF4I6%QVR.Q-OS)LU//]?<;C9TM7A M!:?>!I M1/YQ@+PU8OG]92Z#8JR2!IB^1H?]L\N=:WK=;_66">C*LL/Z5Q[$K%0_SI(U).ZV%X4 M+,_+#F!O7DT;.*73UIH!9&%&TN2H.[;Q(:P6\B[+6<_/ M+7P!\%*=.<"WT?IV:0WQ^0XE^KA;7;;C&Z-LC]M+LNR75S+PY&;M64S-" MP+TW@#*Y?YQ)`Z8D<)E+Z_2?:,H5=SKJ%K<03\VZJXDNRXNWV=;*Y>\V:*U9 M6E)LQ`>0[VUMKRZ#*%GF,C)"Z%.N%P/(6-S",)A'5Q-J;VT%F.X##7+UKB?? MIKGD<$/8#^,L]/_B10<+5\=.YUOFF896@#-=#VM/MKAS"PTG]E)?U>R(3?\F MKGP9272UV:2LA\NI"):4JG):7JZEG6:M.ZC$8V49&4'/,I>9T1_`;E&4A)C% M+5,C.74D0R1U7$HWV**1/L8Q9`S_E4]"RX\?=$0A<]YO.VTS'V!?<6\C):J151#=B+.PM3 M>^XWM"Z)&`-VF#2 MD>U_A9`PNU`%TE">Y"3B;+S;PH#1 M/2%K2TWM#%T>=H>(6.,+1L_<))QQ'?;X==OL5S[9Q*32!TN5&,ZX@5,F-.Z@ M!'?!+;1I,70/9ZA$F\5TR!;S.5%7K0S@1&L^#WC/?\@H@)_L=B2\R^@,$^Y0 M6Y3SW?1EDN7W.&4D20RB)R[`CK$O8]7.SQ019@?7CSJ-`55I0#H"/1#BVX59 MS4FZDUH^:_H=S4@>2Z98`RVRGPL#M"]9U7"C9%4@!9,U1HGN0"!B MP)XT*E'@PH8H6L*T/HD/<";Q3DZ$+_VY5-OEQ'',#+;(\A0EVY3?SSC?2NN+ MS%`=L$$-6U+[D^#!VIZ2*.T^@6>B:OMC=E<,X831]6-OM4L.<4ZMJ38N1PUM M<#W_M1>FA52R[+`KB_OYW:@YNK$83+BP&SS&(ISD!H]VMN7#!5G?7-)P/,"ZO)4?/\EH7N5*,R/#UX^^8WR/C,OK(:N MOU`GJ8PSGW8Y]6Y]>0+Q=S4AB%*RL-O=HT5&E@GYCGO!3^!(&.`YL^\'V MO&_("XH$.KL/;$[Z-CQ@ER,0_U>2\=:\GX%X*QD$I0R.(8Z6>$-#)(B',/OM M.L6TO`:3SY;;\G_B>=^`_U,)=#;_)YITV?Y/SI%-_T>I0)0,5-+Q5AQ@#_E2 MT/,U%4)8"B$5"&$!#I#7%+)'ZF5O=[(_?B+\55*;^G,,I6)ASG&DM_R*$M.\&%&1TK94=Y28T*MZC)@&%57D]Y4=3&D=557D=&-/RM@ MU-9Z4$T?RD*A[0="/Z"NKR(V.*%=N/2I==\4&<86^K'6M`TS3.NVTH>L;HU& MB8RDX1VH%8UBKJA>9P;%&?.;C.$Y&:-3.\:8Q:C0W^+@$.&[]=5N'R5'C!]Q M^A+Z6!))%[(@_[I;/V`_V<3A/T@@S:)E6F64/='FEK*(8IZY@&+2.077"FGG MF,A^1#P?%]V`FL]%B];*V1"?3NH\SU`]9U$(5\[*-[ZLQ"]#O[*9__/M6.S% M\0'ODS2_#6.\>@VEC9IFG_9MV+%,G'.:].FRY4E8\WJR-N(> M_N4ARY,=3B_I-=@XN(H)FQ$][E(93"],@#OX_9BJ;N";H<' MLDX7)M&T(2Y,.-V+L68\;81H/:#N055'"3DNCZ>;V(Z$U%,PY_5G;FDI.[K_ MOLFQ]`F%R6=9R3 M\/O)>Z6%\G1I#N,#V8S?[7'*6)':68\!@$RH-XLMZS#&MJ_X/4GKZG0Y`"I& M0&0(=O_C#-6CH'H8H'SQ=&R&!9LY81/VAL!:CB;1YAM4KCIIW"?@W='/1WB^VJ M6>@KQ_4\13.R,$9\JK.F/RFF0_23*M9,,BE0@9X5R9$A:!\JZH&:]Y2OA]$%%2H!\^0'9L"(-5HJP/,DS.K#^%8B4MAD#\ZD(Q M"&J.@IZ2\AZ4W43:F^%0G5V;@,WJ+EIYTRJN&F"/N(4RQG&<7":@MQN&>Q'Q M8*ZZ%!7K_?R+:"2'G8VN%M55 MG2NR`PW"Z$"WEH_8/Z0DK,/9U:L?'0('G*>=KKR4/IV7E6U^S2X% M3#,)=!7QE*(2UPQ/,0-@A?!TY"OK@9O3H'H>5$Y4;-,:4[$B8CY9H[\_>+W_ M2'E=',4#*$K]9YT1*+$ROQ!;29;YIK.?<)F;EV[R16*ZT!7X8D:^>#MU+;T> MS26;Z+*C5^P:QQ'M/"7(6,4H(G#1^+0NLL-4?QD27&T4CVJ%7`^-U45?5,=WP+JTNP\4S87@%5\`Q M+>'&JUKO/8\3!1LCA56\:3+/ARC'7J1IM04SH5T5`R_-J)I4SV519ZB8Q:6( MM;&<4#/1`3UU#/0/)%-CL;<0R:[]S#+*(WX!<<'U<5C&2C$ M36,UV?758C$BW:+^VS?IP%^]H!]'+[0 M&$V9GY6#`^V&->2W-K@26/M[5B4AW6TH!T!-GA]0CU-#G`L1GO,.' M`=@"C&"WVAX,&`-FZS"84$&W*S(2XD.A>BS6AZ`8#57#L7V85@T":UFG=/0R+(H,;%=Z^NT1:V95$U$, MF`>^U91YJQ`.8O[([WW?HQW,3A.O2] M."\U5]@<0@T/X*U-&*C\M@H8QH/K*>HH1X%"WQEI(%7NW'(?AH70KW;JPYE( MUBAK,.'+F`#T\_WW>(,?#X9ZC&T,]QM$F]N MPQ<K3\EN]`/I57\4T\"U*IU%E&UVKE..H/]EJ\S MD-\QI'IH1`RI'ARQT<\0'?^<38"*&6A7PV*./V2(ST*7IW(>H+ZQ-F1%FQJQ M;DQ>C@%7WF&\7B)QI\23Y%)IKQON1TY(7X$#'9T_@./C:J M!E^2PS`4S.4VC#TX!_&%&,HA34DL5-`M$4$7#,9H9>0VS>\4QKHAB0GH?/F. MRL^CW?3*J4J[#:D%OKK:>#.YLD9^*>#BR.IJJMUQ^1QR&&\>\89F.C*SEGHC M1H;NHS=:*)('MX<."_FF]CB:E6WRRFLHST=4U')5@S8>P*9O(Y0#PU_C;?.N M*-87`4(]\BHCN?VDZRD4P`.N8A(DA7\5)'@!/NUR=;=ND:\LOU?``\4!.@9: M`8$,V'YDH*:DF]&EW;$G/\QO_QW@8$A$ M8'40U/PCS,%/EX+.QRQ`@([F':%/?7`SGL@1%O!7'$7[)(QSN1%T0`#L0$)F M90HG?X>Q!B$1@@[E471/H8!LPIS*_?Q4JBUC*H&.L(\B+;O%7I1O?2]55%7* M(`&L14UT931B,!C;4=$BR97_N0(&LJ0!-&\MT:RVJWF$/<+*5CA7A6&M/P/8 MDX"\RH@:?X.QG`X!W>X`%`+(1IR@3FT-8TF$.)PKNZ$T]U2WNH>,3;&AC]>, MF!.?GRE1`0_(#.CJ:!W'.>OL@V]=:!^KYJTNLADDFB:ZB]K89<]<'6M2Q8*&UL M550)``-X0'U2>$!]4G5X"P`!!"4.```$.0$``.U=;6_C.)+^?L#]!UW?A]L% M-MVV\SZ8N8/SUAM+/__.Q<*UW@`+H>[]\&GX>?+*`Y_@3Z,U^^10%1W;@0/CI M?_[[W__MY_\X.OK[U?.#-?&=:`&\T'(0L$,PL7[`<&Y=(S\(IA`!ZVUE/<-W M$%HO_C3\8>-/DO:MT\_GGX>CX\\#:QZ&RY^^?/GQX\=G1,H&2='/CK\X.DIZ MN[(#W#JN1[L=?1ZNO[E.>O:]GZSA\,O%E]%@>(Q_^^GD]*?!P!I_6Y?\ADF9 MPNJB+O3^>,/]61@/+_CET]8`/]Z0^]E',UQS'%F8.%?02](+0]9U.+-%-4;WAY>?F%?HN+!O"G@-9_\!T[I!RJ')?% M+$'^.DJ+'9&/CH:CH^/AYX]@\@EC8%D_(]\%SV!JT0'\%*Z6X)=/`5PL73)P M^MD<@>DOG\`\G!\1(`>7QP-2_S]O$J%(?XZ]R:T7PG!U[TU]M*"C_V21]G]] MOL^0`>;`=L,Y1BA"!"(B`E](P2]\;7YI.O27$,L2:?_:]R;`PS*'?PE\%TZ( MC%W9+AG5RQQ@*16E0*AIQ82LOPT>I]?^8HGPL+T`*]\]UO<%D$M:96=M$FL' M\SO7_R&9>XPN&A-V`P/']?%@P$NT6-AH]3B]B@+H@2#`"O`"9QZ>T!P;JX/C M^!'6!V_VA,?D0"!,8*.N)!)*X"/_W_XS@N^V2S#%_2>=!L_``?CC-U=81NOT M()-_H>_\,??="5[^2,?AJ@&#"MJ2.-18+5_MCR9"E&E$XN"^@S!N^@F@ESFV M$NH/L:`IB0/]"OP9LI=SZ&RM4%E-NHZ"$'>/&L`LUHO.^8C^;"+T=3O4,#>] MDG\:<%6T'Z7S5%-BV"VJF;.:CK>@*97S5]/A,AO4-)^_XBTNHL6?7-N3,,4U[KDE&)Y!$"+HT!T] M+O6K!T,=F-081DL`T>^>P3)"SMP.0'Y4F^^>$%G(%VJ1:C*>EB"[LR'ZF^U& MZ6AC@0_(1[%M$P31(OY,*51UQM&F5%$//_$/`B^@`[K](+\V7S&;]VP"#%>K MQR5`-C$$[R+/(=_H0Z9L,&IV=8UI+6I+Y;YNRT#%^$4AA0\;^78`'6RPW4`W MPO-[KEIC.J4/I!V0QGB+0X<"WP']*KC]<-QH`B9WR%]D1MXJ9E+&I6DKWAB7 M6IUI(G;#L@??FSU@=DWPB@;"X&JU:<9VQPC8[0)3:V#:07P&[\"+\$3_S?[= M1WI$BG\T"5Q+K)YX0TS;?,#H)!B1(4@]9MYF!_@(`;8V)^M/84AZ&PP&EP/K MR$H;VOX5-VK%K5K;S5(:,!6N[V1Z<,F!OX^J.$X^^4?9N,=O>%=A.V':D&N_ M`3=NB;/>%Z$A)H#3P(,`.)]G_ON7"8`DZ&)$?B'#'QT-ADG8P7_BC];C>,7- M[HQS]^M_G!V?#B]/!^<7EY?GQ\>CP>GEU@BW16&,LJ.UD9.VC7_-24HJ7`"$`DU'XG-3X"%MFOWP:?K*B`(_1I]:Y[;;!B#$> MV(0,[LZU9P684$]-5-:DF*^'1L48>W>&5SG;_#]CH#G\2E'!IIV1_^,1#6,*I$^VXJ4H8=*Z-0=>8,F2[]WA?\O&_8,7DT$ZYOK"(AZR$ M1Q<:>'0=(919)MD6':MH]SDE1%G"K$M]"A6/]ADL?42M]!@*"O>?:8) M4Y=N8`?:.'<'78"NL6#-?,2>"#.E^L*G:J)2]NAP,"2RY"\6OD?/FF+O^F,4 MDMLQQ`1BJU=)I;XP3YC&E) M3/D!+'&XBE6MKXGUB8K/)RJ&GRV4E!*9L%YV(TN-#,L1C.0YH"OB\1]!&> M[JDK3(<0%$?/CL-K&Z$57FMHQ!!#*+CJ&BHD//S.RTI]BI7*SIFF"2076/P= MA`FPK'FDI$JO)$684.;YDO8IXB81T%?[(T:DDLLE-7K%9%$ZF>=3'9X$GA!8 MVG"2!`;BR?$QG`.4094A)1PU>R4M=>EEGI5U6&IXY*,+DM#$UA1=!H28[8>V MFV/VJ:XIPE\"%*[(C07J"L&FTY)LS?!TR9P;V%7Z(0K"%)8L'BE_C\TQ$+[[ MGB-L(VPJ]8/'-6@LF>PU3-(-[. MK`4ZCH?'F]^OOC_Y`=W=&`V1JOT0D=J4,B,[.NQ@JI"*?G&>A[OYL!#M4WM, M:ZD9GJ7H$E.DZ5Q-@OU=2`LS(*3#AO<#M-^@"T,(:%*)W&V_"J<_;W7C9*/N MV4\C@A4$B$OA/-\!#[N"<=QMQ*52IO-07N+(3[5]I-<=_V2OB+^9SQ&?+6PR MKWF8P_;#<]#)P5E-\_CM8NGZ*P">@4O"'O*@,)A<6:]__*Y',L?AB[!IQKBA MAP4216#RS49_`!(]E[B#=ZVOTK+]89LXF4K/4#3I=^HG2JZY\AVN90OW1R1J MT,GA--.T^Z7>(N[YFE&Z?[P5(;3$C::9N=Q\K:#T9#`:7&IV=R@WJ@LI5GK: MI5\J*OWDA67W2#8JB%:ZUFL2#V$O#"?>/1040,J=8L;Q M5Y`A>8YR4=C',-OQ9`)C,IYL.+GWKNTE#&W6H0BC=/_D0810CCVZ)O5^):F; M(K2J5/!\P?ZQE)/&IDO[9:SD'IA1-X\A:OY,$E)Y8')K(P]ZLV#L.-$BHIXH MO)V%#F0M\M45^R'N_7/-;ON\34HE]6 M:%:Y_.BZI%WY1-\VEYG7MD>\U[8WW5F/4RO3H97TJ"6VD?2\'EN%6X996H_= M2<](JJYL[Q8S3M,K6)"U'CEH49!`LXE\)5I)O"`P(*_@D@GH#N0.?SEJ9,D= MC88#S=L!+G[DV2A*HEG.(<89/[5`$T"*SO6WO^\Z(_D(DG704\@V35&S*5`5 MDVW7&%E_2)BVL_H(]LI7$I%:ML93WC)$)@V:U'G%&QL63D MZY3RS*.8K3+&\:L>$XJ.8ZJH[&/:BG6<&7DW;_(.4`B#3=090R#**_560FJ0 MK>*P!?1H_F;RH%/YE%]1JW?BTH1N MYSDN.`K>/MEL:WWW/SY)=;AZ45^HT]\4IDQN4 MH^=T)I7T^&%/#Q,>8=H35?"]X`I,_ECT!6'1JSB7>:U$$VR\N]H3JJ_2S-] M9IV3Y[2L<0P7XF*U$+")-"NT0XTXT*?D-Z%S%0*1E.Z[2)21J31P1)-0_`;@ M;(X)'K]CBW8&OD>+-X`>I[EW?BJ6#-%FLOB>C(;#[H0=2*%5P3-RZH6@;`$1 M:L,X]DOA:7U188-B;HHO!FW)!%KU@EK-5O9<<(1@,?>2:D%8?WH9JF*=X:AI MG(@(+"UUR6._;=FM'4O9=;D['V&E\.(4+L[J%=E>@/$@?/0F]"\WYNKD]R@( MD^SU9?<4U71FG/C5E2F&+[X=P)3NOS1=D2MAA/ALUV,Q$Z6ZG6=*C+@.9P?S M.]?_P?MVZ4G-2W"X&RON1^\KIFMZ^5\O+:BBR8].1O*$_'>(.7.U^A5C?N^M MS[+'>&I\CZ]]EI,FWE!61TZQCFB_3U_-T!VWO`R2C;IOU_!`^GKBAN*7GTY$X&*KO9'R%I#S]Q-=YK#5NQP MOJ*6<1+4&J/S,E8'*J7['&U/L.'!.Y!RG2E5FR('$1+`Q:R[RZRT\IG0[2O? M_P/_&P70`T%`MAT8,U0D'6*5#W(C!3&S+E9UY)[%?DI;`Z3Z>),K#2$A_IH% M6>G+5KSBP@>IJH40QPTOX0TA8RW#=),DHN`&Q#_OON?)RQ]B@P##.`[>8V,6Y+R M58V3H8:,Y)$,3A2:[N\K4DN?FR)/3P@L;3@IOZ5656T?Y8@#@:9[_@H9NC1% MAG:>1Q2>D))Z^RA%/!`HW>AK2I^41X+]YB*W/+&;R.)Z-AJ.](>6J18M0324 M;O1EY<0L5"#NES#Y:_=77F0`(>NRJTD^H;)];%F.O\IZ_16E9A#T,>=+`;0T M\C)^G:[.DL:HOX]")0*%K.N_)@D7?XA%XX@TX\1+90Q3$TR49BS69)HS(+GW MWD$@(P*RI"'CY$Y2!*0HR49E.L9;T\2I.W;^&4$$,'58/<+5DVM[(!OP#C^2^)G7E`:8J+8.ZEIA/'0['? MTBS[J0#IQNM9%M5SC*J9X;G-I:PA)DKM)[/D[`YZMN=(L)]*&C).[B393Z(D M,\5*RZJ&?`>`"4U$1]^)>Z3#"6X_`')@P,SC4EG/.&Y+XE[!6E8+BEZF`DJ< M^B\`O4,'%(=>I:IV.YT"A[*$,.+5?P%AZ(+Q#QM-6&NR2LTF%2>CJMZ<)_NG>Z\]$S6$;(F6-T MZ*.F"]^C"U#%)I1=<7]$K2863<^A*S:?FIRJ&($$CL?I@^_-7@%:)`F^GD:"YC34%I>I)=(6R:IB]^N!OO//='U!IB MHO3I;UUV'#5F'Z?8J)C;W@P\8R5XI*8N>24*_R!.['?;)?K),ML$FC!.UD2] M&XV)9:Z-6K(B%8[["6"IG.R>WC.X+])$Y[G?F-B>O#%0C,,8SZX(K?!$^C?; M9;^HRE.WIY+"0Z6D569)A1(/&X5[)BC#_9"4H;00J5A4;KU)1E#4Y5R[@8'C M^OAC\!(M%C9:;:[,8R!>X,R#4^B0,_0XLAZ#\.2[T-DR=DMSKPT'^#_KR-KT M0Q*QQ5V1%&MI9Q;NS=KJSMKT9ZT[U'&#/D=V57JBD@I:+F>7L?`5<^W*9?M? M^"IG%>(2*X3NJY.53,OSTGK?XFS M*&YU0E4][<;:ZD?*Z].<1#&TN&8;1NQ;_.FMA3Z.ZW7 MU!<\]UU,0D!@"%><&GQB\\G%S:BJ57$3:7JB!NSXM8,>&^MYJN+9CP65Z6)S/+& MJ6$56\I>AVM%`=\!>O,UJ.!7X,^0O9Q#Y]Z;^FAA)Z]W;#D*KJ,@Q'J%>!?* ML[QV;GJQMKK)^<$V/>FP-L&,&#W/8$D2'58^?L2@R>)SN0+2*_ZV:W_DJ=UP>&A"I($A>BH?\!=@! M&0@,5SSLYJK342[7ITU!@+F>H,P?6T@AW\._.O'372)3@6@S'147J>0J2&UF MWJGG*_F';WMW/!@-CIN=?5I_BOL3-/HZ?`@J:8_GS,$DLT)_W":SJOO\=/PXW<;N@3H.Q]]Q2P/GWW7Q;^3"\(B^B_:6E8MAE@M>G-> MK@(9[#U$I!K"N67*UW2V*5C M@>292O*4V,R#_\+0TKMFE$_\HBRYO[V2ZC:P4_`.@)8(9"&GRTG>Z;(=AZS5 MV2(U(!FS_.3\\G0T/+^\&)R<79Y?"K]\QO*P#7OQ+A)0R32N@4H>N=M M'7LAG$`W(K/F"W`B1/-&W7XX;H3G#)*3D1A849A@*1K2+[^CGDBH4C@Z?8@H MK#:JV.R9N,I'C0M'6 MC)L/>&X3J*"Y=TM3\F3?U>J;_;N/UCIXM5I#FT`MZE*LVW`G14TQ^9U>:H3O MM=R`T(8NWX)S(C%]D_6GI.?#S99:`<_1X@V@QRG-:1;<>[_AB75^BP<8KN(K M'^STL]4ULVHQ&@U/NQ767)/"3CM.>*/\JL([Q>:#4?ZBFVBHU)?%:[ MV5E[(RSUR%;P3I[)ZW[^.]$UO_'UINTUOZ#`8;5ON*\A0Z,ODF[&%9`G%N+W MW[^8@$#KXMC9-&P6!"%Y9RF. M)Z17M6[PZ.]LB(IV&*WT:UID63!S@\BK1+( MGEAF=-WG!]?GIQ<'H_.SX^'FBR?NN9C5J=R64=8MI*B[K+Z?(SUN=.7 M%PO%H\#@:A--2=M8,U[@;(S<>#*!,0`)AFLK5Y7DLWL\"'\;@/9EJUL7MGA- MO_L M>&`%/1T$7R603;T*W9?QRID"&Y%3`+=M:`]69;F`.J(+QGN+A@?1EPQG(O+G4OQ%M][$*(]Z M/!FD_NU?R8D5+?[DVI[@-2[N-.7;#O:X_[6#W:(CB.M9=`P'E[M!KX0W6&X> MHS`(;8^A9'HVQEN;W]`,B!`?M\1[BA?1!'.:`[LNR%M:_QN`LSF9&?`FUYZ!=(?SA*##RA[3 M4N\'H5>*9*(*%_OA\`N$/$HJE$+>"`Z*H1S-1#DN^[Y.5,&8(J55,X0&<5". M-@!-3XL&?5>0IMXR#>95HS%EN7TR&I[U[LZE>?BFVM3Y+/;[MRTY:(AD)%-= M:'IFNQ_>5PUJTFQ0!^W1`7"J5)U_T%N>DU"#YG#V?E`1I4BFNM#UE"L;Q,LQ M?!->I)_!PH;DX;5KWZ,LC&SW%:#%J$POVAW)ONB(`:BF^B+G.-P(1_%!:];\ M[6>,B`FPIGK3]-#523?8J>+UXI"_`3^W(^V!EUYX:WHN;\RF0ZD??3R;(7KCI!4]J#V>PWK0,K:I%O7B/%Z. MA9E%K86-PDZ'^Z(#[8&7"GE''[$OR7KRC#4?03(+T%*_>C"4E`+E1#P%RF8P M2=X3,IQ#1I3^9D2I3$OWW??>Z7*EY@Z1:/_9R>$43P[[%S"K%,M#9I6NYV4^ M*(5L*/N3F$49BMF'SEK7AVSW!WU0"^4A=4SW$S8?M$(!FH?$,CW83QR\^G+! M/"2HX4!2/)Q$>HY'%6,\K#D&X"TI'T[?M_3[HX*'%:Y]P)5F;C?ET7J^(^I6 M^NSQRJ,//T.R\.RW&/=F]M8(H*2,.6:^HT&_>P;+"#ESC%K^-'GSW1/R9\A> M"!\MGXH?+<>GQINNBT^5M[Y/QW8X8S;CC#GS^CL=',O^+2C9X^58E.I>G;`6 M$#UVL/8C9D[_DAK[*22EU/?FZ%'V[-$;*TB8[*:G;RIWDADBDHTRP>()6QZ$ M),;<(%2WQ[-$+N@]WNX!_3J*E^KF-6H`HS:DR$`"_@7#.#.SA MJ;J74L,)@R17LV$;G\:S2F^6'E&J>^VQO;,AHK0GSMLT%!-_%',W"*)%_)FH MI_9,W%-+1F/1X6S\MLF(_F*MQV1M#>K@HC7#15O[4MY:`+>8NKZ[`VM@R>)+^S$=>$ZQP8EJ'V-Q\S$;IX*GS&S)0=UL/?\[Y(O084)7G2>RG^ M-_`=3K`%T;;P;_=[$'U%&$HZ+^B5X#_#X(\[!$BL","2%;8E^$7]'@1?$8:2 MSD(Z*_@\CXO1+V\P@FND9:M!O5$`$1]*.AZF*G_">>!EVLC*5RT5Q MX3V0"P'">[+]'KNT<4QPX>I=+B=\E?=`;AH`(6LWZX>VVQV+Y6KUN`3DX49O M=A=Y#OE&U(BYD&_$6%7H_/+L8J3) MVEE+V^UBZ?HK`%X`>H<.8.Q%8C7%OY$TA8X_\^"_,'5TOT%)?B7I&UG&DHJ^ M>C8W%@I&@?G5&I0EUAOT$9X@Z,S;!]&]6CV#I8]"/*6#\0=D7N56W*UQ`MV> MK*F7#&)S?6&8*NIK,LXN<8<@7.W/-=?[;" MU)%$,#Q25%GI($";RRFUL%(0\J#=&OP*/(!LE\[("^A!LH,,X3O@60&YZAZD M;GL)K`^9@K`#[<(GAQ6$"?+4_@.!]G9/!8)F[+HHWI/5E94[497\6Q M26D-'?-`/*`'/PCNL*X0>Q)Z$=[9)J=8OA=<@:F?8>#M!QXO%DWHV6A%->&[ MC[_U0K*5B1\ZI&&(I1`HZ=&X&8=#0+:GBK:AZ8DG;`U'>C:,+=4IK%3!;.E^ MR`X?64RS1(LE/9T"DOAN(]4D?KE(^%E&,G<#7>=Q0TI[Y,;Z$;DG8C=:F+F\6G>/,8MIB;R$\DB2AK- M1C%MC8?\24=DX2%9R9@*F]`S<,8D??7FQ(S MO0M:F7@4ENVT&/!3),E@59!G#T]PB%Y)LUV\FBY\+\E<&X8(ON&U]9+8=*[1=6F["_X!WS^K)0U%C/!8.;9&5W-HTP)A*C/+=*BID3 MK%:R@%Z,AA>:PVTE&!1"M$I*UYF_/J/7I$@PX#0JDM*=%@81FB3EY"PR+#3[ M&L9>""GE\#T^X`QN/QPWFH!)?*2PY8EH['H8B;L>R/".)LGXX@*!E8[0(D/< M]4[TUQ>1WG4YOQP.ANHUR_R`F;$IQ_?+R)W9+"QLTH0J#G9P@!*LW-G)(CXFIU!3QGOK#1'R5.@ZIJQO%:@%D< MG.:AUMQM>)ZS5X!@Z`[V1J+/6FY`G8B*:S.+.7D!W=9]N^4DV[V(/>MUFS!>*"I;NF`VR(%!J M4FCR<*ZS.^U"7&I95-3*HG>)T=,[1*]UH5-4R MC^TUF);;54&ZOUZ>AQ*8[\B%O%>LE<3C*U MWT"OX.:='Z%J9FY*]9F7%51JOYJC:/]7%0G!KF">,$C=XI?36:+9M6URAK*N M[XT6G+@6J6U9>?-Y5@[[CNX*DZIT$W9BB$H_`40^L&>`]6I[697^B$AM:I5Z M=S4=`N?=V]\!5A9$T.<^`=A4Z9^4"%/+L02TFG-0)%)G$P;XX'NS!_@.)N,@ M`.0Y@TTSMCM&P!:.ZLE=DQ*/ZMF^0D4&:-$16O$0R:-3VX.TZ"@UWY&2%`ND MZ3*EA]FW^@U.P-9K1MX&8PKPCJ#<>W&MX)IH#5H]3F_\!70@,V!(;B?&S3]5 M`I"YNJD>"NTN))V2>>6&"D(F(GTI#2^AY+(!8%V3Y:D7%;8KHB-@)AZ MABSM%NNT5'`1T^EW..O92DG&AYYG6%G M?@Y2!8FY8=I9HDK"KO(%S6.^(N[EY803#',CM"QF>>.$@),U M!?:'$(G:MSH,O_U?HX7MV>SCM>WOC>.=&`MVW/*5E)D57LW@WV_`=9<^]$(V M"W>*](N+/,29%0?-8"3)I`8PN);8;*H;)S=- MN"DJ&Q4PM!-W4>@Y_/D+(>7-#@#^X_\!4$L#!!0````(`$AV:$-:C7%V+0L` M`-5N```1`!P`96AT:"TR,#$S,#DS,"YX?WW_[^M[-_=+M_7DQND@.TD')YVN^_OK[VA*)U M?-*>P>UNU]=V@1V0#GQ:[4%ON.FY]#5S=HJ&P_ZO_8/!<`17IX='IX,!&M]M M*._`E1DM)G6,!;$Q@M%@SGDG8M[KJ,?%'+@&P_Z?=[=/FJ[C$9Z^385%8^2J M)6`8]2ES)&8&">@MREYRR%7W%)S>B$_0^]8,3TY.^KJW@R06@,')2$7:(BJ0UUS85V2&74N>=WZXV-(CUD%82D&G MKB0Q`I=%2#P[F6NG>V5*T9?K)>D#!1'4V#!P5H*'L^X6'P!2=841FF%GJKF" M'N7=078,2ZQ!(#KOU7+#"X18UU2UP@2U% M_K0@*/*EG_6U1 MVUI!V7C':I!#S,44X0\32T&&L``=A;7%G\M M=5^G,^;'^[!FO$$\TO+;*&=%^8HZAL6AF:C14O^^_G#I"EMJ$,?,'!L&=^%R M0@P"S5.+J,S"="WBA0](MIBNB,34\K&P._%YB#F$&>(`4!)J5Y`!.3][F(B( M0Z`!!5:@T`ST)3!D@R1%NL+R;4D5 MT:*L$LJ^$3X7>+F@Q@V4V<+67L`8/]$YHS-J8,B174?"$`LG1,@M9_-;J%#, ML>-`E7JQ#L5@:RP(SDJQ=JTN'X7'R90KE(0B%FF416Q"&Z/B"%6&(6T9\DQ# M%VL4-0YIZUI,EL&D_RPT^`TA^,HDK#*1N/AP*D.97ZX-3E2Y%@B(7JK(>]*B M@&C#5B+'<6T;BS4L&:Y#&7&<^'WM)Y&4S1^AH228UE07D!7DX&"87'5^% M7DY\)8E[/=2#`D5M^)LKG.I6107!/D@&NUK)T\:X3AE37)@4Q&V4HBRR/(#=90,5/H+@S9@.\E]TV-90T)^F(^38:[^1+Z%P.X2XJSW MSW7EY+^@:>Z);?O&Y7VI4>E]!V4W%)1ZRM=&K:E-)=[?8T/2595H%@DHBG*R MHBW<-N*W!9K:=Z6-8>!AJ9=G?V"_,Z#1Y(\69ID3^WOE%2&D9)$418BG=X,0 MI#5[?$CK;C'3&&8FQ)&"&GH7-%!]!U.;`U!UX45H.JR.IM`('T+*C!9<'[;3 M<4*6KC`6V"')V(=]CT)5`78=E+U#2Q'TL05%C&D! M]C%;N"_6#TLBL"I/KUUFJ)ZF=W7GJ"B"VJ_-;_16FR`W]J#`H!9N=1]]9Z`E MA2(_V`5;.]KX-+0]?\PDU5O4Z8KH+N?KFV&Y)C&O!;=CN^L;V*W?A+9\W!PE MR_KBS?O*K*[IV^41."BP#"G3MO?WM[OY/_0)?P,[],ONNG_W7I<6!;O_IF-" M5H2YD$KA MG*KS/\X[#K67:K^VU[809';>4<=Z=(-3._X"=WMOMA60*/DY9[)HF&Z/D*\X M$(&%D9"2.*D%A'#(+R4E3C\P/A`@J53LCQ$U2.F!*@A;8&F_,>G@-_ MQ4_7.0._N9"(I9YWE'7ZDG>ZTRTWM*`<%O57-^#KJJ;N\*`[&O;>'#.PL8H) MX1A4,R'@>[<))UYD&9FK@SS*F6$)$>-21IPH(X;'Y8S0DAQB].9\!:"BL4.9 M,BQ(Y5$7W9"YQA`D3Z`J,P+;7)5'H,2)5M7LX.R^IBGIYUV5A&/`H+0>E=,7 M/9)KCO&R=/!3&?O$DD[0D@4%_QPSG>VI2?"OL6$(EYAW6+P0]3S'?\8#":&R M][R3TT\M2^W,.>](H.@@;[;5Y[R=VIQ!?B76-Y+8*B,!=]RI`].:JYSY)KB[ M#$@ID,"\IZ]A/J3@^9VB>B;%@ MW.+SM3HJB3.9]"V?Y'.ZE;QI(!TC`J(]23I8EOASNEKVHX?MZ;,&W^>:2DM_ M[4'>Y(7%C9>JGD<94UWWCO<\E0%=(]'/V8R$PFVO2BW5(\HC7.M5\Q<(,MA`0!VK&&_:HM7X#-GD%5>1FP\$&N+O7 M\SD7IOJ.J]3P>8'9AXUT=86?<\AU)J.:L`5#`(9XK_;&_@'7>IKDOI.Q[*<\ M3UX.H!EW>M.6,C9E)V,U;S,$[-?U*B=N%2VA-23L?TG]EVMCAN/KS%;;GI<4 M!11B>B\!#0!$W-;,WCU;_0>QK"6G3,;-33;OV MNF$F75'3A;N)F=?8IM;Z)G@KK#Y/D%97GZ](D! M9H6E3[M+O^Y=-3G#A)9Z9)'G2P%-3EQ@-29S(G;IP-CF0M+_^IL2+SA_";\C M5O]7`C6)B(&P"L/GK)HVWTL_"KZB:B*!VR:R@5<]D9G-B/HT1#5,8`+-6,\: M$+3_90V"9D"#1S:ASDL`S@>V_=BJ#.6>LY1,&Y]?>4EOHI3[]B8P:2%(QC/$ M>-:NR+=W%C/OJW=9!+^B\EM@&1U?Z#=9WUO;P%<_@]02P$"'@,4```` M"`!(=FA#X9M15IRH``#>M`\`$0`8```````!````I($`````96AT:"TR,#$S M,#DS,"YX;6Q55`4``WA`?5)U>`L``00E#@``!#D!``!02P$"'@,4````"`!( M=FA#BHIYF(0-```GL```%0`8```````!````I('GJ```96AT:"TR,#$S,#DS M,%]C86PN>&UL550%``-X0'U2=7@+``$$)0X```0Y`0``4$L!`AX#%`````@` M2'9H0WUPO+]V"```AV```!4`&````````0```*2!NK8``&5H=&@M,C`Q,S`Y M,S!?9&5F+GAM;%54!0`#>$!]4G5X"P`!!"4.```$.0$``%!+`0(>`Q0````( M`$AV:$.'C;(?1#8``.,Y`P`5`!@```````$```"D@7^_``!E:'1H+3(P,3,P M.3,P7VQA8BYX;6Q55`4``WA`?5)U>`L``00E#@``!#D!``!02P$"'@,4```` M"`!(=FA#8J&O0(PD``!OE@(`%0`8```````!````I($2]@``96AT:"TR,#$S M,#DS,%]P&UL550%``-X0'U2=7@+``$$)0X```0Y`0``4$L!`AX#%``` M``@`2'9H0UJ-<78M"P``U6X``!$`&````````0```*2![1H!`&5H=&@M,C`Q M,S`Y,S`N>'-D550%``-X0'U2=7@+``$$)0X```0Y`0``4$L%!@`````&``8` *&@(``&4F`0`````` ` end XML 15 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Operating activities    
Net income $ 3,681 $ 4,635
Adjustments to reconcile net income to net cash provided by operating activities:    
Deferred income taxes (3,951) 15
Depreciation and amortization 2,290 1,740
Amortization of book-of-business consideration 2,822 1,990
Amortization of intangible assets 1,061 1,261
Stock-based compensation expense 5,361 4,326
Deferred rent and other 917 51
Changes in operating assets and liabilities:    
Accounts receivable (2,131) 4,799
Prepaid expenses and other assets (852) (656)
Accounts payable (1,895) 2,180
Accrued compensation and benefits 2,504 913
Accrued marketing expenses (196) (2,332)
Deferred revenue 3,794 390
Other current liabilities 1,370 341
Net cash provided by operating activities 14,775 19,653
Investing activities    
Purchases of property and equipment (6,735) (3,128)
Consideration paid in connection with book-of-business transfers   (6,243)
Net cash used in investing activities (6,735) (9,371)
Financing activities    
Proceeds from exercise of common stock options 4,650 4,014
Cash used to net-share settle equity awards (940) (991)
Excess tax benefits from stock-based compensation 4,217 2,358
Repurchase of common stock (59,007) (8,441)
Principal payments in connection with capital leases (41) (31)
Net cash used in financing activities (51,121) (3,091)
Effect of exchange rate changes on cash and cash equivalents (17) 2
Net decrease in cash and cash equivalents (43,098) 7,193
Cash and cash equivalents at beginning of period 140,849 123,607
Cash and cash equivalents at end of period $ 97,751 $ 130,800

XML 16 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Geographic Information And Significant Customers
9 Months Ended
Sep. 30, 2013
Geographic Information And Significant Customers [Abstract]  
Geographic Information And Significant Customers

 

 

Note 6 – Geographic Information and Significant Customers

 

Geographic Information—As of December 31, 2012 and September 30, 2013, our long-lived assets consisted primarily of property and equipment, goodwill and other indefinite-lived intangible assets and finite-lived intangible assets. Our long-lived assets are attributed to the geographic location in which they are located. Long-lived assets by geographical area were as follows (in thousands):  

 

 

 

 

 

 

 

 

As of

 

As of

 

December 31, 2012

 

September 30, 2013

 

 

 

 

 

 

United States

$

37,037 

 

$

38,363 

China

 

278 

 

 

342 

Total

$

37,315 

 

$

38,705 

 

Significant Customers—Substantially all revenue for the three and nine months ended September 30, 2012 and 2013 was generated from customers located in the United States. Carriers representing 10% or more of our total revenue in the three and nine months ended September 30, 2012 and 2013 are presented in the table below: 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

Humana

19% 

 

18% 

 

16% 

 

20% 

WellPoint (1)

13% 

 

12% 

 

13% 

 

12% 

UnitedHealthcare (2)

12% 

 

11% 

 

13% 

 

11% 

Aetna (3)

7% 

 

10% 

 

7% 

 

9% 

 

(1)

Wellpoint also includes other carriers owned by Wellpoint. 

(2)

UnitedHealthcare also includes other carriers owned by UnitedHealthcare. 

(3)

Aetna also includes other carriers owned by Aetna. 

 

Commission revenue attributable to major medical individual and family health insurance plans was approximately 79% and 78% of our commission revenue in the three and nine months ended September 30, 2012, respectively. Commission revenue attributable to major medical individual and family health insurance plans was approximately 74% and 72% of our commission revenue in the three and nine months ended September 30, 2013, respectively. We define our individual and family plan offerings as major medical individual and family health insurance plans, which do not include small business, Medicare-related health insurance plan offerings and other ancillary products such as short-term, stand-alone dental, life, vision, accident and student insurance plan offerings. 

 

As of December 31, 2012, four customers represented 25%,  22%, 14% and 11%, respectively, for a combined total of 72% of our $4.5 million outstanding accounts receivable balance. As of September 30, 2013, two customers represented 43%  and 33%, respectively of our $6.6 million outstanding accounts receivable balance. No other customers represented 10% or more of our total accounts receivable at December 31, 2012 and September 30, 2013. We believe the potential for collection issues with any of our customers is minimal as of September 30, 2013. Accordingly, our estimate for uncollectible amounts at September 30, 2013 was not material.   

XML 17 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 18 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Schedule Of Stock Repurchase Activity Under Stock Repurchase Programs) (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
9 Months Ended
Sep. 30, 2013
Stockholders' Equity [Abstract]  
Total Number of Shares Purchased, Cumulative balance at December 31, 2012 6,397,803 [1]
Total Number of Shares Purchased, Repurchases of common stock 2,911,466
Total Number of Shares Purchased, Cumulative balance at September 30, 2013 9,309,269 [1]
Average Price Paid per Share, Cumulative balance at December 31, 2012 $ 14.22 [1],[2]
Average Price Paid per Share, Repurchases of common stock $ 20.27 [2]
Average Price Paid per Share, Cumulative balance at September 30, 2013 $ 16.11 [1],[2]
Amount of Repurchase, Cumulative balance at December 31, 2012 $ 90,991 [1]
Amount of Repurchase, Repurchases of common stock 59,007
Amount of Repurchase, Cumulative balance at September 30, 2013 $ 149,998 [1]
[1] Cumulative balances at December 31, 2012 and September 30, 2013 consist of shares repurchased in connection with our stock repurchase program announced on September 10, 2012, as well as previous stock repurchase plans announced in 2011, 2010 and 2008.
[2] Average price paid per share includes commissions.
XML 19 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cash, Cash Equivalents And Accounts Receivable (Schedule Of Cash And Cash Equivalents) (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2013
Dec. 31, 2012
Sep. 30, 2012
Dec. 31, 2011
Cash, Cash Equivalents And Accounts Receivable [Abstract]        
Cash $ 19,632 $ 27,484    
Money market funds 78,119 113,365    
Total cash and cash equivalents $ 97,751 $ 140,849 $ 130,800 $ 123,607
XML 20 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Schedule Of Stock-Based Compensation Expense By Operating Function) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation expense $ 1,945 $ 1,339 $ 5,361 $ 4,326
Marketing and Advertising Expense [Member]
       
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation expense 517 330 1,446 932
Customer Care And Enrollment Expense [Member]
       
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation expense 92 90 261 243
Technology And Content Expense [Member]
       
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation expense 425 233 1,129 783
General and Administrative Expense [Member]
       
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation expense $ 911 $ 686 $ 2,525 $ 2,368
XML 21 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Schedule Of Stock-Based Compensation Expense) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Stockholders' Equity [Abstract]        
Common stock options $ 654 $ 717 $ 2,103 $ 2,076
Restricted stock units 1,291 622 3,258 2,250
Total stock-based compensation expense $ 1,945 $ 1,339 $ 5,361 $ 4,326
XML 22 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Geographic Information And Significant Customers (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended 12 Months Ended 9 Months Ended 12 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2013
Dec. 31, 2012
Sep. 30, 2013
Commission Revenue [Member]
Major Medical Individual And Family Insurance Plans [Member]
Sep. 30, 2012
Commission Revenue [Member]
Major Medical Individual And Family Insurance Plans [Member]
Sep. 30, 2013
Commission Revenue [Member]
Major Medical Individual And Family Insurance Plans [Member]
Sep. 30, 2012
Commission Revenue [Member]
Major Medical Individual And Family Insurance Plans [Member]
Dec. 31, 2012
Accounts Receivable [Member]
Customer Concentration Risk [Member]
customer
Sep. 30, 2013
Accounts Receivable [Member]
Customer Concentration Risk [Member]
customer
Sep. 30, 2013
Accounts Receivable [Member]
Customer One [Member]
Dec. 31, 2012
Accounts Receivable [Member]
Customer One [Member]
Sep. 30, 2013
Accounts Receivable [Member]
Customer Two [Member]
Dec. 31, 2012
Accounts Receivable [Member]
Customer Two [Member]
Dec. 31, 2012
Accounts Receivable [Member]
Customer Three [Member]
Dec. 31, 2012
Accounts Receivable [Member]
Customer Four [Member]
Concentration Risk [Line Items]                            
Number of significant customers             4 2            
Concentration risk, percentage     74.00% 79.00% 72.00% 78.00% 72.00%   43.00% 25.00% 33.00% 22.00% 14.00% 11.00%
Accounts receivable $ 6,599 $ 4,468                        
XML 23 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Schedule Of Fair Value Of Stock Options, Valuation Assumptions) (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Stockholders' Equity [Abstract]        
Expected term 4 years 3 months 18 days 4 years 7 months 6 days 4 years 3 months 18 days 4 years 8 months 12 days
Expected volatility 39.80% 43.30% 39.70% 44.30%
Expected dividend yield 0.00% 0.00% 0.00% 0.00%
Risk-free interest rate 1.13% 0.61% 0.79% 0.90%
Weighted-average fair value $ 8.39 $ 6.46 $ 7.02 $ 6.41
XML 24 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cash, Cash Equivalents And Accounts Receivable
9 Months Ended
Sep. 30, 2013
Cash, Cash Equivalents And Accounts Receivable [Abstract]  
Cash, Cash Equivalents And Accounts Receivable

 

Note 2 – Cash, Cash Equivalents and Accounts Receivable

 

Cash and Cash EquivalentsAs of December 31, 2012 and September 30, 2013, our cash equivalents consisted of money market accounts that invested in U.S. government-sponsored enterprise bonds and discount notes, U.S. government treasury bills and notes and repurchase agreements collateralized by U.S. government obligations. At December 31, 2012 and September 30, 2013, our cash equivalents carried no unrealized gains or losses and we did not realize any significant gains or losses on sales of cash equivalents during the three and nine months ended September 30, 2012 and 2013.  

 

As of December 31, 2012 and September 30, 2013, our cash and cash equivalent balances were invested as follows (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2012

 

September 30, 2013

 

 

 

 

 

 

Cash

$

27,484 

 

$

19,632 

Money market funds

 

113,365 

 

 

78,119 

Total cash and cash equivalents

$

140,849 

 

$

97,751 

 

We used observable prices in active markets in determining the classification of our money market funds as Level 1 as of December 31, 2012 and September 30, 2013. 

 

Accounts ReceivableAs of December 31, 2012 and September 30, 2013, our accounts receivable consisted of the following (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2012

 

September 30, 2013

 

 

 

 

 

 

Accounts receivable - from other revenues

$

3,319 

 

$

3,340 

Commissions receivable

 

1,149 

 

 

3,259 

Total accounts receivable

$

4,468 

 

$

6,599 

 

XML 25 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes
9 Months Ended
Sep. 30, 2013
Income Taxes [Abstract]  
Income Taxes

 

 

Note 4 – Income Taxes

 

The following table summarizes our provision for income taxes and our effective tax rates for the three and nine months ended September 30, 2012 and 2013 (in thousands, except effective tax rate):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

Income before provision for income taxes

$

1,079 

 

$

381 

 

$

9,160 

 

$

6,307 

Provision for income taxes

$

874 

 

$

207 

 

$

4,525 

 

$

2,626 

Effective tax rate

 

81.0% 

 

 

54.3% 

 

 

49.4% 

 

 

41.6% 

 

Our effective tax rate in the three and nine months ended September 30, 2012 was higher than statutory federal and state tax rates due primarily to non-deductible lobbying expenses and tax shortfalls related to share-based payments. Our effective tax rate in the three and nine months ended September 30, 2013 was higher than statutory federal and state tax rates due primarily to non-deductible lobbying expenses, partially offset by a tax benefit resulting from the recent extension of the federal research tax credit through December 31, 2013.

 

During the three and nine months ended September 30, 2012, we utilized excess federal and state tax benefits related to share-based payments, which resulted in increases of $1.2 million and $2.4 million, respectively, in Additional Paid-In Capital in the condensed consolidated balance sheets. During the three and nine months ended September 30, 2013, we utilized excess federal and state tax benefits related to share-based payments, which resulted in increases of $0.3 million and $4.2 million, respectively, in Additional Paid-In Capital in the condensed consolidated balance sheets. These amounts are also classified in the condensed consolidated statements of cash flows as both a reduction to operating cash flows and as a financing cash inflow. 

   

  

 

 

XML 26 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary Of Business And Significant Accounting Policies (Policy)
9 Months Ended
Sep. 30, 2013
Summary Of Business And Significant Accounting Policies [Abstract]  
Description Of Business

Description of BusinesseHealth, Inc. (the “Company,” “eHealth,” “we” or “us”) is the leading online source of health insurance for individuals, families and small businesses in the United States. Through our website addresses (www.eHealth.com,  www.eHealthInsurance.com,  www.eHealthMedicare.com and www.PlanPrescriber.com), consumers can get quotes from leading health insurance carriers, compare plans side-by-side, and apply for and purchase individual and family, Medicare-related, small business and ancillary health insurance plans. We actively market the availability of Medicare-related insurance plans and offer Medicare plan comparison tools and educational materials for Medicare-related insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans.  Our ecommerce technology also enables us to deliver consumers’ health insurance applications electronically to health insurance carriers. As a result, we simplify and streamline the complex and traditionally paper-intensive health insurance sales and purchasing process. We are licensed to market and sell health insurance in all 50 states and the District of Columbia. 

 

Basis Of Presentation

Basis of Presentation—The accompanying condensed consolidated balance sheet as of September 30, 2013, the condensed consolidated statements of comprehensive income for the three and nine months ended September 30, 2012 and 2013 and the condensed consolidated statements of cash flows for the nine months ended September 30, 2012 and 2013, respectively, are unaudited. The condensed consolidated balance sheet data as of December 31, 2012 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2012, which was filed with the Securities and Exchange Commission on March 13, 2013. The accompanying statements should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K.  

 

The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or U.S. GAAP, for interim financial information. Accordingly, they do not include all of the financial information and footnotes required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2012, and include all adjustments necessary for the fair presentation of eHealth’s statement of financial position as of September 30, 2013, its results of operations for the three and nine months ended September 30, 2012 and 2013 and its cash flows for the nine months ended September 30, 2012 and 2013. All adjustments are of a normal recurring nature. The results for the three and nine months ended September 30, 2013 are not necessarily indicative of the results to be expected for any subsequent period or for the fiscal year ending December 31, 2013.  

 

Seasonality

Seasonality—The number of individual and family health insurance applications submitted through our ecommerce platform has generally increased in our first quarter compared to our fourth quarter and in our third quarter compared to our second quarter. Conversely, we have generally experienced a decline or flattening of individual and family submitted applications in our second quarter compared to our first quarter and in our fourth quarter compared to our third quarter. This seasonality could change in the fourth quarter of 2013 as a result of the initial open enrollment period under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act, which began on October 1, 2013 and is scheduled to run through March 31, 2014.

 

The majority of Medicare plans are sold in our fourth quarter during the Medicare annual enrollment period, when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, we generate a significant amount of Medicare plan-related revenue in the fourth quarter of the year resulting from the sale of new Medicare plans. Additionally, we recognize a majority of our renewal Medicare Advantage and Medicare Part D prescription drug plan commission revenue in the first quarter of each year as the majority of policies sold during the annual enrollment period typically renew on January 1 of each year.

 

Since a significant portion of our marketing and advertising expenses are driven by the number of health insurance applications submitted on our ecommerce platform, those expenses are influenced by these patterns. As a result, marketing and advertising expenses related to individual and family health insurance plans have been highest in our first and third quarters, while marketing and advertising expenses related to Medicare-related plans have been highest in our third and fourth quarters. However, the historical trend of marketing and advertising expenses related to individual and family health insurance plans could be impacted by the initial open enrollment period for individual and family plans that began on October 1, 2013. 

 

Additionally, in preparation for the Medicare annual enrollment period, and to a lesser extent the initial open enrollment period for individual and family plans, we begin ramping up our customer care center staff during our second and third quarters to handle the anticipated increased volume of health insurance transactions during the fourth quarter. Accordingly, our customer care center staffing costs are significantly higher in our third and fourth quarters compared to our first and second quarters.

 

Recently Adopted Accounting Standards

 

Recently Adopted Accounting Standards—Effective January 1, 2013, we adopted an accounting standards update with new guidance on the presentation of reclassifications from accumulated other comprehensive income to net income. This standard requires an entity to present reclassifications from accumulated other comprehensive income to net income either on the face of the condensed consolidated financial statements or in the notes to the condensed consolidated financial statements. In the nine months ended September 30, 2013 we did not have any reclassifications from accumulated other comprehensive income to net income.

XML 27 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Net Income Per Share
9 Months Ended
Sep. 30, 2013
Net Income Per Share [Abstract]  
Net Income Per Share

 

Note 5 – Net Income Per Share

 

Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding for the period (excluding shares subject to repurchase). Diluted net income per share is computed by dividing the net income for the period by the weighted average number of common and common equivalent shares outstanding during the period. Diluted net income per share is computed giving effect to all potential dilutive common stock equivalent shares, including options, restricted stock and restricted stock units. The dilutive effect of outstanding awards is reflected in diluted net income per share by application of the treasury stock method.  

 

The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share amounts):  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

2012

 

2013

 

2012

 

2013

Basic:

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

Net income allocated to common stock

$

205 

 

$

174 

 

$

4,635 

 

$

3,681 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

Net weighted average number of common stock shares outstanding

 

19,970 

 

 

18,436 

 

 

19,711 

 

 

19,310 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share—basic:

$

0.01 

 

$

0.01 

 

$

0.24 

 

$

0.19 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted:

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

Net income allocated to common stock

$

205 

 

$

174 

 

$

4,635 

 

$

3,681 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

Net weighted average number of common stock shares outstanding

 

19,970 

 

 

18,436 

 

 

19,711 

 

 

19,310 

Weighted average number of options

 

703 

 

 

528 

 

 

750 

 

 

478 

Weighted average number of restricted stock units

 

77 

 

 

132 

 

 

102 

 

 

124 

Total common stock shares used in per share calculation

 

20,750 

 

 

19,096 

 

 

20,563 

 

 

19,912 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share—diluted:

$

0.01 

 

$

0.01 

 

$

0.23 

 

$

0.18 

 

 

For each of the three- and nine- month periods ended September 30, 2012 and 2013, we had securities outstanding that could potentially dilute net income per share, but the shares from the assumed exercise of these securities were excluded in the computation of diluted net income per share as their effect would have been anti-dilutive. The number of outstanding weighted average anti-dilutive shares that were excluded from the computation of diluted net income per share consisted of the following (in thousands): 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

Common stock options

1,484 

 

127 

 

1,327 

 

439 

Total

1,484 

 

127 

 

1,327 

 

439 

 

 

XML 28 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Income Taxes [Abstract]        
Income before provision for income taxes $ 381,000 $ 1,079,000 $ 6,307,000 $ 9,160,000
Provision for income taxes 207,000 874,000 2,626,000 4,525,000
Effective income tax rate 54.30% 81.00% 41.60% 49.40%
Increase in Additional paid-in capital related to excess federal and state tax benefits $ 300,000 $ 1,200,000 $ 4,200,000 $ 2,400,000
XML 29 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Geographic Information And Significant Customers (Schedule Of Long Lived Assets By Geographical Areas) (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2013
Dec. 31, 2012
Geographic Information And Significant Customers [Abstract]    
United States $ 38,363 $ 37,037
China 342 278
Total $ 38,705 $ 37,315
EXCEL 30 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]B-S,T960W-E]F8C)F7S0Y-V9?83!A-U\T-3$U M-6(S8C$U.3,B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K:&]L9&5R#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D=E;V=R87!H:6-?26YF;W)M871I;VY?06YD7U-I9SPO>#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I7;W)K#I%>&-E;%=O5]486)L97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O M#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/E-U;6UA#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K:&]L9&5R#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K:&]L9&5R#I%>&-E;%=O#I.86UE/E-T;V-K:&]L9&5R#I7;W)K#I%>&-E;%=O5]38VAE9'5L95]/ M,SPO>#I.86UE/@T*("`@(#QX.E=O#I7 M;W)K#I%>&-E;%=O M5]38VAE9'5L95]/-CPO>#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/DEN8V]M95]487AE#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D=E M;V=R87!H:6-?26YF;W)M871I;VY?06YD7U-I9S(\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I%>&-E M;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O6QE#I! M8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T#I0 M#I0#I0&UL M/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@ M<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC'1087)T7V(W,S1E9#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!296=I M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)UEE2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)T%C8V5L97)A=&5D($9I;&5R/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO2!A;F0@97%U:7!M96YT+"!N970\+W1D/@T*("`@("`@ M("`\=&0@8VQA'!E;G-E'0^)SQS<&%N/CPO M2!S=&]C:RP@ M870@8V]S=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^ M)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO'!E;G-E*2P@;F5T/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M/B@R,BD\&5S/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XS.#$\&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR M,#<\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA2!O<&5R M871I;F<@86-T:79I=&EEF%T:6]N(&]F(&)O;VLM;V8M8G5S M:6YEF%T:6]N(&]F(&EN=&%N9VEB;&4@ M87-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`V,3QS M<&%N/CPO'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@ M("`@("`\=&0@8VQA'!E;G-E M'0^)SQS<&%N/CPO2!A;F0@97%U M:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V+#"!B96YE9FET&-H86YG92!R871E M(&-H86YG97,@;VX@8V%S:"!A;F0@8V%S:"!E<75I=F%L96YT'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^ M)SQS<&%N/CPO2!/9B!"=7-I;F5S'0^ M)SQD:78^(#QD:78@6QE/3-$)VUA6QE/3-$ M)V1I6QE/3-$)W=I9'1H.C0T M-BXT,'!T.W!A9&1I;F3I4:6UE3I4:6UE6QE/3-$)V1IF4Z(#$P<'0G/@T*"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O M;&0[9F]N="US='EL93II=&%L:6,[)SY$97-C6QE.FET86QI8SLG/B8C>#(P,30[/"]F;VYT M/CQF;VYT('-T>6QE/3-$)V1I#(P,40[("8C>#(P,4,[=V4F(W@R,#%$.R!O3H@:6YL:6YE.R<^+"`F M;F)S<#L\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O M;G0M6QE/3-$)V1I6QE/3-$)V1I6QE.FET86QI8SLG/G=W=RYE2&5A;'1H365D:6-A6QE/3-$)V1I6QE/3-$)V1I6QE.FET86QI M8SLG/G=W=RY0;&%N4')E6QE M/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I2!A;'-O(&5N86)L97,@=7,@=&\@ M9&5L:79E6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1IF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L M:6,[)SXF;F)S<#L\+V9O;G0^#0H)"3PO<#X-"@D)/'`@F4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II M=&%L:6,[)SY"87-I2P@87)E('5N875D:71E9"X@5&AE(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@ M8F%L86YC92!S:&5E="!D871A(&%S(&]F($1E8V5M8F5R)FYB65A6QE/3-$)VUA3I4:6UE6QE/3-$)V1I M'0M:6YD96YT.C$X<'0[9F]N="UF86UI M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M2!A8V-E<'1E9"!A8V-O=6YT:6YG('!R:6YC:7!L97,L(&]R(%4N M4RX@1T%!4"P@9F]R(&EN=&5R:6T@9FEN86YC:6%L(&EN9F]R;6%T:6]N+B!! M8V-O2P@=&AE>2!D;R!N;W0@:6YC;'5D92!A;&P@;V8@=&AE(&9I M;F%N8VEA;"!I;F9O2!F;W(@=&AE(&9A M:7(@<')E65A6QE/3-$)V1I M'0M:6YD96YT.C$X<'0[;&EN92UH96EG M:'0Z;F]R;6%L.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I M>F4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE M.R<^)FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I M2!H96%L=&@@:6YS=7)A;F-E(&%P<&QI8V%T:6]N2!E>'!E2`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`\+V9O M;G0^/"]P/@T*"3PO9&EV/B`\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^)SQS<&%N/CPO'0^)SQD:78^(#QD:78@6QE/3-$)VUAF4Z(#%P="<^#0H)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T* M"0D\9&EV('-T>6QE/3-$=VED=&@Z,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<] M,T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SY.;W1E(#(@)B-X,C`Q,SL@0V%S:"P@ M0V%S:"!%<75I=F%L96YT3I4:6UE6QE/3-$)V1IF4Z(#$P<'0G/@T*"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O M;&0[9F]N="US='EL93II=&%L:6,[)SY#87-H(&%N9"!#87-H($5Q=6EV86QE M;G1S/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R<^07,@;V8@1&5C M96UB97(@,S$L(#(P,3(@86YD(#PO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[)SY397!T96UB97(@,S`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.R<^+"`R,#$S+"!O=7(@8V%S:"!E<75I=F%L M96YTF5D(&)Y(%4N4RX@9V]V97)N;65N="!O8FQI M9V%T:6]N3H@:6YL:6YE.R<^+"`R,#$S+"!O M=7(@8V%S:"!E<75I=F%L96YTF4@86YY('-I9VYI M9FEC86YT(&=A:6YS(&]R(&QO6QE/3-$ M)V1I6QE/3-$)V1I'0M:6YD96YT.C$X<'0[9F]N="UF86UI;'DZ5&EM M97,@3F5W(%)O;6%N.V9O;G0MF4Z(#$P<'0G/@T* M"0D)/&9O;G0@3H@:6YL:6YE.R<^07,@;V8@1&5C M96UB97(@,S$L(#(P,3(@86YD(#PO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[)SY397!T96UB97(@,S`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.R<^+"`R,#$S+"!O=7(@8V%S:"!A;F0@8V%S M:"!E<75I=F%L96YT(&)A;&%N8V5S('=E6QE/3-$)V1IF4Z,7!T.R<^)FYB M6QE/3-$)W=I9'1H.B`Q.2XR-"4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`Q.2XX-"4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P M,RXR,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB M6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`R M,BXT-"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UE'0M86QI9VXZ8V5N M=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M=V5I9VAT.F)O;&0[)SY397!T96UB97(@,S`L(#(P,3,\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI M9VX],T1T;W`@6QE/3-$ M)W=I9'1H.B`Q.2XR-"4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4 M:6UEF4Z(#$P<'0G M/@T*"0D)"0D))FYBF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.R<^0V%S:#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,RXR,"4[(&)O3I4:6UE6QE/3-$)V1I3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]WF4Z(#$P<'0G/@T*"0D)"0D))FYB'0M M86QI9VXZ6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ.2PV,S(F;F)S<#L- M"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U,2XS,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^36]N97D@;6%R:V5T(&9U;F1S/"]F;VYT/CPO<#X-"@D) M"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M M86QI9VXZ6QE/3-$)W=I9'1H.B`Q.2XR-"4[ M(&)O6QE/3-$)W=I9'1H.B`P,RXR,"4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)W=I M9'1H.B`Q.2XX-"4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXW."PQ,3DF;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H M.B`U,2XS,B4[(&)O3H@:6YL:6YE.R<^5&]T86P@ M8V%S:"!A;F0@8V%S:"!E<75I=F%L96YT6QE/3-$)W=I9'1H.B`P M,RXR,"4[(&)O3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUAF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q.2XX-"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I M'0M:6YD96YT.C$X<'0[9F]N="UF86UI M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M3H@:6YL:6YE.R<^+"`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`P)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS M<&%C:6YG/3-$,"!A;&EG;CTS1&-E;G1E6QE/3-$)VUA3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,RXR,"4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4 M:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`Q.2XR M-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`Q M.2XX-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB M6QE/3-$ M)W=I9'1H.B`R,RXP-"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`U,2XS,B4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)FYBF4Z(#$P<'0G/@T*"0D) M"0D))FYB3I4:6UE M6QE/3-$)W=I9'1H.B`P,RXR,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA M3I4:6UE6QE/3-$)V1I M6QE/3-$ M)VUAF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q.2XR-"4[(&)O6QE M/3-$)VUA3I4:6UE6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q.2XX-"4[(&)O6QE/3-$)W=I9'1H.B`U,2XS,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^0V]M;6ES6QE M/3-$)W=I9'1H.B`P,RXR,"4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)W=I9'1H.B`P,RXR,"4[ M(&)O6QE/3-$)VUA3I4:6UE M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W3I4:6UE6QE/3-$)V1I'0M86QI M9VXZ6QE/3-$9FQO870Z;&5F=#X\+V1I=CXT+#0V."9N8G-P.PT* M"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,#,N,C`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG.B`P<'0[ M)SX-"@D)"0D)/'`@F4Z(#$P<'0G/@T* M"0D)"0D))FYB'0M86QI9VXZ6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXV+#4Y.29N8G-P.PT*"0D)"3PO=&0^#0H)"0D\+W1R M/@T*"0D\+W1A8FQE/CPO9&EV/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G M/@T*"0D)#0H)"3PO<#X-"@D)/'`^/&9O;G0@6QE/3-$)VUAF4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$ M)V1IF4],T0Q M/B`\+V9O;G0^/"]P/@T*"3PO9&EV/B`\+V1I=CX\'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA2!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQD:78^(#QD:78@6QE M/3-$)VUA3I4:6UE3H@:6YL:6YE.V9O M;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[9F]N="US:7IE.C%P M=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\9&EV('-T>6QE/3-$=VED M=&@Z,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$ M,"!S='EL93TS1"=B;W)D97(M8V]L;&%PF4Z M(#%P="<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H.C$P,"XP,"4[8F%C:V=R;W5N M9"UC;VQOF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SY.;W1E(#,@)B-X,C`Q M,SL@4W1O8VMH;VQD97)S)B-X,C`Q.3L@17%U:71Y/"]F;VYT/CPO<#X-"@D) M"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.C$P,"XP,"4[<&%D9&EN9SHP<'0@-BXU<'0G M/@T*"0D)"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.W1E>'0M:6YD96YT.C(R M+C5P=#ML:6YE+6AE:6=H=#IN;W)M86P[9F]N="UF86UI;'DZ5&EM97,@3F5W M(%)O;6%N.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)V)O6QE/3-$)W=I9'1H.B`U-RXT-B4[(&)O6QE/3-$)V1IF4Z,7!T.R<^)FYBF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`T,BXU-"4[(&)O6QE/3-$)VUA6QE/3-$)V1I6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`T,BXU-"4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUAF5D("@R*3PO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`T,BXU M-"4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE M/3-$)VUA3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)VUA M6QE/3-$)W=I9'1H.B`T,BXU-"4[(&)O6QE/3-$)W=I9'1H.B`U-RXT-B4[(&)O6QE/3-$)V1I3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`T,BXU-"4[(&)OF4Z(#$P<'0G/@T*"0D) M/&9O;G0@3H@:6YL:6YE.R<^)FYB6QE/3-$)V1I3H@:6YL:6YE.R<^)FYB6QE M/3-$)V1I6QE/3-$=VED=&@Z,3`P)3X\=&%B;&4@6QE/3-$)W=I9'1H M.B`S-BXP,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SX-"@D)"3QP('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0[ M;6%R9VEN.C!P=#LG/@T*"0D)"3QF;VYT('-T>6QE/3-$)VUAF4Z(#$P M<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.R<^5&AE M(&9O;&QO=VEN9R!T86)L92!S=6UM87)I>F5S('-T;V-K(&]P=&EO;B!A8W1I M=FET>2!U;F1E3H@:6YL:6YE M.V9O;G0M6QE/3-$)VUAF4Z(#%P="<^#0H)"0D) M"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P M=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XT-"4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D))FYB3I4:6UE6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`Q,"XP,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE M/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXX,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M)FYB3I4:6UE6QE/3-$)VUA6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SXF;F)S<#L\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,#DN-#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T('-O;&ED(",P,#`P,#`[(&)O'0M86QI9VXZ M8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M=V5I9VAT.F)O;&0[)SY.=6UB97(@;V8@4W1O8VL@3W!T:6]N6QE/3-$)W=I9'1H.B`P,BXX,"4[(&)O3I4:6UE3I4:6UE6QE/3-$)V1I&5R8VES92!0 M6QE/3-$)W=I9'1H.B`P,BXX,"4[(&)O3I4:6UE3I4:6UE6QE/3-$)V1I65A'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D))FYB M'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SY!9V=R96=A M=&4@26YT6QE/3-$)V1I6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXX,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,"XP,B4[(&)O3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,BXX,"4[(&)O'0M86QI9VXZ6QE/3-$)W=I M9'1H.B`Q,2XX,"4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)VUA M3I4:6UE'0M86QI9VXZ M6QE/3-$)VUA6QE/3-$ M)W=I9'1H.B`P,BXX,"4[(&)O3I4 M:6UE'0M86QI M9VXZ'0M86QI9VXZ6QE/3-$)W=I9'1H.B`Q,2XX,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`Q M,2XY-"4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D))FYB6QE/3-$)VUA&5R8VES960\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#DN-#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!F;VYT+69A M;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,BXX,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`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`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T M.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$ M)W=I9'1H.B`P,BXX,"4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA M3I4:6UE'0M86QI9VXZ3I4:6UE M6QE/3-$)V1I6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXR+#$V.29N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#(N.#`E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9& M.R!P861D:6YG.B`P<'0[)SX-"@D)"0D)/'`@3I4:6UE6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1I3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)W=I9'1H.B`P,BXX,"4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`Q M,2XX,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N M=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,2XY-"4[(&)O6QE/3-$)VUA6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXR+#$P."9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N.#`E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUA6QE/3-$)W=I9'1H.B`P,BXX,"4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`Q,"XP,B4[(&)O3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,BXX,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXT+C$W)FYB6QE/3-$)W=I9'1H.B`P,BXX,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXS,BPY,3$F;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T M6QE/3-$ M)W=I9'1H.B`T,BXW."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.R<^17AE6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ+#,X M.29N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#(N.#`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D M:6YG.B`P<'0[)SX-"@D)"0D)/'`@F4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,"XP,B4[(&)O6QE/3-$ M)VUA3I4:6UE M6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXS+C0X)FYB6QE/3-$)W=I9'1H.B`P,BXX,"4[(&)O'0M86QI9VXZ6QE M/3-$)W=I9'1H.B`P,BXX,"4[(&)O'0M86QI M9VXZ6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR,BPS.#DF;F)S<#L-"@D) M"0D\+W1D/@T*"0D)/"]T6QE/3-$)V1I6QE/3-$=VED=&@Z,3`P)3X\=&%B M;&4@6QE/3-$)W=I9'1H.B`S-BXP,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SX- M"@D)"3QP('-T>6QE/3-$)VQI;F4M:&5I9VAT.C$Q-24[9F]N="UF86UI;'DZ M0V%L:6)R:3MF;VYT+7-I>F4Z(#$P<'0[;6%R9VEN.C!P=#LG/@T*"0D)"3QF M;VYT('-T>6QE/3-$)VUA3I#86QI8G)I.V9O;G0M3H@:6YL:6YE.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT M+7-I>F4Z,3!P=#LG/F]F($1E8V5M8F5R(#,Q+"`R,#$R(&%N9"!397!T96UB M97(@,S`L(#(P,3,@/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I3I4:6UE2!O M<'1I;VYS(&%S(&]F('1H;W-E(&1A=&5S+CPO9F]N=#X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N M.V9O;G0M3I4 M:6UE6QE/3-$)V1I'0M:6YD96YT.C$X<'0[ M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M3H@:6YL:6YE.R<^(&UI;&QI;VX@86YD("0\+V9O;G0^/&9O;G0@3H@:6YL:6YE.R<^,2XY/"]F;VYT/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R<^(&UI;&QI;VXL(')E2X@/"]F;VYT/@T*"0D\+W`^#0H)"3QP/CQF;VYT('-I>F4],T0Q M/B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$<&%G92UB7,^)FYB'0M M:6YD96YT.C$X<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.SMF;VYT M+7-I>F4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$)V1I'0M:6YD96YT.C(R+C5P=#MF;VYT+69A;6EL>3I4:6UE6QE/3-$)V1I MF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.R<^5&AE(&9O;&QO=VEN9R!T86)L92!S=6UM87)I>F5S(')E M2P@:6YC;'5D:6YG('!E2P@ M=6YD97(@=&AE(%-T;V-K(%!L86YS("AI;B!T:&]U3I4:6UE6QE/3-$ M)V1I3I4:6UE3H@:6YL:6YE.V9O;G0M3I4:6UE3H@:6YL:6YE M.V9O;G0M6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXX,B4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H M.B`P,BXX,B4[(&)O3I4:6UEF4Z(#$P<'0G M/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`Q-2XV-B4[(&)O3I4:6UEF4Z(#$P<'0G M/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXX,B4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SXF;F)S<#L\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,34N-C8E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T('-O;&ED(",P,#`P,#`[(&)O'0M86QI9VXZ M8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M=V5I9VAT.F)O;&0[)SY.=6UB97(@3W5T6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-BXU-"4[(&)O M6QE M/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXX,B4[(&)O3I4:6UE3I4:6UE6QE/3-$)V1I3H@:6YL:6YE M.R<^*#$I/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`T M."XP-B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^0F%L86YC92!O=71S=&%N9&EN9R!A6QE/3-$)W=I9'1H.B`Q-2XV-B4[ M(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M3I4:6UEF4Z(#$P<'0G/@T* M"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1I6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ M,"PT-C0F;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`T."XP-B4[ M(&)O6QE/3-$)V1I6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXU-C0F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@F4Z(#$P M<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA M3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,BXX,B4[(&)O3I4:6UE'0M86QI9VXZ6QE/3-$ M)V1I6QE/3-$)W=I9'1H.B`Q M-2XV-B4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-BXU-"4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H M.B`P,BXX,B4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,BXX,B4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D))FYB3H@:6YL:6YE.R<^0V%N8V5L;&5D/"]F;VYT/CPO<#X-"@D)"0D\ M+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]WF4Z(#$P<'0G/@T*"0D) M"0D))FYB6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,BXX,B4[(&)O3I4:6UE'0M86QI9VXZ3I4:6UE6QE/3-$)V1I6QE/3-$9FQO870Z;&5F=#X\+V1I=CXW-3(F;F)S<#L-"@D)"0D\+W1D/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$)W=I9'1H M.B`Q-BXU-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO M9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,2XR-B4[(&)O6QE/3-$)VUA MF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.R<^)FYB3I#86QI8G)I.V9O;G0M3I#86QI8G)I.V9O;G0M6QE/3-$)V1I3I4:6UE2X\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/B`F;F)S<#LF;F)S<#L\+V9O;G0^/&9O M;G0@3H@:6YL:6YE.R<^)FYB3I4:6UE6QE/3-$)V1I'0M M:6YD96YT.C$X<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M M#(P,3D['!E;G-E(')E;&%T960@=&\@=&AE6QE/3-$)V1I6QE M/3-$)V1I3H@ M:6YL:6YE.R<^(&UI;&QI;VX@86YD("0\+V9O;G0^/&9O;G0@3H@:6YL:6YE.R<^,RXU/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US='EL93II=&%L:6,[)SY3 M=&]C:R!297!U3H@:6YL:6YE.R<^3VX@4V5P=&5M8F5R(#$P+"`R M,#$R+"`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.R<^ M=V4@/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I3H@ M:6YL:6YE.R<^=V4@/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I M&-H86YG92!! M8W0@;V8@,3DS-"P@87,@86UE;F1E9"X@/"]F;VYT/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)V1I6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.R<^1F]R(&%C8V]U;G1I;F<@<'5R<&]S97,L(&-O;6UO;B!S M=&]C:R!R97!U2!A;F0@87)E('!R97-E;G1E9"!U M6QE/3-$)V1I M3I4:6UE6QE/3-$)V1I6QE/3-$)VUA M3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$ M)V1IF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H.B`P,BXV,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB M6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,BXV,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M)FYB6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE M6QE/3-$)V1I6QE/3-$)W=I M9'1H.B`Q-RXQ-B4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$ M)W=I9'1H.B`Q,RXW,B4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE M/3-$)W=I9'1H.B`Q-2XV-B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D))FYB6QE/3-$)W=I9'1H.B`Q-RXQ-B4[(&)O6QE/3-$)VUA M3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UE'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SY!=F5R86=E(%!R M:6-E(%!A:60@<&5R(%-H87)E(#PO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[)SXH,BD\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1'1O<"!S='EL93TS1"=W:61T:#H@,#(N-C(E.R!B;W)D M97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O M;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$ M)VUA3I4:6UE'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SY!;6]U;G0@ M;V8@4F5P=7)C:&%S93PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"3PO='(^ M#0H)"0D\='(^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@-#(N.3@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG.B`P<'0[ M)SX-"@D)"0D)/'`@F4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^0W5M=6QA M=&EV92!B86QA;F-E(&%T($1E8V5M8F5R)FYB6QE/3-$)W=I9'1H.B`P M,BXV,B4[(&)O6QE/3-$)W=I9'1H.B`P,BXV,B4[(&)O'0M86QI9VXZ6QE/3-$)VUA3I4:6UE3I4:6UE6QE/3-$)V1I6QE/3-$9FQO870Z;&5F=#X\+V1I=CXY,"PY.3$F;F)S<#L-"@D)"0D\ M+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`T,BXY."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.R<^4F5P=7)C:&%S97,@;V8@8V]M;6]N('-T;V-K/"]F;VYT/CPO<#X- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$ M)VUA3I4:6UE3I4:6UE6QE/3-$)V1I6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR,"XR-R9N8G-P.PT*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,#(N-C(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D M97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y M.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H) M"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$ M)W=I9'1H.B`Q-2XV-B4[(&)O6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXU.2PP,#6QE/3-$)W=I M9'1H.B`T,BXY."4[(&)O6QE M/3-$)W=I9'1H.B`Q-RXQ-B4[(&)O6QE/3-$)W=I9'1H.B`P,BXV M,B4[(&)O6QE/3-$)W=I9'1H.B`P,BXV,B4[(&)O3I4:6UE6QE/3-$ M)V1I3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)W=I9'1H.B`P,BXV,B4[(&)O6QE/3-$)W=I9'1H.B`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`S/"]F;VYT/CQF;VYT M('-T>6QE/3-$)V1I3H@:6YL:6YE.R<^('-H87)E M3I4:6UE6QE/3-$)V1I3H@:6YL:6YE.R<^5&AE(&9A:7(@=F%L=64@;V8@ M65E6QE/3-$)VUA3I4:6UE3H@:6YL:6YE.V9O;G0M3I4:6UE3H@:6YL:6YE.V9O;G0M M6QE/3-$ M)VUA6QE/3-$)W=I9'1H.B`Q,2XX,"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q,2XX,"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q,2XX,"4[(&)O M3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q,2XX M,"4[(&)O3I4:6UE6QE/3-$)W=I M9'1H.B`S-2XX-"4[(&)O'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SY4 M:')E92!-;VYT:',@16YD960@4V5P=&5M8F5R(#,P+#PO9F]N=#X\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,BXT,B4[(&)O3I4:6UE M3I4:6UE6QE/3-$)V1I M6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SXF;F)S<#L\ M+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D(&-O;'-P86X],T0R('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#`N,#(E.R!B;W)D97(M M=&]P.B`Q<'0@3I4:6UE M6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,"XP,B4[ M(&)O'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O M;&0[)SXR,#$S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@F4Z M(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)O M6QE M/3-$)VUA6QE/3-$ M)W=I9'1H.B`P,"XP,B4[(&)O'0M86QI9VXZ M8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M=V5I9VAT.F)O;&0[)SXR,#$S/"]F;VYT/CPO<#X-"@D)"0D\+W1D M/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`S-2XX-"4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$ M)VUA6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)O M6QE M/3-$)VUA6QE/3-$)W=I9'1H.B`Q,2XX,"4[ M(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P M,BXT,B4[(&)O3I4:6UE3I4:6UE3I4:6UE MF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D))FYB MF4Z(#$P<'0G/@T*"0D)"0D) M)FYB6QE/3-$)VUA'!E8W1E9"!T97)M/"]F;VYT/CPO<#X-"@D)"0D\ M+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$ M)W=I9'1H.B`Q,2XX,"4[(&)O'0M86QI9VXZ M3H@:6YL:6YE.R<^ M('EE87)S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.R<^-"XS/"]F;VYT/CQF M;VYT('-T>6QE/3-$)V1I6QE M/3-$)W=I9'1H.B`P,BXT,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M)FYB3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1I65A3I4:6UE6QE/3-$)VUA6QE M/3-$)W=I9'1H.B`Q,2XX,"4[(&)O'0M86QI M9VXZ3H@:6YL:6YE M.R<^('EE87)S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H M.B`S-2XX-"4[(&)O3I4:6UE6QE M/3-$)V1I6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q,2XX,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,BXT M,B4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXS.2XX)29N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N-#(E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D) M)FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q,2XX,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4:6UE6QE/3-$)V1I6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q M,2XX,"4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D))FYB3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)W=I9'1H.B`P,BXT,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB M3I4:6UE6QE/3-$9FQO870Z;&5F=#X\+V1I=CXP)29N8G-P.PT*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N M-#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG.B`P<'0[)SX-"@D)"0D) M/'`@3I4:6UE6QE/3-$)VUA6QE M/3-$)W=I9'1H.B`Q,2XX,"4[(&)O6QE/3-$)W=I M9'1H.B`S-2XX-"4[(&)O3I4:6UE M6QE/3-$)V1IF4Z(#$P<'0G M/@T*"0D)"0D))FYB6QE/3-$9FQO870Z;&5F=#X\+V1I=CXP+C8Q)29N8G-P.PT*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,#(N-#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D M97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y M.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H) M"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$ M)W=I9'1H.B`P,BXT,B4[(&)O3I4 M:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q M,2XX,"4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)O3I4:6UEF4Z(#$P M<'0G/@T*"0D)"0D))FYB6QE/3-$9FQO870Z;&5F=#X\+V1I=CXP+C6QE/3-$)VUAF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO M9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,2XX,"4[(&)O3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)V1I3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P M,BXT,B4[(&)O'0M86QI9VXZ6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXV+C0Q)FYB6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q,2XX,"4[(&)O'0M:6YD96YT.C(R+C5P=#ML:6YE+6AE:6=H=#IN;W)M86P[9F]N="UF M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0MF4Z M(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.R<^ M5&AE(&9O;&QO=VEN9R!T86)L92!S=6UM87)I>F5S('-T;V-K+6)A'!E;G-E(')E8V]R9&5D(&1UF4Z(#%P="<^#0H)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T* M"0D\9&EV('-T>6QE/3-$=VED=&@Z,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<] M,T0P(&-E;&QS<&%C:6YG/3-$,"!A;&EG;CTS1&-E;G1E6QE/3-$)VUAF4Z(#%P="<^#0H) M"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE M.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXR,"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H M.B`P,BXR,"4[(&)O3I4:6UEF4Z(#$P<'0G M/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXR,"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXR,"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE M/3-$)V1I3I4:6UE M6QE/3-$)V1I6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)V1I6QE/3-$ M)W=I9'1H.B`P,BXR,"4[(&)O3I4:6UE6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)V1I6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.R<^)FYB3I4:6UE3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D))FYB M6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXR,"4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q,2XQ,B4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXR,"4[(&)O3I4:6UE3I4:6UE3I4:6UE6QE/3-$)W=I9'1H.B`T,"XQ,"4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^ M0V]M;6]N('-T;V-K(&]P=&EO;G,\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N,C`E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG.B`P<'0[)SX-"@D)"0D)/'`@ MF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,2XQ,B4[(&)O6QE/3-$)W=I9'1H.B`P,BXR,"4[(&)O'0M86QI9VXZ6QE/3-$ M)W=I9'1H.B`P,BXR,"4[(&)O'0M86QI9VXZ M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXV-30F;F)S<#L-"@D)"0D\+W1D M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`P,BXR,"4[(&)O'0M86QI9VXZ6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR+#`W-B9N8G-P.PT*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N M,C`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG.B`P<'0[)SX-"@D)"0D) M/'`@F4Z(#$P<'0G/@T*"0D) M"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XQ,B4[(&)O M6QE/3-$)W=I9'1H.B`T,"XQ,"4[(&)O3I4:6UE6QE/3-$)V1I'0M86QI9VXZ6QE/3-$)W=I9'1H.B`Q,2XQ,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXV,C(F;F)S<#L-"@D)"0D\ M+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,BXR,"4[(&)O6QE/3-$)VUA3I4:6UE3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)W=I9'1H.B`P,BXR,"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB'0M86QI9VXZ6QE/3-$)W=I M9'1H.B`P,BXR,"4[(&)O6QE/3-$)VUA3I4:6UE3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)V1I'!E;G-E/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)VUA M3I4:6UE6QE M/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXR,"4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H M.B`P,BXR,"4[(&)O'0M86QI9VXZ6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ+#DT-29N8G-P.PT*"0D)"3PO M=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,#(N,C`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B M86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG.B`P<'0[)SX-"@D) M"0D)/'`@3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I M9'1H.B`P,BXR,"4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`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`P)3X\=&%B;&4@8V5L;'!A9&1I M;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!A;&EG;CTS1&-E;G1E6QE/3-$)VUAF4Z(#%P="<^#0H) M"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE M.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$=&]P('-T>6QE/3-$)W=I9'1H.B`P,BXQ-B4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXQ-"4[(&)O M3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P M,BXQ-"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D) M"0D))FYB6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`P,BXQ-"4[(&)O3I4:6UE MF4Z(#$P<'0G M/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O6QE/3-$)VUA MF4Z(#$P<'0G/@T*"0D)"0D))FYB'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF M;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SY.:6YE($UO;G1H6QE/3-$ M)W=I9'1H.B`T,BXV,"4[(&)O3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXQ-"4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P M,"XP,B4[(&)O'0M86QI9VXZ8V5N=&5R.V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I M9VAT.F)O;&0[)SXR,#$S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@F4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXQ M-"4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O'0M M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT M+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SXR,#$S/"]F;VYT/CPO<#X-"@D) M"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`T,BXV,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXQ M-"4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q M,"XV,"4[(&)O6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`P,BXQ-"4[(&)O3I4:6UE M3I4 M:6UE3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D) M)FYBF4Z(#$P<'0G/@T*"0D) M"0D))FYBF4Z(#$P<'0G/@T* M"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)VUA3I4:6UE6QE/3-$)V1I3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]WF4Z M(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q,"XV,"4[(&)O6QE/3-$)W=I9'1H.B`P,BXQ-"4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H M.B`P,BXQ-"4[(&)O'0M86QI9VXZ6QE M/3-$9FQO870Z;&5F=#X\+V1I=CXY,S(F;F)S<#L-"@D)"0D\+W1D/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)VUA6QE/3-$)V1I3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4:6UE6QE/3-$)V1IF4Z(#$P M<'0G/@T*"0D)"0D))FYB6QE/3-$9FQO870Z;&5F=#X\+V1I=CXY,"9N8G-P.PT*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,#(N,30E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D M97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y M.R!B86-K9W)O=6YD+6-O;&]R.B`C1D9&1D9&.R!P861D:6YG.B`P<'0[)SX- M"@D)"0D)/'`@F4Z(#$P<'0G M/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXY,B9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N,30E.R!B;W)D97(M=&]P.B`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I M9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C1D9& M1D9&.R!P861D:6YG.B`P<'0[)SX-"@D)"0D)/'`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`Q,"XV,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXV.#8F;F)S<#L-"@D)"0D\+W1D/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`Q M,"XV,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXY,3$F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T M;VT@6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`Q,"XV,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR+#,V."9N8G-P.PT*"0D)"3PO M=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,#(N,30E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B M86-K9W)O=6YD+6-O;&]R.B`C1D9&1D9&.R!P861D:6YG.B`P<'0[)SX-"@D) M"0D)/'`@F4Z(#$P<'0G/@T* M"0D)"0D))FYB6QE/3-$)VUA3I4:6UE3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W6QE/3-$)V1I'!E;G-E/"]F;VYT/CPO<#X-"@D)"0D\ M+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P M,BXQ-"4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,BXQ-"4[(&)O'0M86QI9VXZ6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXQ+#DT-29N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#(N,30E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9& M.R!P861D:6YG.B`P<'0[)SX-"@D)"0D)/'`@F4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO M9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q,"XV,"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1I6QE/3-$)VUAF4Z M(#%P="<^#0H)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N M="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\<#X\9F]N M="!S:7IE/3-$,3X@/"]F;VYT/CPO<#X-"@D\+V1I=CX@/"]D:78^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO M8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B-S,T960W-E]F M8C)F7S0Y-V9?83!A-U\T-3$U-6(S8C$U.3,-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO8C'0O:'1M;#L@8VAA6QE/3-$;6%R9VEN+6QE9G0Z,'!T M.VUA'0M:6YD96YT.C$X<'0[;&EN92UH96EG:'0Z;F]R;6%L.V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#%P="<^#0H)"0D\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N M8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\9&EV('-T>6QE/3-$=VED=&@Z,3`P M)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL M93TS1&)O6QE M/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H.C0T-BXT,'!T.W!A9&1I M;F3I4:6UE6QE/3-$)V1I#(P,3,[($EN8V]M92!487AE6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)FYBF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.R<^5&AE(&9O;&QO=VEN9R!T86)L92!S=6UM87)I>F5S M(&]U6QE/3-$)V1I3H@:6YL:6YE.R<^(&UO;G1H3H@:6YL:6YE.R<^4V5P=&5M8F5R M/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I&-E<'0@969F96-T:79E M('1A>"!R871E*3H\+V9O;G0^#0H)"3PO<#X-"@D)/'`@3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$)W=I9'1H.B`Q,"XR,B4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D))FYB6QE/3-$ M)VUA3I4:6UE6QE/3-$)W=I9'1H M.B`Q,"XR-B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`Q,"XR,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M)FYB6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`Q,"XR,B4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D))FYB6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P-2XW-"4[(&)O6QE/3-$)W=I9'1H.B`Q,"XR,B4[(&)O6QE/3-$)W=I9'1H.B`P,RXP-B4[(&)O6QE/3-$)W=I9'1H.B`P,RXP-B4[(&)O6QE/3-$ M)W=I9'1H.B`Q,"XR-B4[(&)O6QE/3-$)W=I9'1H.B`P,2XY-B4[ M(&)O6QE/3-$)W=I9'1H.B`P-"XQ,B4[(&)O M6QE/3-$)W=I9'1H.B`Q,"XR,B4[(&)O6QE/3-$)W=I M9'1H.B`P,RXP-"4[(&)O6QE/3-$)W=I9'1H.B`P,RXP-"4[(&)O M6QE/3-$)W=I9'1H.B`Q,"XR,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H M.B`S,BXS-"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA M3I4:6UE'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SY.:6YE($UO;G1H M6QE/3-$)W=I9'1H.B`S-2XP-"4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^ M)FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I M9'1H.B`P,BXW,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$ M)W=I9'1H.B`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`S-2XP-"4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^ M)FYB'0M86QI9VXZ6QE/3-$)W=I9'1H.B`Q,"XX,B4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D))FYB M6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`Q,BXT-B4[(&)O6QE/3-$)VUA MF4Z(#$P<'0G/@T*"0D)"0D) M)FYB6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O M6QE M/3-$)VUAF4Z(#$P<'0G/@T* M"0D)"0D))FYB6QE/3-$)VUA3I4 M:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H M.B`Q,"XR,B4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I'0M86QI9VXZ6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXQ+#`W.29N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N-S(E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG.B`P<'0[)SX-"@D)"0D)/'`@ M'0M86QI9VXZ8V5N M=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P M<'0G/@T*"0D)"0D))FYB'0M86QI9VXZ M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS.#$F;F)S M<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)VUA MF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`Q,2XV,B4[(&)O6QE/3-$)VUA3I4:6UE6QE M/3-$)VUAF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N M=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,"XR,B4[(&)O6QE M/3-$)W=I9'1H.B`S-2XP-"4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^4')O M=FES:6]N(&9O6QE/3-$)VUAF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^ M)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`Q,"XX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE3I4:6UE6QE/3-$)V1I6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR,#6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O'0M86QI9VXZ6QE/3-$ M)W=I9'1H.B`P,RXP-"4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`S-2XP-"4[(&)O3H@:6YL:6YE.R<^169F96-T:79E('1A>"!R871E/"]F;VYT/CPO M<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D))FYB3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H M.B`P,BXW,B4[(&)O6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O3I4:6UE6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU-"XS)29N M8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#$N.38E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG M.B`P<'0[)SX-"@D)"0D)/'`@F4Z(#$P M<'0G/@T*"0D)"0D))FYB'0M86QI9VXZ6QE/3-$)W=I9'1H.B`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`\+V9O;G0^/"]P/CQP('-T>6QE/3-$<&%G92UB7,^)FYB'0M M:6YD96YT.C$X<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.SMF;VYT M+7-I>F4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$)V1IF4Z,7!T.R<^)FYBF4],T0Q/B`\+V9O;G0^/"]P/@T*"3PO9&EV/B`\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD:78^(#QD M:78@6QE/3-$)VUA6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$8F]R9&5R+6-O;&QA<'-E M.F-O;&QA<'-E.W=I9'1H.C0T-BXT,'!T.VUA6QE/3-$ M)VUA6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.R<^)FYB3I4:6UE6QE/3-$)V1I2!D M:79I9&EN9R!T:&4@;F5T(&EN8V]M92!F;W(@=&AE('!E2!T:&4@ M=V5I9VAT960@879E2!S=&]C:R!M971H;V0N("9N M8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T M.W1E>'0M:6YD96YT.C$X<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N M.V9O;G0MF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.R<^5&AE(&9O;&QO=VEN9R!T86)L92!S M971S(&9O&-E<'0@ M<&5R('-H87)E(&%M;W5N=',I.B`F;F)S<#L\+V9O;G0^#0H)"3PO<#X-"@D) M/'`@3I4:6UE3H@:6YL M:6YE.V9O;G0M6QE/3-$)VUAF4Z(#%P="<^#0H) M"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE M.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D))FYB3I4:6UE6QE/3-$)VUA6QE/3-$ M)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D))FYB3I4:6UE6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)W=I M9'1H.B`U,2XT,B4[(&)O'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SY4 M:')E92!-;VYT:',@16YD960@/"]F;VYT/CQB6QE/3-$ M)V1I6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O3I4:6UE3I4:6UE6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT M.F)O;&0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,#`N,#(E.R!B;W)D97(M=&]P.B`Q<'0@3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O6QE/3-$ M)VUA6QE/3-$)W=I M9'1H.B`P,"XP,B4[(&)O'0M86QI9VXZ8V5N M=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M=V5I9VAT.F)O;&0[)SXR,#$S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@F4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P M,2XY,"4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF M;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SXR,#$S/"]F;VYT/CPO<#X- M"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U,2XT,B4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.R<^0F%S:6,Z/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@'0M86QI9VXZ6QE/3-$ M)W=I9'1H.B`P."XX,B4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE'0M86QI9VXZ M6QE/3-$)W=I9'1H.B`P."XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P M."XX,B4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D))FYB3H@:6YL:6YE.R<^3G5M97)A=&]R.CPO9F]N M=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE M/3-$)VUA3I4 M:6UEF4Z(#$P<'0G/@T*"0D)"0D) M)FYB6QE/3-$)VUA'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P M."XX,B4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`U M,2XT,B4[(&)O6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P M,2XY,"4[(&)O'0M86QI9VXZ6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXR,#4F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY M,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XX,B4[ M(&)O6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O M6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO M9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O6QE/3-$)W=I9'1H.B`U,2XT,B4[(&)O6QE/3-$)VUA M3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O3I4:6UEF4Z(#$P<'0G M/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O3I4:6UEF4Z(#$P<'0G/@T* M"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)VUA3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$ M)W=I9'1H.B`P,2XY,"4[(&)O3I4 M:6UEF4Z(#$P<'0G/@T*"0D)"0D) M)FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`P,2XY,"4[(&)O3I4:6UE MF4Z(#$P<'0G/@T*"0D)"0D))FYB M6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P M."XX,B4[(&)O6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ."PT M,S8F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H M.B`P."XX,B4[(&)O6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ M.2PS,3`F;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U,2XT,B4[ M(&)O6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$ M)W=I9'1H.B`P,2XY,"4[(&)O3I4 M:6UE'0M86QI M9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UEF4Z(#$P<'0G/@T*"0D) M"0D))FYB6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.R<^3F5T(&EN8V]M92!P97(@6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P."XX,B4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]WF4Z(#$P<'0G M/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1I6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O3I4:6UE'0M86QI9VXZ6QE/3-$)VUA6QE M/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`U,2XT,B4[(&)O6QE/3-$ M)VUA3I4:6UE M'0M86QI9VXZ M6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE M/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY M,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M)FYB6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE'0M86QI9VXZ3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O'0M86QI9VXZ6QE M/3-$)W=I9'1H.B`P."XX,B4[(&)O'0M86QI M9VXZ6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D) M"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUA3I4:6UE M6QE/3-$)W=I9'1H.B`U,2XT,B4[(&)O6QE/3-$)V1I M6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P M,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D))FYB6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H M.B`P."XX,B4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D))FYB6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`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`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O6QE/3-$)W=I9'1H.B`U,2XT,B4[(&)O6QE/3-$)VUA3I4:6UE'0M M86QI9VXZ6QE/3-$)W=I9'1H.B`P,2XY,"4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB M6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX M,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M)FYB6QE/3-$)VUA'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^ M1&5N;VUI;F%T;W(Z/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@'0M86QI9VXZ6QE/3-$ M)W=I9'1H.B`P."XX,B4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA M3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE M/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$ M)VUA3I4:6UE M'0M86QI9VXZ M6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)W=I M9'1H.B`U,2XT,B4[(&)O6QE/3-$)V1I6QE/3-$ M)VUA3I4:6UE M6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXQ.2PY-S`F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY M,"4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O6QE/3-$)W=I9'1H.B`P M,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P M<'0G/@T*"0D)"0D))FYB3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4:6UE6QE/3-$)VUA6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ M.2PS,3`F;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U,2XT,B4[ M(&)O'0M86QI9VXZ6QE M/3-$)W=I9'1H.B`P."XX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA M6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXU,C@F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@F4Z(#$P<'0G/@T*"0D)"0D))FYB6QE M/3-$)VUA3I4 M:6UE6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUAF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^5V5I M9VAT960@879E6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXW-R9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=W:61T:#H@,#$N.3`E.R!B;W)D97(M=&]P.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@ M8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT M.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9& M.R!P861D:6YG.B`P<'0[)SX-"@D)"0D)/'`@3I4:6UE'0M86QI9VXZ6QE/3-$ M)W=I9'1H.B`P."XX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P M,2XY,"4[(&)O3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T* M"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)VUAF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)FYB6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P M,2XY,"4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H M.B`P,2XY,"4[(&)O3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUA3I4:6UE M'0M86QI9VXZ M6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O'0M86QI9VXZ6QE M/3-$)W=I9'1H.B`P."XX,B4[(&)O'0M86QI M9VXZ#(P,30[9&EL=71E9#H\+V9O;G0^/"]P M/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,#$N.3`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG.B`P M<'0[)SX-"@D)"0D)/'`@F4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)V1I3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`P,2XY,"4[(&)O'0M86QI9VXZ6QE/3-$9FQO870Z;&5F=#X\+V1I=CXP+C(S)FYB6QE/3-$)W=I9'1H.B`P,2XY M,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO M9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P."XX,B4[(&)OF4Z M(#$P<'0G/@T*"0D)#0H)"3PO<#X-"@D)/'`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`P,BXS."4[(&)O3I4:6UEF4Z(#$P<'0G M/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q,RXU,"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.R<^)FYB3I4:6UE6QE M/3-$)V1I6QE/3-$)VUA6QE/3-$)W=I9'1H.B`R.2XS-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`Q,RXU,"4[(&)O'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SXR,#$R/"]F;VYT/CPO M<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1T;W`@3I4 M:6UE6QE/3-$)VUA6QE/3-$)VUA6QE/3-$ M)W=I9'1H.B`Q,RXU,"4[(&)O'0M86QI9VXZ M8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M=V5I9VAT.F)O;&0[)SXR,#$R/"]F;VYT/CPO<#X-"@D)"0D\+W1D M/@T*"0D)"3QT9"!V86QI9VX],T1T;W`@3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`Q,RXU,"4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P M,BXS."4[(&)O3I4:6UE3I4:6UEF4Z M(#$P<'0G/@T*"0D)"0D))FYB'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q,RXT."4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ+#0X-"9N8G-P.PT* M"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,#(N,S@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG.B`P<'0[ M)SX-"@D)"0D)/'`@3I4 M:6UE6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXQ,C6QE M/3-$)VUA6QE/3-$)W=I9'1H.B`Q,RXU M,"4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q,RXT."4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q,RXU,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)W=I9'1H.B`P,BXS."4[(&)O3I4:6UE6QE/3-$)W=I9'1H.B`P,BXS."4[ M(&)O3I4:6UEF4Z(#$P<'0G M/@T*"0D)"0D))FYB6QE/3-$9FQO870Z;&5F=#X\+V1I=CXT,SDF;F)S<#L-"@D) M"0D\+W1D/@T*"0D)/"]T6QE/3-$)V1IF4Z,7!T.R<^)FYBF4],T0Q/B`\+V9O;G0^/"]P/@T*"3PO9&EV/B`\+V1I=CX\'0O:F%V87-C3X- M"B`@("`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`R,#$S+"!O=7(@;&]N9RUL:79E9"!A2!O9B!P2!A;F0@97%U:7!M M96YT+"!G;V]D=VEL;"!A;F0@;W1H97(@:6YD969I;FET92UL:79E9"!I;G1A M;F=I8FQE(&%S2!A3I4:6UE3H@:6YL:6YE.V9O;G0M3I4:6UE3H@:6YL:6YE.V9O M;G0M6QE M/3-$)VUA6QE/3-$)W=I9'1H.B`R,RXS."4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`R,RXS."4[(&)O3I4:6UE6QE/3-$)W=I9'1H.B`T,2XW-B4[ M(&)O6QE/3-$)VUA6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,RXX,B4[(&)O3I4:6UE'0M86QI M9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I M>F4Z(#EP="<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z.7!T.R<^07,@;V8\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT M9"!V86QI9VX],T1T;W`@3I4:6UE6QE M/3-$)V1I6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O6QE/3-$)VUA6QE/3-$)V1I6QE/3-$)W=I9'1H.B`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`Q M<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+6)O='1O;3H@,7!T('-O;&ED(",P,#`P,#`[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H M.B`R,RXS."4[(&)O6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXR-S@F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B M;W1T;VT@F4Z(#$P<'0G M/@T*"0D)"0D))FYB'0M86QI9VXZ6QE/3-$)W=I M9'1H.B`R,RXS."4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXS-#(F;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`T M,2XW-B4[(&)O3H@:6YL:6YE.R<^5&]T86P\+V9O;G0^ M/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#,N.#(E.R!B;W)D97(M=&]P.B`Q<'0@F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`R,RXS."4[(&)O6QE M/3-$)W=I9'1H.B`P,RXX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M)FYBF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`R,RXS."4[(&)O M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)V1I#(P,30[4W5B2!A;&P@3H@:6YL M:6YE.R<^;FEN93PO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[)SX@;6]N=&AS(&5N9&5D(#PO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[)SY397!T96UB97(\+V9O;G0^/&9O;G0@3H@:6YL:6YE.R<^(#,P+"`R,#$R(&%N9"`R,#$S('=A6QE/3-$)V1I3H@:6YL:6YE.R<^(&UO;G1H3H@:6YL:6YE.R<^4V5P=&5M8F5R M/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I3I4:6UE3H@:6YL:6YE.V9O;G0M3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA6QE/3-$)W=I9'1H M.B`P,BXV-"4[(&)O3I4:6UEF4Z(#$P<'0G M/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXV-"4[ M(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`Q-2XU-"4[(&)O3I4:6UE MF4Z(#$P<'0G/@T* M"0D)"0D))FYB3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O6QE/3-$)VUA6QE/3-$ M)V1I6QE M/3-$)W=I9'1H.B`P,BXV-"4[(&)O3I4:6UE3I4:6UE3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE M.CEP=#LG/DYI;F4@36]N=&AS($5N9&5D(%-E<'1E;6)E3I4:6UE6QE M/3-$)V1I6QE/3-$)W=I9'1H M.B`Q-2XU-"4[(&)O'0M86QI9VXZ8V5N=&5R M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#EP="<^ M#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="UW M96EG:'0Z8F]L9#MF;VYT+7-I>F4Z.7!T.R<^,C`Q,CPO9F]N=#X\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,BXV-"4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#EP="<^#0H)"0D)"0D\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I M>F4Z.7!T.R<^,C`Q,SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXV-"4[(&)O3I4:6UE6QE/3-$)VUA6QE/3-$)V1I3I4:6UE6QE/3-$)VUA6QE/3-$)V1I6QE/3-$)W=I9'1H.B`R.2XY,B4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB M6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXV-"4[(&)O3I4:6UE3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4:6UE6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXQ."4F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@6QE/3-$)VUA M6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O M6QE M/3-$)W=I9'1H.B`P,BXV-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M)FYB3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]WF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.R<^5V5L;%!O:6YT("@Q M*3PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q M-2XU-"4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I9'1H M.B`Q-2XU-"4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O6QE/3-$)W=I9'1H.B`P,BXV M-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W3I4:6UE6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ,R4F;F)S<#L- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O6QE/3-$)VUA6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXW)29N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N-C0E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA M6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O M3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,BXV-"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D) M/&9O;G0@3H@:6YL:6YE.R<^)FYBF4Z,3!P=#LG/B`H,2D\+V9O;G0^#0H)"0D\+W`^#0H)"3PO=&0^ M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1T;W`^#0H)"0D\<"!S='EL93TS M1"=B;W)D97(M8F]T=&]M.C%P="!N;VYE("-$.40Y1#D@.VQI;F4M:&5I9VAT M.C$Q-24[9F]N="UF86UI;'DZ0V%L:6)R:3MF;VYT+7-I>F4Z(#$P<'0[;6%R M9VEN.C!P=#LG/@T*"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG M/E=E;&QP;VEN="!A;'-O(&EN8VQU9&5S(&]T:&5R(&-A3H@ M:6YL:6YE.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z M,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/CPO=&%B;&4^/"]D M:78^#0H)"3QD:78@F4Z(#$P<'0[;6%R9VEN.C!P=#LG/@T* M"0D)"3QF;VYT('-T>6QE/3-$)VUA3I#86QI8G)I.V9O;G0M6QE/3-$)V1I3I4:6UE6QE/3-$=VED=&@Z,3`P)3X\=&%B;&4@6QE M/3-$)W=I9'1H.B`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`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`\+V9O;G0^/&9O;G0@3H@:6YL:6YE M.R<^,30\+V9O;G0^/&9O;G0@3H@:6YL:6YE.R<^ M)2!A;F0@/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I2P@9F]R(&$@8V]M8FEN960@=&]T86P@;V8@/"]F;VYT M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I3H@ M:6YL:6YE.R<^(#,P+"`R,#$S+"`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.R<^='=O/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R<^-#,\+V9O;G0^/&9O;G0@3H@:6YL:6YE.R<^)2`F;F)S<#L\+V9O;G0^/&9O;G0@3H@:6YL:6YE.R<^86YD(#PO9F]N=#X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[)SXS,SPO9F]N=#X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[)SXE+"!R97-P96-T:79E;'D@/"]F;VYT/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R<^+CPO9F]N=#X\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[)SXV/"]F;VYT/CQF;VYT('-T>6QE/3-$ M)V1I3H@:6YL:6YE.R<^(#,P+"`R,#$S+B!792!B96QI979E M('1H92!P;W1E;G1I86P@9F]R(&-O;&QE8W1I;VX@:7-S=65S('=I=&@@86YY M(&]F(&]U3H@:6YL:6YE.R<^4V5P=&5M8F5R/"]F;VYT M/CQF;VYT('-T>6QE/3-$)V1I3H@ M:6YL:6YE.R<^(#,P+"`R,#$S('=A6QE.FET86QI8SLG/B9N8G-P.SPO9F]N=#X-"@D) M/"]P/@T*"0D\<#X\9F]N="!S:7IE/3-$,3X@/"]F;VYT/CPO<#X-"@D\+V1I M=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]B-S,T960W-E]F8C)F7S0Y-V9?83!A-U\T-3$U-6(S8C$U.3,-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!/ M9B!"=7-I;F5S'0^)SQS<&%N/CPO6QE/3-$;6%R9VEN+6QE9G0Z,'!T.VUA'0M:6YD96YT M.C$X<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE/3-$)V1I3H@:6YL:6YE.R<^ M94AE86QT:"P@26YC+B`H=&AE("8C>#(P,4,[0V]M<&%N>2PF(W@R,#%$.R`F M(W@R,#%#.V5(96%L=&@L)B-X,C`Q1#L@)B-X,C`Q0SMW928C>#(P,40[(&]R M("8C>#(P,4,[=7,F(W@R,#%$.RD@:7,@=&AE(&QE861I;F<@/"]F;VYT/CQF M;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE.FET86QI8SLG/G=W M=RYE2&5A;'1H+F-O;3PO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[)SXL("9N8G-P.SPO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[9F]N="US='EL93II=&%L:6,[)SYW=W3H@:6YL:6YE M.R<^+"`F;F)S<#L\+V9O;G0^/&9O;G0@3H@:6YL M:6YE.V9O;G0M3H@:6YL:6YE.R<^(&%N M9"`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.V9O;G0M M3H@:6YL:6YE.R<^+"!C;VYS=6UE2US:61E+"!A;F0@87!P M;'D@9F]R(&%N9"!P=7)C:&%S92!I;F1I=FED=6%L(&%N9"!F86UI;'DL($UE M9&EC87)E+7)E;&%T960L('-M86QL(&)U6QE/3-$)V1I3H@:6YL:6YE.R<^365D:6-A3H@ M:6YL:6YE.R<^+B`F;F)S<#L\+V9O;G0^/&9O;G0@3H@:6YL:6YE.R<^3W5R(&5C;VUM97)C92!T96-H;F]L;V=Y(&%L#(P,3D[(&AE86QT:"!I M;G-U2!A;F0@"!A;F0@=')A9&ET:6]N86QL M>2!P87!E3H@:6YL:6YE.R<^5V4@87)E(&QI8V5N3H@:6YL:6YE.R<^-3`\+V9O;G0^/&9O;G0@3H@:6YL:6YE.R<^('-T871E'0M:6YD96YT.C$X<'0[9F]N="UF86UI;'DZ M5&EM97,@3F5W(%)O;6%N.V9O;G0M6QE.FET86QI8SLG/B9N8G-P.SPO9F]N=#X-"@D)/"]P/@T*"0D\<#X\ M9F]N="!S:7IE/3-$,3X@/"]F;VYT/CPO<#X-"@D\+V1I=CX@/"]D:78^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$6QE/3-$;6%R9VEN+6QE9G0Z,'!T.VUA M'0M:6YD96YT.C$X<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O M;G0M6QE M/3-$)V1I&-H86YG92!#;VUM:7-S:6]N(&]N($UAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL M:6YE.R<^)FYB6QE/3-$)VUA M3I4:6UE6QE/3-$ M)V1I#(P,3D[3H@:6YL M:6YE.R<^)FYB6QE/3-$)VUA M6QE/3-$;6%R9VEN M+6QE9G0Z,'!T.VUA'0M:6YD96YT.C$X<'0[9F]N="UF86UI;'DZ5&EM97,@ M3F5W(%)O;6%N.V9O;G0M6QE M.FET86QI8SLG/E-E87-O;F%L:71Y)B-X,C`Q-#L\+V9O;G0^/&9O;G0@3H@:6YL:6YE.R<^5&AE(&YU;6)E2P@=V4@:&%V92!G96YE6QE/3-$)V1I6QE/3-$)V1I'0M:6YD96YT M.C$X<'0[;&EN92UH96EG:'0Z;F]R;6%L.V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.R<^)FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I2!O M9B!-961I8V%R92!P;&%N65A65A M2P@=V4@2!O9B!P;VQI8VEE2!R96YE=R!O;B!*86YU87)Y(#$@ M;V8@96%C:"!Y96%R+B`\+V9O;G0^#0H)"3PO<#X-"@D)/'`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`^/&9O;G0@'0^)SQD M:78^(#QD:78@6QE/3-$)VUA'0M:6YD96YT.C$X<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W M(%)O;6%N.V9O;G0M7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA6QE/3-$)V1IF4Z,7!T.R<^)FYB6QE/3-$ M)W=I9'1H.B`Q.2XR-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE M/3-$)W=I9'1H.B`Q.2XX-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4 M:6UE6QE/3-$)W=I9'1H.B`P,RXR,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`R,BXT-"4[(&)O6QE/3-$)VUA M3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4 M:6UE'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[ M)SY397!T96UB97(@,S`L(#(P,3,\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H) M"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1T;W`@6QE/3-$)W=I9'1H.B`Q.2XR-"4[ M(&)O6QE/3-$)VUAF4Z(#$P<'0G M/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.R<^0V%S:#PO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P,RXR,"4[(&)O3I4:6UE6QE/3-$)V1I M3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]WF4Z M(#$P<'0G/@T*"0D)"0D))FYB'0M86QI9VXZ6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXQ.2PV,S(F;F)S<#L-"@D)"0D\+W1D/@T*"0D) M/"]T6QE M/3-$)W=I9'1H.B`U,2XS,B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^36]N M97D@;6%R:V5T(&9U;F1S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ6QE/3-$)W=I9'1H.B`Q.2XR-"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ,3,L,S8U)FYB6QE/3-$)W=I9'1H M.B`P,RXR,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M)FYB6QE/3-$)W=I9'1H.B`Q.2XX-"4[(&)O M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXW."PQ,3DF M;F)S<#L-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U,2XS,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^5&]T86P@8V%S:"!A;F0@8V%S:"!E M<75I=F%L96YT6QE/3-$)W=I9'1H.B`P,RXR,"4[(&)O3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4 M:6UE6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q.2XX M-"4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE M.R<^)FYBF4],T0Q M/B`\+V9O;G0^/"]P/@T*"3PO9&EV/B`\+V1I=CX\6QE/3-$;6%R9VEN+6QE9G0Z,'!T.VUA6QE/3-$=VED=&@Z,3`P)3X\=&%B M;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!A;&EG;CTS1&-E M;G1E6QE/3-$ M)VUA3I4:6UE3H@:6YL:6YE M.V9O;G0M6QE/3-$)VUA3I4 M:6UE6QE/3-$)W=I9'1H.B`P M,RXR,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`Q.2XR-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE M/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`Q.2XX-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)W=I9'1H.B`R,RXP-"4[(&)O6QE/3-$ M)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`U,2XS,B4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.R<^)FYBF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)W=I9'1H M.B`P,RXR,"4[(&)O6QE/3-$)VUA3I4:6UEF4Z M(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q.2XR-"4[(&)O M6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUAF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q.2XX-"4[(&)O6QE/3-$ M)W=I9'1H.B`U,2XS,B4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^0V]M;6ES M6QE/3-$)W=I9'1H.B`P,RXR,"4[(&)O M6QE M/3-$)VUAF4Z(#$P<'0G/@T* M"0D)"0D))FYB6QE/3-$)W=I9'1H.B`P,RXR,"4[(&)O6QE/3-$)VUA3I4:6UE3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4:6UE6QE M/3-$)V1I'0M86QI9VXZ6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXT+#0V."9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N,C`E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C0T-&1D9&.R!P861D:6YG.B`P<'0[)SX-"@D)"0D)/'`@F4Z(#$P<'0G/@T*"0D)"0D))FYB'0M86QI9VXZ6QE/3-$9FQO870Z;&5F=#X\+V1I=CXV+#4Y.29N M8G-P.PT*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D\+W1A8FQE/CPO9&EV/@T* M"0D\<"!S='EL93TS1"=M87)G:6XZ,'!T.VQI;F4M:&5I9VAT.FYO3I4:6UE6QE/3-$)V1I3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]B-S,T960W-E]F8C)F7S0Y-V9?83!A-U\T-3$U-6(S M8C$U.3,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M2!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^)SQD M:78^(#QD:78@6QE/3-$)V)O6QE/3-$)W=I9'1H.B`U-RXT-B4[(&)O6QE/3-$)V1IF4Z,7!T.R<^)FYBF4Z(#$P M<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`T,BXU-"4[(&)O6QE/3-$)VUA6QE/3-$)V1I6QE/3-$)VUA6QE/3-$)W=I9'1H.B`T M,BXU-"4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)VUAF5D("@R*3PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`T,BXU-"4[(&)O M3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$9FQO870Z;&5F=#X\+V1I=CXH,3$Y*0T*"0D) M"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B M;W1T;VT@6QE/3-$)VUA6QE/3-$)W=I9'1H.B`T,BXU-"4[(&)O6QE M/3-$)W=I9'1H.B`U-RXT-B4[(&)O6QE/3-$)V1I3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`T,BXU-"4[(&)OF4Z(#$P<'0G/@T*"0D)/&9O;G0@ M3H@:6YL:6YE.R<^)FYB6QE/3-$)V1I3H@:6YL:6YE.R<^)FYB6QE/3-$)V1I M6QE/3-$=VED=&@Z,3`P)3X\=&%B;&4@6QE/3-$)W=I9'1H.B`S-BXP M,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SX-"@D)"3QP('-T>6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0[;6%R9VEN M.C!P=#LG/@T*"0D)"3QF;VYT('-T>6QE/3-$)VUA6QE/3-$)V1IF4Z,7!T M.R<^)FYB6QE/3-$)V)O6QE/3-$)W=I9'1H.B`T M,BXW."4[(&)O3I4:6UE3H@:6YL:6YE.V9O;G0M3I4:6UE6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P M,BXX,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)VUA M6QE/3-$)W=I9'1H.B`Q,2XX,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q,2XY M-"4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)V1I3I4:6UE6QE/3-$)V1I6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,"XP,B4[ M(&)O6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q,2XX,"4[(&)O6QE/3-$ M)VUA6QE/3-$)W=I9'1H.B`P,BXX,"4[(&)O3I4:6UE3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`T,BXW M."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^0F%L86YC92!O=71S=&%N9&EN9R!A="!$96-E M;6)E6QE/3-$)W=I9'1H.B`P.2XT-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)W=I9'1H.B`P,BXX,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M)FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ,RXT,29N M8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#(N.#`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG M.B`P<'0[)SX-"@D)"0D)/'`@F4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS+CDQ M)FYB6QE/3-$)W=I9'1H.B`P,BXX,"4[(&)O'0M M86QI9VXZ6QE/3-$)W=I9'1H.B`P,BXX,"4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,2XY-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W3H@:6YL:6YE.R<^1W)A;G1E M9#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P.2XT-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P M,BXX,"4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q,"XP,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,BXX,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$ M)W=I9'1H.B`P,BXX,"4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA M3I4:6UE6QE/3-$)W=I9'1H.B`T,BXW."4[(&)O3H@:6YL:6YE.R<^17AE6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXH.#,T*0T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#(N.#`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D M:6YG.B`P<'0[)SX-"@D)"0D)/'`@3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)V1I M3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`T,BXW."4[(&)O6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P.2XT-"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXH-S(I#0H)"0D) M/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`P,BXX,"4[(&)O3I4:6UE'0M86QI9VXZ'0M86QI9VXZ6QE/3-$)W=I9'1H.B`Q,2XX,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE'0M M86QI9VXZ6QE/3-$)W=I9'1H.B`Q,2XY-"4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB M6QE M/3-$)VUA6QE/3-$)W=I9'1H.B`P.2XT-"4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXX,"4[(&)O'0M M86QI9VXZ6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ-BXV."9N8G-P.PT* M"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,#(N.#`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG.B`P<'0[ M)SX-"@D)"0D)/'`@F4Z(#$P M<'0G/@T*"0D)"0D))FYB3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1I3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]WF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^5F5S=&5D(&%N9"!E>'!E8W1E9"!T;R!V97-T M(&%T(%-E<'1E;6)E6QE/3-$)W=I9'1H.B`P.2XT M-"4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ-BXV-29N M8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#(N.#`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE'0M86QI9VXZ3I4:6UE6QE/3-$)V1I M6QE/3-$)W=I9'1H.B`P.2XT-"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1I3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)W=I9'1H.B`P,BXX,"4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`Q,2XX M,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q,2XY-"4[(&)O6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`Q,#`E)R!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P/CQT M3H@:6YL:6YE.R<^#0H)"0D\<"!S='EL93TS M1"=L:6YE+6AE:6=H=#HQ,34E.V9O;G0M9F%M:6QY.D-A;&EB6QE/3-$)VQI;F4M:&5I9VAT.C$Q-24[9F]N="UF86UI M;'DZ0V%L:6)R:3MF;VYT+7-I>F4Z(#$P<'0[;6%R9VEN.C!P=#LG/@T*"0D) M/&9O;G0@3H@:6YL:6YE.V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/E1H92!A9V=R96=A=&4@ M:6YT6QE/3-$)V1I3I4:6UE&5R8VES92!P3H@:6YL M:6YE.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P M=#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^ M#0H)"3QP('-T>6QE/3-$)VUA3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXX,B4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXX,B4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$ M)V1I6QE/3-$)W=I9'1H.B`Q M-2XV-B4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXX,B4[(&)O3I4:6UEF4Z(#$P<'0G/@T* M"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)VUAF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I M9VAT.F)O;&0[)SXF;F)S<#L\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,34N-C8E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T('-O;&ED(",P,#`P M,#`[(&)O'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[ M)SY.=6UB97(@3W5T6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-BXU-"4[(&)O6QE/3-$)VUA6QE/3-$ M)W=I9'1H.B`P,BXX,B4[(&)O3I4:6UE3I4:6UE6QE/3-$)V1I3H@:6YL:6YE.R<^*#$I/"]F;VYT/CPO<#X- M"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`T."XP-B4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.R<^0F%L86YC92!O=71S=&%N9&EN9R!A6QE/3-$)W=I9'1H.B`Q-2XV-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ,"PT-C0F;F)S<#L-"@D)"0D\ M+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`T."XP-B4[(&)O6QE/3-$)V1I6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU-C0F;F)S<#L- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@F4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE M/3-$)W=I9'1H.B`P,BXX,B4[(&)O3I4:6UE'0M M86QI9VXZ6QE/3-$)V1I6QE/3-$)W=I9'1H.B`Q-2XV-B4[(&)O6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`Q-BXU-"4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,BXX,B4[(&)O'0M86QI9VXZ6QE/3-$ M)W=I9'1H.B`P,BXX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB MF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^ M0V%N8V5L;&5D/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]WF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H M.B`P,BXX,B4[(&)O3I4:6UE'0M86QI9VXZ3I4:6UE M6QE/3-$)V1I6QE/3-$9FQO870Z;&5F=#X\ M+V1I=CXW-3(F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B M;W1T;VT@6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-BXU-"4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M,2XR-B4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE M.R<^)FYB3I#86QI8G)I.V9O;G0M3I#86QI8G)I.V9O M;G0M6QE/3-$)V1I3I4:6UE2X\+V9O;G0^/&9O;G0@3H@:6YL M:6YE.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P M=#LG/B`F;F)S<#LF;F)S<#L\+V9O;G0^/&9O;G0@3H@:6YL:6YE.R<^)FYB3I4:6UE6QE/3-$ M)V1I6QE/3-$;6%R9VEN+6QE9G0Z M,'!T.VUA6QE/3-$=VED=&@Z M,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!A M;&EG;CTS1&-E;G1E6QE/3-$)VUA3I4 M:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA3I4:6UE6QE/3-$ M)W=I9'1H.B`P,BXV,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE M/3-$)W=I9'1H.B`P,BXV,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`T,BXY."4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)FYB6QE/3-$)W=I9'1H.B`P,BXV,B4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA M3I4:6UE6QE/3-$)W=I9'1H.B`P,BXV,B4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$ M)VUA3I4:6UE6QE/3-$)VUA3I4:6UE M6QE/3-$)V1I'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@ M3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SY4 M;W1A;"!.=6UB97(@;V8@4VAA6QE/3-$)W=I M9'1H.B`P,BXV,B4[(&)O'0M M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT M+7-I>F4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXV,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)W=I9'1H.B`T M,BXY."4[(&)O6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXV+#,Y-RPX,#,F;F)S<#L-"@D)"0D\+W1D/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE M3I4:6UE6QE/3-$)V1I M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ-"XR M,B9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#(N-C(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D M:6YG.B`P<'0[)SX-"@D)"0D)/'`@F4Z M(#$P<'0G/@T*"0D)"0D))FYB6QE M/3-$)VUAF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N M=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q-2XV-B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,BXV,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUAF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^ M)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`Q,RXW,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,BXV M,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$9FQO870Z M;&5F=#X\+V1I=CXY+#,P.2PR-CDF;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)VUA3I4:6UE6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,RXW,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUAF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q-2XV-B4[(&)O6QE/3-$)V1I3I4:6UE6QE/3-$)W=I9'1H.B`Q,#`E)R!C96QL M<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P/CQT3H@:6YL:6YE.V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/D-U;75L871I=F4@8F%L86YC M97,@870@1&5C96UB97(@,S$L(#(P,3(@86YD(%-E<'1E;6)E6QE/3-$)V1I3I4:6UEF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.R<^*#(I/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I M6QE/3-$;6%R9VEN M+6QE9G0Z,'!T.VUA6QE/3-$ M=VED=&@Z,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG M/3-$,"!A;&EG;CTS1&-E;G1E6QE/3-$)VUAF4Z(#%P="<^#0H)"0D)"0D\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N M=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$=&]P('-T>6QE M/3-$)W=I9'1H.B`P,BXT,B4[(&)O3I4:6UEF4Z M(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA M6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$ M)V1I6QE M/3-$)W=I9'1H.B`P,"XP,B4[(&)O6QE/3-$)VUAF4Z M(#$P<'0G/@T*"0D)"0D))FYB'0M86QI9VXZ8V5N=&5R.V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I M9VAT.F)O;&0[)SY.:6YE($UO;G1H6QE/3-$)W=I9'1H.B`S-2XX-"4[(&)O M6QE/3-$ M)W=I9'1H.B`P,"XP,B4[(&)O'0M86QI9VXZ M8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.V9O;G0M=V5I9VAT.F)O;&0[)SXR,#$R/"]F;VYT/CPO<#X-"@D)"0D\+W1D M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3I4:6UE6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SXR,#$R/"]F;VYT M/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@3I4:6UE6QE/3-$ M)VUA3I4 M:6UE6QE/3-$)V1I6QE/3-$)W=I M9'1H.B`P,BXT,B4[(&)O6QE/3-$)VUA6QE/3-$ M)W=I9'1H.B`Q,2XX,"4[(&)O6QE/3-$)VUA6QE M/3-$)W=I9'1H.B`P,BXT,B4[(&)O3I4:6UE3I4:6UE3I4:6UEF4Z(#$P<'0G M/@T*"0D)"0D))FYBF4Z(#$P M<'0G/@T*"0D)"0D))FYBF4Z M(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA M6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)O6QE/3-$ M)VUA6QE/3-$)W=I9'1H.B`Q,2XX,"4[(&)O M6QE M/3-$)VUA3I4:6UE6QE/3-$)V1I3I4:6UE6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1I65A3I4:6UE M6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q,2XX,"4[(&)O'0M86QI9VXZ3H@ M:6YL:6YE.R<^('EE87)S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXT M,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^-"XW M/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D))FYB3I4:6UE6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1IF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^ M17AP96-T960@=F]L871I;&ET>3PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXT,B4[ M(&)O3I4:6UEF4Z(#$P<'0G/@T* M"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q,2XX,"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I M9'1H.B`P,BXT,B4[(&)O3I4:6UE MF4Z(#$P<'0G/@T*"0D)"0D))FYB M6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXT-"XS)29N8G-P.PT*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N-#(E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXT M,B4[(&)O3I4:6UE6QE/3-$)W=I9'1H.B`S-2XX M-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^17AP96-T960@9&EV:61E;F0@>6EE;&0\+V9O M;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#(N-#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D M:6YG.B`P<'0[)SX-"@D)"0D)/'`@3I4:6UE6QE/3-$9FQO870Z;&5F=#X\+V1I=CXP)29N8G-P.PT*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N M-#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG.B`P<'0[)SX-"@D)"0D) M/'`@3I4:6UE6QE/3-$)VUA6QE M/3-$)W=I9'1H.B`Q,2XX,"4[(&)O6QE/3-$ M)VUA6QE/3-$)W=I9'1H.B`P,BXT,B4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D))FYB3I4:6UE6QE/3-$9FQO870Z;&5F=#X\+V1I=CXP)29N8G-P M.PT*"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI M9VX],T1B;W1T;VT@F4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.R<^4FES:RUF6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`Q,2XX,"4[(&)O3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ+C$S)29N M8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=W:61T:#H@,#(N-#(E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O M='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N M92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@ M,'!T.R<^#0H)"0D)"3QP('-T>6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$ M)W=I9'1H.B`Q,2XX,"4[(&)O3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W3I4:6UE M6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)O'0M86QI9VXZ6QE/3-$9FQO870Z;&5F=#X\+V1I=CXV M+C0V)FYB6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XX,"4[ M(&)O3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)V1I M3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXT,B4[(&)O'0M86QI9VXZ6QE/3-$9FQO870Z;&5F=#X\+V1I=CXW+C`R)FYB M6QE/3-$)VUAF4Z(#$P<'0G/@T* M"0D)/&9O;G0@3H@:6YL:6YE.R<^)FYBF4],T0Q/B`\+V9O;G0^/"]P M/@T*"3PO9&EV/B`\+V1I=CX\'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#XG/&1I=CX@/&1I=B!S='EL93TS1&UAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL M:6YE.R<^5&AE(&9O;&QO=VEN9R!T86)L92!S=6UM87)I>F5S('-T;V-K+6)A M'!E;G-E(')E8V]R9&5D(&1UF4Z(#%P="<^#0H)"0D\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X-"@D) M/"]P/@T*"0D\9&EV('-T>6QE/3-$=VED=&@Z,3`P)3X\=&%B;&4@8V5L;'!A M9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!A;&EG;CTS1&-E;G1E6QE/3-$)VUAF4Z(#%P M="<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N M="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,BXR,"4[ M(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D) M)FYB6QE/3-$)VUA6QE/3-$ M)W=I9'1H.B`P,BXR,"4[(&)O3I4 M:6UEF4Z M(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$ M)VUA6QE/3-$)W=I9'1H.B`P,BXR,"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXR,"4[ M(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D) M)FYB3I4 M:6UE6QE/3-$)V1I3I4:6UE6QE/3-$)V1I6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$ M)V1I6QE/3-$)W=I9'1H.B`P,BXR,"4[(&)O3I4:6UE6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)V1I6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)FYB3I4:6UE3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D))FYB MF4Z(#$P<'0G/@T*"0D) M"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXR,"4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q,2XQ,B4[(&)O6QE/3-$ M)VUA6QE/3-$)W=I9'1H.B`P,BXR,"4[ M(&)O3I4:6UE3I4:6UE3I4:6UE M6QE/3-$)W=I9'1H.B`T,"XQ,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.R<^0V]M;6]N('-T;V-K(&]P=&EO;G,\+V9O;G0^/"]P/@T*"0D)"3PO M=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,#(N,C`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO M;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B M86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG.B`P<'0[)SX-"@D) M"0D)/'`@F4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N M=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q,2XQ,B4[(&)O6QE/3-$)W=I9'1H.B`P,BXR,"4[(&)O M'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,BXR,"4[(&)O'0M M86QI9VXZ6QE/3-$9FQO870Z;&5F=#X\+V1I=CXV-30F;F)S<#L-"@D) M"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE M/3-$)W=I9'1H.B`P,BXR,"4[(&)O'0M86QI M9VXZ6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR+#`W-B9N8G-P.PT*"0D) M"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,#(N,C`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D M97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y M.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG.B`P<'0[)SX- M"@D)"0D)/'`@F4Z(#$P<'0G M/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XQ M,B4[(&)O6QE/3-$)W=I9'1H.B`T,"XQ,"4[ M(&)O3I4:6UE6QE/3-$)V1I'0M86QI9VXZ M6QE/3-$)W=I9'1H.B`Q,2XQ,B4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXV,C(F;F)S<#L- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,BXR,"4[(&)O6QE/3-$)VUA M3I4:6UE3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,BXR,"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB'0M86QI9VXZ6QE M/3-$)W=I9'1H.B`P,BXR,"4[(&)O6QE/3-$)VUA3I4:6UE3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$ M)V1I'!E;G-E/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V M86QI9VX],T1B;W1T;VT@6QE M/3-$)VUA3I4 M:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXR,"4[(&)O'0M86QI9VXZ6QE/3-$ M)W=I9'1H.B`P,BXR,"4[(&)O'0M86QI M9VXZ6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ+#DT-29N8G-P.PT* M"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,#(N,C`E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG.B`P<'0[ M)SX-"@D)"0D)/'`@3I4 M:6UE6QE/3-$)VUA6QE/3-$)V1I6QE M/3-$)W=I9'1H.B`P,BXR,"4[(&)O'0M86QI M9VXZ6QE/3-$)W=I9'1H.B`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`P)3X\=&%B;&4@8V5L M;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!A;&EG;CTS1&-E;G1E6QE/3-$)VUAF4Z(#%P M="<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N M="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D) M"0D\=&0@=F%L:6=N/3-$=&]P('-T>6QE/3-$)W=I9'1H.B`P,BXQ-B4[(&)O M3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXQ M-"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D) M)FYB6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`P,BXQ-"4[(&)O3I4:6UE MF4Z(#$P<'0G M/@T*"0D)"0D))FYB6QE/3-$)VUA6QE M/3-$)W=I9'1H.B`P,BXQ-"4[(&)O3I4:6UEF4Z M(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O M6QE M/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D))FYB'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SY.:6YE($UO;G1H M6QE/3-$)W=I9'1H.B`T,BXV,"4[(&)O3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXQ-"4[(&)O6QE/3-$ M)VUA6QE/3-$)W=I M9'1H.B`P,"XP,B4[(&)O'0M86QI9VXZ8V5N M=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M=V5I9VAT.F)O;&0[)SXR,#$S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@F4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H M.B`P,BXQ-"4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SXR,#$S/"]F;VYT/CPO M<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`T,BXV,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H M.B`P,BXQ-"4[(&)O6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`Q,"XV,"4[(&)O6QE/3-$)VUA6QE M/3-$)W=I9'1H.B`P,BXQ-"4[(&)O3I4:6UE3I4:6UE3I4:6UEF4Z(#$P<'0G/@T* M"0D)"0D))FYBF4Z(#$P<'0G M/@T*"0D)"0D))FYBF4Z(#$P M<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1I3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W MF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q,"XV,"4[(&)O6QE/3-$)W=I9'1H.B`P,BXQ-"4[(&)O'0M86QI9VXZ6QE/3-$ M)W=I9'1H.B`P,BXQ-"4[(&)O'0M86QI9VXZ M6QE/3-$9FQO870Z;&5F=#X\+V1I=CXY,S(F;F)S<#L-"@D)"0D\+W1D M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)V1I M3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4:6UE6QE/3-$)V1IF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$9FQO870Z;&5F=#X\+V1I=CXY,"9N8G-P M.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,#(N,30E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C1D9&1D9&.R!P861D:6YG.B`P M<'0[)SX-"@D)"0D)/'`@F4Z M(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXY,B9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N,30E.R!B;W)D97(M M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R M9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R M.B`C1D9&1D9&.R!P861D:6YG.B`P<'0[)SX-"@D)"0D)/'`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`Q,"XV,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXV.#8F;F)S<#L-"@D)"0D\ M+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I M9'1H.B`Q,"XV,"4[(&)O6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXY,3$F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`Q,"XV,"4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR+#,V."9N8G-P.PT* M"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W M:61T:#H@,#(N,30E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B M;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$ M.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C1D9&1D9&.R!P861D:6YG.B`P<'0[ M)SX-"@D)"0D)/'`@F4Z(#$P M<'0G/@T*"0D)"0D))FYB6QE/3-$ M)VUA3I4:6UE M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)V1I'!E;G-E/"]F;VYT/CPO<#X- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I M9'1H.B`P,BXQ-"4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,BXQ-"4[(&)O'0M86QI9VXZ6QE/3-$9FQO870Z;&5F M=#X\+V1I=CXQ+#DT-29N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N,30E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M0T-&1D9&.R!P861D:6YG.B`P<'0[)SX-"@D)"0D)/'`@F4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,"XV,"4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUA3I4:6UE M6QE/3-$)V1I6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL M:6YE.R<^)FYBF4] M,T0Q/B`\+V9O;G0^/"]P/@T*"3PO9&EV/B`\+V1I=CX\'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA&5S(%M!8G-T6QE/3-$;6%R9VEN+6QE M9G0Z,'!T.VUA6QE/3-$=VED M=&@Z,3`P)3X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$ M,"!S='EL93TS1"=B;W)D97(M8V]L;&%P6QE/3-$)VUA M3I4:6UE3H@:6YL:6YE.V9O M;G0M6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,RXP-B4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H M.B`P,2XY-B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,RXP-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M)FYB6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE MF4Z(#$P<'0G/@T* M"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)FYB6QE/3-$)W=I9'1H.B`S-2XP-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.R<^)FYB'0M86QI M9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I M>F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL M:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SY4:')E92!-;VYT:',@16YD960@4V5P M=&5M8F5R(#,P+#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`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`Q-"XS-"4[(&)O M6QE/3-$)W=I9'1H.B`Q,RXR-B4[ M(&)O3I4 M:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D))FYB M3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,2XY-B4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,RXP-"4[(&)O'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE'0M86QI M9VXZF4Z(#$P<'0G M/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^26YC M;VUE(&)E9F]R92!P6QE M/3-$)W=I9'1H.B`P,RXV,B4[(&)O3I4:6UE6QE/3-$)V1I M3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P,BXW,B4[ M(&)O6QE/3-$)W=I9'1H.B`P,BXW M,B4[(&)O3I4:6UE6QE/3-$)V1I3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]WF4Z(#$P<'0G M/@T*"0D)"0D))FYB'0M86QI9VXZ6QE/3-$9FQO870Z;&5F=#X\+V1I=CXY+#$V,"9N8G-P.PT*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N M,#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG.B`P<'0[)SX-"@D)"0D) M/'`@'0M86QI9VXZ M8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z M(#$P<'0G/@T*"0D)"0D))FYB'0M86QI9VXZ6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXV+#,P-R9N8G-P.PT*"0D)"3PO=&0^#0H)"0D\ M+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`P,RXV M,B4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUAF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@8V]L6QE/3-$)W=I9'1H.B`Q,BXT-B4[(&)O M3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3I4:6UE3I4 M:6UE6QE/3-$)V1I6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXT+#4R-29N8G-P.PT*"0D)"3PO=&0^#0H)"0D) M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N,#0E.R!B M;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T M(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$ M.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD M+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP('-T>6QE M/3-$)VUA3I4:6UE3I4:6UE6QE/3-$)V1I6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR+#8R-B9N8G-P.PT* M"0D)"3PO=&0^#0H)"0D\+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)VUA'0M86QI9VXZ6QE M/3-$)W=I9'1H.B`Q,"XX,B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$ M)VUAF4Z(#$P<'0G/@T*"0D) M"0D))FYB3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE M/3-$)W=I9'1H.B`P,2XY-B4[(&)O6QE/3-$)W=I9'1H.B`P,BXW,B4[(&)O3I4:6UE6QE/3-$9FQO870Z;&5F=#X\+V1I=CXT.2XT)29N8G-P M.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,#,N,#0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y M.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O M;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C M1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG.B`P M<'0[)SX-"@D)"0D)/'`@F4Z(#$P<'0G M/@T*"0D)"0D))FYB'0M86QI9VXZ6QE/3-$)W=I9'1H.B`Q,"XR,B4[(&)O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE M/3-$)VUAF4Z(#%P="<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[9F]N="US:7IE.C%P=#LG/B9N8G-P.SPO9F]N=#X\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE M/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M)FYB3I4:6UE6QE/3-$)VUA6QE/3-$)W=I9'1H M.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$ M)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB M3I4:6UE6QE/3-$)W=I9'1H.B`U,2XT,B4[(&)O'0M86QI9VXZ8V5N M=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O M;G0M=V5I9VAT.F)O;&0[)SY4:')E92!-;VYT:',@16YD960@/"]F;VYT/CQB M6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,2XY M,"4[(&)O3I4:6UE3I4:6UE6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@ M:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SXF;F)S<#L\+V9O;G0^/"]P/@T* M"0D)"3PO=&0^#0H)"0D)/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,#`N,#(E.R!B;W)D97(M=&]P.B`Q<'0@3I4:6UE6QE/3-$)V1I6QE/3-$)W=I M9'1H.B`P,2XY,"4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SXR,#$S/"]F;VYT M/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@F4Z(#$P<'0G/@T*"0D)"0D) M)FYB3I4:6UE M6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O M'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[ M)SXR,#$S/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`U M,2XT,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^0F%S:6,Z/"]F;VYT/CPO<#X-"@D)"0D\ M+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4 M:6UE'0M M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D) M)FYB3I4:6UE'0M86QI9VXZ6QE/3-$)W=I M9'1H.B`P."XX,B4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D))FYB3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z M(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE M.R<^3G5M97)A=&]R.CPO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE M/3-$)VUA3I4 M:6UE'0M86QI M9VXZ6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O M3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P M,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`U,2XT,B4[(&)O6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O'0M86QI9VXZ6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR,#4F;F)S<#L- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`P."XX,B4[(&)O6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D) M/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^ M#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`P."XX,B4[(&)O6QE/3-$ M)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O M6QE/3-$)W=I9'1H.B`U,2XT,B4[(&)O6QE/3-$)VUA3I4:6UEF4Z(#$P M<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA M6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O M3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)VUA3I4:6UEF4Z(#$P<'0G/@T*"0D) M"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE M/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY M,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D) M)FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O3I4:6UEF4Z M(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$ M)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[ M(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O6QE/3-$)W=I9'1H.B`P,2XY M,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE M6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXQ."PT,S8F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT M9"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY M,"4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O6QE/3-$)W=I9'1H.B`P M,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4 M:6UE6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXQ.2PS,3`F;F)S<#L-"@D)"0D\+W1D/@T*"0D) M/"]T6QE M/3-$)W=I9'1H.B`U,2XT,B4[(&)O6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O3I4:6UE'0M86QI9VXZ6QE/3-$ M)W=I9'1H.B`P."XX,B4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA M6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE'0M M86QI9VXZ6QE/3-$)VUAF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^ M3F5T(&EN8V]M92!P97(@6QE/3-$ M)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^ M)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M('1E>'0M86QI9VXZ(')I9VAT.R<@;F]WF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$9FQO M870Z;&5F=#X\+V1I=CXP+C`Q)FYB6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O3I4:6UE'0M86QI9VXZ6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XX M,B4[(&)O3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)W=I9'1H.B`U,2XT,B4[(&)O M6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I M9'1H.B`P,2XY,"4[(&)O3I4:6UE M'0M86QI9VXZ M6QE/3-$)W=I9'1H.B`P."XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE M/3-$)VUA3I4 M:6UEF4Z(#$P<'0G/@T*"0D)"0D) M)FYB6QE/3-$)VUA'0M86QI9VXZ3I4:6UE6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`P,2XY,"4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O'0M86QI9VXZ6QE/3-$ M)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB MF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D) M)FYB3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H M.B`U,2XT,B4[(&)O6QE/3-$)V1I6QE/3-$)VUA'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE'0M M86QI9VXZ6QE/3-$)W=I9'1H.B`P,2XY,"4[ M(&)O3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`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`P,2XY,"4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M."XX,B4[(&)O6QE/3-$)W=I9'1H.B`U,2XT M,B4[(&)O6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE M/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z M(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$ M)VUA3I4:6UE M'0M86QI9VXZ M6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE M/3-$)VUA3I4 M:6UE'0M86QI M9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O MF4Z(#$P<'0G/@T*"0D)"0D))FYB3H@:6YL:6YE.R<^1&5N;VUI;F%T;W(Z/"]F;VYT/CPO<#X-"@D) M"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H M.B`P."XX,B4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I M9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`U,2XT,B4[(&)O6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ.2PY-S`F;F)S<#L- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O'0M M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[ M(&)O6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T* M"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D))FYB3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W3I4:6UE6QE M/3-$)VUA3I4 M:6UE6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXQ.2PS,3`F;F)S<#L-"@D)"0D\+W1D/@T*"0D) M/"]T6QE M/3-$)W=I9'1H.B`U,2XT,B4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$ M)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D))FYB6QE/3-$9FQO870Z;&5F=#X\+V1I=CXU,C@F;F)S<#L-"@D) M"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@F4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)W=I M9'1H.B`P,2XY,"4[(&)O3I4:6UE M'0M86QI9VXZ M6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA3H@:6YL:6YE.R<^5V5I9VAT960@879E6QE/3-$)W=I9'1H.B`P,2XY,"4[ M(&)OF4Z(#$P<'0G/@T*"0D)"0D) M)FYB6QE/3-$9FQO870Z;&5F=#X\+V1I=CXW-R9N8G-P.PT*"0D)"3PO=&0^#0H) M"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N.3`E M.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@ M,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O M=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D:6YG.B`P<'0[)SX-"@D)"0D)/'`@ M3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4:6UE M'0M86QI M9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O M3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P M."XX,B4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)V1I6QE/3-$)VUA3I4:6UE6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O3I4:6UE'0M86QI9VXZ6QE/3-$)W=I9'1H M.B`P."XX,B4[(&)O3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I M9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$ M9FQO870Z;&5F=#X\+V1I=CXR,"PU-C,F;F)S<#L-"@D)"0D\+W1D/@T*"0D) M"3QT9"!V86QI9VX],T1B;W1T;VT@F4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA3I4:6UE6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)FYB6QE/3-$)VUA3I4:6UE6QE/3-$)VUA'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX M,B4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$)VUA3I4:6UE'0M86QI9VXZ6QE/3-$)W=I M9'1H.B`P,2XY,"4[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O'0M86QI9VXZ#(P,30[ M9&EL=71E9#H\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#$N.3`E.R!B;W)D97(M=&]P M.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y M1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C M0T-&1D9&.R!P861D:6YG.B`P<'0[)SX-"@D)"0D)/'`@F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X- M"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XX M,B4[(&)O3I4:6UE6QE/3-$)VUA3I4:6UE6QE/3-$ M)V1I3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W M6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)O'0M86QI9VXZ6QE/3-$9FQO870Z;&5F=#X\+V1I=CXP+C(S M)FYB6QE/3-$)W=I9'1H.B`P,2XY,"4[(&)OF4Z(#$P<'0G/@T*"0D) M"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P."XX,B4[(&)O M3I4:6UE6QE/3-$)V1I&-L=61E9"!&3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA6QE M/3-$)W=I9'1H.B`P,BXS."4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE M/3-$)VUA6QE/3-$)W=I9'1H.B`Q,RXU,"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)VUAF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^ M)FYB3I4:6UE6QE/3-$)V1I6QE/3-$)VUA6QE/3-$)W=I9'1H.B`R.2XS-B4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`Q,RXU,"4[(&)O'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SXR,#$R M/"]F;VYT/CPO<#X-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1T;W`@ M3I4:6UE6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q,RXU,"4[(&)O'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF M;VYT+7-I>F4Z(#$P<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O;&0[)SXR,#$R/"]F;VYT/CPO<#X- M"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1T;W`@3I4:6UE M6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`Q,RXU,"4[(&)O6QE/3-$ M)VUA6QE/3-$ M)W=I9'1H.B`P,BXS."4[(&)O3I4 M:6UE3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB'0M86QI9VXZ8V5N=&5R.V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#$P<'0G/@T*"0D) M"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q,RXT."4[(&)O6QE/3-$)VUA3I4:6UE6QE/3-$)V1I6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ+#0X M-"9N8G-P.PT*"0D)"3PO=&0^#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@,#(N,S@E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C M1#E$.40Y.R!B;W)D97(M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R M+6)O='1O;3H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@ M;F]N92`C1#E$.40Y.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-&1D9&.R!P861D M:6YG.B`P<'0[)SX-"@D)"0D)/'`@3I4:6UE6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ,C6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`Q,RXU,"4[(&)O6QE/3-$)VUA M6QE/3-$)W=I9'1H.B`Q,RXT."4[(&)O M6QE/3-$)VUA M6QE/3-$)W=I9'1H.B`Q,RXU M,"4[(&)O3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@ M;F]W6QE/3-$)W=I9'1H.B`P,BXS."4[(&)O3I4:6UE6QE/3-$)W=I9'1H M.B`P,BXS."4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA6QE/3-$)W=I9'1H.B`R M,RXS."4[(&)O3I4:6UEF4Z(#$P<'0G/@T* M"0D)"0D))FYB6QE/3-$)VUA6QE/3-$ M)W=I9'1H.B`R,RXS."4[(&)O3I4 M:6UE6QE/3-$)W=I9'1H.B`T,2XW-B4[(&)O6QE/3-$)VUA6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P M,RXX,B4[(&)O3I4:6UE'0M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#EP="<^#0H)"0D)"0D\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT M+7-I>F4Z.7!T.R<^07,@;V8\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D\ M+W1R/@T*"0D)/'1R/@T*"0D)"3QT9"!V86QI9VX],T1T;W`@3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,"XP,B4[(&)O M6QE M/3-$)VUA6QE/3-$)V1I6QE/3-$)W=I M9'1H.B`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`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M M;&5F=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T('-O M;&ED(",P,#`P,#`[(&)O'0M86QI9VXZ6QE/3-$)W=I9'1H.B`R,RXS."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXR-S@F;F)S<#L-"@D)"0D\+W1D M/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@F4Z(#$P<'0G/@T*"0D)"0D))FYB'0M86QI9VXZ6QE/3-$)W=I9'1H.B`R,RXS."4[(&)O6QE/3-$9FQO870Z;&5F=#X\+V1I=CXS-#(F;F)S<#L-"@D)"0D\ M+W1D/@T*"0D)/"]T6QE/3-$)W=I9'1H.B`T,2XW-B4[(&)O3H@ M:6YL:6YE.R<^5&]T86P\+V9O;G0^/"]P/@T*"0D)"3PO=&0^#0H)"0D)/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#,N.#(E.R!B;W)D M97(M=&]P.B`Q<'0@F4Z(#$P<'0G/@T*"0D)"0D)/&9O M;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\+W`^#0H) M"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`R,RXS."4[(&)O6QE/3-$)W=I9'1H.B`P,RXX,B4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D) M"0D)/&9O;G0@3H@:6YL:6YE.R<^)#PO9F]N=#X\ M+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`R,RXS."4[(&)O6QE/3-$)VUAF4Z(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.R<^)FYBF4],T0Q/B`\+V9O;G0^/"]P/@T*"3PO9&EV/B`\+V1I=CX\ M3I4:6UE3H@:6YL:6YE.V9O;G0M6QE/3-$)VUA6QE/3-$)W=I9'1H.B`P,BXV-"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-2XU-"4[ M(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I M9'1H.B`P,BXV-"4[(&)O3I4:6UE MF4Z(#$P<'0G/@T* M"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYB3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,"XP,B4[ M(&)O6QE/3-$)VUA6QE/3-$)V1I6QE/3-$)W=I9'1H.B`P,BXV-"4[(&)O3I4:6UE3I4:6UE3H@:6YL:6YE.V9O;G0M=V5I9VAT.F)O M;&0[9F]N="US:7IE.CEP=#LG/DYI;F4@36]N=&AS($5N9&5D(%-E<'1E;6)E M3I4:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O'0M M86QI9VXZ8V5N=&5R.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT M+7-I>F4Z(#EP="<^#0H)"0D)"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z.7!T.R<^,C`Q,CPO M9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P,BXV-"4[(&)O6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-2XU M-"4[(&)O'0M86QI9VXZ8V5N=&5R.V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z(#EP="<^#0H)"0D) M"0D\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[9F]N="UW96EG:'0Z M8F]L9#MF;VYT+7-I>F4Z.7!T.R<^,C`Q,SPO9F]N=#X\+W`^#0H)"0D)/"]T M9#X-"@D)"0D\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`P M,BXV-"4[(&)O3I4:6UE6QE/3-$)VUA6QE/3-$)V1I3I4:6UE6QE/3-$ M)VUA6QE/3-$)V1I6QE/3-$)W=I M9'1H.B`R.2XY,B4[(&)OF4Z(#$P<'0G M/@T*"0D)"0D))FYB6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O6QE/3-$ M)VUA6QE/3-$)W=I9'1H.B`P,BXV-"4[ M(&)O3I4:6UE3I4:6UEF4Z(#$P<'0G/@T*"0D)"0D))FYBF4Z(#$P<'0G/@T*"0D)"0D))FYB M6QE M/3-$)VUA3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4:6UE6QE/3-$9FQO870Z;&5F=#X\+V1I=CXQ."4F;F)S<#L-"@D)"0D\+W1D/@T* M"0D)"3QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)VUA6QE/3-$)W=I9'1H M.B`Q-2XU-"4[(&)O6QE/3-$)W=I9'1H.B`P,BXV-"4[(&)OF4Z(#$P M<'0G/@T*"0D)"0D))FYB3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]WF4Z(#$P M<'0G/@T*"0D)"0D)/&9O;G0@3H@:6YL:6YE.R<^ M5V5L;%!O:6YT("@Q*3PO9F]N=#X\+W`^#0H)"0D)/"]T9#X-"@D)"0D\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE M/3-$)W=I9'1H.B`Q-2XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA M6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O M3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O6QE/3-$ M)W=I9'1H.B`P,BXV-"4[(&)OF4Z(#$P<'0G/@T*"0D)"0D))FYB M3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT.R<@;F]W3I4:6UE6QE/3-$9FQO870Z;&5F=#X\+V1I M=CXQ,R4F;F)S<#L-"@D)"0D\+W1D/@T*"0D)"3QT9"!V86QI9VX],T1B;W1T M;VT@6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O6QE/3-$)VUA6QE/3-$9FQO870Z;&5F=#X\+V1I=CXW)29N8G-P.PT*"0D)"3PO=&0^ M#0H)"0D)/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,#(N M-C0E.R!B;W)D97(M=&]P.B`Q<'0@;F]N92`C1#E$.40Y.R!B;W)D97(M;&5F M=#H@,7!T(&YO;F4@(T0Y1#E$.3L@8F]R9&5R+6)O='1O;3H@,7!T(&YO;F4@ M(T0Y1#E$.3L@8F]R9&5R+7)I9VAT.B`Q<'0@;F]N92`C1#E$.40Y.R!B86-K M9W)O=6YD+6-O;&]R.B`C875T;SL@<&%D9&EN9SH@,'!T.R<^#0H)"0D)"3QP M('-T>6QE/3-$)VUA6QE/3-$)W=I9'1H M.B`Q-2XU-"4[(&)O3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M.R<@;F]W6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-2XU-"4[(&)O3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT.R<@;F]W6QE/3-$)W=I9'1H.B`P M,BXV-"4[(&)O3I4:6UEF4Z M(#$P<'0G/@T*"0D)/&9O;G0@3H@:6YL:6YE.R<^ M)FYBF4Z,3!P=#LG/B`H,2D\+V9O;G0^#0H)"0D\ M+W`^#0H)"3PO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1T;W`^#0H) M"0D\<"!S='EL93TS1"=B;W)D97(M8F]T=&]M.C%P="!N;VYE("-$.40Y1#D@ M.VQI;F4M:&5I9VAT.C$Q-24[9F]N="UF86UI;'DZ0V%L:6)R:3MF;VYT+7-I M>F4Z(#$P<'0[;6%R9VEN.C!P=#LG/@T*"0D)/&9O;G0@3H@:6YL:6YE.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT M+7-I>F4Z,3!P=#LG/E=E;&QP;VEN="!A;'-O(&EN8VQU9&5S(&]T:&5R(&-A M3H@:6YL:6YE.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;CMF;VYT+7-I>F4Z,3!P=#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X\+W1R M/CPO=&%B;&4^/"]D:78^#0H)"3QD:78@6QE/3-$)VUA3I#86QI8G)I.V9O;G0M6QE/3-$)V1I3I4:6UE6QE/3-$=VED=&@Z,3`P M)3X\=&%B;&4@6QE/3-$)W=I9'1H.B`S-BXP,'!T.R!D:7-P;&%Y.B!I;FQI M;F4[)SX-"@D)"3QP('-T>6QE/3-$)V)O3I#86QI8G)I.V9O M;G0M6QE/3-$)V1I3I4:6UE3H@:6YL:6YE.V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/B9N8G-P.SPO M9F]N=#X-"@D)/"]P/@T*"0D\<#X\9F]N="!S:7IE/3-$,3X@/"]F;VYT/CPO M<#X-"@D\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]B-S,T960W-E]F8C)F7S0Y-V9?83!A-U\T-3$U-6(S M8C$U.3,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M2!/9B!"=7-I;F5S7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!M87)K970@ M9G5N9',\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]B-S,T960W-E]F8C)F7S0Y-V9?83!A-U\T-3$U-6(S M8C$U.3,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA&-E<'0@4VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!E;7!L;WEE97,@=&\@2!T87@@=VET:&AO;&1I;F=S/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A2!;06)S M=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!);F-E;G1I=F4@4&QA;B!W87,@875T;VUA=&EC86QL>2!I M;F-R96%S960@<'5R2!);F-E;G1I=F4@4&QA;BX\+W1D/@T*("`@("`@/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E8W1E9"!T;R!V97-T M(&%T(%-E<'1E;6)E'0^)SQS<&%N/CPO&5R8VES92!0&5R8VES86)L92!A="!397!T96UB M97(@,S`L(#(P,3,\+W1D/@T*("`@("`@("`\=&0@8VQA7,\'0^)S0@>65A'0^)SQS<&%N/CPO7,\'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA2`H4V-H M961U;&4@3V8@4F5S=')I8W1E9"!3=&]C:R!5;FET($%C=&EV:71Y(%5N9&5R M(%-T;V-K(%!L86YS*2`H1&5T86EL'0^)S(@>65A'0^)S(@>65A7,\2!T M:&4@;G5M8F5R(&]F(')E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]B-S,T960W-E]F8C)F7S0Y-V9?83!A-U\T-3$U-6(S8C$U.3,-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8C'0O:'1M;#L@8VAA&-E<'0@4VAA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2`H4V-H961U;&4@3V8@1F%I2!; M06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'!E8W1E9"!T97)M/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG-"!Y96%R'0^)S0@>65A'0^)S0@>65A7,\6EE;&0\+W1D/@T*("`@("`@ M("`\=&0@8VQA3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]B-S,T960W-E]F8C)F7S0Y-V9?83!A-U\T-3$U M-6(S8C$U.3,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^)SQS M<&%N/CPO'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD M(#$L.30U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B-S,T960W-E]F8C)F7S0Y-V9?83!A M-U\T-3$U-6(S8C$U.3,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M8C'0O:'1M;#L@8VAA M'!E;G-E($)Y($]P97)A=&EN9R!& M=6YC=&EO;BD@*$1E=&%I;',I("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!U M;FQEF5D(%!E'0^)SQS M<&%N/CPO'!E;G-E/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L.30U/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPOF5D(%!E'0^)SQS<&%N/CPO'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY,CQS M<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]B-S,T960W-E]F8C)F7S0Y-V9?83!A-U\T-3$U-6(S8C$U.3,- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R&5S("A$971A:6QS*2`H55-$("0I/&)R/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&-E'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^ M)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B M-S,T960W-E]F8C)F7S0Y-V9?83!A-U\T-3$U-6(S8C$U.3,-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8C'0O:'1M;#L@8VAA'0^)SQS M<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO M2!5;FET961(96%L=&AC M87)E+CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$:6YN M97)&;V]T;F]T93X-"B`@("`@("`@/'1D('9A;&EG;CTS1'1O<#Y;,UT\+W1D M/@T*("`@("`@("`\=&0@8V]L XML 31 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 60 165 1 true 17 0 false 6 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://www.ehealthinsurance.com/role/DocumentDocumentAndEntityInformation Document And Entity Information true false R2.htm 00100 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.ehealthinsurance.com/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets false false R3.htm 00200 - Statement - Condensed Consolidated Statements Of Comprehensive Income Sheet http://www.ehealthinsurance.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncome Condensed Consolidated Statements Of Comprehensive Income false false R4.htm 00400 - Statement - Condensed Consolidated Statements Of Cash Flows Sheet http://www.ehealthinsurance.com/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements Of Cash Flows false false R5.htm 10101 - Disclosure - Summary Of Business And Significant Accounting Policies Sheet http://www.ehealthinsurance.com/role/DisclosureSummaryOfBusinessAndSignificantAccountingPolicies Summary Of Business And Significant Accounting Policies false false R6.htm 10201 - Disclosure - Cash, Cash Equivalents And Accounts Receivable Sheet http://www.ehealthinsurance.com/role/DisclosureCashCashEquivalentsAndAccountsReceivable Cash, Cash Equivalents And Accounts Receivable false false R7.htm 10301 - Disclosure - Stockholders' Equity Sheet http://www.ehealthinsurance.com/role/DisclosureStockholdersEquity Stockholders' Equity false false R8.htm 10401 - Disclosure - Income Taxes Sheet http://www.ehealthinsurance.com/role/DisclosureIncomeTaxes Income Taxes false false R9.htm 10501 - Disclosure - Net Income Per Share Sheet http://www.ehealthinsurance.com/role/DisclosureNetIncomePerShare Net Income Per Share false false R10.htm 10601 - Disclosure - Geographic Information And Significant Customers Sheet http://www.ehealthinsurance.com/role/DisclosureGeographicInformationAndSignificantCustomers Geographic Information And Significant Customers false false R11.htm 20102 - Disclosure - Summary Of Business And Significant Accounting Policies (Policy) Sheet http://www.ehealthinsurance.com/role/DisclosureSummaryOfBusinessAndSignificantAccountingPoliciesPolicy Summary Of Business And Significant Accounting Policies (Policy) false false R12.htm 30203 - Disclosure - Cash, Cash Equivalents And Accounts Receivable (Tables) Sheet http://www.ehealthinsurance.com/role/DisclosureCashCashEquivalentsAndAccountsReceivableTables Cash, Cash Equivalents And Accounts Receivable (Tables) false false R13.htm 30303 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.ehealthinsurance.com/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) false false R14.htm 30403 - Disclosure - Income Taxes (Tables) Sheet http://www.ehealthinsurance.com/role/DisclosureIncomeTaxesTables Income Taxes (Tables) false false R15.htm 30503 - Disclosure - Net Income Per Share (Tables) Sheet http://www.ehealthinsurance.com/role/DisclosureNetIncomePerShareTables Net Income Per Share (Tables) false false R16.htm 30603 - Disclosure - Geographic Information And Significant Customers (Tables) Sheet http://www.ehealthinsurance.com/role/DisclosureGeographicInformationAndSignificantCustomersTables Geographic Information And Significant Customers (Tables) false false R17.htm 40101 - Disclosure - Summary Of Business And Significant Accounting Policies (Details) Sheet http://www.ehealthinsurance.com/role/DisclosureSummaryOfBusinessAndSignificantAccountingPoliciesDetails Summary Of Business And Significant Accounting Policies (Details) false false R18.htm 40202 - Disclosure - Cash, Cash Equivalents And Accounts Receivable (Schedule Of Cash And Cash Equivalents) (Details) Sheet http://www.ehealthinsurance.com/role/DisclosureCashCashEquivalentsAndAccountsReceivableScheduleOfCashAndCashEquivalentsDetails Cash, Cash Equivalents And Accounts Receivable (Schedule Of Cash And Cash Equivalents) (Details) false false R19.htm 40203 - Disclosure - Cash, Cash Equivalents And Accounts Receivable (Schedule Of Accounts Receivable) (Details) Sheet http://www.ehealthinsurance.com/role/DisclosureCashCashEquivalentsAndAccountsReceivableScheduleOfAccountsReceivableDetails Cash, Cash Equivalents And Accounts Receivable (Schedule Of Accounts Receivable) (Details) false false R20.htm 40301 - Disclosure - Stockholders' Equity (Details) Sheet http://www.ehealthinsurance.com/role/DisclosureStockholdersEquityDetails Stockholders' Equity (Details) false false R21.htm 40302 - Disclosure - Stockholders' Equity (Schedule Of Equity Activity) (Details) Sheet http://www.ehealthinsurance.com/role/DisclosureStockholdersEquityScheduleOfEquityActivityDetails Stockholders' Equity (Schedule Of Equity Activity) (Details) false false R22.htm 40303 - Disclosure - Stockholders' Equity (Schedule Of Option Activity Under Stock Plans) (Details) Sheet http://www.ehealthinsurance.com/role/DisclosureStockholdersEquityScheduleOfOptionActivityUnderStockPlansDetails Stockholders' Equity (Schedule Of Option Activity Under Stock Plans) (Details) false false R23.htm 40304 - Disclosure - Stockholders' Equity (Schedule Of Restricted Stock Unit Activity Under Stock Plans) (Details) Sheet http://www.ehealthinsurance.com/role/DisclosureStockholdersEquityScheduleOfRestrictedStockUnitActivityUnderStockPlansDetails Stockholders' Equity (Schedule Of Restricted Stock Unit Activity Under Stock Plans) (Details) false false R24.htm 40305 - Disclosure - Stockholders' Equity (Schedule Of Stock Repurchase Activity Under Stock Repurchase Programs) (Details) Sheet http://www.ehealthinsurance.com/role/DisclosureStockholdersEquityScheduleOfStockRepurchaseActivityUnderStockRepurchaseProgramsDetails Stockholders' Equity (Schedule Of Stock Repurchase Activity Under Stock Repurchase Programs) (Details) false false R25.htm 40306 - Disclosure - Stockholders' Equity (Schedule Of Fair Value Of Stock Options, Valuation Assumptions) (Details) Sheet http://www.ehealthinsurance.com/role/DisclosureStockholdersEquityScheduleOfFairValueOfStockOptionsValuationAssumptionsDetails Stockholders' Equity (Schedule Of Fair Value Of Stock Options, Valuation Assumptions) (Details) false false R26.htm 40307 - Disclosure - Stockholders' Equity (Schedule Of Stock-Based Compensation Expense) (Details) Sheet http://www.ehealthinsurance.com/role/DisclosureStockholdersEquityScheduleOfStockBasedCompensationExpenseDetails Stockholders' Equity (Schedule Of Stock-Based Compensation Expense) (Details) false false R27.htm 40308 - Disclosure - Stockholders' Equity (Schedule Of Stock-Based Compensation Expense By Operating Function) (Details) Sheet http://www.ehealthinsurance.com/role/DisclosureStockholdersEquityScheduleOfStockBasedCompensationExpenseByOperatingFunctionDetails Stockholders' Equity (Schedule Of Stock-Based Compensation Expense By Operating Function) (Details) false false R28.htm 40401 - Disclosure - Income Taxes (Details) Sheet http://www.ehealthinsurance.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) false false R29.htm 40501 - Disclosure - Net Income Per Share (Schedule Of Computation Of Basic And Diluted Net Income Per Share) (Details) Sheet http://www.ehealthinsurance.com/role/DisclosureNetIncomePerShareScheduleOfComputationOfBasicAndDilutedNetIncomePerShareDetails Net Income Per Share (Schedule Of Computation Of Basic And Diluted Net Income Per Share) (Details) false false R30.htm 40502 - Disclosure - Net Income Per Share (Schedule Of Anti-dilutive Shares Excluded From Computation Of Net Income Per Share) (Details) Sheet http://www.ehealthinsurance.com/role/DisclosureNetIncomePerShareScheduleOfAntiDilutiveSharesExcludedFromComputationOfNetIncomePerShareDetails Net Income Per Share (Schedule Of Anti-dilutive Shares Excluded From Computation Of Net Income Per Share) (Details) false false R31.htm 40601 - Disclosure - Geographic Information And Significant Customers (Details) Sheet http://www.ehealthinsurance.com/role/DisclosureGeographicInformationAndSignificantCustomersDetails Geographic Information And Significant Customers (Details) false false R32.htm 40602 - Disclosure - Geographic Information And Significant Customers (Schedule Of Long Lived Assets By Geographical Areas) (Details) Sheet http://www.ehealthinsurance.com/role/DisclosureGeographicInformationAndSignificantCustomersScheduleOfLongLivedAssetsByGeographicalAreasDetails Geographic Information And Significant Customers (Schedule Of Long Lived Assets By Geographical Areas) (Details) false false R33.htm 40603 - Disclosure - Geographic Information And Significant Customers (Schedule Of Revenue By Major Customers) (Details) Sheet http://www.ehealthinsurance.com/role/DisclosureGeographicInformationAndSignificantCustomersScheduleOfRevenueByMajorCustomersDetails Geographic Information And Significant Customers (Schedule Of Revenue By Major Customers) (Details) false false All Reports Book All Reports 'Monetary' elements on report '40401 - Disclosure - Income Taxes (Details)' had a mix of different decimal attribute values. Process Flow-Through: 00100 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: Removing column 'Sep. 30, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 00200 - Statement - Condensed Consolidated Statements Of Comprehensive Income Process Flow-Through: 00400 - Statement - Condensed Consolidated Statements Of Cash Flows ehth-20130930.xml ehth-20130930.xsd ehth-20130930_cal.xml ehth-20130930_def.xml ehth-20130930_lab.xml ehth-20130930_pre.xml true true XML 32 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements Of Comprehensive Income (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Revenue        
Commission $ 36,000 $ 31,291 $ 109,193 $ 93,358
Other 6,008 6,295 15,822 16,810
Total revenue 42,008 37,586 125,015 110,168
Operating costs and expenses:        
Cost of revenue 806 1,099 4,441 3,538
Marketing and advertising 14,852 13,988 43,448 39,142
Customer care and enrollment 8,936 8,823 23,914 21,152
Technology and content 9,117 5,503 23,585 16,018
General and administrative 7,540 6,744 22,191 19,938
Amortization of intangible assets 354 354 1,061 1,261
Total operating costs and expenses 41,605 36,511 118,640 101,049
Income from operations 403 1,075 6,375 9,119
Other income (expense), net (22) 4 (68) 41
Income before provision for income taxes 381 1,079 6,307 9,160
Provision for income taxes 207 874 2,626 4,525
Net income 174 205 3,681 4,635
Net Income Per Share:        
Basic $ 0.01 $ 0.01 $ 0.19 $ 0.24
Diluted $ 0.01 $ 0.01 $ 0.18 $ 0.23
Weighted-average number of shares used in per share amounts:        
Basic 18,436 19,970 19,310 19,711
Diluted 19,096 20,750 19,912 20,563
Comprehensive income:        
Foreign currency translation adjustment (7) 3 (25) 1
Comprehensive income $ 167 $ 208 $ 3,656 $ 4,636
XML 33 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Tables)
9 Months Ended
Sep. 30, 2013
Income Taxes [Abstract]  
Summary Of Provision For Income Taxes And Effective Tax Rates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

Income before provision for income taxes

$

1,079 

 

$

381 

 

$

9,160 

 

$

6,307 

Provision for income taxes

$

874 

 

$

207 

 

$

4,525 

 

$

2,626 

Effective tax rate

 

81.0% 

 

 

54.3% 

 

 

49.4% 

 

 

41.6% 

 

XML 34 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary Of Business And Significant Accounting Policies
9 Months Ended
Sep. 30, 2013
Summary Of Business And Significant Accounting Policies [Abstract]  
Summary Of Business And Significant Accounting Policies

 

Note 1 - Summary of Business and Significant Accounting Policies

 

Description of BusinesseHealth, Inc. (the “Company,” “eHealth,” “we” or “us”) is the leading online source of health insurance for individuals, families and small businesses in the United States. Through our website addresses (www.eHealth.com,  www.eHealthInsurance.com,  www.eHealthMedicare.com and www.PlanPrescriber.com), consumers can get quotes from leading health insurance carriers, compare plans side-by-side, and apply for and purchase individual and family, Medicare-related, small business and ancillary health insurance plans. We actively market the availability of Medicare-related insurance plans and offer Medicare plan comparison tools and educational materials for Medicare-related insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans.  Our ecommerce technology also enables us to deliver consumers’ health insurance applications electronically to health insurance carriers. As a result, we simplify and streamline the complex and traditionally paper-intensive health insurance sales and purchasing process. We are licensed to market and sell health insurance in all 50 states and the District of Columbia. 

 

Basis of Presentation—The accompanying condensed consolidated balance sheet as of September 30, 2013, the condensed consolidated statements of comprehensive income for the three and nine months ended September 30, 2012 and 2013 and the condensed consolidated statements of cash flows for the nine months ended September 30, 2012 and 2013, respectively, are unaudited. The condensed consolidated balance sheet data as of December 31, 2012 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2012, which was filed with the Securities and Exchange Commission on March 13, 2013. The accompanying statements should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K.  

 

The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or U.S. GAAP, for interim financial information. Accordingly, they do not include all of the financial information and footnotes required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2012, and include all adjustments necessary for the fair presentation of eHealth’s statement of financial position as of September 30, 2013, its results of operations for the three and nine months ended September 30, 2012 and 2013 and its cash flows for the nine months ended September 30, 2012 and 2013. All adjustments are of a normal recurring nature. The results for the three and nine months ended September 30, 2013 are not necessarily indicative of the results to be expected for any subsequent period or for the fiscal year ending December 31, 2013.  

 

Seasonality—The number of individual and family health insurance applications submitted through our ecommerce platform has generally increased in our first quarter compared to our fourth quarter and in our third quarter compared to our second quarter. Conversely, we have generally experienced a decline or flattening of individual and family submitted applications in our second quarter compared to our first quarter and in our fourth quarter compared to our third quarter. This seasonality could change in the fourth quarter of 2013 as a result of the initial open enrollment period under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act, which began on October 1, 2013 and is scheduled to run through March 31, 2014.

 

The majority of Medicare plans are sold in our fourth quarter during the Medicare annual enrollment period, when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, we generate a significant amount of Medicare plan-related revenue in the fourth quarter of the year resulting from the sale of new Medicare plans. Additionally, we recognize a majority of our renewal Medicare Advantage and Medicare Part D prescription drug plan commission revenue in the first quarter of each year as the majority of policies sold during the annual enrollment period typically renew on January 1 of each year.

 

Since a significant portion of our marketing and advertising expenses are driven by the number of health insurance applications submitted on our ecommerce platform, those expenses are influenced by these patterns. As a result, marketing and advertising expenses related to individual and family health insurance plans have been highest in our first and third quarters, while marketing and advertising expenses related to Medicare-related plans have been highest in our third and fourth quarters. However, the historical trend of marketing and advertising expenses related to individual and family health insurance plans could be impacted by the initial open enrollment period for individual and family plans that began on October 1, 2013. 

 

Additionally, in preparation for the Medicare annual enrollment period, and to a lesser extent the initial open enrollment period for individual and family plans, we begin ramping up our customer care center staff during our second and third quarters to handle the anticipated increased volume of health insurance transactions during the fourth quarter. Accordingly, our customer care center staffing costs are significantly higher in our third and fourth quarters compared to our first and second quarters.

 

Recently Adopted Accounting Standards—Effective January 1, 2013, we adopted an accounting standards update with new guidance on the presentation of reclassifications from accumulated other comprehensive income to net income. This standard requires an entity to present reclassifications from accumulated other comprehensive income to net income either on the face of the condensed consolidated financial statements or in the notes to the condensed consolidated financial statements. In the nine months ended September 30, 2013 we did not have any reclassifications from accumulated other comprehensive income to net income.

 

XML 35 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2013
Dec. 31, 2012
Current Assets:    
Cash and cash equivalents $ 97,751 $ 140,849
Accounts receivable 6,599 4,468
Deferred income taxes 7,115 4,098
Prepaid expenses and other current assets 6,720 6,643
Total current assets 118,185 156,058
Property and equipment, net 10,677 6,185
Deferred income taxes 4,198 2,928
Other assets 6,082 8,123
Intangible assets, net 7,850 8,911
Goodwill 14,096 14,096
Total assets 161,088 196,301
Current Liabilities:    
Accounts payable 4,230 6,123
Accrued compensation and benefits 10,764 8,244
Accrued marketing expenses 3,746 3,941
Deferred revenue 4,353 926
Other current liabilities 2,969 1,575
Total current liabilities 26,062 20,809
Non-current liabilities 6,222 4,625
Stockholders' equity:    
Common stock 28 27
Additional paid-in capital 246,190 232,903
Treasury stock, at cost (149,998) [1] (90,991) [1]
Retained earnings 32,424 28,743
Accumulated other comprehensive income 160 185
Total stockholders' equity 128,804 170,867
Total liabilities and stockholders' equity $ 161,088 $ 196,301
[1] Cumulative balances at December 31, 2012 and September 30, 2013 consist of shares repurchased in connection with our stock repurchase program announced on September 10, 2012, as well as previous stock repurchase plans announced in 2011, 2010 and 2008.
XML 36 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Net Income Per Share (Schedule Of Computation Of Basic And Diluted Net Income Per Share) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Net Income Per Share [Abstract]        
Net income allocated to common stock $ 174 $ 205 $ 3,681 $ 4,635
Net weighted average number of common stock shares outstanding 18,436 19,970 19,310 19,711
Net income per share-basic: $ 0.01 $ 0.01 $ 0.19 $ 0.24
Weighted average number of options 528 703 478 750
Weighted average number of restricted stock units 132 77 124 102
Total common stock equivalent shares used in per share calculation 19,096 20,750 19,912 20,563
Net income per share-diluted: $ 0.01 $ 0.01 $ 0.18 $ 0.23
XML 37 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Schedule Of Restricted Stock Unit Activity Under Stock Plans) (Details) (USD $)
In Thousands, unless otherwise specified
9 Months Ended 12 Months Ended
Sep. 30, 2013
Dec. 31, 2012
Stockholders' Equity [Abstract]    
Number Outstanding, Balance outstanding at December 31, 2012 381  
Number Outstanding, Granted 564 [1]  
Number Outstanding, Vested (172)  
Number Outstanding, Cancelled (21) [1]  
Number Outstanding, Balance outstanding at September 30, 2013 752 381
Weighted-Average Remaining Contractual Life (years), Balance outstanding at December 31, 2012 2 years 6 months 18 days 2 years 2 months 19 days
Weighted-Average Remaining Contractual Life (years), Balance outstanding at September 30, 2013 2 years 6 months 18 days 2 years 2 months 19 days
Aggregate Intrinsic Value, Balance outstanding at December 31, 2012 $ 10,464 [2]  
Aggregate Intrinsic Value, Balance outstanding at September 30, 2013 $ 24,248 [2] $ 10,464 [2]
[1] Shares available for grant do not include treasury stock shares that could also become available for grant if we determined to do so.
[2] The aggregate intrinsic value is calculated as eHealth’s closing stock price as of December 31, 2012 and September 30, 2013 multiplied by the number of restricted stock units outstanding as of December 31, 2012 and September 30, 2013, respectively.
XML 38 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2013
Stockholders' Equity [Abstract]  
Schedule Of Shares Available For Grant

 

 

 

Shares Available for Grant (1)

Shares available for grant December 31, 2012

3,982 

Additional shares authorized (2)

818 

Restricted stock units granted

(564)

Options granted

(119)

Restricted stock units cancelled

21 

Options cancelled

72 

Shares available for grant September 30, 2013

4,210 

 

(1)

Shares available for grant do not include treasury stock shares that could also become available for grant if we determined to do so. 

 

(2)

On January 1, 2013, the number of shares authorized for issuance under the 2006 Equity Incentive Plan was automatically increased pursuant to the terms of the 2006 Equity Incentive Plan.   

Schedule Of Option Activity Under Stock Plans

 

 

 

 

 

 

 

 

 

 

 

 

Number of Stock Options

 

Weighted Average Exercise Price

 

Weighted-Average Remaining Contractual Life (years)

 

Aggregate Intrinsic Value (1)

Balance outstanding at December 31, 2012

2,956 

 

$

13.41 

 

3.91 

 

$

41,642 

Granted

119 

 

$

21.18 

 

 

 

 

 

Exercised

(834)

 

$

5.57 

 

 

 

 

 

Cancelled

(72)

 

$

18.52 

 

 

 

 

 

Balance outstanding at September 30, 2013

2,169 

 

$

16.68 

 

4.21 

 

$

33,784 

Vested and expected to vest at September 30, 2013

2,108 

 

$

16.65 

 

4.17 

 

$

32,911 

Exercisable at September 30, 2013

1,389 

 

$

16.14 

 

3.48 

 

$

22,389 

 

(1)

The aggregate intrinsic value is calculated as the difference between eHealth’s closing stock price as of December 31, 2012 and September 30, 2013 and the exercise price of in-the-money options as of those dates. 

 

Schedule Of Restricted Stock Unit Activity Under Stock Plans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number Outstanding

 

Weighted-Average Remaining Contractual Life (years)

 

Aggregate Intrinsic Value (1)

Balance outstanding as of December 31, 2012

381 

 

2.22 

 

$

10,464 

Granted

564 

 

 

 

 

 

Vested

(172)

 

 

 

 

 

Cancelled

(21)

 

 

 

 

 

Balance outstanding as of September 30, 2013

752 

 

2.55 

 

$

24,248 

 

(1)

The aggregate intrinsic value is calculated as eHealth’s closing stock price as of December 31, 2012 and September 30, 2013 multiplied by the number of restricted stock units outstanding as of December 31, 2012 and September 30, 2013, respectively.    

 

Schedule Of Stock Repurchase Activity Under Stock Repurchase Programs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Number of Shares Purchased

 

Average Price Paid per Share (2)

 

Amount of Repurchase

Cumulative balance at December 31, 2012 (1)

6,397,803 

 

$

14.22 

 

$

90,991 

Repurchases of common stock

2,911,466 

 

$

20.27 

 

 

59,007 

Cumulative balance at September 30, 2013 (1)

9,309,269 

 

$

16.11 

 

$

149,998 

 

(1)

Cumulative balances at December 31, 2012 and September 30, 2013 consist of shares repurchased in connection with our stock repurchase program announced on September 10, 2012, as well as previous stock repurchase plans announced in 2011, 2010 and 2008.   

(2)Average price paid per share includes commissions. 

 

Schedule Of Fair Value Of Stock Options, Valuation Assumptions

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

Expected term

 

4.6 years

 

 

4.3 years

 

 

4.7 years

 

 

4.3 years

Expected volatility

 

43.3% 

 

 

39.8% 

 

 

44.3% 

 

 

39.7% 

Expected dividend yield

 

0% 

 

 

0% 

 

 

0% 

 

 

0% 

Risk-free interest rate

 

0.61% 

 

 

1.13% 

 

 

0.90% 

 

 

0.79% 

Weighted-average fair value

$

6.46 

 

$

8.39 

 

$

6.41 

 

$

7.02 

 

Schedule Of Stock-Based Compensation Expense

The following table summarizes stock-based compensation expense recorded during the three and nine months ended September 30, 2012 and 2013 (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

Common stock options

$

717 

 

$

654 

 

$

2,076 

 

$

2,103 

Restricted stock units

 

622 

 

 

1,291 

 

 

2,250 

 

 

3,258 

Total stock-based compensation expense

$

1,339 

 

$

1,945 

 

$

4,326 

 

$

5,361 

 

The following table summarizes stock-based compensation expense by operating function for the three and nine months ended September 30, 2012 and 2013 (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

Marketing and advertising

$

330 

 

$

517 

 

$

932 

 

$

1,446 

Customer care and enrollment

 

90 

 

 

92 

 

 

243 

 

 

261 

Technology and content

 

233 

 

 

425 

 

 

783 

 

 

1,129 

General and administrative

 

686 

 

 

911 

 

 

2,368 

 

 

2,525 

Total stock-based compensation expense

$

1,339 

 

$

1,945 

 

$

4,326 

 

$

5,361 

 

XML 39 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Net Income Per Share (Schedule Of Anti-dilutive Shares Excluded From Computation Of Net Income Per Share) (Details)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 127 1,484 439 1,327
Common Stock Options [Member]
       
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 127 1,484 439 1,327
XML 40 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Geographic Information And Significant Customers (Tables)
9 Months Ended
Sep. 30, 2013
Geographic Information And Significant Customers [Abstract]  
Schedule Of Long Lived Assets By Geographical Areas

 

 

 

 

 

 

 

As of

 

As of

 

December 31, 2012

 

September 30, 2013

 

 

 

 

 

 

United States

$

37,037 

 

$

38,363 

China

 

278 

 

 

342 

Total

$

37,315 

 

$

38,705 

 

Schedule of Revenue by Major Customers

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

Humana

19% 

 

18% 

 

16% 

 

20% 

WellPoint (1)

13% 

 

12% 

 

13% 

 

12% 

UnitedHealthcare (2)

12% 

 

11% 

 

13% 

 

11% 

Aetna (3)

7% 

 

10% 

 

7% 

 

9% 

 

(1)

Wellpoint also includes other carriers owned by Wellpoint. 

(2)

UnitedHealthcare also includes other carriers owned by UnitedHealthcare. 

(3)

Aetna also includes other carriers owned by Aetna. 

 

XML 41 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cash, Cash Equivalents And Accounts Receivable (Tables)
9 Months Ended
Sep. 30, 2013
Cash, Cash Equivalents And Accounts Receivable [Abstract]  
Schedule Of Cash And Cash Equivalents

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2012

 

September 30, 2013

 

 

 

 

 

 

Cash

$

27,484 

 

$

19,632 

Money market funds

 

113,365 

 

 

78,119 

Total cash and cash equivalents

$

140,849 

 

$

97,751 

 

Schedule Of Accounts Receivable

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2012

 

September 30, 2013

 

 

 

 

 

 

Accounts receivable - from other revenues

$

3,319 

 

$

3,340 

Commissions receivable

 

1,149 

 

 

3,259 

Total accounts receivable

$

4,468 

 

$

6,599 

 

XML 42 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity
9 Months Ended
Sep. 30, 2013
Stockholders' Equity [Abstract]  
Stockholders' Equity

 

 

Note 3 – Stockholders’ Equity

 

Stock Plans—The following table summarizes activity under our 2006 Equity Incentive Plan, 1998 Stock Plan and 2005 Stock Plan (collectively, the “Stock Plans”) (in thousands):

 

 

 

Shares Available for Grant (1)

Shares available for grant December 31, 2012

3,982 

Additional shares authorized (2)

818 

Restricted stock units granted

(564)

Options granted

(119)

Restricted stock units cancelled

21 

Options cancelled

72 

Shares available for grant September 30, 2013

4,210 

 

(1)

Shares available for grant do not include treasury stock shares that could also become available for grant if we determined to do so. 

 

(2)

On January 1, 2013, the number of shares authorized for issuance under the 2006 Equity Incentive Plan was automatically increased pursuant to the terms of the 2006 Equity Incentive Plan.   

 

The following table summarizes stock option activity under the Stock Plans (in thousands, except per share amounts and weighted average remaining contractual life data): 

 

 

 

 

 

 

 

 

 

 

 

 

Number of Stock Options

 

Weighted Average Exercise Price

 

Weighted-Average Remaining Contractual Life (years)

 

Aggregate Intrinsic Value (1)

Balance outstanding at December 31, 2012

2,956 

 

$

13.41 

 

3.91 

 

$

41,642 

Granted

119 

 

$

21.18 

 

 

 

 

 

Exercised

(834)

 

$

5.57 

 

 

 

 

 

Cancelled

(72)

 

$

18.52 

 

 

 

 

 

Balance outstanding at September 30, 2013

2,169 

 

$

16.68 

 

4.21 

 

$

33,784 

Vested and expected to vest at September 30, 2013

2,108 

 

$

16.65 

 

4.17 

 

$

32,911 

Exercisable at September 30, 2013

1,389 

 

$

16.14 

 

3.48 

 

$

22,389 

 

(1)

The aggregate intrinsic value is calculated as the difference between eHealth’s closing stock price as of December 31, 2012 and September 30, 2013 and the exercise price of in-the-money options as of those dates. 

 

The total grant date fair value of stock options vested during the three and nine months ended September 30, 2012 was $0.5 million and $1.9 million, respectively. The total grant date fair value of stock options vested during the three and nine months ended September 30, 2013 was $0.7 million and $2.6 million, respectively.

 

 

 

The following table summarizes restricted stock unit activity, including performance-based restricted stock unit activity, under the Stock Plans (in thousands, except weighted average remaining contractual life data): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number Outstanding

 

Weighted-Average Remaining Contractual Life (years)

 

Aggregate Intrinsic Value (1)

Balance outstanding as of December 31, 2012

381 

 

2.22 

 

$

10,464 

Granted

564 

 

 

 

 

 

Vested

(172)

 

 

 

 

 

Cancelled

(21)

 

 

 

 

 

Balance outstanding as of September 30, 2013

752 

 

2.55 

 

$

24,248 

 

(1)

The aggregate intrinsic value is calculated as eHealth’s closing stock price as of December 31, 2012 and September 30, 2013 multiplied by the number of restricted stock units outstanding as of December 31, 2012 and September 30, 2013, respectively.    

 

The fair value of the restricted stock units is based on eHealth’s stock price on the date of grant, and compensation expense related to these awards is recognized on a straight-line basis over the vesting period. The fair value of performance-based restricted stock units is based on eHealth’s stock price on the date of grant, and compensation expense related to these awards is recognized on an accelerated basis over the vesting period. The total grant date fair value of restricted stock units vested during the nine months ended September 30, 2012 was $3.7 million. The total grant date fair value of restricted stock units vested during the three months ended September 30, 2012 was not material. The total grant date fair value of restricted stock units vested during the three and nine months ended September 30, 2013 was $0.2 million and $3.5 million, respectively.

Stock Repurchase Programs—On September 10, 2012, we announced that our board of directors approved a stock repurchase program authorizing us to purchase up to $30 million of our common stock and on March 6, 2013, we announced that our board of directors increased the approved repurchase amount under this program to $60 million. Purchases under this program were made in the open market and complied with Rule 10b-18 under the Securities Exchange Act of 1934, as amended. The cost of the repurchased shares was funded from available working capital. 

For accounting purposes, common stock repurchased under our stock repurchase programs is recorded based upon the settlement date of the applicable trade. Such repurchased shares are held in treasury and are presented using the cost method. 

Stock repurchase activity under our stock repurchase programs during the nine months ended September 30, 2013 is summarized as follows (dollars in thousands, except share and per share amounts): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Number of Shares Purchased

 

Average Price Paid per Share (2)

 

Amount of Repurchase

Cumulative balance at December 31, 2012 (1)

6,397,803 

 

$

14.22 

 

$

90,991 

Repurchases of common stock

2,911,466 

 

$

20.27 

 

 

59,007 

Cumulative balance at September 30, 2013 (1)

9,309,269 

 

$

16.11 

 

$

149,998 

 

(1)

Cumulative balances at December 31, 2012 and September 30, 2013 consist of shares repurchased in connection with our stock repurchase program announced on September 10, 2012, as well as previous stock repurchase plans announced in 2011, 2010 and 2008.   

(2)Average price paid per share includes commissions. 

 

In addition to the shares repurchased under our repurchase programs as of September 30, 2013, we have in treasury 209,925 shares that were previously surrendered by employees to satisfy tax withholdings due in connection with the vesting of certain restricted stock units. As of December 31, 2012 and September 30, 2013, we had a total of 6,556,303 shares and 9,519,194 shares, respectively, held in treasury. 

Stock-Based Compensation—The fair value of stock options granted to employees for the three and nine months ended September 30, 2012 and 2013 was estimated using the following weighted average assumptions: 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

Expected term

 

4.6 years

 

 

4.3 years

 

 

4.7 years

 

 

4.3 years

Expected volatility

 

43.3% 

 

 

39.8% 

 

 

44.3% 

 

 

39.7% 

Expected dividend yield

 

0% 

 

 

0% 

 

 

0% 

 

 

0% 

Risk-free interest rate

 

0.61% 

 

 

1.13% 

 

 

0.90% 

 

 

0.79% 

Weighted-average fair value

$

6.46 

 

$

8.39 

 

$

6.41 

 

$

7.02 

 

The following table summarizes stock-based compensation expense recorded during the three and nine months ended September 30, 2012 and 2013 (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

Common stock options

$

717 

 

$

654 

 

$

2,076 

 

$

2,103 

Restricted stock units

 

622 

 

 

1,291 

 

 

2,250 

 

 

3,258 

Total stock-based compensation expense

$

1,339 

 

$

1,945 

 

$

4,326 

 

$

5,361 

 

The following table summarizes stock-based compensation expense by operating function for the three and nine months ended September 30, 2012 and 2013 (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

Marketing and advertising

$

330 

 

$

517 

 

$

932 

 

$

1,446 

Customer care and enrollment

 

90 

 

 

92 

 

 

243 

 

 

261 

Technology and content

 

233 

 

 

425 

 

 

783 

 

 

1,129 

General and administrative

 

686 

 

 

911 

 

 

2,368 

 

 

2,525 

Total stock-based compensation expense

$

1,339 

 

$

1,945 

 

$

4,326 

 

$

5,361 

 

XML 43 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 44 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Geographic Information And Significant Customers (Schedule Of Revenue By Major Customers) (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Humana [Member]
       
Revenue, Major Customer [Line Items]        
Major customer revenue, percentage 18.00% 19.00% 20.00% 16.00%
WellPoint [Member]
       
Revenue, Major Customer [Line Items]        
Major customer revenue, percentage 12.00% [1] 13.00% [1] 12.00% [1] 13.00% [1]
UnitedHealthcare [Member]
       
Revenue, Major Customer [Line Items]        
Major customer revenue, percentage 11.00% [2] 12.00% [2] 11.00% [2] 13.00% [2]
Aetna [Member]
       
Revenue, Major Customer [Line Items]        
Major customer revenue, percentage 10.00% [3] 7.00% [3] 9.00% [3] 7.00% [3]
[1] Wellpoint also includes other carriers owned by Wellpoint.
[2] UnitedHealthcare also includes other carriers owned by UnitedHealthcare.
[3] Aetna also includes other carriers owned by Aetna.
XML 45 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cash, Cash Equivalents And Accounts Receivable (Schedule Of Accounts Receivable) (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2013
Dec. 31, 2012
Cash, Cash Equivalents And Accounts Receivable [Abstract]    
Accounts receivable - from other revenues $ 3,340 $ 3,319
Commissions receivable 3,259 1,149
Total accounts receivable $ 6,599 $ 4,468
XML 46 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Net Income Per Share (Tables)
9 Months Ended
Sep. 30, 2013
Net Income Per Share [Abstract]  
Schedule Of Computation Of Basic And Diluted Net Income Per Share

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

2012

 

2013

 

2012

 

2013

Basic:

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

Net income allocated to common stock

$

205 

 

$

174 

 

$

4,635 

 

$

3,681 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

Net weighted average number of common stock shares outstanding

 

19,970 

 

 

18,436 

 

 

19,711 

 

 

19,310 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share—basic:

$

0.01 

 

$

0.01 

 

$

0.24 

 

$

0.19 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted:

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

Net income allocated to common stock

$

205 

 

$

174 

 

$

4,635 

 

$

3,681 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

Net weighted average number of common stock shares outstanding

 

19,970 

 

 

18,436 

 

 

19,711 

 

 

19,310 

Weighted average number of options

 

703 

 

 

528 

 

 

750 

 

 

478 

Weighted average number of restricted stock units

 

77 

 

 

132 

 

 

102 

 

 

124 

Total common stock shares used in per share calculation

 

20,750 

 

 

19,096 

 

 

20,563 

 

 

19,912 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share—diluted:

$

0.01 

 

$

0.01 

 

$

0.23 

 

$

0.18 

 

Schedule Of Anti-dilutive Shares Excluded From Computation Of Net Income Per Share

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2012

 

2013

 

2012

 

2013

 

 

 

 

 

 

 

 

Common stock options

1,484 

 

127 

 

1,327 

 

439 

Total

1,484 

 

127 

 

1,327 

 

439 

 

XML 47 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Schedule Of Option Activity Under Stock Plans) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
9 Months Ended 12 Months Ended
Sep. 30, 2013
Dec. 31, 2012
Stockholders' Equity [Abstract]    
Number of Stock Options, Balance outstanding at December 31, 2012 2,956  
Number of Stock Options, Granted 119 [1]  
Number of Stock Options, Exercised (834)  
Number of Stock Options, Cancelled (72) [1]  
Number of Stock Options, Balance outstanding at September 30, 2013 2,169 2,956
Number of Stock Options, Vested and expected to vest at September 30, 2013 2,108  
Number of Stock Options, Exercisable at September 30, 2013 1,389  
Weighted Average Exercise Price, Balance outstanding at December 31, 2012 $ 13.41  
Weighted Average Exercise Price, Granted $ 21.18  
Weighted Average Exercise Price, Exercised $ 5.57  
Weighted Average Exercise Price, Cancelled $ 18.52  
Weighted Average Exercise Price, Balance outstanding at September 30, 2013 $ 16.68 $ 13.41
Weighted Average Exercise Price, Vested and expected to vest at September 30, 2013 $ 16.65  
Weighted Average Exercise Price, Exercisable at September 30, 2013 $ 16.14  
Weighted-Average Remaining Contractual Life (years), Balance outstanding at December 31, 2012 4 years 2 months 16 days 3 years 10 months 28 days
Weighted-Average Remaining Contractual Life (years), Balance outstanding at September 30, 2013 4 years 2 months 16 days 3 years 10 months 28 days
Weighted-Average Remaining Contractual Life (years), Vested and expected to vest at September 30, 2013 4 years 2 months 1 day  
Weighted-Average Remaining Contractual Life (years), Exercisable at September 30, 2013 3 years 5 months 23 days  
Aggregate Intrinsic Value, Balance outstanding at December 31, 2012 $ 41,642 [2]  
Aggregate Intrinsic Value, Balance outstanding at September 30, 2013 33,784 [2] 41,642 [2]
Aggregate Intrinsic Value, Vested and expected to vest at September 30, 2013 32,911 [2]  
Aggregate Intrinsic Value, Exercisable at September 30, 2013 $ 22,389 [2]  
[1] Shares available for grant do not include treasury stock shares that could also become available for grant if we determined to do so.
[2] The aggregate intrinsic value is calculated as the difference between eHealth’s closing stock price as of December 31, 2012 and September 30, 2013 and the exercise price of in-the-money options as of those dates.
XML 48 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Details) (USD $)
In Millions, except Share data, unless otherwise specified
0 Months Ended 3 Months Ended 9 Months Ended
Sep. 10, 2012
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Dec. 31, 2012
Stockholders' Equity [Abstract]            
Total grant date fair value of stock options vested   $ 0.7 $ 0.5 $ 2.6 $ 1.9  
Total grant date fair value of restricted stock units vested   0.2   3.5 3.7  
Stock repurchase program, authorized amount $ 30     $ 60    
Shares surrendered by employees to satisfy tax withholdings   209,925   209,925    
Treasury stock, number of shares held   9,519,194   9,519,194   6,556,303
XML 49 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document And Entity Information
9 Months Ended
Sep. 30, 2013
Oct. 31, 2013
Document And Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2013  
Document Fiscal Year Focus 2013  
Document Fiscal Period Focus Q3  
Trading Symbol EHTH  
Entity Registrant Name eHealth, Inc.  
Entity Central Index Key 0001333493  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Filer Category Accelerated Filer  
Entity Common Stock, Shares Outstanding   18,621,347
XML 50 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Schedule Of Equity Activity) (Details)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2013
Stockholders' Equity [Abstract]  
Shares available for grant December 31, 2012 3,982 [1]
Additional shares authorized 818 [1],[2]
Restricted stock units granted (564) [1]
Options granted (119) [1]
Restricted stock units cancelled 21 [1]
Options cancelled 72 [1]
Shares available for grant September 30, 2013 4,210 [1]
[1] Shares available for grant do not include treasury stock shares that could also become available for grant if we determined to do so.
[2] On January 1, 2013, the number of shares authorized for issuance under the 2006 Equity Incentive Plan was automatically increased pursuant to the terms of the 2006 Equity Incentive Plan.